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Abstract 
The modification of basic sensor platforms, incorporating specially designed materials, 
enhances the capacity for the development of new and improved biosensors. Novel 
transduction strategies employ surface modification technologies as a key element in the 
detection of biologically important molecules. These modiiications can be chemical, 
electrochemical or physical. Surface modification of polymer substrates for blochip 
applications, thin-film deposition of biocompatible surfaces for implants and 
electropolymerisation of electrodes for immunoassay development are the basis of much of 
the research described in t h ~ s  thesis. A number of immunosensing methods were investigated 
for the generahon of improved biosensors for the detection of small haptens, proteins and 
whole cells. These Included fluorescence, chemiluminescence and impedance-based 
detection systems. Microtitre plates, polymer chps, fluorescence-enhancement chips and 
screen-printed electrodes were all examined. The specific targets chosen were Internalin B 
@dB), an mnvasion-associated proteln of Listerla monocytogenes, parvovirus B19, the first 
human parvovirus and warfarin, the ninth most prescribed drug in the world. 
A panel of antibodies and antibody fragments directed against InlB (previously produced) 
was used for the development of fluorescence and impedance-based assays. A recombinant 
form of the InlB protein was cloned, expressed ~n E.coli and purified by immobilised metal 
affinity chromatography (IMAC). An epitope mapping study of InlB was also performed, 
whereby the recombinant protein was portioned into three fragments to estabhsh the relative 
location of antibody-bindmg epitopes on its structure. The Listeria monocytogenes-derived 
proteins, peptides and anhbodies were characterised using plate-based methods and 
subsequently used for the development of immunoassays using novel fluorescent labels and 
an impedimettic sensor. The recomb~nant InlB-derived peptides were also cloned Into the 
PAC 4 vector for in vrvo biotinylation, expressed in E. coli and purif~ed using a monomeric 
streptavidin affinity column. The m vrvo hiotinylated fragments were characterised using 
SDS-PAGE, Western blotting, lmmunoassay and BiacoreTM (Chapter 3) 
xxii 
Quantum dots and phosphorescent porphyrins were used as labels in the generation of solid- 
phase immunoassays. Fluorescence-based munoassays using functionalised dye-doped 
nanoparticles were also developed. These doped particles were conjugated to specific 
antibodies and proteins using various surface mohfication techniques. The optimisation of 
solid-phase fluorescence-based immunoassays, incorporating labelled antibody-nanoparticle 
conjugates, for the detection of hIgG was investigated. A number of plate-based assay 
formats for the detection of parvovirus B19 was also investigated, in conjunction with an 
industrial partner; Biotnn International Ltd. Enzyme, chemiluminescence and fluorescence- 
based detection strategies were employed. A series of immobilisation studies was performed 
to study biomolecule attachment onto cone platforms for detection. (Chapter 4) 
Platform technologies using carbon screen-printed electrodes and ultra-thin polymer coatings 
for antibody-based biosensors were also examined. Antibodies directed against InlB were 
depos~ted onto electrodes within conducting polyaniline (PANI) films to produce conductive 
affl~nty matrices with clearly defined binding characteristics. The binding of specific 
anhbodies to their target molecules was monitored via electrical impedance spectroscopy 
( ! ) ,  as the films function as labelfree reversible immuno-biosensors, when interrogated 
with a pulsed potential waveform (Chapter 5). 
Finally, the thin-film deposition of biocompatible surfaces for implants was also studied. The 
adhesion of thin-films to 316L stainless steel substrates was investigated. These f h  were 
prepared by plasma-enhanced chemical vapour deposition (PECVD) of 
hexamethyldisiloxane W S O )  and oxygen mixtures. The film properties were found to be 
dependent on the Oxygen/HMDSO flow ratio and RF (radio frequency) power. 
Biocompatibility studies were camed out using rat aortic smooth muscle (RASM) cells. Cell 
proliferation, viability and toxicity were assessed using commercial kits and scanning 
electron microscopy (SEM) was performed on substrates post incubation in culture to 
monitor the biocompatibility effects of the films (Appenax). 

1.0 General Overview 
The binding between an antigen and its homologous antibody, in order to identify the 
specific antigen or antibody in a complex sample, is the basic principle of 
immnnoassay (Roitt, 1994). Immunochermcal techniques capitalise upon the extreme 
specificity, at the molecular level, of each antibody for its antigen, even in the 
presence of high levels of contaminating molecules. The selectivity of an 
immnnoassay is based on the innate selectivity of the antibody-antigen reaction and 
its sensitivity is determined by the detection limit of the label and the affinity of the 
specific antibody (Van Emon et al., 1989). The multivalency of most antigens and 
antibodies enables them to interact to form a precipitate. Antibodies and antibody 
fragments are used in a wide variety of experimental applications for immnnoassay, 
imaging and immnnotherapy (Lefranc and Lefranc, 1990). Immnnosensing techniques 
are useful for the detection of biologically important analytes and have wide ranging 
applications in clinical diagnostics (Luppa et al., 2001; Vo-Dinh et aL, 2001; Glockler 
and Angenendt, 2003). The main advantages of these systems are the provision of 
accurate, rapid reproducible results with little sample pre-treatment in a number of 
biological matrices, such as sernm, plasma, wine or cerebrospinal fluid (Aizawa, 
1994). Low imprecision, small lot-to-lot variahons, high analytical sensitivity and 
long calibration stability are just some of the advantages of modem immunosensors. 
This thesis describes the use of novel antibody-based detection strategies for the 
immunosensing of haptens, proteins and whole cells, using both novel fluorescence- 
based and impedance-based methods. The specificity of antigens to recognise theu 
corresponding antibody and form a stable complex is the basis of both the analytical 
immunoassay in solutlon and the immunosensor on solid-state interfaces (Luppa et 
a l ,  2001). Indeed, the specificity for the measurement of analytes in all 
immunosensing systems, as in the case of immunoassays, is dependent on the 
application of binding molecules (Ekins, 1999) and their corresponding antigens. 
With th~s  in mind a general overview of antibody and antigens and their role in the 
development of novel antibody-based biosensors is presented. 
1.1 Antibody struchnre & function 
An antibody is a glycoprotein molecule used by the immune system to identify and 
destroy foreign objects llke bacteria and viruses (Janeway et al., 1999). Each antibody 
recognises a unique, specific antigen as its target (Killard et al, 1995). Antibodies 
exlst as one or more copies of a Y-shaped unit, composed of four polypeptide chains. 
Each Y contains two identical copies of a heavy chain, and two identical copies of a 
l~ght chain, named as such by their relative molecular weights. Antibodies can be 
divided into five classes: IgG, IgM, IgA, IgD and IgE, based on the number of Y umts 
and the type of heavy chain. Heavy chains of IgG, IgM, IgA, IgD, and IgE, are known 
as gamma, mu, alpha, delta, and epsdon, respectively. The light chains of any 
anhbody can be classified as either a kappa or lambda type (based on small 
polypeptide structural differences); however, the heavy chain determines the subclass 
of each antibody. Although antibodies can vary in structure, they are generally 
typified by the immunoglobulin G (IgG) molecule, the most abundant subclass found 
in the serum of mammals (Stapleton et al., 2004). 
The basic four-polypeptide chain structure of an ~mmunoglobul~n G (IgG) molecule and 
the various associated IgG antibody fragments, which may be generated through genetic, 
enzymatic or chemical manipulations, is shown in Figure 1.1. It consists of two identical 
heavy chains and two identical light chams, which are held together by a number of 
disulphide bonds. The antibody chains can be further divided into constant (C) and 
variable (V) regions based on their ammo acid variability. The variable regions, which 
are located at the N-temnnal portions of both the heavy and light chains, form the 
antigen-binding fragment (Fab). Withim this region there are areas of hyper 
variability, referred to as the hypervariable loops or the complementarity determining 
reDons (CDRs), which are p n m d y  ~nvolved in antigen b~nding (Branden and 
Tooze, 1991) It is the variation in the ammo acid sequence of the CDRs that allows 
for the generation of a multitude of dtfferent antibodies with hfferent binding 
specificities. The remainder of the vmable heavy and light domains exh~bit far less 
variation and these stretches are known as the framework regons (FRs). The 
crystallisable fragment (Fc) of the anhbody 1s involved in binding surface receptors 
and plays a number of important physiological roles in immunological responses. This 
Fc portion is linked to the two Fab domains by a hinge region, which provides 
flexib~lity, allowing binding sltes on each Fab arm to work independently of each 
other. 
Figure 1.1 Diagrammatic represenrntion of an immunoglobulin G (IgG) molecule 
and the various IgG &'body fmgments, which may be generated through genetic, 
enzymatic or chemMcal manipulaliom The IgG molecule (A) consists of two identical 
heavy chains and two identical KOr /Z light chains and has a molecular weight of 150- 
I60 Wla. The light chains comprise a variable (Vd and constant (Cd domain. The 
heavy chain consists of one variable (VH) and three constant (CHI, CH.2 and Cn3) 
domains with a hinge region connecting the CHI and CH2 regions. The heavy and 
light chains are connected via disulphide bonds; disulphide bonds are also present in 
the constant and variable regions. Eke CDRs within the variable domains confer 
antigenic specificcity and contain considerable amino acid sequence variaiiom The 
F(ab'h (B) consists of two antigen binding fragments linked at the hinge regions, with 
the Fab fragment (C) mis t ing  of one antigen binding domain and the Fd (D) 
comprising one VH and one CH domain. The Fv fragment (E) consists of one VH and 
one VL which, following s t a b i l i s h  by a synthetic linker, results in the formation of 
the scFv fragment (F). The CDR (G) represenis the smallest antibody fragment 
capable of antigen binding. 
IgG can be cleaved into three parts i.e. two F(ab) regions and one Fc, by the 
proteolytic enzyme papain or into two parts, one F(ab')2 and one Fc by the proteolytic 
enzyme pepsin (Yamagnchi et al., 1995). The number of F(ab) regions on the 
antibody, corresponds with its subclass, and determines the "valency" of the antibody 
loosely stated, the number of "arms" with which the antibody may bind its antigen 
(Benjamini et al., 2000) The lower part of the antibody comprises the Fc fragment, 
which binds to Fc receptors (Jain et al., 2007). It is not needed for antigen binding, 
but for the physiological activity of the antibody. This part is glycosylated (in the C E ~  
domains), and this glycosylation is important for maintaining the structure and, thus, 
activity. The highly specific interaction between an antibody and its respective 
antigen is mainly due to non-covalent forces such as hydrogen bonds. In addition to 
hydrogen bonds, other weak interactions such as van der Waals forces, hydrophobic 
interactions and electrostatic forces improve the binding specii?city between antibody 
and antigen. These interactions occur over large and sometimes discontinuous regions 
of the molecules, improving binding affity.  Avidity is a measure of the overall 
stability of the antibody-antigen complex. It is controlled by three major factors - the 
affinity of the antibody for the epitope, the valency of the antigen and antibody, and 
the structural arrangement of the interacting parts. These charactenstics can be altered 
using antibody engineering techniques to improve the binding capacity and specifcity 
of the antibodies (Cbowdhury and Wu, 2005). 
Various antibody fragments, including the Fab, Fv and scFv, can be produced using 
recombinant DNA technology (McCafferty et al., 1990; Winter et al., 1994; Azzazy 
and Highsmith, 2002). The Fv fragment is one of the smallest antibody fragments 
required for complete antigen binding. However, a more stable version of the Fv 
fragment, the single chain Fv fragment (scFv) can be produced by adding a synthetic 
peptide linker to form a disulphide bridge (Young et a l ,  1995). Other fragments can 
also be engineered with the ability to bind antigen, which include both the Fd 
fragment and the CDR (Burton and Barbas, 1993). 
1.2 Antigens 
Antigens can be defined as molecules that contain distinct sites or epitopes that are 
recognised by and interact with various components of the immune system. 
Immunisation of an animal with an antigen yields monospecific antiserum while 
mixtures of antigens, such as a cell or unpurified crude preparations, yield 
multispecific or polyspecfic antiserum (Mayer and Walker, 1987). However, not all 
antigens present can be presumed to elicit the same immune response and the degree 
of response to a particular antigen may dffer from that to another. Generally proteins 
and large molecules are capable of eliciting good immune responses with the aid of 
adjuvants (immune stimulants), such as is the case with MB, a cell surface protein of 
Listeria monocytogenes. Smaller molecules, such as warfarin, with a molecular 
weight of less than 5,000 Da, are often too small to elicit an immune response on their 
own. They are referred to as "haptens" and require conjugation to larger carrier 
molecules to render them immunogenic. Vanous carrier proteins, such as bovme 
serum albumin, ovalburnin, keyhole limpet haemocyanin or thyroglobulin, are 
commonly used for this purpose. However, other carners composed of synthetic or 
natural polymers (e.g. dextran, poly-L-lysine), lipid bilayers or synthetic organic 
molecules have also been used (Hermanson, 1996). Regardless of the type of 
molecule, a carrier must be highly immunogenic, have the required solubility 
properties, be non-toxic in vtvo and possess suitable funchonal groups for coupling to 
the hapten. 
There are a variety of coupling chemistries available for coupling haptens to camer 
molecules (Hermanson, 1996). The choice of method is governed by the functional 
groups available on both the hapten and the carrier and the desired orientation of the 
hapten for presentation to the immune system. Conjugation procedures employing the 
carbodilmide EDC (1-ethyl-3- (3-dimethyl-aminopropyl) carbodiimide hydrochloride) 
are commonly used for immunogeu formation, as the method is both efficient and 
relahvely simple. Another advantage of this cross-lin!ung methodology is that no 
bridging molecule is introduced between the hapteu and carrier, thus eliminating the 
potential of anhbodies being generated against the couplmg reagent, which could 
dilute the desired antibody response against the hapten. 
13 Antibody Prodnetion 
Antibodies are produced in reaction to an immune response elicited by a foreign body 
and can be generated in a variety of ways. It is possible to produce antibodies against 
a broad range of antigens including larger molecules such as proteins, peptides and 
carbohydrates or smaller molecules such as hormones and drugs @elves, 1997). 
A n h i e s  can be polyclonal, monoclonal a recombinant in nature. Polyclonal 
antibody mixtures generally contain multiple epitope specificity and only a fAte 
amount of antibody can be obtained from the s e m  of an immunised animal. 
Monoclonal antibodies on the other hand have single eptope specificity and a 
potentially limitless supply. Recombinant antibodies are produced using phage 
display technology, whereby hapten, peptide and protein h i e s  can be presented on 
the surface of filamentous phage and specific binders selected (Maynard and 
Georgiou, 2000). Rgure 1.2 shows a schematic highlighting the three main types of 
antibody production. 
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figure 1.2 Schematic showing the production, isolation and subsequent purification 
ofmonoclonal, plyclonal and recombinant rmtrbodre . . S. 
1.3.1 Polyclonal antibody production 
Antibodies secreted in response to immunisation with a specific antigen are usually 
polyclonal, in that a mixed population of antigen reactive B-cells is stimulated, which 
recognise different epitopes on the immunogen (Mayforth, 1993). This system 
produces heterogeneous antibody populations, with a wide range of binding affinities. 
Immunisation of an animal with a particular immunogen creates an immune response 
that is induced against the foreign antigen. Polyclonal antiserum, containing several 
antibody populaaons aganst the immnnogen, can be recovered from the immunised 
animal. Animals, such as rabbits, goats, and sheep, are generally used for polyclonal 
antibody production, as they are relatively easy to handle for immunisation and 
bleeding purposes. When a sufficient titre of antibody is obtained, the animal is bled 
and the antibodies are purified from the serum. Polyclonal antibo&es can be produced 
quickly and relatively cheaply and do not require the same amount of expertise or 
time as monoclonal antibody production. They can also be very specific and high 
concentrations can be purified from small amounts of senun. However, polyclonal 
anhserum contains a heterogeneous population of antibodies, which can be hard to 
reproduce in subsequent immunisations. Unlike monoclonal antibody production, a 
consistent source of antibodies cannot be generated. 
1.3.2 Monoclonal antibody production 
During monoclonal antibody production, however, the antibody molecule is derived 
from a single clone of B-cells and each antibody secreted by the clone has identical 
antigen binding specificity. In other words monoclonal antibodies provide single 
epitope specificity and potentially limitless amounts of identical antibody. 
Monoclonal antibodies are most commonly produced by employing the hybndoma 
technique, fist  described by Kohler and Milstein in 1975. In this method, 
spleenocytes (normal B cells) from an immunised animal are fused with myeloma 
cells (tumour B cells) using a fusion medium such as polyethylene glycol (PEG). 
Stock myeloma cell lines selected for the fusion process are specifically chosen 
because they are derived from a common ancestor MOPC-21 known to have lost the 
ability to produce IgG, so that the only antibody produced is derived from the antigen- 
sensitised spleeuocyte. The resultant hybrid cell is known as a hybridoma and inherits 
antigen specificity from the spleenocytes and immortality from the myeloma cells, 
thus creating a permanent cell line, which secretes a homogeneous antibody of desired 
spec~ficity. Cloning is undertaken to ensure that all hybridomas are derived from a 
single parent that secretes the required antibody and that non-secretors arising either 
in the original fusion wells or as spontaneous variants, do not outgrow the antibody- 
secreting hybnds (Hadas and Theden, 1987). This ensures that the hybridomas secrete 
antibody that is homogeneous and monospecific. Early cloning allows selection of 
cells that have chromosomes for antibody production, otherwise vanants not 
producing IgG will overgrow. There are two common methods used to clone out 
hybridomas, soft agar and limiting dilution. In soft agar the cells are plated out on a 
serm-solid medium such as low agar plates and single cells produce colonies that are 
fnrther expanded, whereas limiting dilution involves seedmg the cells at a known 
concentration in 96 well plates. It is impoaant to seed at very low densities to ensure 
monoclonality and so growth conditions must be optimised to ensure that such low 
cell densities can survive. This is achieved by the use of special media such as 
Briclone. However, it is necessary to carry out several rounds of clorung before the 
presence of a stable monoclonal antibody-secreting hybridoma can be assumed. 
Hybndomas can become unstable over tune and hence stocks of original clone must 
he mamtained by cryopreservation (De Leij et al., 1983). 
1.3.3 Recombinant antibody production 
The use of phage display vectors for displaying polypeptides on the surface of 
bactenophage and bacteria, combined with in vitro selection technology, has changed 
the way in which antibodies are generated (Dillon et al., 2003). Recombinant 
antibody technology has several advantages over convenhonal antibody produchon, 
including speed, the possibility of altering affinity and specificity and the ability to 
generate novel functionahties, (Hoogenboom et al., 1998; Soderl~nd et al., 1999; 
Borrebaeck, 2000). The emergence of this technique has made it possible to generate 
high binding a f f i t y  molecules against a number of chosen targets, resulting in 
potentially limitless applications (Krebber et aL, 1997; Hayhurst and Georgiou, 2001; 
Cao and Lam, 2003). These targets include bacterial pathogens such as Brucella 
abortus, toxins like aflatoxin, tumour markers and small haptens including drugs of 
abuse, antibiotics and therapeuhc drugs such as warfarin. The scFv is one of the most 
commonly used antibody fragments and recombinant scFvs with specific affinities 
have also been produced and applied to the detect~on of ilhcit drugs (Brennan et aL, 
2003; Dillon et aL, 2003) and food contaminants (Leonard, 2003; O'Kennedy et al., 
ZOOS). 
Recombinant antibodies consist of only the antigen binding domains and are produced 
from immune tissue or hybndoma cell lines through the use of recombinant DNA 
technology. Recombinant antibodies are maintained in bacteria and offer a stable 
reproducible genetic source. Recombinant ant~hody technology represents a fusion of 
cDNA library procedures and phage display technology to create and screen large 
numbers of immunoglobulin clones (Mc Cafferty et al., 1990; Posner et al., 1993). 
Phage display technology was first introduced by Smith (1985). This technique 
allowed the expression of antibody fragments on the surface of filamentous phage as a 
fusion partner to a phage coat protein. Phage particles which display the antibody 
fragment of interest are subsequently selected using a method known as hiopanning, 
which enables the isolation of high affinity antibodies (Barbas, et al., 1991; 
Hoogenboom et al., 1998). Large antibody repertoire libraries can be generated from 
a variety of naive, immunised and synthehc sources. 
Recombinant antibodies have already contributed greatly in the analytical and 
diagnostic fields (Mazuet et al., 2006; Padoa and Crowther, 2006). They are 
especially ideal for tumour targeting where small, rapidly-penetrating hut high affinity 
molecules are essential. With the development of new expression vectors it is now 
also possible to express antibody fragments on a large scale, link the fragment to an 
enzyme allowing direct detection or engineer a histidine (His) tag into the antibody 
sequence to facilitate p d ~ c a t i o n  by immobihzed metal affinity chromatography 
(IMAC), (Brennan et al., 2003). Recombinant antibody fragments can also be 
expressed as fusion proteins coupled to reporter molecules (Casaedi et al., 1990). 
These advances in antibody engineering have had a positive influence on 
immunodiagnostics in general with the creation of efficient and stable biomolecules 
for use in immunosensing technology (Hock, 1997). 
1.4 Antibody Purification 
Punfication of antibodies is carried out to improve the functional achvity of the 
antibody by removing any interfenng immunoglobulins or contaminants. There are a 
number of methods available for antibody purificahon and the choice of technique is 
dependent on a number of factors These include the level of purity required, the 
antibody class, antibody source and intended application (Roque et al., 2007). 
Antibodies may be separated according to charge or size, using traditional protein 
purification techniques. A precipitation technique such as saturated ammomum 
sulphate (SAS) precipitation isolates the IgG molecules from other serum proteins, 
thus stabilislng the antibody and reducing lipid content. Purification by ion exchange 
chromatography is based on the fact that y globulins are the least negatively charged 
of the serum proteins. This makes them easy to purify using positively charged IOU 
exchange matrices. Polyclonal antiserum is subjected to SAS precipitation to remove 
crude proteins pnor to purification using affinity chromatography to isolate IgG 
A f f i ~ t y  purification techniques purify antibodies by capturing them on a gel matrix 
containing a covalently coupled analyte (Muronetz and Korpela, 2003). Purified 
antibody can be acquired by coupling antigen to an affinity column. The most 
commonly used method of affinity purification exploits the abllity of Protein A and 
Protein G to bind specifically to certain portions of the IgG molecule (Dancette et aL, 
1999; Fahrner et al., 1999). When Protein A and Protein G are immobilised onto 
Sepharose the purification of monoclonal and polyclonal antibodies is possible. 
Protein G purification was the method chosen for the purification of the polyclonal 
and monoclonal antibodies used in this research. A heterogeneous mixture of 
molecules in solution, contaimng the protein of Interest (in this case, SAS cut 
polyclonal serum or monoclonal antibody supernatant) is added to a column 
containing the affimty pamer (Protein G) ~mmohilised on some matnx (Sepharose 
resm). Target molecules are captured by their immobilised affinity partner, on a solid 
or stationary phase. Contaminating molecules in the solution are not captured since 
they do not exhibit the same affinity properties of the target molecule for the 
immobilised capture molecules. The sohd medium can then be removed from the 
mixture, washed, and the target molecule released in a process known as elution 
(Huse et al., 2002). 
The use of aftinity chromatography for the highly selective purification of 
recombinant antibodies has been reported by many authors (Casey et al., 1995; Cho et 
al., 2000). Immobiized metal ion affiity chromatography (JMAC) is an important 
technique employed for antibody fragment purification and was used in the research 
described in this thesis. JMAC is based on the specific covalent binding of amino 
acids, allowing proteins with an affinity for metal ions to he retained in a column 
containing immobilized metal ions, such as cobalt, nickel, copper, zinc, or iron 
(IClpriyanov et al., 1997). Porath and associates (1975) were first to introduce the use 
of IMAC, while working on the fractionation of proteins from human serum. It is 
now possible to engineer a histidine tag into an antibody fragment sequence which 
will bind the metal chelate column, thus facilitating purification (Miiller et al., 1998). 
IMAC is now routinely used for the purification of recombinant proteins and antibody 
fragments, due to relatively low costs, high recovery, high stability and high 
 cation yield, (Arnold, 1991). 
Following purification, determination of the class and subclass of the antibody can be 
performed in a number of ways including ra&oimmnnoassay (RIA), enzyme-linked 
immunosorhent assay (ELISA) and immune precipitation, using subclass-specfic 
antisera. Commercially available antibody isotyping kits are used for this purpose. In 
the case of monoclonal antibodies, determination of the antibody class does not prove 
that the antibody is truly monoclonal. However, if the antibody was produced from a 
hybridoma that has undergone a rigorous and technically satisfacto~y cloning 
procedure and the antibody shows evidence of monoclonal spec~ficity as established 
by a predetermined classification, it is assumed that the antibody exhibits 
monoclonality. 
Antibody specificity is investigated by performing cross-reactivity studies with the 
antigen and other structurally similar antigens using ELISA, RIA, Biacore, Western 
and Dot Blotting. The affinity of the antibody for its specific antigen can be 
investigated using ELISA or biosensors. Biacore is a real-time surface plasmon 
resonance (SPR)-based biosensor that can be used to study biomolecular interactions 
without the need for labelling. The anhbody-antigen interaction can be studied using 
Biacore, thus providing valuable information on the kinetics of association and 
dissociation (Alfthan, 1998). 
1.5 Biosensors & Immunosensors 
One of the most importaut issues in analytical biochemistry is selectivity, particularly 
at low analyte coucentrations and in the presence of interfering substances. In recent 
years, high selectivity has been obtained by advances in analytical instrumentation 
such as high-performance liquid chromatography, gas chromatography, mass 
spectrometry and atomic absorption spectroscopy (Ashwin et a l ,  2005; Jin et aL 
2007). However, these powerful instruments are not applicable for in situ operation 
and can only be used in specialised laboratory environments. Therefore there is a need 
for highly selective seasom that me rapid and simple to use, for a number of 
applications, such as medical, environmental and industrial parmanin-Sheehan et al., 
2003). Biosensors are genedly defined as analytical devices incorporating either a 
biological material or a biologically-derived material intimately associated with a 
physicochemical transducer or transducing microsystem, which may be optical, 
electrochemical, thermometric, piezoelectric, magnetic or micromechanical (Turner et 
al., 1986). F i  1.3shows the general layout of a biosensor. 
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Figure 1.3 Schematic layout of a biosensor consisting of biological detection element 
and si& processing unit - (Adaped from Eggins, 1996). A biological matrix 
containing the analyte of interest is applied to a biological detection element which 
t m d u c e s  the resultant physical or chemical signal that occurs upon bincomplex 
formation The signal is then converted to a readable output (usually electronic), 
using a signal processor and sojiware. 
Biosensors are concerned with sensing and measuring a particular chemical or 
biological species, known as an analyte, (Byfield and Abuknesha, 1994). The 
recognition element must be biologically sensitive i.e. a molecule that is capable of 
either reacting with the analyte or catalysing a reaction involving the analyte. This 
element is irnmobilised at the transducer by a suitable method such as covalent 
attachment or physical entrapment The transducer can take a number of different 
forms, but basically converts an observed change (physical or chemical) into a 
measurable signal whose magnitude is proportional to the concentration of the analyte 
under investigation (Luppa et al., 2001). Biosensors combine the specificity and 
sensitivity of biological systems with the computing power of a signal processor 
(Buerk, 1993). Many types of molecules qualify for bio-recognition, and these include 
enzymes, receptors, peptides, DNA and l~ving cells (Scouten et al., 1995; Rao et al., 
1996; Quinn and O'Kennedy, 1999). However, if antibodies or antibody fragments 
are applied as the biological element, the device is known as an immunosensor 
(Taylor, 1991). Irnmunosensors can either be direct or indirect Direct sensors are able 
to detect the physical changes occnrrmg during immune complex formation, whereas 
indrect sensors use signal-generating labels, which allow more sensitive and versatile 
detection modes when incorporated into the complex (Blum and Conlet, 1991). 
The most significant obstacles in immunosensor development are related to 
immobilisation, orientation and retention of the specific properties of immuno- 
molecules on transducer smfaces. The optimum density and orientation of antibodies 
at immunosensor surfaces is a critical parameter. A wide variety of materials can be 
used as sensing surfaces for immunosensor applicanons and these include but are not 
l i i t e d  to polymers, metals, glass and plastics @armanin-Sheehan et al., 2003). 
Therefore, antibody immobilisation techniques must be tailored for the type of 
material used at the sensor surface (Turkova, 1999) and a suitable method of 
immobilisation derived (Lu et al., 1996). In doing so, optimal biomolecule 
immobilisation is achieved and therefore maximum antibody fnnctlonality and 
reaction kinetic parameters are retained. There are four main types of immobilisation 
currently used at immunosensor surfaces. These include amongst others; the oriented 
coupling of antiboches by binding to Fc receptors such as protein A or G on the 
surface (Quinn and O'Kennedy, 1999), affinity coupling of biomolecnles using other 
binding partners at the surface, such as biotin-avidin, (Schetters, 1999), coupling to 
solid supports via an oxidised carbohydrate moiety (Kang et al., 2007) and the 
binding of Fab or scFv fragments to the surface via a sulphydryl group in the C- 
terminal region of the antibody fragment @omen et al, 1990). 
The regeneration of the binding sltes of anhbodies on lrnmunosensor surfaces is also 
an important consideration. Antibody regeneration using acidic or alkaline solutions 
can be potentially harmful to the hindmg ability of the antibody and can lead to 
denaturation of the molecule. There are a number of different approaches that can be 
used to solve this problem. One method is to d~splace the antigenic analyte using a 
highly concentrated solution of a related antigen with weak affmity to the surface- 
bound antibody; however this is only useful for small molecules (haptens). A more 
robust approach is to use antibody engineering techniques to improve the chemical 
stability of anhbodies as whole molecules or as Fab fragments. Phage display 
techniques, (Winter et al., 1994) offer such a tool and can be helpful in the selection 
of antkbody fragments with improved stability for b~osensor apphcahons (Jung et a l ,  
1999). 
Biosensors can be categorised based on the detechon principle used. The five 
pnncipal classes of transducer used in biosensors are; electrochemical, optical, 
thermometric, piezoelectric and magnetic Electrochemical sensors may be subdivided 
Into potentiometric, amperometric, or condnctimetric sensors. Potentiometric sensors 
measure the change in charge denaty at the surface of an electrode (Ghindilis et al., 
1998; Pnrvis et al., 2003). Amperometric sensors monitor currents generated when 
electrons are exchanged either directly or indirectly between a h~ologlcal system and 
an electrode (Skladal et al., 2002; Kameswara Rao et al., 2005). Condnctimetric 
sensors measure changes in ionic conductance (Kim et al., 2000). Optical biosensors 
correlate changes in concentration or mass, to direct changes in the characteristics of 
ermtted light (Myong Song et al., 2005; Lenng et al., 2007). Other physicochemical 
sensors, such as thermometric, piezoelectric, and magnetic sensors, monitor biological 
interactions through changes in heat, mass or magnetic properties (Eggins, 1996). The 
research described in this thesis focuses on the use of both optical and 
electrochemical-based methods, namely fluorescence-based and impedance-based 
sensors for the detechon of haptens, proteins and whole cells. 
1.5.1 Fluorescence-based Detection 
The use of fluorescence to facilitate measurements in biological systems has increased 
dramatically and includes applications in spectroscopy (Hoshina et al., 2007), flow 
cytometry (Manger et al., 2007), climcal chemistry (Hernhdez-Caraballo & Marco- 
Pma, 2003), in situ hybridisation (Baylis et al., 2007), immunoassay (Tully et al., 
2006), immunocytochemistry (Buchwalow et al., 2005), immunohistochemistry 
Peir6 et al., 2007) and micmarrays (Rucker et al., 2005). 
Luminescence is the emission of light from any substance occurring when an electron 
returns from an electronically excited state to ground state. There are two main 
categories of luminescence; fluorescence and phosphorescence and these are 
dependent on the nature of the excited state of the electrons involved in the process. 
Fluorescence is the property whereby some atoms and molecules absorb light at a 
paaicular wavelength and subsequently emit light of longer wavelength after a brief 
interval, termed the fluorescence life-time (Lackowicz, 1999). Photons from an 
external source are absorbed by the fluorophore and this produces excited singlet state 
electrons. The tlme taken for these electrons to return to the lower energy level is 
known as the excited state life-&me. The emission of light occurs as fluorescence 
from an excited electron singlet state, where all the electrons in the molecule are spin- 
paired. The return to ground states occurs, with the ennssion of photons. Emission 
rates are fast, being in the region of 10~s-', and fluorescence hfe-times are relatively 
short. Many fluomphores have sub-nanosecond life-times and, therefore, the 
fluorescence enutted by these dyes is shoa-lived. 
Phosphorescence is the emission of light from triplet-excited states, whereby one set 
of electron spins is unpaired. This means that electrons in the excited orbital have the 
same spin as ground state electrons. Therefore, transition to ground state is not 
possible and emission rates are slow (in the region of 10~-10's~'). Phosphorescent hfe- 
times have durations in the millisecond range. Following exposure to light, 
phosphorescent substances glow for several minutes as the excited phosphors return 
to the ground state very slowly. 1.4 shows a modified Jablonski diagram 
depicting both fluorescence and phosphorescence-based light emssion. 
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Figure 1A When a photon provided by an external light source is absorbed by a 
fluorophore, it is excitedfrom a vibrational level in the electronic ground state (So) 
to a higher electronically excited state. The electronic state of an organic molecule 
can be either a singlet siate whereby all electrons in the molecule are spin-parparred or 
a triplet state where one set of electrons is unpaired The excited singlet states (S1.3) 
are reached afer initial ab~0rptiOn A molecule in this energy level will quickly fall 
to the lowest vibrational level of this state by energy loss through collision 
Fluorescence occurs as photon of light is emitted; retu)7~~ng the fluorophore to 
ground state. The Jablonski diagram shows the possible routes by which an excited 
molecule can return to ground state via unstable triplet states. A quick return to 
ground state results in fluorescence, whereas a delayed return is known as 
phosphorescence - (Adapted from Lackowicz, 1999). 
Biological molecules can be tagged with a fluorescent chemical group (fluorophore) 
using simple chemical reactions which allows sensitive and quantitative detection of 
the molecule. A number of processes involved in fluorescence emission can have an 
effect on the fluorescence characteristics of a fluorophore. These include collisions 
with quenchers, rotational and translational diffusion and complex formation with 
solvent/solute. Fluomscent molecules a b s d  photons of energy at one wavelength 
and subsequently emit energy at another wavelength (Wolfbeis, 1993). During the 
absorption process (excitation), the quantum energy levels of some fluorophores 
increases with photon uptake. This absorption band is not isolated at a discrete 
(single) photon energy level but spread over a range of wavelengths, giving rise to a 
peak of maximal absorbance. The extinction coefficient @) is measured at the 
absorbance peak maxlmum and is specific for each fluorophore. The ratio of total 
photon emission over the entire range of fluorescence to the total photon absorption 
(range 0-1) is known as the quantum yield (Q). The higher the quantum yield the 
brighter the fluorescence (photon emssion) will he. Another characteristic that is an 
important consideration for a fluorophore is the size of its Stokes shift. Stokes Law 
states that the emiss~on wavelength of a given fluorophore should be longer and of 
lower energy than the excitation wavelength, so that the emission spectrum should be 
separated sufficiently from its excitation spectrnm (Mason, 1993). 
The intensity of emitted fluorescence can be decreased by a number of processes and 
this is known as quenching. Collisional quenching occurs when the excited state 
fluorophore is de-activated upon contact with some other molecule in solution. 
Fluorophores can form non-fluorescent complexes with quenchers and static 
quenching can occur in the ground state, since no diffusion or molecular collisions are 
occurring. Quenching can also happen by other non-molecular mechamsms such as 
attenuahon of the incident light by the fluomphore itself or the presence of another 
absorbing species in the sample (Hennanson, 1996). Another pmblem encountered 
with the use of fluorescence for analysis is over labelling. Decreases in emission 
intensities can occur, as the level of probe attachment to biological molecule is 
increased. This happens since fluorophores can self-quench at hgh label levels, due to 
the energy transfers from excited state molecules to ground state dimers. 
However, fluorescence-based detection is a safe, rapid, non-invasive technique 
suitable for many biological applications (Hall et al., 1999; Sutherland, 2002; Lochner 
et al., 2003) and has many advantages over other light-based investigative methods. 
Changes in concentration can be monitored very rapidly and samples are not affected 
or destroyed in the process. A fluorescence emission spectnun is a plot of 
fluorescence intensity versus wavelength (nm) or wavenumber (cml). Emission 
spectra vary widely from fluor to fluor and are dependent on chemical strncture and 
environmental cond~tions e.g. pH, buffer components, solvent polarity and dissolved 
oxygen. 
1.5.1.1 Fluorescent probes 
Detection of labels for use in biological applications can be performed by either 
spectrophotometric or radioactive methods (Wolfbeu, 1993). The use of 
spectrophotometric probes includes both chromogenic (coloured) labels and 
fluorescent labels. Cbromogenic labels are mainly used for the non-covalent staining 
of structural features within cells as the coloured pigments in the dye bind to specific 
areas in the cell. However, there are a number of problems associated with these tags. 
The sensitivity of visible wavelength dyes is generally not sufficient for detection of 
low concentrations of antigen and, even if a biomolecule is covalently modified with 
the cbromogen, a relatively large amount of dye is required. 
Fluorescent probes (flnorophores) are relatively small molecules that are used to label 
biomolecules such as proteins, antibodes and nncleic acids. They contain fnnctlonal 
groups and specific physical and chemical characteristics that confer suitability for 
their use as detection moieties. To date, thousands of fluorescent probes are known 
each with varying spectral properties. Fluorescent labels have provided excellent 
sensitivity for a range of assay systems that can be applied to the determination of 
almost any aualyte. Fluorescent tags have a number of attributes including large 
quantum emssion yield upon excitation and easy conjugation to biomolecules via 
reactive groups that make them highly suitable for biological detection. The physical 
and chemical properhes exhibited by an ideal fluorescent label are shown in Table 1.1 
Table 1.1 Lit of ideal properties for fluorescent probes 
These ~nclude high quantum yield and a large Stokes shift to ensure good separation 
of excitation and emiss~on wavelengths. A large Stokes shift will increase the 
fluorescent signal generated as interference from Rayleigh scattered excitation light is 
decreased. The aromatic ring system contained in most fluorophores generates the 
luminescence and, as the ring gets larger, the emission shifts to red and the quantum 
yield increases. Aromatic nng constituents affect the fluorescent behaviour of each 
dye. Ring activators i.e. electron donating groups increase the quantum yield of a 
fluorophore whereas electron withdrawing groups decrease it. The presence of heavy 
atoms can also d h n i s h  the quantum yield by enhancing the probability of the excited 
smglet state going into triplet transition. Energy decay from a triplet excited state 
causes phosphorescence instead of fluorescence. The phosphorescent band is located 
at longer wavelengths and, hence, at lower energies, relative to the fluorescence 
spectrum (Lackowicz, 1999). Polycychc structures in the aromatic ring system are 
important to maintain fluorescent properties. Co-planar structures, 1.e. rings III the 
same dimensional plane, show the greatest fluorescence. Malachite green and 
rhodamine have very sirmlar structures, yet the oxygen bndges on the upper phenyl 
rings of rhodamine confer a planar shape, thus enhancing its luminescent qualities 
(Hemanson, 1996). 
Intrinsic fluorophores are naturally occurring whereby the intrinsic fluorescence 
originates within the aromatlc amino acids such as tryptophan, tyrosine and 
phenyldamne. The indole groups of tryptophan residues are the domnant source of 
W ahsorbance/ernissiou in proteins. Em~ss~on f tryptophan is very sensitive to local 
environmental changes and can be used as a reporter group for protein conformational 
changes. The emsslon maximum of proteins reflects the average exposure of 
tryptophan residues to the aqueous phase. Tryptophan fluorescence is subject to 
quenching by iodide, aclylamide and disulphide groups and also by nearby electron- 
deficient groups and protonated histidine residues (Suresh Kumar et al., 2007). 
Exixinsic fluorophores, on the other hand, are added to samples to provide 
fluorescence when the molecule of interest is non-fluorescent or the Intrinsic 
fluorescence 1s too weak. Prote~ns wtth weak inbinsic fluorescence can be labelled 
with fluorophores that have longer excitation and emission wavelengths than their 
constituent aromatic amino acids. Tbere are huge numbers of such fluorophores. 
Reagents are available that can be used for both the covalent and non-covalent 
labelling of proteins. In the case of covalently bound probes a variety of reactive 
groups is available for effective couphng with amme, sulphydryl and histidine side 
chains in proteins. Ideally, for labelling of biomolecules, each fluorophore should 
have several analog foms each with a different reactive group suitable for coupling to 
a diierent specific functional group on the target molecule. Popular organic labels 
include denvatwes of fluorescem, rhodamine, coumarin, and cyauine, as shown in 
Table 1.2. 
Table 1.2 Lit of common organic fluorophores. 
Tbere are many techniques available for the dlrect and indirect labeling of 
biomolecules with fluorescent tags for biologcal applications (Sun et al., 2006; Tirat 
et al, 2006; Lundberg et al., 2007). The selection of an appropriate fluorescent tag is 
dependent on a number of parameters such as sample type, mode of action, 
immobilisation strategy, excitation and ennssion characteristics of the fluorophore and 
the type of analyte being detected. Fluorescence-based detection of antibody-antigen 
binding interactions was traditionally performed with organic fluorescent tags such as 
FITC or rhodamine (Hermanson, 1996) which display a number of advantageous 
properties such as long absorption maxlma, insensitivity to solvent polarity, high 
molar extinction co-efficients and the avsulability of a wide variety of reactive 
derivatives. Fluorescein derivabves are characterised by a multi-ring aromatic 
structure, due to the planar nature of an upper, fused, three-ring system p i p r e  1.5). 
Figure 1.5 Structure of Fluorescein 
Derivatives of the basic structure of fluorescein involve substitution of carbons 
number 5 or 6 of the lower ring, for modification and labeling of biomolecules. The 
effective excitation wavelength range is between 488-495nm, whlle the emission 
spectrum lies between 518-525nm, depending on the derivative. Tbe quantum yield of 
fluorescein derivatives can be up to 0.75 (Hermanson, 1996). However, quick 
photobleaching can occur when the dye is dissolved in buffers, exposed to light or pH 
variations or subjected to long-term storage. The main applications of FITC mclude; 
labelling of antibodies to detect antigens in cells, tissues, immunoassays, blots, chips, 
and microarrays, identification of molecules separated by capillary zone 
electrophoresis and use as a label in flow cytometry. 
There are significant problems associated with the use of organic fluorophores, such 
as fluorescein, in biological applications. These molecules often have narrow 
excitation spectra and broad emission bands and so multiplexing of assays is difficult 
as spectral overlap can take place. Quenching, photobleaching and autofluorescence 
can also occur, affecting the generated signal, and giving rise to skewed or invalid 
results. Therefore, the need for more photostable and robust labels was identified. The 
following sections (Sections 1.5.1.2-1.5.1.5) give a general overview of the 
development of more stable, sensitive fluorescent labels and their associated 
technologies. 
1.5.1.2 Near-infrared ( N I R )  Fluorescent Probes 
Near-infrared (NR) detection of biomolecules has a number of advantages over 
conventional fluorophores, includmg low fluorescence background, since very few 
naturally occurring molecules can undergo electronic transitions in this low energy 
region of the spectrum (Basbeer et al., 2007). Scatter is also reduced at higher 
wavelengths at this end of the spectrum thus reducing sample photodecomposition. 
NIR probes have high quantum yields, large Stokes shifts, photochemical stability and 
a high tolerance to quenching. Good examples of N R  probes are the cyanine dyes. 
These molecules have emission maximums between 600-800nm. The quantum yields 
of these probes in aqueous solutions are very low. However, on binding to analytes 
changes in absorption and emission wavelengths are increased as the fluorescent life- 
time increases. Figure 1.6 shows the basic structure of a cyanine dye. 
Figure 1.6 Structure of Cyanine 5 
Cyanine dye fluorophores fluoresce brightly and contain a (-CH=CH-), group linking 
two niogen-containing hetcrocychc rings, as shown in Figure 1.6. They can he 
functionalised with NHS-ester, maleimde, isothiocyanate and hydrazine chemistries 
for biomolecule attachment and exhibit high molar extinction coefficients and 
favowable quantum yields. The small size of these dyes reduces steric hindrance, and 
therefore, loss of activity (Hermanson, 1996). Cyanine dyes are used for standard 
fluorescence, fluorescence resonance energy transfer (FRET), time-resolved 
fluorescence (TRF) and fluorescence polarisation applications. Cyanine dyes can be 
used to label proteins both covalently and non-covalently (Song et al., 2004). 
1.5.1.3 In vivo labelling 
The green fluorescent protein (GFP) from the jellyfish, Aequorea victoria, is a 
versatile reporter for monitoring gene expression and protem localisation in a variety 
of cells and organisms (Tsien, 1998; Kukar et al., 2002). GFP emits bright green light 
on excitation. The chromophore in GET is intnnsic to the pnrnary structure of the 
protein, and fluorescence from GFP does not require additional gene products, 
substrates or other factors. GFT fluorescence is stable, species-independent and can be 
momtored non-invasively using the techniques of fluorescence microscopy, 
fluorescence-activated cell sorting (FACS), flow cytometry and fluorescence 
resonance energy transfer (TRET). Since the first use of GFP in living organisms, live 
cell fluorescence mcroscopy has become an indispensable tool for cell biologists. In 
recent years many fluorescent reporters suitable for in vivo experiments have been 
developed, including a wide range of fluorescent proteins in various colours (Awais et 
al., 2007). The technique of labelling genes and proteins in vivo for microarray 
purposes has become an important tool in the development of gene and protein 
expression analysis (Todman et al., 2005). In vivo labelling methods give accurate 
pictures of what is happening in the natural dynamic environment and these 
techques  are a vital tool for fluorescence-based detection, especially for microarray 
applicahons. 
1.5.1.4 Lanthanides 
Fluorescence typ~cally occurs from aromatic molecules (Basheer et al., 2007) e.g. 
naturally occurring fluorescent substances such as qumine, fluorescein, rhodamine B, 
acridine orange and 7-hydroxycoumarin. In contrast to aromatic organic molecules, 
atoms are generally non-fluorescent in the condensed phase. However, the 
lanthanides, a group of elements includmg terbium and europium, do not follow this 
rule. Fluorescence occurs in these molecules as a result of electron transitions 
between orbitals. Lanthanides exhibit long decay-times due to the shielding effect of 
electron transitions between the orbitals and short emission rates because of their low 
extinction co-efficients (Lamture et al., 1996). 
Long life-t~me probes are those with fluorescent life-times greater than those of 
traditional orgamc probes (1-1011s). Lanthanides are transition metals with fluorescent 
life-time decay times between 0.5-3ms (Hand1 and Gillies, 2005). Transition metal 
llgand complexes are made up of metal and organic ligands. They contain mixed 
singlet-triplet states and have intermediate lifetimes of 400 nanoseconds to 
microseconds. Their absorption co-efficients are very low and emissive rates slow, 
giving rise to long life-times. They are not directly excited but use chelated organic 
liquids as conduits. Lanthanides can substitute chemically for calcium in calcium- 
dependent proteins. They can he used with proteins that do not have intrinsic binding 
sites and are particularly useful in immunoassay applicahons (Gudgin-Dickson et al., 
1995). Biological samples can exhibit autofluorescence, which can he limiting, since 
autofluorescence from the sample decays on a nanosecond timescale, as does the 
fluorescence of most probes. However, due to the long decay time of lanthanides, they 
continue to emtt following the disappearance of autofluorescence. Time-gated 
detection can he used with lanthanides whereby steady state intensity measurements 
are taken over a penod of time following pulsed excitation. This principle of time- 
gated detection of long life-time probes is illustrated in Figure 1.7. 
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Figure 1.7 Principle of time-gated fluorescence detection Time-gated fluorescence 
detection is used to monitor the fluorescence of a sample as a function of time, after 
excitation by a flash or pulse of light. This figure shows a schematic of the system used 
with lanthanide molecules whereby steady-state intensity measurements of emitted 
fluorescence are taken over a period of time following pulsed excitation. Time resolution 
is optically gated, whereby a short laser pulse acts as a gate for the detection of emitted 
fluorescence and only fluorescence that arrives at the detector at the same time as the 
gated pulse is collected. In time-gated detection system, the detector is turned on after 
excitation and the fluorescence intensity generated is integrated. This method is useful for 
long lifetime probes. 
1.5.1.5 Novel Fluorophores 
The evolution of novel fluorophores that exhibit greater stability and brightness, has 
led to unproved sensitivity and reproducibility in biological monitoring (Chan et al., 
2002). The advent of inorganic fluorophores such as quantum dots, nanocrystals and 
nanoparticles has revolutionised fluorescence-based detection methods. These novel 
fluorescent molecules exhibit large Stokes shift, hgh quantum yields and can be 
excited with a broad range of excitation sources (Seydack, 2005). Functionalisation 
of the polymer shell of such molecules is generally quite simple and allows direct 
coupling of the probe to biomolecules. Novel fluorescent probes have higher quantum 
yields and high resistance to photodegradation and the main advantages of such 
probes are their narrow predictable emissions, extreme photostability and brightness 
(Rruchez et al., 1998;   an^ et al., 2004; Goldman et al., 2005). Quantum dots, dye- 
doped nanoparticles and phosphorescent porphyrin dyes were used in the 
development of novel lmmunoassays described in this thesis. 
1.5.1.5.1 Quantum Dots 
Quantum dots are tiny light-emitting particles on the nanometer scale. They are a new 
class of biological label with improved characteristics and properties that are superior 
to traditional organic dyes and fluorescent proteins. Recent advances have led to 
quantum dot bioconjugates that are highly luminescent and stable (Chan and Nie, 
1998; Mattoussi et al., 2000; Goldman et al., 2004). These bioconjugates rase new 
possibilities for studying genes, proteins and drug targets in single cells, tissue 
specimens and even in living an~mals (Ackerman et al., 2002; Gao and Nie, 2003; 
Mulvaney et al., 2004; Goldman et al., 2006; Kerman et al., 2007). 
Quantum dots are nanocrystalline semi-conductors that exhibit unique light emitting 
properties that can be custornised by changing the size or composition of the dots 
(Nivisatos, 2004). They are typically 2-8nm in size and covered with a layer of 
organic material that allows functlonalisation of the surface for biomolecule 
attachment (Bruchez et al., 1998; Seydack, 2005). The colour is determined by the 
size of the particles and the composition of the materials used, which in turn dictate 
the optical properties. Smaller dots fluoresce at shorter wavelengths (blue), while 
larger dots emit at longer wavelengths, (red). One of the main advantages of 
nanocrystalline fluorophores is that they absorb light over a broad spectral range. By 
abwhing al l  wavelengths shorter than their emission wavelength (blue wavelengths), 
a single light source is required for the excitation of multiple coloured dots. This 
simplifies instnunentation, lowering costs and enabling multiplexing of assays 
(Goldman et al., 2004). Typically in fluorescence-based measurements, when dealing 
with ordinary fluorescence labeling using proteins, such as green fluorescent protein, 
or organic dyes, such as rhodamine, it is difficult to utilise more than two or three 
colours at once. Eaeh of the fluorophores must first be excited with a specific 
wavelength of light, which can block the emitted colour of a second or third 
fluorescent probe. However, with quantum dots the same wavelength of light can be 
used to excite different sized &dots (and therefore colours), thus facilitating simple 
multiplexing of assays. Figure 1.8 shows a schematic representation of the basic 
quantum dot structure. 
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Figure 1.8 Schematic depicting the component layers of a quantum dot. An inorganic 
zinc sulphide (ZnS) shell e n c a p h s  the core nunocrystal composed qf cadmium 
selenide (CdSe). The inorganic shell is subsequently capped and an organic layer and 
a polymer suface coating are applied to enable biomolecule attachment. For the 
quantum dots used in this thesis the polymer shell is directly coupled to streptavidin 
through a carbodihide-mediated coupling reaction for bwmolecule attachment. 
For the research described in this thesis, streptavidin conjugated quantum dots were 
purchased from the Quantum Dot Corporation, (USA). These unlque fluorescent 
probes have an emission maximum near 605nm and can be excited with a range of 
excitation sources. The quantum dots comprise of a cadmum selenide (CdSe) core 
shell coated with a zinc sulphide (ZnS) semi-conducting inorganic coating to improve 
optical properties. l lus  is further functionalised by coating with a polymer shell to 
allow direct coupling to biomolecules. In this case the polymer shell was directly 
coupled to streptavidin through a carbodi~mide-mediated coupling reaction as shown 
In Figure 1.8. 
The narrow emission spectra of nanocrystals glve rise to sharper colours and high 
spectral resolution, which improves assay sensitivity since nanocrystals emit more 
light than their constituent dye. Quantum dots are not liable to photobleaching, e A h i t  
excellent photostability and, relative to conventional fluorophores, are up to 100 times 
more stable (Seydack 2005). It is this photostability that allows repeated interrogation 
of the materials over longer periods. Quantum dots have high excitation cross 
sections, in that they absorb much of the light with which they are irradiated, and high 
quantum yields whereby they re-emit more than 50% of the light they absorb (Sun et 
al., 2001). Thls gives rise to strong fluorescence signals, thus increasing detectlon 
sensitivity. 
The potential uses of quantum dots in biological applications include drug delivery, 
diagnostics, drug discovery, genetic analysis and observation of biomolecular 
interactions (Aoyagi and Kudo, 2005; Kerman et al., 2007; Lucas et al., 2007). In the 
research described in this thesis, quantum dots were investigated as novel labels for 
the development of immunoassays for the detectlon of InlB and warfarin. An imagng 
application was also performed using quantum dots as the fluorescent label for the 
unmunosta~ning of L. monocytogenes whole cells. 
1.5.1.5.2 Porphyrins 
Organic fluorescent labels such as HTC, Cy5 and rhodamine can exh~hit high opt~cal 
background in immunoassay applications, which reduces sens~tivity (Wolfbeis, 1993). 
The use of long-decay fluorescent prohes and time-resolved detection allows for a 
significant decrease in background and, therefore, an increase in sensitivity. The 
lanthanide chelates, such as europium and terbium have traditionally been used as 
probes for the time-resolved fluorescent detection of analytes (Yuan and Wang, 
2006). Functionalised denvatives of these dyes are available commercially for both 
homogenous and heterogeneous assays. However, an enhancement step is often 
necessary, such as dissociative enhancement (DELFIA) or addition of enzyme labels 
to improve performance, resulting in an enzyme-amplifi~ed lanthanide luminescence 
system (Gudgin-Dickson et al., 1995; Hand1 and Gillies, 2005). 
Another group of structures, the metalloporphyrins, is particularly suitable for 
biological applications, due to their relatively long decay times. Metalloporphyrins 
provide a realistic alternative to fluorescent lanthanide chelate labels. Phosphorescent 
metalloporphyrins, such as the water-soluble platinum and palladium complexes of 
coproporphyrin, have a number of advantages as labels for immunoassay 
development (Hemmil& & Mukkala, 2001). Palladium (II) and platinum (11) 
complexes of porphyrins were first synthesised and studied by Eastwood and 
Gouterman (1970). These complexes of porphyrin and related tetrapyrrol~c pigments 
emit strong phosphorescence at room temperature, which is characterised by long 
lifetimes falling into the sub-milhsecond range and long-wave spectral characteristics. 
These include high quantum yields of up to 40%, simple laser excitation at 532nm 
and broad red emission (600-75011111). It is these features that make porphyrin dyes 
useful as prohes for a number of bioanalytical applications, particularly those 
employing time-resolved fluorescent detection (Papkovsky, 1991 and 1993). The 
basic structure of porphyrin consists of four pyrrole units linked by four methene 
bridges (Figure 1.9). 
Figure 1.9 Structure ofporphyrin 
Metalloporphyrins can be synthesised to have either isothiocyanate reactive groups or 
malemide reactive groups, allowing conjugation to be tailored exactly to suit the 
substance being labelled. There are two main conjugation strategies for porphyrin 
attachment to proteins. The first involves the activation of the porphyrin by 
carbodi ide ,  followed by nucleophilic attack of the primary amino groups of the 
biomolecule to produce bioconjngates vla the amide bond. The second method 
employs carbodiiide to preactivate the porphyrin in the presence of an active ester, 
which results in a porphyrin derivative, with active functional groups that can react 
with the amino groups of a biomolecule (O'Riordan et al., 2001; Papkovsky and 
O'Rordan, 2005). 
Novel derivatives of platinum and palladium coproporphyrin were made available for 
the development of novel mununoassays, in associaaon with an industrial partner 
Luxcel Biosciences Ltd. (UCC, Cork). The derivatives were used to make 
phosphorescent conjugates of antibodies and neuQavidin. The labels and conjugates 
were then evaluated in solid phase immunoassays using a commercial 
phosphorescence-based detector, and investigated as novel probes for the detection of 
both InlB and wdarin. 
1.5.1.5.3 Nanoparticles 
Fluorescent labeling of biological materials using organic fluorescent dyes is widely 
employed in immunoassays and biological imaging (Lackowicz, 1999). However, 
organic fluorophores have limitations such as poor photostability and brightness, 
especially for samples with high background fluorescence (Trau et al, 2002). Indeed 
even the highly luminescent quantum dots described by Chan and Nie (1998) have 
certain characteristics which limit their effectiveness. These include poor solubility in 
water, hlinlung and highly toxic cadnuum components. Fluorescent nanoparticles 
exhibit considerable advantages in detection over both organic fluorescent dye 
molecules and quantum dots. The supenority of nanopahcles is apparent in their 
stability, brighmess and ease of functionalisation for bioconjugation. 
Organically modified silicate materials have become an attractive field of study due to 
the versatility and flexibility associated with theu preparation (Pham et al., 2007). 
Dye-doped silica nanoparticles display lngh stability and retam their optical activity, 
thus providing a viable method for the production of tailored materials with unique 
properties for biolo@cal applications. Ow et al. (2005) described a class of lnghly 
fluorescent core-shell nanoparticles, up to 20 times brighter and more photostable 
than theu constituent fluorophore. The fabrication of such molecules employs a 
microemulsion technology. This method encapsulates fluorescent dye molecules into 
a silica matrix, giving rise to dye-doped nanoparticles with a high intensity 
fluorescent signal. The excellent photostability of doped nanoparticles is due to 
exclusion of oxygen by the sihca encapsulation. Surface modification post-fabricat~on 
allows efficient conjugation to biomolecules. Silica is easy to modify, either through 
NHS activation, silanisation or carhoxyl modification (Lian et al., 2004). Scanning 
electron microscopy (SEM), transmission electron microscopy (TEM) and 
fluorescence spectroscopy are used to characterise the doped nanoparticles to 
determine size u~llformity, quantum yield, fluorescent life-time and fluorescent 
intensity. Each nanoparticle encapsulates thousands of fluorescent dye molecules in 
the protective silica matrix, providing a highly amplified and reproducible signal for 
fluorescence-based bioanalysis. Figure 1.10 shows a schematic depicting the structure 
of dye-doped nanopahcles. 
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Figure 1.10 Schematic depicting the component layers of ruthenium dye-doped silica 
namparticles. A silica shell encapsulates the constituent dye (ruthenium) using a 
water in oil microemulsion technique. The silica surface ofthe doped nanoparticles is 
mod$ied for biomolecule attachment by silanisation with 
aminopropyltrimethaxysilane (APTES) and subsequent glutaraldehyde crosslinking. 
Traditional immunoassays employ the use of one or more fluorescent dye molecules 
linked to an antibody, to trace the antibody-antigen bimding interaction. Nanoparticles 
have been successfully conjugated to antibodies, proteins, s+vidin and avidin 
(Santra et aL, 2001; Ye et al., 2005; Dahint et al., 2007). The efficiency of the 
conjugation process can be monitored and the conjugation rate predict& with respect 
to the initial ratio of biomolecule to nanoparticle (NP) by applying mathematical 
formulae which take into account the size of the nanoparticles, their capacity for 
binding (mg protein present per mn? of nanoparticle surface) and the mean diameter 
of the nanoparticles. Functionalisation of the polymer shell of such molecules is 
generally quite simple and allows direct coupling of the probe to biomolecules @an 
et aZ., 2004). In this research, ruthenium dye-doped silica-shell nanoparticles were 
investigated in association with Dr. Rbbert Nooney of the Biomedical Diagnostics 
Institute (BDI), Dm. Nanopar&icles were synthesised using a microemulsion method 
and conjugated to antibodies for the development of fluorescence-based 
immunoassays with improved sensitivities. 
1.5.2 Electrochemical-based detection 
Over the past 30 years electrochemical sensors have been used as tools for the 
detection of a wide range of analytes (Pejcic and DeMarco, 2006). These sensors are 
dependent on the condition and stability of the membranelelectrode surface and the 
behaviour of immob'ised biomolecules at this interface. Electrical impedance 
spectroscopy (EIS) has been used to provide information on the various processes 
occumng at electrochemical sensor surfaces (i.e., adsorption, film formation, rate of 
charge transfer, ion exchange, diffusion and mass transport) slnce the understanding 
of these processes assists the development of improved immunosensing strategies. 
Biosensors have expenenced rapid, extensive improvement as a result of studying the 
electrochemical phenomena occumng at sensor surfaces. Advanced sensor materials 
and coupling strategies have been developed to maintain the bioactivity of 
biomolecules, thus enriching generated signals. Enhancement of bio-immobilisation 
matrices with materials such as hydrogels, sol-gel-denved composites, polymer thh- 
films and lipid membranes (Xu et al., 2006) bas assisted in the evolution of smart, 
novel immunosensors. Continued improvements in surface chemistries at electrode 
interfaces, immob'ilisation strategies, proteln engineering techniques and transduction 
system deslgn have aided in the creation of a new generahon of electrochemical 
immunosensors 
Electrochermstry involves the study of the mterrelationship of electrical potentials and 
their assoc~ated currents with chemical systems and their underlying chemistries 
p a r d  and Faukner, 1980). It is the study of reactions in whch charged particles cross 
the interface between two phases of matter, typically an electronic conductor 
(electrode) and a conductive solution (electrolyte). Electrochemstry may be used as a 
fundamental analytical tool (Fejcic and DeMarco, 2006) as well as having numerous 
industrial applications. Processes taking place at the surface of the electrode produce 
an imbalance in the electncal charges of both the electrode and the electrolyte. This is 
known as a potential difference and is the determining factor of the resultant 
electrochemical reaction. The unit of measurement of potential difference, voltage 
(V), can be described using Equation 1.1. 
Equation 1.1 V = JIC, 
whereby a volt is srmply the energy (J)  required to move a charge (c). 
The application of a potential to an electrode supplies electrical energy and alters the 
energy level of the electrons withm the electrode since they possess charge (Buerk, 
1993). An electrochemical cell is a device capable of producing electric current from 
energy released by a redox reaction. This lund of cell is also known as galvanic cell , 
named after Luigi Galvani, the 18" century scienhst responsible for conducting some 
of the fust experiments on chemical reactions lnvolvlng electnc current. In a galvanic 
cell the anode is defined as the electrode where oxidation occurs and the cathode 1s 
the electrode where reduction takes place. The electrodes in galvamc cells have 
different dissolving rates (unequal amounts of electrons in each metal) which cause a 
difference in electrode potential between the electrolyte and the electrodes. If an 
electrical connection, such as a wire or direct contact, is formed between the anode 
and cathode, electrical current will flow between the metal electrodes (Bard and 
Faullcner, 1980). The application of a potential to an electrode can, therefore, supply 
electrical energy, thus altering the energy level of the electrons withtn a metal 
electrode since they possess charge. If we consider a single electron transfer reachon 
as described in Equaaon 1.2; 
Equation 1.2 0 + e-- R, 
where 0 is a molecule in an oxidised state, R is a molecule in a reduced state and e is 
an electron 
It can be assumed that there are arbitrary amounts of (0) and (R) in the solution and 
so the total current flowing, i, is determined by calculating the sum of the reductive i,, 
and oxidative i,, currents, as shown in Equation 1.3. 
Equation 1.3 i = i, + i, = n F k d  [Ole - nFAk,, @lo, 
where A is the electrode area (cm2), F is the Faraday constant 2.e. amount of electric 
charge in one mole of electrons (-9.65 x lb' Coulomb/mol), n is the number of 
electrons transferred [ 10 are the su&ce concentrations of either (0) or (R), 
respectively. 
The free energies of activation for the electrode reaction are related to both the 
chemical properties of the reactants, the transition state of the reactants and their 
response to applied potential. The Butler-Volmer equation, (Equation 1.4) provides 
further information on the fundamental relationship between current flow and applied 
voltage. 
where, F is the Faraday constant (-9.65 x 1@ Coulomb/mol) n is the number of 
electrons transferred, E is the applced voltage, E, is the voltage established by the 
mixture of (0) and (R) at equilibrium, [ lo are the surface concentrations of either 
(0) or (R), respectively, and the aterm reflects the sensztzvtty of the transition state to 
the applied voltage. 
If a is equal to zero, then the transition state shows no dependence on potential 
Typically, however, a tends to approximate to 0.5. This means that the transition state 
responds to potential m a manner halfway between the reactants' and the products' 
response. Current flow therefore responds to changes in the value of a, the value of io 
(the exchange cnrrent density) and changes in potential. 
Electrochemical reactions involve the ~nterfacial transfer of charge between an 
electrode and a species in soluhon (Eg~ns ,  1996). The exponential relationship of 
appl~ed potential to rate of electron transfer would suggest that it is possible to 
transfer unlimited amounts of material to and from the electrode surface. However, 
for a fvred electrode surface area, the reaction rate is controlled by the rate constant 
and the surface concentration of the reactant. If the rate constant is sufficiently large 
so that any reactant close to the electrode surface is immediately converted mto 
reaction product, then the current will be controlled by the amount of fresh reactant 
reaching the surface over time from the bulk solution (Lower, 1994). This important 
factor shows that mass transport of reaction materials greatly affects measured 
current. 
Specifically there are three forms of mass transport, which can affect an 
electrochemical experiment, namely diffusion, convection, and migration (Brett and 
Oliveira Brett, 1993). Diffusion occurs in all solutions and arises from local 
differences in concentrations of reactants (Bakker ef al., 2004). Entropy forces act to 
try and equalise these differences and are the main driving forces for diffusion. 
Convection, however, results from the achon of a force on the solution, for example a 
stirrer or gravity, whereas migration is an electrostatic effect arising from the 
application of a polansing potential at an electrode, thus creating a charged interface 
Charged species within the local solnhon will become attracted to, or repelled from, 
the electrode. 
The common feature connecting electrochemical sensors is that they rely on the 
detection of an electrical property and are normally classed according to the mode of 
measurement, i.e., potentiometric, conducllmetric or amperometric, (Pejcic and 
DeMarco, 2006). The most important consideration in electrochemical sensor design 
is the understanding of the relationship between surface chemistry and reactivity. 
Examination of the processes occurring at surface layers and the interaction of such 
layers with biomolecules during electrochemical interrogation is the fundamental 
pnnclple behind electroanalytlcal techniques (Eggms, 1996) 
Surface modification and immobilisation techniques that are specific for the detection 
method employed and the electrical processes occurring at the sensor surface are 
paramount to ensuring optimal sensor operation. This can involve tailoring surface 
chemistries at electrode surfaces to improve biomolecule adsorption or altering the 
bulk electrical conduction properties of the sensor by modifying the membrane 
composition (Schultze, 2000). Understandmg how various parameters influence the 
response mechanism and interfacial reaction kinetics will assist with the development 
of electrochemical sensors with new and improved response charactenstics. 
Electrochemical impedance spectroscopy (EIS) is a non-destructive steady-state 
technique that is capable of probing these phenomena over a range of frequencies 
(Macdonald, 1987; Fletcher, 2001). 
1.5.2.1 impedance-based detection 
Electrical impedance spectroscopy (EIS) is an effective method for probing the 
features of surface-modified electrodes (Bard and Fanllcner, 1980, Stoynov 1989 and 
Stoynov et al., 1991). When a small-amphtude perturbing sinusoidal voltage signal is 
applied to the electrochemical cell, the resulting current response can be measured. 
The impedance is calculated as the ratio between the system voltage phasor, U (j w), 
and the current phasor, I (jw), which are generated by a frequency response analyser 
during the experiment. Complex impedance can be presented as the sum of the real, 
he(@), and imaginary, Z,,(w) components that originate mainly from the resistive and 
capacitive components of the cell, respectively. 
Equation 1.5 
U t i d  20'4 =- =Z,(LI$+ jZ,(LI$, 10'4 
where w=2n$ j = d-1 , w ls equal to the Warburg impedance ( rad . i l )  and f is the 
excitation frequency (Hz) 
One of the most important parameters governing impedance spectroscopy is the 
applled frequency. At very low frequencies the impedance value is determined by the 
DC-conductivity of the electrolyte solution, whereas at very high frequencies, the 
inductance of the electrochemical cell and connecting wires contribute to the resulting 
impedance spectra. To eliminate these effects, useful impedance spectra are recorded 
at frequencies where only the interfacial properties of the modified electrodes control 
the resulting data (10 mHz < f < 100 Hz). Experimental results can be analysed 
graphically as in the case of Faradac impedance spectra, usually by the use of the 
Nyquist coordinates (Z, vs. G), in the frame of the theoretical model (Ghindilis and 
Kurochkin, 1994). Thus, impedance spectroscopy provides a suitable transduction 
technique to follow the interfacial interactions of biomolecules at electrode surfaces 
(Cheng et al., 2002; Szymdska et al., 2007). EIS is a powerful method for the 
characterisation of the structural features of sensing interfaces and for explaining the 
actual events occurring at these surfaces. In this thesis, the development of a labeless 
impedance-based sensor for the detection of InlB is described. 
1.6 Target molecules for immunnsensnr development 
Immunoassays rely on the specific interaction between antibody and antigen for 
analyte determination (Ekins, 1999). Recent advances in antibody technology have 
allowed for the standardisation of anhbody preparations and revolutionised their use 
as clinical and diagnostic tools. Given the unique specificity of antibodies and the use 
of antibody libraries, common biosensor formats can now be easily and quicMy 
adapted for the detection of specific analytes in solution wlthout the need for 
developmg individual chromatographic assay separation techniques (Hock 1997). 
Point of care (POC) diagnostic Instruments are becoming more important in the 
current climate and the need for rapid, disposable polymer biochips for the detection 
of clinically important analytes is a key issue. Photostable fluorescent probes can be 
used to multiplex assays in chip format and the use of novel fluorescent labels such as 
quantum dots and nanoparticles, in the development of biochip and microarray 
platforms is paramount in the advancement of such systems. Characterisation of novel 
fluorescent labels on solid-phase platforms is an essential step, prior to transfer to 
biochip, as are comparahve stu&es based on traditional immnnochernical techmques 
such as ELISA. This allows determination of the advantages of novel labels with 
respect to assay performance, speed and detection limits attainable. 
The work in this thesis describes the development of novel antibody-based biosensors 
that employ both optical and electrochemical transduction methods for the detechon 
of a hapten, bacterial proteins and whole cells. Three distinctly different target 
molecules were chosen for the development of the antibody-based biosensors 
described in this research. Internalin B (InlB), an invasion-associated protein of 
Listeria monocytogenes, parvovirus B 19, the first human parvovirus and warfarin, the 
ninth most prescribed drug in the world. The following sections give a general 
overview of structure and function of each target and their clinical importance for 
detection. 
1.6.1 Warfarin 
Warfarm, a synthetic denvative of 4-hydroxycoumarin. is the most widely prescribed 
oral anticoagulant for the management of a wide variety of thromboembolic disorders 
such as atrial fibrillation and deep vein thrombosis (Hirsh et al., 2001). It is a vitamin 
K antagonist and, therefore, an indirect anti-coagulant. %tarnin K is a necessary 
element for the synthesis of a number of clotting factors in the blood (11, W, M and 
X). The production of these clotting factors is dependent on the carboxylation of 
glutamic acid residues, a process requiring the presence of vitamin K, a co-factor in 
the production of carboxylase (Cooke et al., 1997). The carboxylation of glutamate 
residues on the N-terminal portion of the clotting factors determines the required 
structure for the binding of calcium ions. It is these calcium ions that control the 
Interaction of the clotting factors with negatively charged phosphohpid surfaces such 
as platelets, thereby greatly enhancing the coagulation cascade and fibrin formation 
(Mueller, 2004). Warfarm reduces the rate at which these factors are produced, thus 
producing an anticoagulant effect. Figure 1.1 1 shows the basic structure of warfarin. 
The amount of fnncbonal vitamin K-dependent clotting factors produced can he 
reduced by up to 50% by the administration of warfarin therapy (Majerus et al., 
1996). Warfarin is nearly always administered orally and is absorbed rapidly, with 
peak blood levels attained after 90 minutes (King et al., 1995). The plasma half-life is 
between 36-42 hours; however, plasma concentrations do not correlate well with 
anticoagulant effect, implying variable hepatic metabolism in different individuals 
(Prandoni and Wright, 1942).Warfarin can he detected in the plasma one hour after 
oral administration, and peak concentrations occur two to eight hours later. The drug 
is highly bound to plasma proteins (-99%) and is metabolised in the liver and 
kidneys, with the subsequent production of inactive metabolites that are excreted in 
the unne and stool. 
There is currently a wide range of analytical techniques available for the 
determination of warfarin in biolo~cal fluids, ranging from chromatography to 
phosphorescence-based measurements (Capith-Vallvey et al., 1999; Osman et al., 
2005; Hou et al., 2007). However, these analytical techniques involve lengthy sample 
pre-treatment and post-column reactions for the determination of unbound warfarin in 
plasma samples. The current trend in warfarin therapy is towards lower intens~ty 
treatment. Consequently, there is the need to develop more sensitive analytical 
techniques capable of detecting lower concentrations of warfarin in biolog~cal flulds. 
Fitzpahick and O'Kemedy (2004) describe the development of a Biacore-based 
idubition immunoassay for the determination of warfarin in plasma ultraHtrate. This 
format demonstrated a range of detection from approximately 4-250 nglml, which is 
within the chnical range and showed good reproducibihty and robustness. The use of 
surface plasmon resonance technology for the detection of warfarin provides a viable 
alternative to traditional chromatographic techniques. However, recent advances in 
polymer technology and fluorescence-based detection methods have identified the 
importance of microarray and bioch~p formats in immunoassay development (Bashir, 
2004, Wacker et al., 2004). Therefore, improved fluorescent labels such as quantum 
dots and p o r p b y ~  dyes were evaluated for the development of sensitive and 
reproducible immunoassays for the detection of warfarin. The use of these novel 
fluorescent labels ~n plate-based assays and validation of such assays would then 
facilitate transfer of such optimised reagents to chip-based methods for the detection 
of warfarin 
1.6.2 Listeria rnonocytogenes 
Listena monocytogenes is an important food-borne pathogen with an extremely high 
mortality rate of approximately 30%. Llsteria monocytogenes is a gram-positive 
facultatively anaerobic rod-shaped bacterium that grows between 1 - 45°C (Jones and 
Seeliger, 1992). It is responsible for most food-borne outbreaks of listeriosis and 
belongs to the bactenal genus Listeria. Currently, there are six recogmzed species of 
Listeria (L. innocua, L. ivanovii, L. monocytogenes, L. grayi, L. seeligeri, L. 
welshcmerr), with L. monocytogenes the principal human pathogen. L monocytogenes 
can be readily isolated from a number of sources such as, soil, water, plants, fertilizer 
and processed foods, even when stored at 4'C (Southwick and Purich, 1996). 
Listeriosis is most prevalent in immunocompromised patients, with the risk of 
infection up 1000 times more hkely than that of the general public (Jensen et al., 
1994). The elderly, pregnant women and newborns are also especially at risk to 
hsteriosis, however, the general population can also be susceptible (Hof, 2003). In 
most cases of infection, symptoms present as those commonly associated with food 
poisoning and include fever, vomting, diarrhoea and headache. In more severe cases, 
listenosis can cause gastroenteritis, meningitis, septicaemia, and meningo- 
encephalnis. Links have also been found between listeriosis infection and 
spontaneous abortion and stillbirth (Doganay, 2003). The ability of the bacteria to 
cross the intestinal, bloodbram and foeto-placental barriers during infection is an 
important consideration in understanding the pathogenic effect of the disease. In all 
infected tissues, Listeria is intracellular owing to its capaclty to survive in phagocytic 
cells and also to invade and survive in non-phagocytic cells (Cossart et al., 2003). The 
bactena rely on actin-based motihty to spread from cell to cell, escaping the 
internalisation vacuole by this method. A family of bacterial cell-wall surface proteins 
known as the internalins aid in this process by promoting entry into epithelial cells 
and hepatocytes (Dramsi et al., 1995). 
The life cycle of L. monocytogenes m host cells 1s described in detail by Southwick 
and Purich (1996) and involves a number of distinct stages. The initial entry of the 
bacteria into the host cells is dependent on vuulence factors. Phagocytosed L. 
monocytogenes survive the phagocytic vacuole by activation of listeriolysin 0 &LO) 
and the bacterial metalloprotease (MpL) as the pH inside the phagolysosome drops 
(Cossart, 2002). This &srupts the phagosomal membranes and allows the bacteria to 
escape into the cytosol. Within the cytosol the L. monocytogenes cells replicate and 
direct cell-to-cell spread using actin-based motility. The internalin family of protelns 
are involved in the invasion of host cells, with Internalin A (MA) and Internalin B 
(InlB) the most important. The structure of the internalins is characterised by the 
presence of two distinct repeat regions separated by an inter-repeat region (Schubert 
et al., 2001). The proteins generally comprise a short N-terminal conserved cap 
region, followed by several leucine-rich repeats (LlZR), an inter-repeat ('IgG-like') 
region and a second repeat region known as the B repeats (B~erne and Cossart, 2002). 
The research described in this thesis focuses on the study of Internalin B &lB) and 
Figure 1.12 illustrates the InlB amino acid structure and the regions and domains into 
which it can be divided. 
N Terminus 
Cap D o m n  36-85aa 
'Leucme-nch' Repeats (LRR) 
86-239aa -F3 
Inter Repeats (IR) 240-321aa 
'IgG-me' domm - F4 
C Terminus B Repeats 322-392aa - F5 
J GW Repeats 393-630aa - Full protein 
Fig. 1.12 Internalin B amino acid structure. The amino acid sequence of the InlB 
protein is organised into a number of distinct domains. schematic domain 
organization of full length InlB, comprising an N-terminal signal sequence (resrdues 
1-35), cap domain (3&85), LRR-domain (8&239), ZR-region (24&321), B-repeat 
(322-392) and three GW-modules (393430). This schematic also shows how the full 
recombinant Internalin B protein was divided into three smallerpeptide fragments for 
epitope mapping F3, F4 and F5. F3 covers amino acids 0-239, F4 covers amino acids 
0-321 and F5 covers amino acids 0-392 (Adapted from Schubert d., 2001; 
Freiberg d., 2004). 
InlB promotes invasion into the host cell by activation of phosphatidylinositol-3- 
kinase (Ireton and Cossart, 1997). The InlB protein contruns four distinct domains, 
similar to the other members of the internalin family. The amino terminal part of the 
protein incorporates the internalin domam, housing the cap domain, 'leucine-rich' 
repeats (LRR) and inter-repeat (IR) region and is involved in Met recognition. The 
LRR provide a structural framework for the formation of protein-protein interactions 
(Kobe and Kajava, 2001), whereas the carhoxy-terminal anchors the protein to the cell 
via the GW repeat domains. These repeats cause a loose association of the protein to 
the bacterial surface through non-covalent interactions with lipoteichoic acid. This is a 
membrane-anchored polymer that IS present on the surface of Gram-positive bacteria 
(Jonquieres et al., 1999) 
L. monocytogenes can he found in a wide variety of foods such as soft cheeses, pate, 
processed meats, chicken, shellfish and milk (Rea et al., 1992; Dalton et al., 1997; 
Holhngsworth, 1999; de Valk et al., 2001). The isolation of L monocytogenes from 
these foodstuffs and the link of food-poisoning outbreaks to Listeria-contaminated 
samples, have prompted the development of more rapid and sensitive methods for 
detection. Traditionally, recognition of L monocytogenes in a sample was performed 
using immunoassays which target the whole bacterial cell (Mena et al., 2004). These 
methods can he both dangerous and time-consuming in that pathogenic bacterial cells 
are involved. An unproved technique for the detection of Listeria, employing the L. 
monocytogenes cell surface proteins InlB as antigemc determinant, was investigated 
for the development of optnnised systems described in this thesis. The use of L. 
monocytogenes-derived recombinant proteins such as InlB in assay development 
eliminates the need to culture and handle pathogenic cells and a constant supply of 
antigen can be maintained. Both electrochemical and optical-based sensing methods 
were examined for the enhanced detection of MB. Novel fluorescent labels were 
characterised on solid-phase platforms prior to transfer to a biochip for enhanced 
detection of InlB. Impedance-based detection of InlB was also investigated and the 
development of a novel platform for the labeless sensing of InlB via impedimetric 
transduchon described. 
1.6.3 Parvovirus 
Parvovims is a small un-enveloped single stranded DNA virus (Coon, 2003). The 
members of the parvo-vindae are among the smallest of all DNA viruses. Its members 
infect many species, from insects to higher annnals, but only one member, parvovlrus 
B 19, is able to cause human disease. Infection with Parvovirus B19 is common in 
humans and symptoms range from completely asymptomatic infection to serious and 
potentially fatal conditions in a minority of the population (Brown, 2004). Figure 
1.13 shows an x-ray crystallographic image of Parvovims B19, the human strain of 
this disease. 
Fig 1.13 X-ray crystallographic image of the Parvovirus B19 capsid protein VP2 
particle (obtained from Barbel Kaujinann e l ,  2005). 
Parvovirus B19 can cause many illnesses ranging from a deadly infection to anaemia 
and arthropathy, dependmg on the age and immune status of the affected patient 
(Coon et al., 2003). In children, infection commonly manifests as Fifth disease or 
erythema infectiosum, whereas in adults, especially women, polyarthropathy 1s 
common. In immunosuppressed patients manifestation is as pure red cell aplasia, and 
during pregnancy as hydrops fetalis or intrauterine death (Young and Brown, 2004). 
Many assays are available to test for parvovirus infections and these include antibody 
serology studies, DNA-based methods such as PCR and various methods based on 
antigen detection. Parvovirus first emerged in the 1970's as a disease affecting dogs 
and cats caused by the tiny virus effecting eukaryotes. In both species, parvovirus 
causes serious problems for newborns and can be fatal; older animals can suffer some 
effects, but they are mild and temporary. The virus can stay active in soil for long 
periods of time, so dogs must be vaccinated close to birth, immediately after maternal 
antibodies wane. In 1975, Cossart et al., mscovered the human form, Parvovirus B19, 
to be the causative agent of F i  disease, a mild rash on the body, typically described 
by doctors as a "slapped-cheek pattern on the face. Transmission is greatest during 
vlraemia prior to symptoms arising and the virus is mainly spread via aerosol droplets 
through the respiratory route. It is usually transmitted by hand-to-mouth contact, 
blood or blood products but can also be spread transplacentally to the foetus during 
active maternal infection, w~th infection rates of up to 33% reported (Anonymous, 
1990). During outbreaks, which predominantly occur in winter and spring time, 
infechon rates of up to 50% have been noted m the school and home, respectively 
(Anderson, 1987). 
Parvovirus B19 preferentially Infects and replicates ~n erytbroid cells. Erythrocytes 
will lyse causing elythropoiesis, following Parvovirus B19 infection and lymphocyte, 
granulocyte and platelet counts may also fall during infection. The incubation penod 
for the virus is usually 4-14 days and all non-immune individuals are susceptible 
(which can be up to 50% of the populaaon). The highest risk of infection for pregnant 
women is during epidemics and follow~ng exposure to infected children (Valeur- 
Jensen, 1999). Persons w~th pre-existmg anaemia and congenital or acquired 
immunodeficiencies are also highly susceptible. The consequences of parvovirus 
infection during pregnancy are extremely serious @e Yong et al., 2004), the main 
risk being foetal anaemia which can lead to Non-Immune Hydrops Fetalis 0, 
resulting in miscarriage. It has been estimated that maternal Parvovirus B 19 infection 
occurs in approximately 1 in every 400 pregnancies and up to 20% of NIHF is 
parvovirus B19 related (Jordan, 1996). The majority of foetal losses due to B19 
infection occur in the second trimester and most pregnant woman are asymptomatic, 
therefore, the only was to identify patients at risk is to screen for parvovirus B19 
antibod~es and treat appropriately. 
Parvovirus B19 infection is also a major concern for transplant patients. Parvovirus 
B19 can cause acute or chronic aplastic anaemia in organ transplant recipients and can 
contribute to some cases of rejection (Murer et al., 2000). Patients who have 
undergone an organ transplant are at risk of develop~ng Parvovims B19 due to 
acquired infection from the transplanted organ and blood transfusions. However, 
Intravenous immunoglobulin ( M G )  therapy has been shown to be effective in 
treating chronic Parvovirus B19 infection in transplant patients. 
Parvovirus B19 has been associated with persistent chronic anaemia and with 
transient aplastic crisis in children with sickle cell disease. Reports suggest that 
Parvovirus B19 can be transmitted through blood transfusions and plasma-derived 
products (Prowse et al., 1997). B19 is a non-enveloped virus and is resistant to high 
temperatures and most solvent-detergent treatments. Despite this fact, routine 
screening of blood products for B19 DNA does not occur. It was suggested that 
ind~vidual donors should be screened for B19 IgG and those with continually high 
levels could be identifled. The blood or plasma from these donors could then not be 
used for treatment of any immunocompromised or other high risk patients, thereby 
reducmg the risk of B19 infection (Yoto et al., 1995). Although intravenous 
immunoglobulin (IVIG) therapy is effective for the treatment of Parvovirus B19 
infection in humans, work is currently being carried out to produce a vaccine. 
There are many different diagnostic tests available for the detection of Parvovirus B19 
(Beersma et al., 2005; Peterlana et al., 2006; Wong & Brown, 2006). However, with 
the increasing use of microarray and chip-based technologies in diagnostics, there is a 
need for the development of sensitive and reproducible assays that employ 
fluorescence-based methods for the detection of Parvovirus-associated antigens. The 
successful development of fluorescence and chemiluminescence-based munoassays 
for the detection of Parvovirus antigens in plate-based assays would facilitate further 
investigation of these methods and their potential transfer to novel chip-based 
formats. 
1.7 Aims of research 
The overall aim of this thesis was the development of novel biosensing strategies for 
the detection of haptens, proteins and whole cells. Assays were developed for the 
detection of InlB, warfarin and Parvovirus B19, using antibody-based methods. The 
research sought to exploit novel antigens, antibodies, labels and immobilisation 
strategies. Optical and electrochemical-based techniques were inveshgated using a 
number of detection methods including microscopy, biosensors and immunoassays. 
Chapter 3 describes the production and characterisation of L. monocytogenes-specific 
recombmant InlB protein fragments. Recombinant InlB protein was sub-divided into 
three shorter overlapping peptide fragments which were cloned into both the pQE-60 
vector for His puritication and the pAC4 vector for in vivo biotinylation. Following 
high-level expression, the recombinant proteins were purified using m o b i l ~ s e d  
metal affimty chromatography (IMAC) and avidm affinity chromatography. 
Extensive characterisation of the cloned proteins using SDS-PAGE, Western blotting 
and Biacore was performed. The InlB protein fragments were subsequently used m 
the development of novel biosensing strategies for the detection of InlB. 
Chapter 4 describes the development of fluorescence-based biosensing strategies for 
the detection of InlB, warfarin, Parvovirus B19 and human IgG. Solid-phase plate 
based methods were employed to inveshgate novel fluorescent labels, such as 
quantum dots, porphyrins and dye-doped nanoparticles. Subsequent transfer to a 
hiochip format was undertaken for some of the assays and optmisation of 
immobilisation strategies explored. 
Chapter 5 describes the development of a labeless impedance-based immunosensor 
for the detection of InlB. Electrochemical impedance spectroscopy techniques were 
used to investigate 'labeless' detection via impedimetric transduction. Sensors were 
fabricated by electropolymerising planar screen printed carbon electrodes with 
polyaniline to produce a conduchve substrate and biomolecules were subsequently 
~ncorporated onto the polyaniline layer. Upon exposure to a range of concentrations of 
antigen solution, complex plane impedance analyses were performed to assess the 
Impedance of the polymer, thereby allowing the amount of bound antigen to be 
determined. 
Chapter 2: Materials and Methods 
2.1 Material and equipment 
2.1.1 Materials 
All reagents and chemicals were of analytical grade and supplied by Sigma-Aldrich 
Co. (Poole, Dorset, U.K ), unless listed below (Table 2.1). 
Table 2.1: Reagents and chemicals used and the relevant suppliers. 
Hydrochloric acid Wunstorfer, Strahe 40, D-30926, 
Dl-sodium hydrogen orthophosphate Poole, Dorset, 
Bishop Meadows Rd., Loughborough, 
AVB 101 E. Coli 1899 Gaylord St., 
13 Charlemont Tce., 
T4 DNA ligase Dun Laoghaire, 
Neutravidin North Meridian Rd., 
Immunopure Avidin 
Biotin-Sulfo-NHS RocHord, IL., 
Pre-stained MW markers (Blueranger) 
Ni-NTA resin 
pQE-60 vector 
QIAgen, QIAgen House, 
Flemng Way, Crawley, 
West Sussex, UK. 
Wizard Mini Prep K I ~  2800 Wood Hollow Rd., 
Madison, WI., 
Milton Keynes, 
261 18 Research Rd., 
Hayward, CA., 
L-glutamine (200mM) Trident House, Renfrew Rd., 
Non-essential armno acids (100~)  Paisley, PA4 9RF, 
Scotland, UK 
Industriestrasse 25, 
Agar Technical (L0013) 
Yeast Extract (L0042) 
2.1.2 Equipment 
Table 2.2: List detailing equipment used and the relevant suppliers. 
Equipment 
3015 pH meter 
Atto dual minislab AE-6450 
Atto AE-6100 
Hybrid PCR express 
Beckman ultracentrifuge (L8-70M) 
Beckman centrifuge (J2-21) 
BiacoreTM 1000 & 3000 
Nikon Diaphot inverted microscope 
Nikon Fluorescent microscope (TE2000) 
Ultrafiltration Surred Cell (8400) 
Stuart Platform Shaker (STR6) 
Biometra T gradient Uno I1 
Thermocycler 
Supplier 
Jeuway Ltd., 
Gransmore Green, 
Felsted, Dunmow, Essex, UK. 
Medical Supply Company (MSC), 
Damastown, Mulhuddart, 
Dublin 15, 
Ireland. 
Beckman-Coulter Inc., 
4300N Harbour Boulevard, 
Fulleaon, CA 92834-3100, USA. 
Biacore AB, 
2 Meadway Court, 
Meadway, Stevenage, Herts., 
SGI ZEF, UK. 
Nikon Corporation, 
2-3 Marunonchi 
3-chome, Chiyoda-ku, 
Tokyo, Japan. 
Amicon Inc., 
72 Cherry Hill Drive, 
Beverly, MA., 
01915, USA. 
Lennox, P.O. Box 212A, 
John F.Kennedy Drive, 
Naas Rd., 
Dublin 12. 
Anachem Ltd., Anachem House, 
Charles St., Luton, 
Bedfordshire, UK 
- 
Trans-Blot Sem-Dry Electrophorehc 
Transfer Cell (170-3940) 
Econo-PacTM chromatography column 
Eppendorf centrifuge (5810 R) 
Eppendorf tubes 
Grant waterbath (Y6) 
Heraeus Christ Labofuge 6000 
Image Master VSD gel documentation 
system 
NUNC Maxisorb plates 
Orbital incubator (100X400.Ml.C) 
BioRad Laboratories Inc., 
B~oRad House, 
Maylands Ave., Hemel Hempstead, 
Hertfordshire, UK. 
Eppendorf AG, 
10 Signet Com, 
Swann Rd., Cambridge, UK. 
Sarstedt, 
Drinagh, 
Wexford, Ireland. 
Grant Instruments (Cambridge) Ltd., 
29 Station Rd., Shepreth, Royston, 
Hertfordshire, UK. 
Heraeus Instruments Inc. 
11 1-a Corporate Blvd. 
South Plainfield, NJ, USA. 
Amersham Pharmacia Biotech AB, 
SE-751 84, Uppsala, Sweden. 
NUNC, Kamstmp DK, 
Roskilde, Denmark. 
Sanyo Gallenkamp Plc, Monarch Way, 
Belton Pa& Loughborough, 
Greenville Hall, 228 South Cucula~ Rd., 
Untersbergstrasse la, A-5082 Grodig / 
230 Upper 5th Street, Milton Keynes, 
72 Sackville Street, 
fluorescent imaging software Dublin City University, 
Scanning Electron iWcroscope 1-chome, Chiyoda-ku, 
PC interface Wear Ind. Est, Washington, Tyne & Wear 
NE38 9EZ, UK. 
response analyser Grange-over-Sands, Cumbna, UK, 
Castlefield Road, Reigate, Surrey 
Sartorius Group, 30625 Hannover, 
2.13 Composition of culture media 
Table 2.3: Composition of culture media used. 
* Solid medium was prepared by adding 15 g/l of bacteriological agar to the above 
medium 
Culture Media* 
2x Tryptone Yeast extract (2x TY) medlum 
- 
Luria Broth medium 
Super Broth medium 
Terrifc Broth medium 
Super Optimal Catabolite (SOC) medium 
Brain Heart Infusion 
Listeria-Enrichment Broth 
Formulation 
Tryptone 16 gfl, 
Yeast extract 10 gfl, 
NaCl 5 dl.  
Tryptone 10 d l ,  
Yeast extract 5 gfl, 
NaCl 10 gn. 
MOPS 10 gfl, 
Yeast Exh-act 20 go, 
Tryptone 30 dl.  
Tryptone 12 gfl, 
Yeast extract 24 gfl, 
Glycerol 4 d, 
m p o 4  17mM, 
KzHPO4 72mM. 
Tryptone 20 gn, 
Yeast extract 5 g/l, 
NaCl 0.5 gil, 
KC1 2.5mM, 
MsCl2 Z O ~ M ,  
Glucose 2OmM. 
BHI 54.4 gfl. 
LEB 37 dl .  
2.1.4 Standard buffers 
Table 2-4: Composition of buffers used. 
2.5mM KC1, 
lOmM NazHF'04, 
18mM KHzPO4, 
2.5mM KC1, 
l0mM NazHF'O4, 
18mM KIhP04, 
0.05% (v/v) Tween 20, 
3.4mM EDTA, 
0.05% (vlv) Tween 20, 
150rnM NaC1, 
monomer soluhon 
lOOmM NaH2P04, 
0.2M NaHCO3, 
electrophoresis buffer (TAE) 
0.5M Sucrose, 
0.5mM EDTA, 
Bromde (CTAB) soluhon 1mM NaOH, 
" Denotes toxic material. Use according to manufacturer's instructions and with extreme caution. 
2.1.5 Bacterial strains 
Table 2.5: Bacterial host strains and theu genotypes 
lacP ZAMl5 TnlO (Tetr)] 
relAl@Olac7AM15 A (lacZYA-argF) U16 A- 
(rirnk'McrB-) thi h(lac-proAB) 
thi-1, recAl gyrA96, reD11, lacHte [F' proAB lacPZhMl5 
2.1.6 Cell culture of mammalian cell lines 
Table 2.6: Mammalian cell lines 
2.1.7 Cell culture media preparation 
Table 2.7: Cell culture media preparation 
Growth Media Supplemented with - 
Foetal Calf Sermn 10% (vlv), 
L-glutamine (ZmM), 
Growth Media Supplemented with - 
Foetal Calf Serum 10% (vlv), 
Lglutamine (ZmM), 
Sodium Pyruvate 1% (vlv), 
Non-essenhal amino acids 1% (vlv), 
Gentamycin (25yglml). 
2.2 Cloning and expression of Listeria rnonocytogenes-specific protein fragments 
in pQE-60 vector. 
E. coli XL-10 Gold cells containing the plasmid pQE60, bearing the Internalin B 
(InlB) gene, were kindly donated by Dr. Paul Leonard, Applied Biochemstry Group, 
Dublin City University. T%e previously expressed recombinant InlB protein was used 
as a template for the cloning and expression of smaller InlB protein fragments into the 
PQE-60 vector (Qiagen Ltd., Crawley, West Sussex, UK). 
2.2.1 Plasmid DNA purification using miniprep DNA purification system 
A Promega WizardM Plus SV Miprep  DNA purification system was used to purify 
plasmid DNA as follows: single colonies of E. coli cells harbouring the plasmid were 
inoculated in 5ml of LB broth, containing the appropriate antibiohcs, and grown while 
shaking at 37°C overnight. The overnight culture was centrifuged at 10,000 x g for 20 
min. The supernatant was discarded and the tube was blotted on tissue paper to 
remove any rema~ning supernatant. The bacterial pellet was completely resuspended 
in 250pl of cell resuspension solution (50mM Tris-HC1, pH 7.5, lOmM EDTA and 
1Opg RNase A) by repeated pipetting The resuspended pellet was then transferred to 
a sterile 1.51111 microcentnfuge tube and 250 pl of cell lysis solution (0.2M NaOH and 
1% (wlv) SDS) was added and mixed gently by inverting the tube four times. The 
suspension was then incubated at room temperature for approximately 5 min, until the 
cell suspension cleared, to ensure complete cell lysis. Alkaline protease solution 
(10~1) was then added and mixed by inverting the tube four times. After five minutes 
incubation, 350pl of neutralisation solution (buffer containing 4.09 M guanidine 
hydrochloride, 0.795 M potassium acetate and 2.12 M glacial acetic acid, pH 4.2) was 
added and mixed by inversion. The bacterial lysate was then centrifuged at 10,000 x g 
for 10 mins at room temperature. The cleared bacterial lysate was transferred to a spin 
column and centrifuged at 10,000 x g for 1 minute at room temperature, after whch 
the spin column was removed and the flow-through discarded. The spin column was 
re-inserted into the collection tube and 750pl of column wash solution (162.8mM 
potassium acetate, 22.6mM Tris-HC1, pH 7.5 and 0.109mM EDTA) previously 
diluted with ethanol to 95% (vlv) h a 1  concentration, was added. The column was 
then centrifuged at 10,000 x g for 1 rnin at room temperature and the flow-through 
discarded. Wash solution (250~1) was added to the column, which was then 
centrifuged at 10,000 x g for 2 min at room temperature. The spin column was then 
transferred to a sterile 1.5ml microcentrlfuge tube and the plasmid DNA was eluted 
from the column by adding 100pl of autoclaved upHzO. The column was centrifuged 
at 10,000 x g for 1 min at room temperature. The eluted plasmid DNA was then stored 
at -20°C. 
2.2.2 Agarose gel electrophoresis for DNA characterisation 
DNA samples were analysed by horizontal electrophoresis in agarose gels containing 
0.5pglml etludium bromide*, using an Atto horizontal gel apparatus. Gels were 
prepared by dissolving O.5g electrophoresis grade agarose in 50ml lxTAE and boiling 
the mixture in a microwave oven (this gives a 1% w/v gel). Ethidium bromide was 
added to the solubilised agarose to yield a final concentration of 0.5pglml. When the 
solution had cooled sufficiently, the gel was poured into a horizontal gel platform, 
combs inserted and the gel left to solidify. Once set, the gel was placed in the 
electrophoresis unit f i e d  with lx TAE buffer and the comb removed. A loading dye 
was incorporated into the DNA samples (1pl of dye to 5 ~ 1  of sample) to facihtate 
loading. The samples were resolved by applying a direct current of appropriate 
voltage. Mini- and maxi-gels were run at IOOV for 1 hour or until the tracking dye 
reached the base of the gel. Gels were then visualised on a UV transilluminator and 
photographed using a W image analyser (Image master VSD system, Amersham 
Pharmacia). 
* Denotes toxic matenal. Use according to manufacturer's instructions and with extreme caution 
2.2.3 DNA agarose gel purification 
DNA was purified from the agarose gel using a WizardTM PCR-prep purification kit. 
DNA was electrophoresed on a 1% (wlv) low melt agarose gel at 70V for 
approximately 1 - 2 hours. The gel was then visualised under ultra violet (UV) hght 
and the bands of interest excised from the gel using a sterile scalpel and placed in a 
sterile 1.51111 microcentrifuge tube. The gel bands were tlien incubated in a 70°C water 
bath until the gel was completely melted. Immediately after the gel melted lml of 
resin was added. The gel resin-mix was then flushed through a Wizard mini-column 
using a 5ml syringe barrel. The mini-column was then washed with 2ml of 80% (vlv) 
propanol. The syringe barrel was then removed and the mini-column placed in a fresh 
1 . 5 ~ 1  microcentrifuge tube. The column and eppendorf were then centrifuged at 
10,000 x g for 2 min, to remove the propanol. The column was once again transferred 
to a fresh 1.5ml microcenhifuge tuhe and 50pl of upH20 added. This was incubated 
at room temperature for 1 nun and the column was then centrifuged at 10,000 x g for 
20 s. The eluted DNA was collected in a sterile microcenhifuge tuhe and stored at - 
20°C. 
2.2.4 Preparation of high efficiency competent bacterial cells for transformation. 
High efficiency competent cells were prepared as previously described by Inoue et al., 
(1990). A single E. coli colony was inoculated in 5ml of 2x TY, containing the 
appropriate antibiotics, and grown overnight at 37% while shaking. lOOml of 2x TY 
was inoculated with the overnight culture and the culture incubated, while shaking at 
37"C, until the optical density at 550nm (OD5%) was between 0.3 and 0.4. The cells 
were then left on ice for 15 rnin and centrifuged at 3200 x g for 20 min at 4°C. The 
supernatant was decanted and the pellet was resuspended in 20ml of cold lOOmM 
MgC12. The cells were centrifuged at 3200 x g for 20 min at 4°C and the pellet was 
resuspended m 20ml of cold 50mM CaC12. The cells were incubated on ice for 30 rnin 
and collected by centrifugation at 3200 x g for 20 min at 4'C. The supernatant was 
decanted and the cells were resuspended in 2ml of CaC12. The CaClz-competent E. 
coli were flash £rozen in 200pl aliqnots and stored at -80°C. 
2.2.5 Sodium dodecyl sulphate - polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE analysis was used to assess protein purity and determine the apparent 
molecular mass of proteins. Protein electrophoresis was performed using an Atto dual 
minislab AE-6450 electrophoresis system. Polyacrylamide gel electrophoresis was 
canied out using the discontinuous system in the presence of sodium dodecyl sulphate 
(SDS), as described by Laemmli (1970). Table 2.8a details the composition of the 
gels, running buffer and sample loading buffer. Samples for analysis (approx. 1 
mglml) were diluted with the sample loading dye (4: I ,  sample: buffer) and boiled for 
10 min prior to loadmg. Boiled samples (20p.l) were added to the gel and 
electrophoresed alongside appropriate molecular weight markers (Table 2.8b). 
Initially the gels were electrophoresed at 15mA per plate nnhl the samples migrated 
through the stacking gel and then they were electrophoresed at 20mA per plate until 
the sample had migrated to the end of the gel (approximately 90 min). 
Table 2.8a: Composition of SDS-PAGE gels and buffers 
Solution 
Stacking gel 
Separating gel 
Sample loading buffer 
Composition 
5% (wlv) acrylamide, 
0.13% (wlv) his-acrylamide, 
125mM Tns, 
0.1% (wlv) SDS, 
0.15% (wlv) ammonium persnlphate, 
0.25% (vlv) TEMED. 
10% (wlv) acrylamide, 
0.27% (wlv) bis-acrylamide, 
375mM Tris, 
0.1% (wlv) SDS, 
0.08% (wlv) ammonium persulphate, 
0.08% (vlv) TEMED. 
6OmM Tris, 
25% (vlv) glycerol, 
2% (vlv) SDS, 
14.4 mM 2-mercaptoethanol, 
0.1 % (wlv) hromophenol blue. 
192mM Glycine, 
0.1% (wlv) SDS. 
Table 2.8b: Molecular weight markers used in SDS-PAGE analysis 
Molecular weight range: Trypsmn mnhibitor, soybean (20,000), 
6,500- 205,000 Da Trypsinogen, bovine pancreas (24,000), 
Carbomc anhydrase, bovine erythrocytes (29,000), 
Glyceraldehyde-3-phosphate dehydrogenase, rabbmt 
Ovalbumin, chicken egg (45,000), 
Glutamic dehydrogenase, bovine lmver (55,000), 
Albumin, bovine serum (66,000), 
Phosphorylase B, rabbit muscle (97,000), 
P-Galactosidase, E. colz (1 16,000), 
pre-stained marker (26681) Trypsin mnhibitor (28,000), 
Carbonic anhydrase (39,200), 
Molecular weight range: Ovalbumin (60,000), 
18,300- 215,000 Da Bovine serum Albumin (84,000), 
Phosphorylase (120,000), 
pre-stained marker (RPNSOO) Recombinant Protemn (15,000), 
Molecular weight range: Recombinant Protein (30,000), 
10,000- 250,000 Da Recombinant Protein (35,000), 
Recombinant Protein (50,000), 
Recombmant Protein (75,000), 
Recombinant Protein (105,000), 
Recombinant Protein (160,000), 
Recombinant Protein (250,000). 
2.2.6 Coomassie blue staining of SDS-PAGE gels 
SDS-PAGE gels were staned for 4 hours using Coomassie blue to allow visualisation 
of the protein bands, and then destained overnight in destaimng solution (Table 2.9). 
Table 2.9: Composition of Coomassie blue stanlng and desta~ning solnt~ons. 
2.2.7 western blot analysis 
Proteins were transferred from SDS-PAGE gels (Sectron 2.2.5) to nitrocellulose 
membrane by electophoretic means using a BioRad sem-dry blotter (Trans-Blot SD 
Semi-Dry Electophorehc Transfer Cell 170-3940). The SDS-PAGE gel, nitrocellulose 
and Whatman chromatography paper were pre-soaked in Bjemm and Schafer- 
Nielson transfer buffer, pH 9.2 (48 mM Tris, 39mM Glycine 0.0375% (wlv) SDS 
20% (vlv) methanol) for 20 min. The gel was transferred to the membrane for 20 min 
at 15V. The membrane was blocked overnight at 4°C with PBS (Table 2.4) 
containing 5% (wlv) powdered milk. The blocked membrane was then washed using 
PBS (Table 2.4) using 3 x lOmin washes. The membrane was probed with the 
primary antibody, made up to the appropriate working dilution in PBS (Table 2.4) 
containing 1% (wlv) powdered milk. The antibody solution was left to incubate for 
1.5 hours at room temperature, and the membrane washed as before. An enzyme- 
labelled secondary antibody diluted to 112000 in PBS (Table 2.4) contaming 4% (wlv) 
powdered milk was added and the blot incubated and washed as before. Colour 
development was then observed following addition of the appropriate substrate, 
(BCIP-NBT for alkaline-phosphatase labelled antibody or TMB for horseradish- 
peroxidase labelled anhbody), and the reaction stopped after 5 min, by addition of 
50mM EDTA. 
Solution 
Coomassie blue staining solution 
Destaining soluaon 
Composition 
0.1 % (wlv) Coomass~e Brilliant Blue R-250 , 
25% (vlv) methanol, 
10% (vlv) acehc acid 
14% (vlv) methanol, 
10% (vlv) acehc acid. 
22.8 Primer design for Epitope Mapping 
Forward and reverse DNA primers were designed for the genes encoding the InlB 
protein based on DNA sequences previously submitted to GenBank The Internalin B 
recombinant protein was portioned into three smaller fragments and primers designed 
to ccde for portioning the protein at these points, (F3, F4 and P5). The F3, F4 and F5 
primers were based on the sequence of the recombinant InlB protein cloned and 
expressed by Chakraborty and associates (1995) from L. monocyfogenes (Accession 
number AJ01234GenBank). NcoI and B ~ ~ H I '  restriction enzyme sites were 
incorporated into the forward and reverse primers, respectively, for subsequent 
directional cloning into the high-level expression vector pQE60. The DNA sequences 
of the forward and reverse primers for each of the three fmgments F3, F4 & F5 of the 
InlB gene are shown in Table 2.10. 
Table 2.10: The nucleotide sequences of the InlB-specific forward and reverse primers. 
2.29 PCR amplification of genes encoding the InlB specific proteins 
Standard polymerase chain reactions VCRs) were set up as detailed in Table 2.1 1.The 
PCRs were used to amplify the genes encoding F3, F4 and P5 using the PCR cycle 
detailed in Table 2.12. A temperature gradient PCR was performed to determine the 
optimum annealing temperature for subsequent reactions and the optimum 
temperature was calculated to be 55'C. 
Primer 
lnlB forward 
P3 reverse 
P4 reverse 
P5 reverse 
DNA sequence 
Ncol site 
5'- CAT G 3A GAG ACT ATC ACC GTG CCA ACG C- 3' 
'start codon 
- 
BamHl site 
5'- CGC 7\CA TTC TTG GCT AAA TAA TTC- 3' 
5'- CGC TAC TGT GTA AAC CTC m CAG TGG- 3' 
BamHl site 
5'- CGC GGA TCC 7TG TTI' AAG CGA GTT ATC TM31 TCG - 3' 
Table 2.11: The components for a standardPCR reachon. 
Thermo buffer, containing M~~~ (lox) 
Forward primers (O.SnMIk1) 
Forward primers (0.5nMIfl) 
Template DNA (5-7ug) 
Taq polymerase (1UIp1) 
Table 2.12: The stages and steps for a standard PCR reaction. 
Step 2: 55°C for 30 s 
Step 3: 72°C for 1 min 
2.2.10 Direct Purification of insert PCR Products 
Direct pdcation of the PCR amplifications of each of the inserts F3, F4 & F5 was 
performed using a commercial kit (Promega WizardTM PCR Prep DNA purification 
system). Direct purification buffer (50mM KC1, lOmM Tris-HC1, pH 8.8, 1.5mM 
MgClz & 0.1% (vlv) Triton@ X-100) was added to 200~1 of the PCR reaction 
(pooled) and vortexed briefly to mix. Once the PCR reaction I buffer mixture was 
sufficiently combined, lml of resin was added. A wizard nunicolurnn was prepared 
for'each sample by attaching a 3ml luer lock syringe (with the plunger removed) to a 
minicolumn with a collection tube. The resinlDNA mix was transferred to the 
syringe/column assembly and the plunger inserted to push the DNAIresin slurry 
through the column. The syringe was then detached from the minicolumn, the plunger 
removed from the barrel and the barrel re-attached to the column. Two ml of 
isopropanol 80% (vlv) was added to the syringe and pushed through, using the 
plunger, to wash the column. The syringe was then removed completely and the 
mnicolumn transferred to a fresh microcentrifuge tube. The column was then 
centrifuged at 10,000 x g for 2 min at room temperature. The minicolumn was 
transferred to another clean microcenhifuge tube and 50ul of 'nuclease-free' water 
added and let sit for 1 rnin. The column was then centrifuged at 10,000 x g for 20 s at 
mom temperature. The eluted DNA was stored at -20°C. 
2.2.11 BamHliNcol restriction analysis on E. coli transformed with pQE-60 
BamHl/Ncol restriction enzyme analysis was carried out on the pQE-60 plasmid 
DNA isolated from the transformed XL-10 Gold E. coli. Overnight cultures of the 
clones for analysis were inoculated in 5ml of LB with appropriate antibiotics and 
grown while shaking, overnight at 37'C. The plasmid DNA was purified from each 
clone using the Wizard PlusTM SV Miniprep DNA purification system, (Sectcon 
2.2.1). BamHl/Ncol restriction enzyme digests were set up as follows, (Table 2.13). 
Table 2.13: Components for restriction digest 
Component 
NE buffer 2 (10X) 
BSA (10mghl) 
Plasmid DNA 
UpHz0 (Stenle) 
BamHl(lOU/~l) 
Ncol (10UIp.I) 
Total Volume of reaction: 
. 
Volume in reaction 
51.11 
0.5N 
1 0 ~ 1  
30 5 ~ 1  
2Fl 
21.11 
SON 
2.2.12 Ligation of InlB insert into pQE60 plasmid DNA 
A single XL-10 gold E. coli colony harbouring pQE-60 was grown overnight in Sml 
of LB broth containing 100 ~ g l m l  ampicillin, while shaking at 37°C. The pQE-60 
plasmid DNA was purified using the Promega Wizard PlusTM Miniprep DNA 
punfication system (Section 2.2.1). The pQE-60 plasmid DNA was then linearised 
using a BarnHl I Ncol restriction hgest as described in Section 2.2.11 and the 
linearised plasmid was gel purified, following agarose gel electrophoresis, using the 
WizardTM PCR-prep punfication kit (Section 2.2.3). The DNA encoding the gene of 
interest was then diiectionally cloned into the linearised pQE-60 using T4 DNA 
ligase. The ligation reaction was set up as shown in table 2.14. 
Table 2.14: Components of ligation reaction 
Gene of insert 
T4 DNA hgase (lU/pl) 
Ligation buffer (10X) 
Total volume of reaction: 
The ligation reaction was incubated at 14°C for at least 4 hours, but preferably 
overnight. The ligation mixture was then centrifuged at 10,000g for 30 seconds and 
stored at -2OoC. 
2.2.13 Transformation of competent XL-10 Gold E.coli cells with pQE-60 
containing the cloned inserts 
CaClz-competent XL-10 Gold E. coli were prepared as described in Sect~on 2.2.4. The 
competent XL-10 Gold E. coli were then transformed with the pQE-60, containing the 
gene of interest (InlB F3, F4, or FS). Vials containing the ligation reaction were 
centrifuged at 10,000 x g for 30 seconds and then placed on ice. 2 ~ 1  of the overnight 
ligation reaction was added to SON of competent Xl-10 Gold E. coli cells and mixed 
gently. The vials were then incubated on ice for 30 min. The transformation reaction 
was then exposed to heat shock, by placing the vials in a 42'C water bath for 30 s and 
then directly back on ice. SOC medium (250fl) was then added to each 
transformation reaction. The transformation reaction was then incubated at 37°C for 1 
hour, while shaking at 225rpm. Each transformation reaction (150~1) was then spread 
onto LB agar plates, containing anhbiotics (100pgIml ampicillin, 25pg/ml 
chloramphenicol and 10pgIml tetracycline). The plates were then incubated, inverted, 
at 37°C for at least 18 hours. 
2.2.14 Initial expression of recombinant fragments of InlB protein 
Ten ml of LB broth (10 g tryptone, 5 g yeast extract and 10 g NaCl per htre) 
containing 100 pglml ampicillin, 25pgIml chloramphenicol and 10pg/ml tetracycline 
was inoculated with 100p1 of an overnight culture of E. coli XI-10 Gold cells 
containing the InlB gene fragments (from a single colony). The culture was mcubated 
shaking at 37°C until the optical density at 550nm (ODsso) reached 0.5. Protein 
expression was then induced following addition of 1mM PTG. The culture was 
further incubated, at 37"C, while shaking for 4 hours and then centrifuged at 3,200 x g 
for 20 min. The supernatant was discarded and the pellet resuspended in 500p.l of 
denaturing buffer and sonicated for 30 s with 3 s pulses at 220V. The lysed cells were 
then centrifuged at 20,000 x g for 15 rnin and the supernatant analysed using SDS- 
PAGE for assessment of protein expression. 
2.2.15 Optimisation of IPTG concentration 
In order to determine optimal concentration of IPTG for maximum protein expression, 
several "small-scale" expression cultures (101111) were performed. The growth 
conditions for each culture were identical to those described m Sectron 2.2.14, with 
the exception that various IPTG concentrattons (ranging from 0 - I&), were used 
for induction of protein expression. 
2.2.16 Optimisation of sonieation conditions 
In order to determine optimal conditions for so~cat ion for maximum protein 
expression, several "small-scale" expression cultures (10ml) were performed. The 
growth conditions for each culture are the same as those described in Section 2.2.14, 
except that a range of so~cation times from 0-60 seconds were examined for optimal 
protein isolation. Sonication was performed at 220watts using 3 second pulses. 
2.2.17 T i e  course expression cultures 
A "small-scale" expression culture (10ml) was carried out as described in Section 
2.2.14. A lml sample was taken pre-induction with IPTG and then at hourly intervals 
for up to five hours. The culture was allowed grow and following overnight induction 
a final lml sample was taken. 
2.2.18 Large-scale expression culture 
LB broth (1Oml) containing 100 ~ g l m l  ampicillin, 10 pg/ml tetracycline and 25 p g / d  
chloramphenicol was inoculated with 2 0 ~ 1  of XL-10 Gold E. coli harbouring the 
pQE-60 plasmid. The culture was grown at 37°C overnight, while shaking. The 
overnight culture was then used to inoculate 5001111 of LB broth for large scale 
expression. The culture was incubated at 37"C, while shaking, until the optical density 
at 550um (ODsso) reached 0.5. Protein expression was then induced following 
addition of O.lmM JITG. The culture was incubated, at 37'C, while shaking, for a 
further 4 hours and then centrifuged at 3,200 x g for 20 min. The supernatant was 
discarded and the pellet resuspended in 25ml of IMAC purification buffer and 
sonicated three times for 30 s followed by a 30 s interval. This was repeated three 
times. The lysed cells were then centrifuged at 3,200 x g for 15 mins and the 
supernatant analysed using SDS-PAGE (Section 2.2.5) for protein expression and the 
His-tagged recombinant proteins purified using IMAC (Sectron 2.2.19). 
2.2.19 IMAC purification of the 6xHis-tagged recombinant proteins and 
antibody fragments 
Ni-NTA resin (2ml) was loaded into an empty Econo-PacTM chromatography column 
(BioRad International Inc.) and allowed to settle to form a lml packed column. AU 
punfication steps were performed at 4'C to optimise Ni-binding. IMAC wash buffer 
(20ml), as described in Table 2.15, was added to the packed column for equilibration. 
The sample for purification was filtered to remove protein aggregates and applied to 
the column. The 'flow-through' fraction was collected and re-applied to the column 
three times. The column was then washed with 2 x 20ml of wash buffer (Table 2.15) 
and the wash fractions retained. The protein was eluted from the column using 5ml of 
elution buffer (Table 2.13, and collected in 5 x lml fractions. The eluted fractions 
were then pooled and concentrated in a Vivaspin concentrator and buffer exchanged 
Into PBS (Table 2.4) at 4°C. The concentration of the purif~ed protein was then 
determined using a BCA assay (Section 2 2.20) and the purified proteln was stored m 
lml fractious at -20°C. 
Table 2.15: Buffers used during the IMAC purificahon of His-tagged proteins 
20mM Imidazole, 
250mM Imidazole, 
2.2.20 Bicinchoninic acid (BCA) assay 
BCA reagents were supplied as components of the BCA protein assay kit (Pierce, 
23225). Reagent A contained an optimised formulat~on of sodium carbonate, sodium 
bicarbonate, bicinchoninic acid and sodium tartarate in a 0.1 M NaOH solution. 
Reagent B consisted of an aqueous solution of 4% (wlv) cupric sulphate. Bovine 
serum albumin protein standards m a concentration range from 0.25 to 2 mglml were 
prepared in PBS (Table 2.4). Each standard (10~1) was added to a 96-well microtitre 
plate in triplicate. This was repeated for the samples under investigation (protein 
samples of unknown concentration). The BCA workmg reagent was prepared by 
mixing reagents A & B m the ratlo of 50:l. A 200~1  aliquot of worlung reagent was 
added to each well and the plate was allowed develop at 37°C for 30 rnin. Absorbance 
values were measured at 562nm using a Tecan Safue plate reader. The blank (Opg) 
absorbance value was subtracted and a standard curve of net absorbance at 562nm 
versus concentration (pglml) was constructed and used to calculate the protein 
concentration of the test samples. 
2.2.21 Sequencing of cloned inserts 
Plasmid DNA for sequencing was purified from overnight cultures using the Promega 
Wizard Plasmid DNA purification kit (Section 2.2.1). The plasmid DNA was quantified 
by deterrmning its absorbance at 260nm. DNA (20~g) was dispensed into a fresh 1.5ml 
microcentrifuge tube and vacuum dried. Sequence analysis was then conducted by 
MWG-Biotech and the results given in Section 3.3.8. The web-based bioinformatics tools 
listed in Table 2.16 were used for the analysis and alignment of cloned sequence data, 
with known DNA sequences. 
Table 2.16: Web-based bioinformatics tools and their source location 
www.exaasv org 
2.2.22 Expression of anti-InlB scFv 
An anti-Inll3 human scFv clone, previously isolated from a ndive phage display 
library by Dr. Paul Leonard, was used in this research for the development of 
immunoassays for the detection of InlB. SB broth (Table 2.3) containing 100pg/ml 
amp~cillin, 25 pg/ml chloramphenicol was inoculated with a single colony of TOP 
10E' E. coli contaming the anti-InlB scFv plasmid. The cultures were grown at 37'C 
overnight, while shaking. The overnight cultures were then used to inoculate 500ml of 
SB containing 100pg/ml ampicillin, 25 pg/d  chlorarnphenicol and 2% (w/v) glucose. 
The culture was incubated at 37"C, while shaking for 8 hours. The culture was then 
centrifuged at 3,200 x g for 20 min at 4°C and resuspended in fresh SB broth 
containing 100pg/ml ampicillin, 25 pg/ml chloramphenicol, to remove all glucose 
from the medium. Protein expression was induced following addition of 1mM IPTG 
and the culture was incubated shaking at 30°C overnight. The culture was centrifuged 
at 3,200 x g for 20 nun, the supernatant discarded and the pellet resuspended in 25ml 
of IMAC wash buffer (Table 2.15) and sonicated for 30 s. The lysed cells were then 
centrifuged at 3200g for 15 mins and the supernatant retained for purification by 
IMAC (Section 2.2.19). 
2.2.23 Screening of optimised expression conditions of anti-InlB scFv by ELISA 
A 96-well mtcrotitre plate was coated with InlB recombinant protein (20ug/ml). The 
plate was incubated for 1 hour at 37°C and the contents emphed. The plate was then 
washed three times with PBS (Table 2.4) containing 0.05% (vlv) Tween and three 
times with PBS (Table 2.4). The plate was blocked using 200~1  of PBS (as before), 
containing 4% (wlv) powdered milk and incubated at 4°C overnight. Anti-InlB scFv 
lysates from each expression study (Sechon 3.5.1) were added to the plate neat 
100CLywel1, in triplicate. The plate was incubated at 37'C for 1 hour and washed as 
before. HRP-labelled anti-cmyc antibody previously diluted to 111,000 with PBS (as 
before) containing 1% (wlv) Marvel, was added to the plate (100CLywell) and the plate 
Incubated at 37°C for 1 hour. Following the wash step (as before), 100~VweU of TMB 
substrate was added and, after 30 min incubation at 37'C, the absorbance at 620nm 
was determined using a Tecan Safue plate reader. The absorbance value of each 
sample was plotted to determine which conditions were optimal for the expression of 
the anti-InlB scFv 
2.3 In vivo biotinylation of Internalin B protein fragments F3, F4 & F5 
The pAC4 vector for in vivo biotinylation of recombinant proteins (Avidity 
Corporation, USA), has both a BamHl and Ncol restriction site, thus allowing easy 
transfer of inserts from Qiagen's pQE-60 vector into the PAC 4 vector. 
2.3.1 Restriction digests of pAC4 vector & pQE-60 inserts F3, F4 & F5 
A single XL-1 Blue E. coli colony harbouring pAC4 was grown overnight in 5ml of 
LB broth containing 100 pg/rnl ampicillin and 10 pglml tetracycline at 37°C while 
shaking. The pAC4 vector plasmid DNA was purified using the Promega Wizard 
PlusTM Miniprep DNA purification system (Section 2.2.1) and linearised using a 
BamHl I Ncol restriction digest as described in Sectton 2.2.11. BamHl/Ncol 
restriction enzyme analysis was also carried out on pQE-60 plasmid DNA isolated 
from XL-10 Gold E. coli containing the InlB F3, F4 & F5 fragments. Overnight 
cultures were prepared by inoculating a single colony of each fragment in 5ml of LB, 
with appropriate antibiotics and growing overnight at 37°C while shaking. The 
plasmid DNA was purified from each clone using the Wizard Plus" SV Miniprep 
DNA purification system (Sectzon 2.2.1) and BamHl/Ncol resmctlon enzyme digests 
were set up as described in Section 2.2.11. 
The resulting restricted products (pAC4 vector & pQE-60 inserts F3, F4 & F5) were 
analysed by horizontal electrophoresis (Section 2.2.2), on a 1% (wlv) agarose gel. The 
gels were visualised on a W transilluminator (Image master VSD system, Amersham 
Pharmacia) and the appropriate hands were cut, and purified, using the WizardTM 
PCR-prep purification kit (Section 2.2.3). 
2.3.2 Ligation of InlB insert into pAC4 vector DNA 
The DNA encodmg the genes of interest was cloned into the hneansed pAC4 using 
T4 DNA ligase. The ligation reaction was set up as shown (Table 2.17). 
Table 2.17: Components of ligation reaction 
The ligation reaction was incubated at 14°C for at least 4 hours, but preferably 
overnight. The ligafion mixture was then centrifuged at 10,000 x g for 30 seconds and 
stored at -20°C. 
Component 
pAC4 DNA 
Gene of insert (F'3, F4 or F5) 
T4 DNA ligase (1UIpl) 
Ligation buffer (10X) 
Total volume of reaction: 
2.3.3 Transformation of electro-competent AVBlOl E.coli cells with pAC4 
containing the cloned inserts 
Electro-competent AVBlOl E. coli (Avidity Corporation, US) were transformed with 
pAC4 containing the genes of mterest (InlB F3, F4, or F5). Ligations and 
electroporation cnvettes (0.2cm Bio-Rad) were incubated on ice for 10 minutes. At 
the same time the electrecompetent AVBlOl cells were thawed on ice. Each ligation 
was added to the cells (300pl), mxed gently, transferred to a chilled cuvene and 
incubated in ice for 1 minute. The sample was the electroporated at 2.5kV, 25@, 
200!2 (z = 4msec). The cuvette was immediately flushed with lml SOC, followed by 
lml SOC (x2) at room temperature and transferred to 50ml polypropylene tube. The 
cells were incubated at 37°C for one hour with shahng at 250rpm. Each 
transformation reaction (150~1) was then spread onto LB agar plates, containing 
antibiotics (100pg/ml of ampicillin and 25pg/ml chloramphenicol). The plates were 
then incubated, inverted, at 37°C for at least 18 hours. 
Volume in reaction 
4Fl 
41.11 
1 Fl 
1 fl 
1 0 ~ 1  
2.3.4 Expression of in vivo biotinylated InlS protein fragments 
Twenty ml of LB broth containing 100 pg/ml ampicilhn and 25pg/ml 
chloramphenicol was inoculated with a single colony of AVBlOl E. co l~  contaming 
the InlS gene fragments, (F3, F4 and F5). The cultures were incubated at 37"C, while 
shaking until the optical density at 550nm (ODssa) reached 0.5. Protein expression 
was then induced following addition of 1mM IlTG and 50mM D-biotin. The 
AVBlOl strain contains the pACYC184 plasmid wtth an IlTG inducible birA gene to 
overexpress biotin ligase. The culture was further incubated, for 4 hours, at 37'C, 
whle shaking and then centrifuged at 3,200 x g for 20 mins. The supematant was 
discarded and the pellet resuspended in lml of PBS and sonicated for 30 s with 3 sec 
pulses at 220V. The lysed cells were then cenbfiged at 20,000 x g for 15 min and the 
supernatant analysed using SDS-PAGE for assessment of protein expression. 
2.3.5 Purification of in vivo biotinylated protein fragments using a monomeric 
avidin affinity column. 
The biotinylated InlB fragments were purified using immohilised monomeric avidim 
(Pierce, 20267). The monomeric avidim was equilibrated at room temperature for 10 
nun and 4ml of resin was used to pack a clean, empty PD-10 column (Amersham 
Pharmacia). The resin was allowed to settle to form a 2nd packed column of 
lmmohilised monomeric avidin. The column was then washed twice with 8 ml of PBS 
(Table 2.4). Biotin blocking/elution buffer (2mM D-biotin in PBS, as before) was 
added (6ml), to block non-reversible biotin bm&ng sites. Biotin was then removed 
from the reversible binding sites by the addition of 12ml of regeneration buffer (0.1 M 
glycine, pH 2.8). The column was washed with 8ml of PBS (as before) and the 
biotinylated protein was applied to the column. When the entire sample had passed 
through the column, 0.25 ml of PBS was added to force sample completely into the 
resin bed. The biotinylated sample was left to incubate on the column for 1 hour at 
room temperature, to maximize binding. The column was then placed in a fresh 
collection tube and 12ml of PBS (as before) was added and collected in 2ml fractions 
until all non-bound protem was removed. The bound b~otinylated molecule was eluted 
with the addition of Biotin hlocking/elutlon buffer (as before) and 500yl fractions of 
purified protein were collected until no further protein was detected (Absorbance at 
280m 5 0.05). The fractions were then analysed at 280 nm in quartz cuvettes and 
fractions contaming the majority of protein were pooled and stored in 0.01% (wlv) 
azide. The column was regenerated by washing twlce with 4 ml of regeneration buffer 
and once with 5 ml of PBS. The column was stored in PBS containing 0.01% (wlv) 
sodium azide at 4°C 
2.3.6 Characterisation of in vivo biotinylated proteins 
The in vivo biotinylated protein fragments were characterised using the following 
methods; SDS-PAGE (Section 2.2.5) for protein expression analysis, Western 
Blotting (Section 2.2.7) with an anti-biotin antibody and Biacore analysis (Section 
2.6), to assess binding w~th the associated anti-InlB polyclonal antibody. Enzyme and 
fluorescence-based analysis was also performed (Sections 2.3.6.1-2.3.6.4) 
2.3.6.1 Titre of in vivo biotinylated recombinant InlB fragments using extravidin- 
peroxidase 
Anti-MB polyclonal antibody at a concentrahon of 10pg/ml in O.1M carbonate buffer 
(pH 9.6) was used to coat the wells of a microtitre plate (100pl/well). The plate was 
~ncubated for 1 hour at 37°C and the contents emptied. The plate was then washed 
three times with PBS (Table 2.4) contaitllng 0.05% (vlv) Tween 20 and three times 
with PBS (Table 2.4). The plate was blocked using 200pl of PBS (Table 2.4), 
contrumng 2% (wlv) BSA and incubated at 4°C overnight. Serial in vtvo biotmylated 
recombmant InlB fragment (F3, F4 & F5) dilutions ranging from 115 - 115120 were 
then prepared in PBS (Table 2.4 ) containing 0.2% (wlv) BSA and lOOpl of each 
dilution added to the wells in triplicate. The plate was incubated at 37'C for 1 hour 
and washed as before. Extravidin-Peroxidase, prev~ously diluted to 111,000 with PBS 
(as before) containing 1% (wlv)BSA, was added to the plate (100~Wwell) and the 
plate incubated at 37°C for 1 hour. Following the wash step, 100~Wwell of TMB 
substrate was added and, after 30 mins incubation at 37"C, the absorbance at 450nm 
was determined using a Tecan Safue plate reader. 
2.3.6.2 Titre of in vivo biotinylated recombinant InlB fragment F3, using 
streptavidin-Cy5 as tracer molecule 
Antl-InlB polyclonal anhbody at a concentration of 10~gIml in 0.1M carbonate buffer 
(pH 9 6) was used to coat the wells of a microtitre plate (100pllwell). The plate was 
incubated for 1 hour at 37°C and the contents emptied. The plate was then washed 
three times with PBS (Table 2.4) containing 0.05% (vlv) Tween 20 and three times 
with PBS (Table 2.4). The plate was blocked using 200pl of PBS (Table 2.4), 
containing 2% (wlv) BSA and incubated at 4°C overnight. Serial in vivo biotinylated 
recombinant InlB fragment F3 dilutions ranging from 115 - 115120 were then 
prepared in PBS (Table 2.4) containing 0.2% (wlv) BSA and 100pl of each dilution 
added to the wells in triplicate. The plate was incubated at 37°C for 1 hour and 
washed as before. Streptavidin-Cy5, previously diluted to 111,000 with PBS (as 
before) containing 1% (wlv) BSA, was added to the plate (100pllwell) and the plate 
incubated at 37°C for 1 hour. Following the wash step, the fluorescence response of 
bound antigen was determined using a Tecan S&ue plate reader with excitation at 
649nm and emission at 670nm. 
2.3.6.3 Optimisation of blocking reagent for fluorescence-based assays using in 
vivo biotinylated recombinant InlB fragment F3, traced with streptauidin-Cy5 
Anti-InlB polyclonal antibody at a concentration of 10pgIml in 0.1M carbonate buffer 
(pH 9.6) was used to coat the wells of a microtitre plate (100plIwell). The plate was 
incubated for 1 hour at 37'C and the contents emptied. The plate was then washed 
three times with PBS (Table 2.4) containing 0.05% (vlv) Tween 20 and three times 
with PBS (Table 2.4). The plate was blocked using 200pl of PBS (Table 2.4), 
containing 1% (wlv) BSA and incubated at 4°C overnight. Serial in vivo biotinylated 
recombinant InlB fragment F3 dilutions ranging from 115 - 115120 were then 
prepared in PBS (Table 2.4) contruning 0.1% (wlv) BSA and 100pl of each dllution 
added to the wells in triplicate. The plate was incubated at 37°C for 1 hour and 
washed as before. Streptavidm-Cy5, previously diluted to 111,000 with PBS (as 
before) containing 1% (wlv) BSA, was added to the plate (100p/well) and the plate 
incubated at 37°C for 1 hour. Following the wash step, the fluorescence response of 
bound antigen was determined using a Tecan Safve plate reader with excitation at 
649nm and emission at 670nm. 
2.3.6.4 Direct detection of in vivo bintinylated recombinant InlB fragment F3, 
traced with fluorescent labels; streptandin-Cy5, avidin-FITC and streptavidin- 
Linked quantum dots 
Anti-InlB polyclonal antibody at a concentrahon of 1OgpIml ~n 0.1M carbonate buffer 
@H 9.6) was used to coat the wells of a rmcrotltre plate (100flwell). The plate was 
incubated for 1 hour at 37°C and the contents emptied. The plate was then washed 
three times with PBS (Table 2.4) containmg 0.05% (vlv) Tween 20 and three times 
wlth PBS (Table 2.4). The plate was blocked using 200N of PBS (Table 2.4), 
contaimng 1% (wlv) BSA and incubated at 4'C ovem~ght. Senal in vivo biotlnylated 
recombinant Id3 fragment F3 dilutions ranging from 115 - 115120 were then 
prepared in PBS (Table 2.4) containing 0.1% (wlv) BSA and 100pl of each dilution 
added to the wells in triplicate. The plate was incubated at 37°C for 1 hour and 
washed as before. The fluorescent label (streptavidnCy5, avid~n-FITC and 
streptavidin-linked quantum dots), prev~ously diluted to 111,000 with PBS (as before) 
conta~nmg 1% (wlv) BSA, was added to the plate (100pllwell) and the plate incubated 
at 37°C for 1 hour. Following the wash step, the fluorescence response of bound 
antigen was determined using a Tecan Safue plate reader. Excitation and ermsslon 
was performed at 649nm and 670nm for streptavidin-Cy5 wells, 494nm and 518nm 
for avidin-FITC wells and 450nm and 605nm for streptav~din-quantum dot wells. The 
fluorescent response was nomalised against background fluorescence and the results 
plotted usmg normalised fluorescence response units (NFRU). 
2.4 Antibody Purifkation & Characterisation 
2.4.1 Polyclonal antibody purification and characterisation 
Rabbit serum containing polyclonal antibodies directed against InlB was obtained 
from Dr. Paul Leonard (Applied Biochemistry Group, DCU). The polyclonal 
antibodies were initially purif~ed from the rabbit serum using saturated ammonium 
sulphate precipitation followed by protein G affinity chromatography. 
2.4.1.1. Saturated ammonium sulphate (SAS) precipitation of polyclonal serum 
SAS (3.6ml) was added 'drop-wise' to 3.61111 of the rabbit semm on ice. The mixture 
was then left stirring on ice for one hour. The precipitated mixture was then 
centrifuged at 3,200 x g for 20 m n  at 4°C. The supernatant was discarded and the 
pellet was resuspended in 3.6ml of 45% (wlv) SAS. The resuspended pellet was then 
centrifuged at 3,200 x g for 20 min at 4°C. The supernatant was again discarded and 
the pellet resuspended m 3.6ml of 45% (wlv) SAS. The resuspended pellet was then 
centrifuged at 3,200 x g for 20 rmn at 4°C. The pellet was finally resuspended in 
1.8ml of PBS (Table 2.4) and the solution was dialysed overnight at 4°C in PBS (as 
before). 
2.4.1.2 Proteii G affinity-chromatography of SAS-purified polyclonal serum 
A 2ml suspension of immobilised Protem G (immob~lised on Sepharose 4B) was 
equilibrated in an empty PD-I0 desalting column (Amersham Biosciences) with 201111 
of sterile filtered mnning buffer, PBS (Table 2.4). The column was stoppered when 
the running buffer reached the top of the gel. The SAS- purified sample (2nd) was 
added to the column. The effluent was momtored at 280 nm, and fractions contaming 
protein (i.e. Absorbance 280nm t 0.05) collected. Running buffer was continually 
added to prevent the column running dry. After all the protein was collected the 
fractions were passed over the column two more times. The gel was washed with 
201111 of wash buffer (Table 2.18) and any protein collected at this stage was kept and 
stored in 0.01% (vlv) azide. The column was then equilibrated using running buffer, 
which was allowed to pass through the column for five mins. The running buffer was 
allowed reach the top of the gel and then 1.5ml of elution buffer (Table 2.18) was 
added. The elution buffer was allowed to mn Into the column. Then the column was 
stoppered and the elution buffer was left within the column for 15 min. The stopper 
was removed and and 500~1 frachons of protein were collected into tubes containing 
50 vl of neutralismg buffer (Table 2. 18), once protein was detected. Fractions were 
collected until no further protein was detected (Absorbance at 280nm 5 0.05). The 
fracttons were then analysed at 280 nm in quartz cuvettes and fractions containing the 
majority of protein were pooled and stored in 0.01% (wlv) azide. The proteln G 
column was then washed using running buffer and stored in 20% (vlv) methanol. 
Table 2.18: Composihon of buffers used dunng.the protein G purification of rabbit 
IgG polyclonal antibodies. 
2.5mM KCl, 
1 OmM Na2HP04, 
18mM KH2PO* 
2.4.1.3 Checkerboard ELISA for tbe determination of optimal antigen 
concentration and antibody dilution 
A 96-well nncrohtre plate was coated with different InlB-F3 recombinant protein 
concentrations, ranging from 0 to 50ng/ml, by adding 100pl of each concentration per 
well. The plate was incubated for 1 hour at 37'C and the contents emptied. The plate 
was then washed three times with PBS (Table 2.4) containing 0.05% (vlv) Tween and 
three times with PBS (Table 2.4). The plate was blocked using 200pl of PBS (as 
before), contaming 2% (wlv) BSA and incubated at 4°C overnight. Serial biotinylated 
anti-InlB polyclonal anttbody &lntions ranging from 1150 - 1112,800 were then 
prepared in PBS (as before), containing 1% (wlv) BSA and 100pl of each dilution 
added to the wells in triphcate. The plate was incubated at 37'C for 1 hour and 
washed as before. Extravidin-Peroxidase, prev~ously diluted to 111,000 with PBS (as 
before) containing 1% (wlv) BSA, was added to the plate (100pl/well) and the plate 
~ncubated at 37°C for 1 hour. Extravidrn-peroxidase is a commercially available 
conjugate (Sigma-Aldrich) prepared from egg white avidin and linked to horseradish 
peroxidase for detecuon. It is a tetrameric protern containing four high affinity 
binding sites for biotin. Extravidin combines the high specific activity of avidin with 
the low background staining of streptavidin, a biotin binding protein produced by the 
bacteria Streptomyces avidinii. Following the wash step, 1 0 0 ~ w e l l  of TMB 
substrate was added and, after 30 min incubation at 37"C, the absorbance at 450nm 
was determined using a Tecan Sake  plate reader. 
2.4.2 Monoclonal antibody purification and characterisation 
Monoclonal antibodies to warfarin were produced by Dr. Brian Fitzpatrick (Applied 
Biochemistry Group, DCU). A direct ELISA format was used to screen the 
hybndoma-clone supernatants for speciiic antibody production, and 'positive' wells 
were propagated and cloned by limiting ddution. Stocks of positive antibody- 
secreting clones were frozen down for subsequent rounds of cloning out. A frozen 
stock of both the anti-warfarin monoclonal antrbody and antr-InlB monoclonal 
anfibody was obtained and grown up for subsequent rounds of cloning out by limiting 
dilution, to ensure monoclonality. Once sufficient antibody-containing supernatant 
was collected, the antibodies were concentrated for purification using an Amicon 
ultrafiltration system. 
2.4.2.1 M ~ e a t i o n  of murine IgG by Protein-G aft%@ chromatography 
Supernatants from hapten-specific antibody-secreting hybridomas were collected and 
concentrated 10-fold using an Amicon concentration device. 10 mls of concentrated 
supernatant were passed through a PD-10 column contaming Protein G rmmobilised 
on Sephaose 4B. The eluate was collected and passed through the column a second 
time. The column was then washed with 25 ml of PBS (Table 2.4 ) containing 0.05% 
(vIv) Tween 20 and the retained protein eluted with 0.1 M glycine-HC1 (pH 2.5). 850 
p1 fractions were collected in eppendorf tubes containing 150 yl of Tris-HC1 (pH 8.5) 
to return the pH to -7.0 to prevent antibody denaturation. The absorbance of each 
fraction was then measured at 280 nm for protein concentration determination. 
W r e d  antibodies were stored at -20°C prior to further use. 
2.4.2.2 Checkerboard ELISA for the determination of optimal antigen coating 
concentration and antibody dilution 
A 96-well microtitre plate was coated with different warfarin-BSA conjugate 
concentrations, ranging from 50pgIml to OpgIml, by adding 100pl of each 
concentration per well. The plate was ~ncubated for 1 hour at 37'C and the contents 
emptied. The plate was then washed three times with PBS (Table 2.4) containmg 
0.05% (vlv) Tween 20 and three times w~th PBS (Table 2.4). The plate was blocked 
using 200pl of PBS (Table 2.4), containing 2% (wlv) BSA and incubated at 4'C 
overnight. Serial biotinylated anti-warfann monoclonal antibody dilutions ranging 
from 1/50 - 1112,800 were then prepared in PBS (Table 2.4) containing 1% (wlv) 
BSA and 100~1 of each ddution added to the wells in tnphcate. The plate was 
incubated at 37°C for 1 hour and washed as before. Extravidin-Peroxidase (as per 
Section 2.4.1.3) was diluted to 111,000 w~th PBS (as before) contaming 1% (wlv) 
BSA, was added to the plate (100pVwell) and the plate incubated at 37'C for 1 hour. 
Follow~ng the wash step, 100pllwell of TMB substrate was added and, after 30 min 
incubation at 37"C, the absorbance at 450nm was determined using a Tecan Safire 
plate reader. 
2.5 Conjugate Synthesis 
2.5.1 Preparation and cbaracterisation of 4'-azowarfarin-protein conjugates 
A 501x11 solution contairung 0.1 M HC1 and 7 mM potassium bromide was used to 
dissolve 350 mg of 4'-aminowarfarin. A 0.014 M solution of sodium nitnte (10ml) 
was added dropwise to the solution containing 4-aminowaxfarin. and maintained with 
continuous stimng on an ice-bath for 1 hour. The act~vated 4'-aminowarfarin solution 
was then added dropwise to 10 ml of a 5% (wlv) solution of BSA, and the pH 
maintained between 9.09.5 with the simultaneous addition of 0.1 M NaOH, and 
stured overnight at 4'C (Satoh et al., 1982). The resulting dark brown solution was 
then dialysed against several changes of PBS, pH 7 4, and lyoplnhsed pnor to further 
studies. The drug-protein conjugates following lyophilisation were characterised by 
W spectroscopy. A direct comparison of the reference spectra obtained for the drug- 
protein conjugate to 4'-aminowaxfarin and a 'control' protein (i.e. a protein solution 
whlcb had undergone the same chenncal procedure as the conjugate solution, except 
the drug soluhon had been omitted from the coupling step) was made from 200-400 
nm 
2.5.2 Preparation of biotinylated antibodies 
2.5.2.1 Biotinylation of antibodies for fluorescence-based immunoassays (FIA) 
Antibodies, at a concentration of -1mg/ml, were dialysed overnight to remove any 
traces of az~de, for subsequent use m the biotinylation reaction. Long-chain b~otm 
(Sulfo-NHS-LC-Biotin, Pierce, 21335) was dissolved in DMSO to prepare a lOmM 
stock solution of biotin. The extent of biotin labeling depends on the distribution of 
amino groups on the protein, the protein concentration and the amount of reagent 
used. Experiments were performed using a 20-fold molar excess of biotin reagent to 
label lmg antibody (in lml PBS, Table 2.4), which results in conjugation of 4-6 biohn 
groups per antibody molecule. The biotin stock solution (13pl) was added to 1ml of 
antibody (concentration lmg) and the solution was incubated end on end, overnight, 
at 4°C The biotin conjugate was subjected to gel filtration to stop the reaction and to 
remove any unbound biotin using a PD-I0 desalting column (Amersham Pharmacia). 
The conjugate concentration and biotidprotein ratio was determined using 
commercial HABNAvidin reagent (Sigma Aldrich, H2153). 
2.5.2.2 Biotinylation of antibodies for electrical impedance spectroscopy WIS) 
Antibodies were biotinylated to facilitate immobilisation onto the neutravidin- 
modified polymer f i b s  with biotinamidohexanoicacid-3-sulfo-N-hydroxysuccinhide 
(BAC-sulfo-NHS), using the procedure outlined in the Sigma Innnunoprobe 
biotinylation k t  (BKIO1). The strong affimity between avidin and biotin (affinity 
constant K, = 10 l5 M-I) allows duect coupling of the biohnylated antibodies to the 
modified electrode. The extended spacer arm from the hexanoic acid improved the 
interaction between avidin and the biotinylated antibody by overcomng steric 
hindrances present at the biotin bindmg sites. A molar ratio of 10:l biotin to antibody 
was used to ensure efficient labelling and the antibody was subjected to fast gel 
filtration post-biotinylation to remove any unreacted biotin. An avidin-HABA (4- 
Hydroxyazobenzene-2-carboxylic acid) assay was then performed to determine the 
degree of biotinylation; dyetprotein ratio and biotin-antibody conjugate concentration. 
Biotinylated antibodies were diluted in PBS, comprismg 0.13 mM NaHzP04, 0.528 
mM NazHP04 and 0 51 mM NaCI, pH 7.4, and stored at -20' C at a concentration of 1 
mglml. 
2.5.3 Fluorescent labelling of antibodies and proteins 
A standard protocol for the fluorescent labelling of biomolecules is difficult to derive 
as optimisation of labelhng condition such as buffer pH and concentration is highly 
specific for each dye. Gel filtration is used to remove sodium azide, which is often 
found as a preservahve in biological preparations and interferes with the labellmg 
process. Typically, phosphate buffered saline comprising 0.13 mM NaHzP04 0.528 
rnM Na&IP04 and 0.51 mM NaCI, pH 7.4 or 0.5M carbonate buffer, pH 9.6, are used 
for labelling reactions. The amount of fluorescent labelling reagent used for each 
reaction is dependent on the amount of protein to be labelled. By using the 
appropriate molar ratio of labellmg reagent to protein, the extent of conjugation can 
be optimally controlled. For protein concentrations in the range of 2-5mg/ml, a 10- 
fold molar excess is used, for concentrations <2mg/ml, a 15 molar excess is used and 
for protein concentrations <lmg/ml, 20 molar excess of dye is used. 
Using ruthenium dye as an example, the label was dissolved in an organic solvent 
DMSO) at a concentration of 10mgIml (as most fluorescent dyes are insoluble in 
aqueous soluhon). Taking into account an optimal 20 fold molar excess based on the 
antibody concentration (lmg/ml), the appropriate volume of label was determined and 
added to the protein stock. The dyelprotein solution was left to react overnight at KC. 
Excess dye was removed via centrifugation using a commercial Vivaspin column at 
3,200 x g (or by dialysis). The conjugate concentration and dyelprotein ratio were 
then determined spectrqphotometrically. The level of label incorporation can be 
measured by determining the absorbance at or near the characteristic extinction 
maximum of the label. It is also important to determine the dyelprotein ratio for all 
derivatives prepared with tags. The equations below are used to calculate this 
information. 
Equation. 2.1 
where A280 is the absorbance of the dydprotein conjugate at 280nm; A, is the 
absorbance of the conjugate at the excitat~on maximum wavelength for the dye; CF is 
the correction factor Le. A280 dye /A,, dye, DF is the dilutlon factor, E,,, is the 
protein molar extlnctlon co-eflccent. 
Equation 2.2 [" Edyr x  conc. ) x D F  
where A, is the absorbance of the conjugate at the excitatio~z manimum wavelength 
for the dye; &mi, is the dye molar extinction co-eficient; Conc. is the dye/protein 
conjugate concentration in moles per 1 and DF is the d~lutzon factor. 
2.6 Analysis of irr vivo biotinylated InlS protein fragments and associated 
antibodies using Biacore 
Analysis was performed using a Biacore 3 0 0 0 ~  instrument operated with the Biacore 
3000 Control Software package version 3.1.1. All data analysis was performed using 
Biaevaluation 4.0.1. Research grade CM5 (carboxymethylated 5) sensor chips were 
employed and Hepes Buffered Saline (HBS), pH 7.4, containing l0mM HEPES (4-(2- 
hydroxyethy1)piperazine-1-ethanesulphonic acid), 150mM NaCI, 3.4mM EDTA and 
0.05% (vlv) Tween 20, was used as the running buffer. This was freshly prepared, 
filtered (pore slze 0 . 2 2 ~ )  and degassed using a vacuum filtration apparatus 
Nllipore sintered glass filtration unit) before use. All samples were syringe filtered 
(0.2pm pore size) to remove any particulate matter. 
2.6.1 Preconcentration studies 
Neutravidin was prepared in lOmM sodium acetate buffer that had been adjusted with 
10% (vlv) acetic acid to a range of pH values. The protein sample, at the respective 
pH, was passed over an underivatised chip surface, at a flow rate of l0pllmin for 1 
minute, and the amount of electrostatic Interaction monitored. The pH which gave the 
hghest degree of binding, i.e. maximum response, was chosen as the buffer for 
subsequent immobilisations. 
2.6.2 lmmobiiiation of neutravididbiotinylated F3 onto sensor surfaces 
Immobilisation of neutravidin was carried out according to standard amine coupling 
chemistry. Briefly, the carboxymethylated dextran surface was activated by W n g  
equal volumes of lO0mM NHS (N-hydroxysuccinimide) and 400mM EDC @-ethyl- 
N-(dimethyl-aminopropyl) carbodiimide hydrochloride) and injecting the mixture 
over the sensor chip surface for 8 minutes at a flow rate of 10flmin. Neutravidin at a 
concentration of 50pgIml in l0mM sodium acetate buffer, at pH 4.6, was injected 
over the activated surface for 40 minutes at a flow rate of 5pWmin. Unreacted NHS 
groups were capped by an injection of 1M ethanolamine, pH 8.5, for 7 minutes. 
Loosely bound neutravidin protem was removed using three 30sec pulses of 5mM 
NaOH. In vivo biotinylated InlB protein fragment F3 (60pg/ml) was subsequently 
immobiised on the neutravidin surface using a manual 6 minute injection, at a flow 
rate of 5flmin The F3 fragment was stabilised on the surface of the chip with a 30 
second pulse of EDC/NHS. 
2.6.3 Non-specific binding studies 
Antl-InlB polyclonal ant~body at the opamal assay dilution (1120) was simultaneously 
injected over both the blank neutravldin surface (reference flow cell) and the 
neutravidin surface with the immobilised biotlnylated InlB F3. The bindmg response 
following each mnjecuon was monitored and used to determine the degree of non- 
specific binding of the antibodies to the neutravidin surface in the absence of 
biotmylated F3. 
2.6.4 Regeneration studies 
A known concentration of antibody was passed over the chip surface, at the optimised 
flowrate, and the surface regenerated by passing over various concentrations of NaOH 
rangng from 1-100mM to assess the stability of the immobiised protein surface. 
This cycle of bindmg and regeneration was usually completed for more than 50 
cycles; however, due to low stocks of anti-InlB polyclonal antibody, only 10 
regenerations were performed. After each cycle of injection of antibody and 
subsequent regeneration, the binding signal was measured to assess the stability and 
suitability of the immobilised surface for assay purposes. 
2.6.5 Biacore inhibitive immunoassay for the detection of lnlB 
Standards of free InlB-F3 were prepared at varying concentration ranges. Each 
standard was incubated with an equal volume of anti-InlB polyclonal antibody and 
allowed equilibrate for 30 minutes at room temperature. Each sample was then 
injected over the immobilised protein surface, in triplicate, and the surface 
regenerated with the appropriate concentration of sodium hydroxide, 27.5mM, as 
determined from Section 2.6.4. A calibration curve was then constructed by plotting 
the change in response (RU) for each standard against the log of concentration and a 
four-parameter equation fttted to the data using Biaevaluation software 4.0.1. 
2.7 Nanoparticle Synthesis 
2.7.1 Synthesis of silica dye-doped nanoparticles 
Dye-doped high brightness nanoparticles were synthesised* by Dr. Robert Nooney of 
the Biomedical Diagnoshcs Institute (BDI), National Centre for Sensor Research 
(NCSR), using a micrvemnlsion method adapted from Santra et al. (2001). A 
microemulsion was formed by mixing Triton X surfactant, hexanol co-solvent and 
cyclohexane oil phase together. Separately an aqueous solution of 20mM Ru (bpy)3 
C12 (mtheniurn bipyridine salt) was prepared and the pH adjusted to 1.6 wlth the 
addition of 1N HCl. The aqueous Ru (bpy)$2lz solution was added to the oil phase 
with rapid stimng. To ensure formation of the water in oil microemulsion the solution 
was sonicated and stirred for a further five minutes. Following this, 
tetraethylorthosilicate (TEOS) was added. After 30 minutes of gentle mixing on a 
blood rotor, NH&H was added to initiate polymerisation. This mixture was left to 
further react for 24 hours at room temperature. To prevent aggregation of the 
nanoparticles, 3-(trihydroxysilyl) propyl-methyl phosphonate, monosodium salt, 42% 
(wlv) in water was added for 5 minutes. Aminopropyltrimethoxysilane (AE'TES) was 
then added for conjugation with antibokes and the solution stirred for a further 24 
hours. The NPs were separated from the solution with the addition of an excess of 
absolute ethanol to break the microemulsion state. The solidified silica nanoparticles 
were then harvested by centrifugation for 10 minutes and washed twice in absolute 
ethanol. The nanoparticles were washed once more with deionised water and 
characterised using a transmission electron microscope (TEM) for imagmg and size 
measurements. The modiiied particles were stored in deionised water at 4 "C for 
antibody attachment. 
* Please note that due to the proprietary nature of these methods (Biomedical 
Diagnostics Institute, DCU) details on actual volumes and experimental conditions 
cannot be given. The methods used were adapted from Santra et al, (2001),   an^ et 
al., (2004) and Qhobosheane et al, (2001). 
2.7.2 Surface modification of nanoparticles for antibody conjugation 
Amino-activated-nanoparticles m deionised water were centrifuged at 20,000 x g for 
10 minutes and dried overnight in a 60°C oven The dried particles (2mg) were 
suspended in 900~1 of 0.1M phosphate buffer, pH 7.4, supplemented with differing 
ratios of glutaraldehyde and BSA*. Antibodies were attached to the amino-modified 
nanoparticles usmg glutaraldehyde crosslinking. This mmture was left to react for 24 
hours at 4°C w~th gentle stirrmg. The nanoparticle m x  was then centrifuged at 
20,000 x g for 10 minutes and the resultant pellet washed twice with O.1M phosphate 
buffer, pH 7.4. The aminelglutaraldehyde modified nanoparhcles were resuspended in 
lml of 0.1M phosphate buffer, pH7.4, containing 0.25mg of polyclonal anti-human 
IgG antibody. This was left to react for 24 hours at 4'C, with gentle stirring. The 
antibody-conjugated nanoparticles were then separated by washing twice in 0.1M 
phosphate buffer, pH 7.4 and stored in 0.1M phosphate buffer, pH 7.4, containing 
0.1% (wlv) BSA and 0.02% (wlv) N*. 
* Please note that due to the proprietary nature of these methods (BDZ, DCU) details 
on actual volumes and experimental conditions cannot be gzven 
2.7.3 Nanoparticle-antibody conjugate characterisation 
2.7.3.1 Titre of antibody-nanoparticle conjugates 
Black FluoronuncTM 96-well mcrotitre plates were coated w~th 1 0 0 ~ ~ w e l l  of human 
IgG (51g) and incubated for 1 hour at 37°C. The plates were then emptied and washed 
3 times with PBS (Table 2.4), containing 0.05% (vlv) Tween 20 (PBST) and three 
times with PBS (Table 2.4). The plates were then blocked by adding 200pUwell of 
PBS containing 1% (wlv) BSA and incubated for 1 hour at 37'C. The plates were 
washed as before and serial dilutions of the various anti-human IgG nanoparticle 
conjugates (w~th differing glutaraldehyde concentrations) were prepared in PBS 
contruning 0.1% (wlv) BSA. These were added to the plates (100pVwell) in triplicate 
and incubated at 37°C for 1 hour and washed as before. Following the final wash step, 
the fluorescent response was determined using a using a Tecan SafireZ 
monochromator-based microplate reader, with excitation at 453nm and emission at 
618nm. 
2.7.3.2 Sandwich assay for tbe detection of human IgG using antibody- 
conjugated nanoparticles as fluorescent tracer molecule 
Black Fluoronuncm 96-well microtitre plates were coated with 100pl of anti-human 
IgG (5pg) and incubated for 1 hour at 37'C. The plates were then emptied and washed 
3 times with PBS (Tahle 2.4), containing 0.05% (vlv) Tween 20 and three hmes with 
PBS (Table 2.4). The plate were then blocked by adding 2 0 0 ~ w e l l  of PBS (Table 
2.4) containing 1% (wlv) BSA and incubated for 1 hour. Free human IgG dilutions, 
ranging from 0.005nglml to 500,000 nglml, were prepared in PBS containing 0.1% 
(wlv) BSA. The plates were washed (as before) and 100pl of the free human-IgG 
&lntions (in triplicate) were added to each well and incubated for 1 hour at 37'C. The 
plates were then washed again and 100pl of the anti-hIgG-conjugated nanoparticles; 
previously diluted to 11100 with PBS containing 0.1% (wlv) BSA was added to each 
well. The plates were then incubated at 37°C for 1 hour before washing (as before). 
Following the final wash step, the fluorescent response was determined using a using 
a Tecan safire2 monochromator-based nncroplate reader, with excitation at 453nm 
and emiss~on at 618nm. The fluorescent response was normalized against a zero 
control (blank well containing no fluorescent molecules). 
2.8 Development of fluorescence-based immunoassays 
2.8.1 Determination of optimal fluorescent label working dilution 
Black FluoronnncTM 96-well microtitre plate were coated with the appropriate amount 
of coating antigen as determined by checkerboard ELISA (100pllwell); either 
20pgIml InlB or 50pglml Warfarin-BSA and incubated at 37°C for 1 hour. The plates 
were washed 3 times w~th PBST (Tahle 2.4), PBS containing 0.05% (vlv) Tween 20 
and 3 times with PBS (Table 2.4). The plates were then blocked with 200pVwell of 
1% (wlv) BSA diluted 1n PBS. Powdered milk was not used as a bloclung reagent in 
this case, since milk contains biotin which could interfere with the produced signal. 
Following incubation for lhr at 37'C the plates were washed as before. A 11300 
diluhon of the biotinylated anti-InlB polyclonal antibody or anti-warfarin monoclonal 
antibody was prepared in PBS (Table 2.4) containing 0.1% (wlv) BSA and 1OOpl 
added to each well of the plate (in triplicate) The plates were then incubated for 1 
hour at 37'C and washed as before. The avldin-h&ed fluorescent conjugate (Table 
2.19), was titrated from a lOnm w o r h g  stock. Dilutions ranging from 112 to 114,096 
were prepared in 0.2M borate buffer, pH 8.2 and added to the plate 100pllwell (in 
triplicate) and the plate incubated at 37'C for 30mns. Following the wash step, the 
fluorescent response was d e t e m e d  using a Tecan safie2 monochromator-based 
microplate reader with excitation and emission wavelengths dependent on the 
fluorophore used. The fluorescent response was normalized against a zero control 
(blank well contaming no fluorescent molecules). 
Table 2.19: Excitation and emission wavelength of fluorescent labels 
2.8.2 Development of a competitive assay for the detection of InlBIwarfarin with 
quantum dot-labelled antibodies 
Black FluoronuncTM 96-well microtitre plates were coated with either 50pglml 
warfarin-BSA conjugate or 20pg/ml InlB-F3 and incubated for 1 hour at 37°C. The 
plates were then emptied and washed 3 times with PBS (Table 2.4) containing 0.05% 
(v/v) Tween 20 and three times with PBS (Table 2.4). The plates were blocked by 
adding 200~1 of PBS containing 1% (wlv) BSA to each well and incubated for 1 hour 
at 37°C. Free warfarin or purified InlB-F3 dilutions, ranang from 1.5ngIml to 
50000Rg/ml, were prepared in PBS (Table 2.4) containing 0.1% (wlv) BSA. The 
plates were washed as before and 5 0 ~ 1  of free haptenlprotein dilution was added to 
each well (in triplicate) along with 50pl of the biotinylated anti-warfadanti-Inll3 
antibody previously diluted to 11300 in PBS containing 0.1% (wlv) BSA. The plates 
were then incubated at 37°C for 1 hour and washed as before. The quantum dot- 
streptavidin conjugate was diluted to a worlung solutlon of 11500 of the ongmal stock 
(2nM concentration as determined in Section 2.8.1) in the supplied incubation buffer, 
(0.2M borate buffer, pH 8.2), added to the plate (100pllwell) and the plate incubated 
at 37°C for 30min. Following the wash step, the fluorescent response was determined 
using a using a Tecan safire2 monochromator-based microplate reader with excitation 
at 450nm and emission at 605nm. The fluorescent response was normalized against a 
zero control. 
2.8.3 Development of competitive assay for the detection of warfarinlInlS with 
porphyrin-labelled antibodies 
Black FluoronuncTM 96-well microtitre plates were coated with either 50pg/ml 
warfarin-BSA conjugate or 20pglml InU3-F3 and incubated for 1 hour at 37'C. The 
plates were then emptied and washed 3 times with PBS (Table 2.4) containing 0.05% 
(vlv) Tween 20 and three hmes with PBS (Table 2.4). The plates were blocked by 
adding 200pl of PBS containing 1% (wlv) BSA to each well and incubated for 1 hour 
at 37'C. Free warfann or purified InlB-F3 dilutions, ranpng from 1.5nglml to 
5000Ong/ml, were prepared in PBS containing 0.1% (wlv) BSA. The plates were 
washed as before and 50pl of free haptenlprotein dilution was added to each well (in 
triplicate) along with 50pl of the biotinylated anti-warfarinJanti-InlB antibody 
previously diluted to 11300 with PBS contaimng 0.1% (wiv) BSA. The plates were 
then incubated at 37°C for 1 hour and washed as before. The porphyrin-labeled 
neutravidin conjugate was diluted to a worlung solution of 11500 of the original stock 
in 0.2M borate buffer, pH 8.2, and added to the plates (100pl/well) for 30 min at 
37°C. Following the final wash step, the fluorescent response was deterrmned using a 
using a Tecan safire2 microplate reader w~th  excitation at 380nm and emission at 
650nm. The fluorescent response was normalized against a zero control. 
2.8.4 Immobilisation of biotinylated anti-InlB polyclonal antibody on biochip 
platform, traced with streptavidin-Cy5 
Biotinylated anti-InlB antibody was immobilised by passive adsorption onto 
polystyrene (PS) cone platforms (1/100 of stock) and left to react for two hours at 
mom temperature. The platforms were then washed 5 times with PBS (Table 2.4) 
contaimng 0.05% (vlv) Tween 20 and five times with PBS (Table 2.4) to remove any 
unbound antibody. The platforms were blocked by immersing the chip in PBS (as 
before) containing 1% (wlv) BSA and incubating the chip for 1 hour at 37'C. The 
blocked platforms were subsequently washed as before and skptavidin-Cy5 diluted 
in PBS was added to the antibody spots on the cone surface (11500 dilution). T h ~ s  was 
left to react for two hours at room temperature, after which the platforms were washed 
as before. The fluorescent signal generated from the immobilised biotinylated anti- 
InlB antibody, traced with streptavidmCy5, was detected using a CCD camera with 
exposure hmes of 5-10 seconds. 
2.8.5 Biochip assay for detection of InlB with streptavidin-Cy5 as tracer molecule 
InlB-F3 recombinant protein fragment was immobilised by passive adsorption onto 
polystyrene (PS) cone platforms (2Ongtp1) and left to react for two hours at room 
temperature. The platforms were then washed 5 tnnes with PBS (Table 2.4) 
contiuning 0.05% (vlv) Tween 20 and five times with PBS (Table 2.4) to remove any 
unbound antigen. The platforms were blocked by immersing the chip in PBS (as 
before) containing 1% (wlv) BSA and left to incubate for 1 hour at 37'C. The blocked 
platforms were washed as before and biohnylated anti-InlB polyclonal antibody was 
spotted onto the InlB-F3 immobilised cones (11100 dilution) and left to react for two 
hours at room temperature. The platforms were then emptied and washed as before to 
remove any unbound antibody. Streptavidin-Cy5 diluted in PBS (as before) was then 
added to the antibody-antigen spots on the cone surface (11500 dilution). This was left 
to react for two hours at room temperature, after which the platforms were washed as 
before. The fluorescent signal generated from the immobilised biotinylated anti-InlB 
antibody, traced with streptavidin-Cy5 was detected using both a CCD camera with 
exposure times of 5-10 seconds. 
2.9 Detection of Parvovirus El9 
2.9.1 Enzyme-linked immunosorbent assay (ELISA) for the detection of 
Parvovirus El9 
Microt~tre plates were coated with 4pg of coating antibody (anti-parvowus B19 
ant~body) and ~ncubated for 1 hour at 37°C. The plates were emptied and washed 5 
times with TBS (Table 2.4) contaming 0.05% (vlv) Tween 20 (TBST), and blocked to 
prevent non-specific binding w~th blocking solut~on (200pYwell). This blocking 
soluhon comprised of PBS (Table 2.4) containing 10% (wlv) sucrose and 1% (wlv) 
BSA. The plates were Incubated for 1 hour at 37C and washed as before with TBST. 
Recombinant VP2 capmd protein dilutions were prepared in low pH sample diiuent 
(B~otnn International, Dubhn), at concentrations ranging from lpg-10yglml. Each 
VP2 concentration was added to the plates in triplicate (100pVweU) and incubated at 
37°C for 1 hour. The plates were washed as before and peroxidase-labelled anu-VP2 
antibody added, previously diluted to 1110000 with enzyme conjugate diluent, 
( 100~we l l )  and incubated at 37°C for 1 hour The plates were washed, as before, and 
TMB substrate added (100yVwell). After 10 minutes incubation at 37'C the 
absorbances at 620 nm were determined using a Tecan safire2 plate reader. 
2.9.2 Fluorescence-based immunoassay (FL) for the detection of Parvovirus B19 
Microtitre plates were coated with 4yg of coating antibody (anti-Parvovuus B19 
antibody), and incubated for 1 hour at 37C. The plates were then emptied and washed 
5 times with TBS (Table 2.4) containing 0.05% (vlv) Tween 20 and blocked to 
prevent non-specific binding with blocking solution (as before, Section 2.9.1). The 
plates were then Incubated for 1 hour at 37 OC. Recombinant VP2 capsid protein 
dilutions were prepared in low pH sample diluent (Biotrin International, Dublm), at 
concentrations ranging from lpg-lOpg/ml. The plates were washed as before and each 
VP2 concentration was added in triplicate (lOOpVwell), and incubated at 37 OC for 1 
hour. The plates were washed (as before) and biotio-labelled anti-VP2 antibody, 
previously diluted to 11800 with enzyme conjugate diluent, (Biotrin International, 
Dublin) was added (5OpVwell) along with avidin-FITC conjugate previously .diluted 
ln the same diluent to 20pg/ml, (50yVwell). The plates were incubated at 37°C for 1 
hour, washed as before and the fluorescence response determined using a Tecan 
safire2 plate reader with excitation at 494 nm and emission 518 nm. 
2.9.3 Chemiluminescence-based immunoassay for the detection Parvovirus B19 
Microtitre plates were coated with 4pg of coating ant~body (anti-Parvovims B19 
antibody), and mcubated for 1 hour at 37C. The plates were then emptied and washed 
5 times with TBS (Table 2.4) conta~nmg 0.05% (vlv) Tween 20 and blocked to 
prevent non-specific binding with blocking solution (as before, Section 2.9.1). The 
plates were then incubated for 1 hour at 37 'C. Recombinant W 2  capsid protein 
dilutions were prepared in low pH sample diluent (Biotrin International, Dublin), at 
concentrations ranging from lpg-10pgIml. The plates were washed as before and each 
VP2 concentration was added In hiphcate (lOOpWwell), and incubated at 37 OC for 1 
hour. The plates were washed, as before, and peroxidase-labelled anti-W2 antibody, 
previously diluted to 1/10000 with enzyme conjugate dilnent was added (lOOyVwell), 
and incubated at 37°C for 1 hour. The plates were washed, as before, and 
luminoUiodophenol/hydrogen peroxide substrate was added, (100pWwell). The 
luminescence response was determined usmg a Biotek plate reader. 
2.9.4 Biomolecule immobiisation on cone platforms 
Plate-based assays for the detection of Parvovirus B19 were reproduced on optical 
enhancement cone structures (Optical sensors group, Biomedical Diagnostics 
Institute, DCU) using the same antibodies, antigen and reagents provided by Biotrin 
International, Dublin. Both polycarbonate (PC) and polystyrene (PS) cone platforms 
were made available for investigation. A number of surface modification strategies for 
optimal biomolecular immobilisat~on were exarmned. These included treatment of the 
polymers with an oxygen plasma prior to immob'ilisation, modification of the 
platforms with glutaraldehyde and the use of indium tin oxide @TO)-coated polymer 
materials with and without aminopropyl-tn-ethoxysilane (APTES). A matrix 
approach was taken for each modificat~on step, in that each method was exarmned in 
series, with appropriate controls. The success of each strategy was evaluated by 
determjning the amount of horseradish peroxldase (HRP) successfully immob~lised on 
each modified surface. This was achieved by lmmobilising a range of concentrations 
of HRP (0-1000pg/ml) on the modified platforms and assessing HRP incorporation 
with TMB substrate. Once an optimal method was chosen, the procedure was repeated 
for the anti-VP2 antibody (Biotrin International, Dublin) for further assay 
development. 
2.9.4.1 Investigation of biomolecule immobiisation on cone platforms 
Dilutions of plant HRP were prepared in PBS (Table 2.4) and 20p.I~ of each 
concentration (0-1000 &ml) was added to the modified cone platforms and left to 
react for two hours at room temperahue. The platforms were then emptied and 
washed 5 times with PBS (Table 2.4) containing 0.05% (vlv) Tween and five times 
with PBS (Table 2.4). The amount of bound HRP was determined by adding TMB 
(3,3',5,5'-Tetramethylbenzidine dihydrochloride) substrate to each of the cone 
assemblies. The TMF3 substrate was prepared by dissolving lmg of TMB in 200pl 
dimethylsulphoxide (final concentration of DMSO was 2% wlv). This TMF3 solution 
was added to 9.8ml of lOOmM citric acid buffer, pH 5.5, and mixed to homogeneity. 
To this solution, immedrately prior to assay, 3pl of Hz02 (30%, vlv) was added and 
mixed to give a final concentration of 0.03% (vlv) Hz@in the reaction solution. 
Twenty microlitres of prepared TMB substrate was added to each cone assembly and 
the platforms were covered to protect from light as the reaction proceeded. Fifteen 
microlitres of the reacted TMB substrate from each cone was then pipetted into an 
appropriate well in a microplate and 135N of reaction solution was added and mixed 
for 3min (1110 dilution, total volume of reaction in each well is 150pl). The 
absorbances for all samples were read at 620nm. This method was based on the fact 
that TMB substrate produces a blue colour in the presence of HRP catalytic activity, 
which can be spectrophotometrically measured at 620nm (Ryan et al., 1994). 
2.9.4.2 Detection of immobiised anti-VPt antibody on cone platforms 
HRF-conjugated anti-VP2 antibody was immobilised via glutsiraldehyde crosslinking 
on polystyrene (PS) cone platforms (0-1000pglml) and left to react for two hours at 
room temperature. The platforms were washed 5 times with PBS (Table 2.4) 
contaming 0.05% (vlv) Tween 20 and five times with PBS (Table 2.4) to remove any 
unbound antibody. The amount of bound HRP-conjugated anti-VP2 antibody was 
detemned using TMB substrate, (as before, Section 2.9.4.1). 
2.9.4.3 Enzyme-based sandwich assay for the detection of VP2 on cone platforms 
Polystyrene cone platforms were treated with diffenng percentage concentrations of 
glutaraldehyde; 2.5%, 1% and 0.25% (vlv), prepared in PBS (Table 2.4). Anti-VP2 
coatmg antibody (3.91pg) was spotted on the cones of each platform and incubated 
for 2 hours at RT. The platforms were washed 5 times with TBS (Table 2.4) 
containing 0.05% (vlv) Tween (TEST), and blocked to prevent non-specific binding 
with blocking solution (200plIwell), as before, Section 2.9.1. The platforms were 
incubated for 2 hours at RT and washed as before with TBST. Recombinant W 2  
capsid protein dilutions were prepared in low pH sample diluent (Biotrin 
International, Dublin), at concentrations ranging from lng - 10,000nglml. Each VP2 
concentration was added in triplicate (3 cones) and incubated at RT for 2 hours. The 
chip platforms were washed as before and peroxidase-labelled anti-VP2 antibody 
(previously diluted to 1110000 with enzyme conjugate diluent) was added to each 
cone and incubated at RT for 2 hours. The platforms were washed, as before, and 
TMB substrate (prepared as per Section 2.9.4.1) was added (20pVcone).The 
absorbances for all samples were read at 620111x1. 
2.9.4.4 Chemiluminescence-based detection of HRP on cone platforms 
The immobilisation of HRP vla glutaraldehyde crosslinking on polystyrene (PS) cone 
platforms (0-1000 pglml) was v~sualised by the in sthr addition of luminoViodophenol 
substrate to cone platforms using a 5ml luer-lock syringe. The detection of the 
chemilumnescence signal generated from immob~l~sed-HRP, was captured wlth a 
CCD camera using an exposure time of -40 s. 
2.9.4.5 Fluorescence-based detection of anti-VP2 antibody on cone platforms 
Anti-VF2 antibody-biotin conjugate was immobilised via glutaraldehyde crosslinking 
on polystyrene (FS) cone platforms (11800 dilutlon as per Section 2.9.2) and left to 
react for two hours at RT. The platforms were then emptied and washed 5 times with 
PBS (Table 2.4) containing 0.05% (vlv) Tween and five times with PBS (Table 2.4) 
to remove any unbound antibody. Streptavidin-Cy5 prepared in PBS (as before) was 
then added to the antibody spots (0-1000 pglml) and left to react for two hours at RT. 
The platforms were emptied and washed as before. The fluorescent signal generated 
from the immobilised biotln anti-VP2 antibody traced with streptavidin-Cy5 was 
detected using a CCD camera with exposure. times of 5-10 seconds. 
2.10 Lmmunostaining Application 
2.10.1 Slide Preparation 
Glass microscope slides were cleaned in 50:50 MeOH: HCI solution for thirty 
minutes. They were then nnsed three times in de-ionised water and left to air dry for 
thirty minutes in a slide rack. Two types of poly-L-lysine were rnvestigated for 
optimal coating of the glass slides. The first method involved the use of stock poly-L 
lysine solution diluted 1/10 (vlv) in sterile filtered PBS (Table 2.4). This solution was 
spotted onto clean slides and left to incubate for two hours. It was then nnsed off wlth 
ultra pure water and left to air-dry ovcmight. The second method utilized poly-L- 
lysine hydrobromide &luted 0.1% (wlv) in sterile molecular grade water. This 
solution was spotted onto clean slides and left to incubate for two hours. It was then 
nnsed off with ultra pure water and left to air-dry ovennght. 
2.10.2 Cell Preparation 
lml of Listeria monocytogenes cells were used to inoculate 50ml of Brain Heart 
Infus~on (BHI) medium (Table 2.3). This was grown at 200rpm for 4 hours at 37'C, 
while shaking. The cells were then sub-cultured by inoculating 3ml into 50ml of 
Listeria Enrichment Broth (LEB) (Table 2.3) and growing overnight at 37'C, while 
shaking at 200rpm. The culture was then centrifuged at 3,200 x g to pellet the cells. 
The pellet was resnspended in a 1/10 dilution of PBS (Table 2.4), to wash the cells 
and re-centrifuged at 3,200 x g. This was repeated three times and the cells were 
finally resuspended in 2.5% (vlv) glntaraldehyde in PBS (Table 2.4). A series of 
dilnhons (Neat, 1/25, 1/50, 11100) of the cell suspension were prepared in PBS (as 
above), and spotted onto the poly-L-lysine coated slides. The cells were left to fix for 
thirty minutes at room temperature. 
2.10.3 Immunostaining with anti-InlA antibody and quantum dots 
Once the cells had been fixed for t h i i  minutes, the slides were washed three times m 
PBS (Table 2.4). A 2% (wlv) solution of BSA was prepared in PBS (as before) and 
used to block the slides for lh  at RT, to prevent non-specific binding. The slides were 
washed again in PBS and the primary antibody was prepared. An anti-InlA 
monoclonal antibody was biotinylated (Section 2.5.2.1) and subsequently diluted 
11100 (40pglml) in a 1% (wlv) solution of BSA prepxed in PBS (as before). Thls was 
added to each slide and incubated for lhr at RT, after which the slides were washed 
three times in PBS (as before). A 20nM solution of avidin-linked fluorescent label 
(quantum dots, Cy5 or FITC) was diluted in incubation buffer (0.2M baste, pH8.2), 
added to each slide and incubated at RT for thirty minutes. The slides were washed 
three times in PBS (as before), and mounted with 90% (vlv) glycerol for imaging. 
210.4 Camera anmgement 
For each fluorescent label a specific emission fitex was purchased from Chroma 
Technology and inserted into the filter block of a Nikon fluorescent microscope with 
12-bit cooled QICAM fast m o n o c m t i c  camera (Figure 2.1) and Image Pm Plus 
software. The slides were viewed using the oil immersion lens and an objective of 
40x. The resulting images were processed using the image pro software. 
Figure 21. Nikon Fluorescent microscope (TE2000, Nikon Inc.) and 12-bit cooled 
QICAM fast monochmrnatic camera (1394, QImagingTM) used for the fluorescent 
imaging of quantum dot-labelled bacterial cells. This set up was controlled with 
Image Pro Plus software, supplied by Slidepath, DCU. 
2.11 Development of labeless reversible immunosensors for the detection of InlB 
2.11.1 Fabrication of electrode sensor platforms 
Screen-printed electrode sensor platforms were provided by Microarray Ltd. 
(Manchester, UK) as shown in Figure 2.2. The actual size of the sensor is 60x20mm 
and the area of the working and the counter electrodes are 22mmz and 72&, 
respectively. 
Area masked by &electric 
coat to ensure consistent 
electrode dimensions 
Carbon-111k 
counter electrode 
AgIAgCI 
reference electrode 
Contact pad area 
for connection to 
inshument 
, Carbon-mk 
working electrode 
Figure 2.2 Screen-printed electrode sensor platform (Microarray Ltd., Manchester, 
UK)  
2.11.2 Instrumentation 
A Sycopel PCI-100 MK3 Potentiostat computer interface was used m conjunchon 
with a 'Ministat Potentiostat' for electrochemical deposition (Figure 2.3). All 
currentlcharge transients were recorded using compatible PC and Sycopel software. 
AC Impedance measurements were performed using an ACM Auto AC DSP 
frequency response analyser (Rgure 2.4). The test frequency varied from IOOOOHz to 
1% a.c. and a 5mV amplitude perturbation was used. The potentiostat was linked to 
compatible PC utilislng ACM software for data acquisition. 
Figure 2.3 AEW2 'Mini Potentiostat' used in conjunction with Sycopel PCI-100 MK3 
Potentiostat computer inte$ace for all electrochemzcal deposztzon investigattons. 
Figure 2.4 ACM Auto AC DSPfrequency response analyser used in conjunction with 
Sycopel impedance software for all electrical impedance measurements. 
2.11.3 Electrochemical insulation of carbon working electrode with polyaniline 
The monomer solution used was thoroughly purged with N2 for 20 minutes m a sealed 
cell to provide an oxygen-free atmosphere. The cycle number and potentiodynarnic 
sweep rates were determined for each set of electrodes prior to deposition (data not 
shown). The insulation of planar carbon electrodes was achieved by sequentially 
scanning the worlung electrode potential from -200mV to 800mV (vs. AgIAgC1) and 
back to the starting potential, at a scan rate of 5OmVIs. A 0.2M aniline hydrochloride 
solution was prepared in a 0.5 M KCl, pH 1.0. The conducting films increased in 
thickness, as more charge was passed with each potential sweep. The optimisation of 
cycle number and the polymerisation time was dependent on the quality of the 
monomer solution and previous studies have shown that 15 cycles was sufficient for 
optimal electrodeposition of the polymer thin-films. 
2.11.4 Sensor modification 
Potentiodyuamic cyclic voltammetry was employed for the electrodeposition of 
polyaniline (PANI) as a planar thin-film over the working electrode of the carbon 
sensor After 15 cycles the sensor was subjected to a single linear sweep to 800mV, 
removed from the set-up, rinsed in aniline buffer at pH 1.0 and left to air-dry 
overnight. Water-soluble biotin-sulpho-NHS (30pl), at 'a concenuation of 10 mglml 
was placed on the polymer-coated working electrode surface for 24 hours. The 
sensors were then rinsed with deionised water. Neutravidin (30~11, at a concentration 
of IOpgIml was then placed on the workmg electrode for 1 hour. Finally, the sensor 
surface was thoroughly rinsed with de-ionised water. 
2.11.5 Immobilisation of biotinylated antibodies on modified sensor surfaces 
Biotinylated antibody (100pl of a lmglml solution) was added to the sensor surface. 
This solution was left to incorporate at the working electrode for 1 hour at room 
temperature and any unbound material nnsed off with deiomsed water. Finally, any 
non-specific interactions were blocked by adding M bovine serum albumin 
(BSA) in PBS (Table 2.4) to the sensors for 1 hour at room temperature. The modified 
sensors were washed with deionised water and left in PBS, (as above), ovemight at 4' 
C. 
2.11.6 Electrnchemical Impedance Spectroscopy (EIS). 
A Gill AC DSP Frequency Response Analyser was used to perform electrochenucal 
impedance spectroscopy (EIS). Data processing and interpretation of the 
electrochemical Impedance measurements were analysed, over a frequency range 
from 10,000Hz to I%, (5mV amplitude perturbation). Following the immobilisation 
of antibody molecules at the sensor surfaces, EIS was performed to interrogate the 
electrodes. A baseline trace was recorded initially in PBS, (Table 2.4), alone. 
Ant~hody-loaded sensors (electropolymerised carbon thin-film), were then exposed 
for 30 minute time periods to increasing concentrations of antigen by serial addition. 
After 30 minutes exposure to a single concentration, the working electrode was 
flushed with PBS, (as before) and the Impedance trace was then recorded in PBS, (pH 
7.4) alone between 10,000Hz to 1Hz. This process was then repeated for the full 
range of anhgen concentrations from lng/ml- 100ng/ml. 
Complex plane impedance analyses were used to relate the changes in sensor output 
to the antihodylantigen binding events at the electrode-polymer interface. These 
changes included the differing redox states of the polymer, the faradaic charge 
transfers and also the capacitive transduction events. Results were plotted in 
representatwe Nyquist and Bode forms as well as a percentage change in impedance 
from the baseline response. 
2.12 Biocompatibility Testing 
2.12.1 Culturing of rat aortic smooth muscle cells (RASM) 
Cell culture medium was made as per Table 2.7. The medium was poured off 
carefully and the cells washed gently with PBS (Table 2.4). The cells were harvested 
by adding 3ml of lox trypsin-EDTA to the flask and incubating for three minutes, at 
37°C. The flask was then tapped gently to &dodge harvested cells. 9 ml of medium 
was added to neutralize the trypsin and the contents transferred to a sterile universal 
tube. The cells were centrifuged at 1,600 x g for 10 minutes. The medium was then 
poured off gently and the pellet resuspended in lml PBS (as above). An additional 9 
mls of PBS (as above) was added to the resuspended pellet and the solution 
centrifuged again at 1600g for 10 minutes to wash pellet. The supernatant was poured 
off and lml medium added to the tube to resuspend the pellet. The cell suspension 
was then added to 301111 of medium using an appropriate split ratio (1:4), and 
transferred to T-75 flasks for incubation at 37'C in 5% COz .The cclls were fed every 
two days by pouring off medium and gently adding 14 ml of new medium to the flask 
taking care not to disturb cells. 
2.12.2 Freezing of cell lines 
The cells were trypsinised and then pelleted by centrifugation at 1,600 x g for 10 
nunutes. The pellet was resuspended in foetal calf serum with 10% (vlv) DMSO and 
aliquoted into lml cryovials. The cryovials were frozen in the vapour phase of liquid 
nitrogen for two hours before transferring to liquid phase for long-term storage. The 
vials were labeled with cell line, stock, date and passage. 
2.12.3 CeU Counting 
The cells were trypsinised to harvest as before. The pelleted cells were resuspended in 
Iml fresh medium and 5 0 ~ 1  of cell suspension removed to a sterile eppendorf. 1 0 ~ 1  of 
Trypan Blue was added to the cell suspension and incubated at RT for five minutes. A 
haemocytometer was used to count the cells using the following formula to calculate 
number of cellslml, 
~ ~ ~ ~ ~ 2 5 x 1 0 ~  
where N is the average number of cells counted and DF is dilution factor of cells to 
dye. Dead cells are stained blue, whlle healthy cells remain white. Percentage viability 
is calculated by expressing blue cells (dead) over white cells (alive) as a percentage. 
2.12.4 Preparation of substrates for bioeompatibility testing 
Substrates were placed in a beaker of methanol with a magnetic stirrer for five to ten 
minutes. The stainless steel substrates were subsequently rinsed in de-ionised water. 
They were then placed in aluminium foil and autoclaved at 121°C. 
2.12.5 Cytotoxicity testing of 316L stainless steel substrates 
An IvfIT (3-[4,5-diethylthiazol-2-yll-2,s-diphenylteoum bromide) assay kit 
(Roche Diagnostics), was used to assess the toxicity of treated and untreated 
substrates on RASM cells in culture. Cells were seeded with the treated and untreated 
substrates as per the plate layout with the plates in triplicate. Cells were grown in 24 
well plates with substrates for 48 h and 72h at high density. IOOpl (x6) of suspension 
from each sample was removed to a 96 well plate and ~ncubated with the yellow MTT 
solution for approx. 4 h. After this incubation period, purple formazan salt crystals 
were formed. These salt crystals are insoluble in aqueous solution, but may be 
solubilised by adding the solubilisation soluhon and incubating the plates overnight in 
humidified atmosphere (37"C, 5% C02). The solubilised formazan product was 
spectrophotometrically quantified using a Tecan Safue plate reader. An increase in 
number of living cells results in an increase in the total metabolic activity in the 
sample. This lncrease directly correlates to the amount of purple formazan crystals 
formed as monitored by the absorbance at 503nm. 
2.12.6 Cell Proliferation & Viability 
The cells were seeded with substrates in triplicate ( lxl~~cells/ml).  The plates were 
incubated for 24 h at 37°C in 5% COz and fed as before. After 24 hours, samples were 
removed from each well and retained for subsequent testmg; the plates were then 
incubated for a further 24,48 and 96 h in the same environmental conditions (37°C in 
5% COz) At each tlme point (24 h, 48 h and 96h) the cells were trypsinised for 
assessment with Trypan Blue stain to determine cell proliferation, density and 
viability. The substrates were retained for cell adhesion testing, on completion of the 
entire tlme course. 
2.12.7 Standard Glutaraldehyde Fixation for SEM 
Samples were removed from culture medium, rinsed with PBS (Table 2.4) and 
incubated at room temperature for 1 hour in PBS (as before) containing 2.5% (vlv) 
glutaraldehyde. The samples were then washed in 0 1M cacodylate buffer, pH 7.4 
(Table 2.4) and incubated for a further 2 hours at 4'C m 1% (vlv) osmium tetroxide in 
0.1M cacodylate buffer, pH 7.4. The glutaraldehydelosmium tetroxide-modified 
substrates were then washed briefly in 0.1M cacodylate buffer, pH 7.4. Dehydration 
was performed on each of the samples to remove any traces of moisture, by 
incubating the substrates in a graded series of ethanol concentrations from 50,60,70, 
80, and 90% (vlv), for 15 minutes each. Finally the substrates were incubated 2 x 10 
nnn in 100% (vlv) ethanol and dried overnight in a bell chamber under vacuum. 
2.12.8 Characterisation of substrates post incubation in culture 
Two techniques were used for the characterisation of substrates post incubation in 
culture. In order to assess cell adhesion, cells were fixed with glutaraldehydePBS, as 
per Section 2.12.7. Scanning electron microscopy was used to study the morphology 
of adherent RASM cells and to compare the cell adhesion response on the different 
surfaces. All tests were performed on a Hitachi S 300N scanning electron microscope 
(SEM) located in the School of Chenncal Sciences, DCU. The samples were 
immobilised on a 25mm aluminum stub and fixed in place using a sticky carbon disc. 
The secondary electron detector mode was used and measurements were taken using a 
relatively high KV (-20KV) since large magnifications were not required. The 
parameters for each sample were in&vidually optimised to give the highest resolution, 
by altering the following conditions of gun alignment, shift, tilt, spot size, beam 
current and stigmata. In order to assess the effect of culture conditions on the 
substrates, the cells were fust removed by trypsinisation. The substrates were then 
passed on to colleagues ~n the School of Engineering, (DCU) for evaluation, whereby 
contact angle measurement was used to assess hydrophobicity and hydrophilicity of 
the substrates post incubation in culture. 
Chapter 3: 
Production & characterisation of Listeria 
monocytogenes-derived proteins and 
expressionn of ati-InnB antibodies. 
3.1 Chapter introduction 
This chapter describes the cloning and expression of the L. monocytogenes invasion- 
associated protein Internalin B (InlB) peptide fragments into two vector systems, the pQE- 
60 vector (Qiagen Ltd.) and the pAC4 vector (Avidity Corporation). The Internalin B 
proteln was previously cloned an expressed in pQE-60 (Leonard, 2003). The InlB protein 
was sub-divided into three shorter overlapping peptide fragments with molecular weights 
of 23, 34 and 45kDa, respectively. Expression of the InlB fragments in E. coli XL-I0 Gold 
cells, using the Qiagen system allows purification of His-tagged proteins using 
immobilised metal affinity chromatography (MAC). Expression of recombinant InlB 
protein fragments in E. coli AVBlOl cells, using the Avidity system enables m vivo 
blotmylation of the fragments and subsequent affinity purification using monomeric avidin. 
The cloning and subsequent expression of recombinant L. monocytogenes protein 
fragments offers several advantages over the isolation of native proteins from whole L 
monocytogenes cells. Cloning eliminates the need for growing large-scale cultures of this 
bactenal pathogen and provides an unlimited supply of the recombinant proteins that may 
have incorporated aff~nity tags enabling one-step purification and enhanced funchonality. 
The fusion of a polyhistidine tag at the C terminus of each protein fragment enables easy 
purification and expression, while the addihon of a Biotin AviTag to the fragments allows 
in vivo expression of biotin on each fragment. The incorporation of such tags into the 
recombinant protein fragments generated improved reagents which could be used in 
association with anh-InlB antibodies, for the development of enhanced assays for the 
detechon of InlB. An overview of both vector systems 1s presented here and a description 
of protein expression and purif~cation is also described. 
3.1.1 QIAexpress cloning 
High-level expression of 6xHis-tagged proteins in E. coli is achieved using the QIAexpress 
pQE vectors, which enable selective purification of cloned proteins using nickel- 
nitrilotriacetic acid (Ni-NTA). The pQE plasmids belong to the pDS plasmid family 
(Bujard et al., 1987) which were derived from the plasmids pDS56/RBSII and 
pDS781RBSII-DHFRS (Stnber et aL, 1990). The 6xHis tag is an affinity tag of six 
wmaxtive histidine residues and is uncharged at physiological pH. Depending on the 
intended use of the expressed protein pQE vectors incorporating either C- or N-terminal 
6xHis tags are available. When incorporating C-terminal His tags the cloned insert must be 
in-fmme with the ATG start codon and the 6xHis tag thus ensuring only full-length 
proteins are purified. The pQE-60 expression vector incorporates a number of important 
features which contribute to the high level expression of recombinant proteins in El coli 
Figure 3.1). 
Ffgure 3.1 pQE-60 vector used for C-terminal 6xHis tag constructs. PT5: T5 promoter 
with a repression module to regulate eqression of proteins in E. Lac 0: Two lac 
operator sequences for increased lac repressor binding and therefore eficient repression 
of T5; RBS: synthetic ribosomal binding site for eflcient translation; ATG: start codon; 
MCS: multiple cloning site with Nco I, Barn HI and Bgl111 restridion sites; 6nHis: qfiniiy 
tag of 6 consecutive histidine residues; Stop codons: Stop codom in all three reading 
frames; Col El: Col El origin of replication 
The RNA polymerase from E. coli recognises the phage T5 promoter found in the plasmid, 
which also harbours two lac operator sequences that increase lac repressor binding, 
therefore allowing efficient repression of the T5 promoter. The plasmd also compnses a 
synthetic ribosomal bindiig site, RBSII, for increased translation and a sequence coding a 
6xHis-tag located 3' to the cloning region. A mult~ple cloning site and translational stop 
codons in all reading frames facilitate preparahon of the expression construct. The P- 
lactamase gene (bla), which confers ampicillin resistance and the colEl origin of 
repl~cation are also important features that are encoded for in the pQE-60 plasmd. 
3.1.2 pAC4 Avidity cloning 
The Biotin AviTag is a unique peptide sequence, 15 resldues long, that is recognised by 
biotin ligase (Schatz, 1993). In the presence of ATP, the ligase specifically attaches biotin 
to lysine residue in the sequence of target molecules. Avidity Corporation (Colorado, USA) 
has developed a series of vectors, namely AviTag pAC4, pACS & pAC6 that enable the 
efficient fusion of the Biotin AviTag to proteins and antibodies. Efficient biotinylation of 
Biotin AviTag-fused proteins can be acheved by expressing in a specialised E. coli strain 
(AVB101) also from Avidity Corporation. The AVBlOl strain contains the pACYC184 
ColEl compatible plasmid wlth an PTG-inducible birA gene to over express biotin ligase 
(pBirAcm). This strain is recommended for protein expression because of its robust 
growth and the absence of the OmpT and Lon proteases. Elevated levels of biotin ligase in 
the cells ensure complete biotinylation of Biotin AvlTag-fused proteins. The Biotin AviTag 
can be easily introduced at either the N- or C- terminus of any cloned target protein 
(Tatsumi et al., 1996). The InlB protein fragments were sub-cloned from the pQE-60 
vector as BamHl/NcoI constructs and transferred into the pAC4 vector for subsequent 
expression in E. coli AVBlOl cells. The main advantage of the pAC4 vector is that it has 
multiple cloning sites, a high copy number plasmid and a strong IPTG-inducible promoter 
which facilitates simple transfer of the recombinant protein fragments to this expression 
system. In addition the Biotin AviTag has only one fifth of the bulk of alternat~ve 
biotmylation tag sequences that are over 85 amino acid residues long. This greatly reduces 
steric problems. Figure 3.2 shows the vector map of the pAC4 expression vector. 
Ampicillin resistance 
Figwe 3.2 pAC4 vector used for C-terminal AviTag protein fusions. Promoter: promoter 
with a repression module to regulate expression of proteins in E. Start codon: start 
codon; MCS: multiple cloning site with Nco I and Bam HI restriction sites; Biotin AviTag 
peptide: 15 residue peptide sequence recognised by biotin ligase, for cre&.on of a 
biotinylated-fusion protein; Transcriptional terminators; transcriptioml terminators are 
also encoded on the plasmid, which prevent read-through tmcription and increase 
construct stability; Stop codon: Stop codons in all three reading frames; Ampicillin 
resistance: the&lactamase gene (amp) confers ampicillin resistrmee. 
The plasmid has an IPTG-inducible Trc promoter, which is recognised by the RNA 
polymerase from E coli. A multiple cloning site and fmnslational stop codom in a l l  
reading frames facilitate preparation of the expression construct. A glutamic acid residue 
which has been shown to greatly enhance biotinylation rates of the AviTag (Becketl et aL, 
1999) is  also included. Other impatant  feature,^ that are encoded in the pAC4 plasmid are 
the p-lactamase gene @la) confers ampicillin resistance and the lac P inserted at EcoRV 
site (thus disrupting the t& gene). 
3.1.3 Protein expression 
E. coli 1s the most frequently employed host w~th many available expression systems for 
producing proteins (Makndes, 1996). High-level recombinant protein expression using 
pQE-60 is induced upon addition of isopropyl-P-D-thiogalactoside w G ) .  IPTG binds to 
the lac repressor protein resulting in its dissociation. This allows the host strain's RNA 
polymerase to transcribe the sequence downstream of the promoter sequence with the 
resultant transcript being translated into the specific recombinant protein sequence 
required. However, sometimes the levels of protein expression are low desplte the use of 
strong transcriptional and translational signals. In such cases, there are a number of 
approaches that can he used to optimise expression levels. 
Examination of the codon usage of the heterologous protein can be advantageous since not 
all mRNA codons are used equally The so-called major codons are those that occur in 
highly expressed proteins, whereas the minor or rare codons tend to be in genes expressed 
at a low level. If the codon usage of your target protein differs signiticantly from the 
average codon usage of the expression host, this can cause signii7cant problems during 
expression such as decreased mRNA stability, premature termination of translation, 
frarneshifts, deletions and nnsincorporations (Kane, 1995). If any of these problems occur, 
protein synthesis can be inhibited and the observed levels of expression are often low. 
However, expression levels in such situations can he Improved by replacing codons that are 
rarely found in highly expressed E. coli genes with more favourable codons throughout the 
whole gene (Lain6 et al., 2002). A high GC content in the 5'-end of the gene of interest can 
also cause interrupted translation and lower levels of expression. Thus, higher expression 
levels can be obtained by changing G and C residues at the 5'-end of the codimg sequence 
to A and T residues without changrng the amino acids. The addition of a fusion partner can 
also improve expression levels (Murby et al., 1996). Fusion of the N-terminus of a 
heterologous protein to the C-terminus of a highly-expressed fusion partner often results in 
high level expression of the fusion protein (La Vallie et al., 1993). 
Another problem with protein expression is that m many cases the expressed protein is 
insoluble and accumulates in so-called inclusion bodies (Makrides, 1996; Choi et al., 
2005). This is especially true under con&tions of high level expression. Several strategies 
are available to improve the solubility of the expressed protein by reducing the rate of 
protein synthesis, thus improving levels of soluble expression. This can be achieved by 
lowering the gmwth temperature, growth time, inducer concentrahon or by using a lower 
copy number plasmid. Co-expression of chaperones and foldases can also improve soluble 
protein expression (Bessene et al., 1999). Molecular chaperones promote cellular targeting 
by transiently interachng with folding intermediates (Georgiou and Valax, 1996). Foldases 
such as disulphide oxidoreductase (DsbA), disulphide isomerase (DsbC) and protein 
disulphide isomerase (F'DI) also exhibit chaperone activity and co-expression of one or 
more of these foldases with the target protein can lead to higher levels of soluble protein. 
Periplasmc expression also has a positive effect on protein expression since the oxidising 
environment of the periplasm allows for the formation of disulphide bonds, which do not 
occur m the reducing environment of the cytoplasm (Hockney, 1994). Secretion of the 
target protein in the penplasm is achieved by the addition of a leader sequence (signal 
peptide) to the N-terminus of the target protein and results in reduced proteolysis, thus 
increasing soluble expression (Humphreys et al., 2000). The most common leader 
sequences are pelB and ompT. E coli does not express large proteins (> 70 kDa) very 
efficiently and, therefore, expression of smaller peptide fragments of the target protein can 
also lmprove expression levels and solubhty. 
In this chapter the high level expression and purScation of InlB protein fragments from 
two vector systems is presented. His-tagged recombinant InlB protein fragments, from the 
pQE-60 vector are expressed upon the addition of IPTG whereas in vivo biotinylated 
recombinant proteins fragments cloned into the pAC4 vector are induced upon the addition 
of both IPTG and biotin. The PAC series of vectors are used to express C-terminal AviTag- 
protein fusions. The pAC4 vector allows co-expression of the AviTag plasmid and the 
pBirA gene. The expression of an anti-InlB scFv isolated from a naive human library is 
also described and the optimisation of growth, induction and purification conditions is 
shown. 
3.1.4 Protein purif~cation using aftinity chromatography 
Affinity Chromatography can be used to separate biochemical mixtures, based on highly 
specific biologic interactions such as antigen with an antibody or a protein with a hexa- 
histidine tag and a metal ion (e.g. Ni+). A heterogeneous mixture of molecules in solution, 
containing the protein of interest (6xHis tagged protein, biotin-tagged protein) IS added to a 
column containing the affinity partner immobilised on a matrix m-NTA resin or 
monomeric avidin on Sepharose). The target molecule for purification binds to the column 
while other impurities pass through. Subsequently the captured target molecule can be 
specifically eluted and the associated fractions collected. 
Hochuli and co-workers (1987) applied MAC for the purification of recombinant proteins 
contamng engineered N- or C-terminal histldie tags. Methods used to elute the a s -  
tagged protein of interest included changing the pH, or adding a specific molecule, such as 
imidazole which competes for binding to ~ i ' +  on the column. One of the main advantages 
of IMAC purification is its sutabihty for protein purification under both native and 
denaturing conditions since the interaction between the Ni-NTA and the 6xHis tagged 
recombinant protein does not depend on the tertiary structure. There are several 
cornmerclally available chelating ligands available. However, for the purpose of this 
research, nitrilotriacetic acid (NTA) containing four metal-chelating sites was used, mnce it 
binds to the metal ions more stably and retains them under stringent washing and eluting 
conditions. IMAC purification was used to purify recombinant InlB protein fragments 
cloned from Qiagen's pQE-60 vector, whereas affinity chromatography using immobilised 
monomeric avldin on Sepharose was used to purify in vivo biotinylated recombinant InlB 
clones from Avidity's pAC4 vector. Both of these systems are described in this chapter. 
3.1.5 Chapter outline 
This chapter outlines the production and characterisation of Internalin B-derived protein 
fragments. The successful expression and purification of a recombinant form of Internalin 
B, a cell surface protein of Listeria monocytogenes is described. The entire InlB 
recombinant protein was sub-divided into three shorter overlapping peptide fragments with 
molecular weights of 23,34 and 45kDa, respectively. Identification of the antibody binding 
regions was achieved by probing the expressed polypeptide domains with a panel of InlB- 
assoc~ated antibodies. Purificahon of the InlB fragments by irnrnobilised metal affinity 
chromatography (IMAC) was optimised and purity monitored by electrophoresis and 
Western blotting. 
The InlB protein fragments were also successfully cloned into another expression system, 
Avidity's pAC4 vector for in vivo biotinylation. Purification of the in vivo biotinylated InlB 
fragments was performed via affinity chromatography using monomeric streptandin. 
Characterisation of cloned proteins was monitored by electrophoresis, Western blotting, 
Biacore and fluorescence-based detection methods. Finally an anti-InlB antibody fragment 
(scFv), previously isolated from a naive human library was studied and optimisation of 
expression and purification conditions was investigated. 
The expression and purification of the InlB protein fragments, epitope mapping and 
recombinant anti-InlB anhbody expression were investigated for the subsequent application 
of these reagents as antigens and antibodies in novel immunoassay formats for the 
lmproved detection of InlB. 
3.2 Epitope mapping of InlB 
An epitope mapping study of the Lzsteria monocytogenes invasion-associated protein 
marker, InlB, was undertahen in order to identify peptlde fragments that could be employed 
as antibody binding sites for irnmunoassay development. Epitope mapping is used for the 
determination of the relative location of epitopes on the surface of antigens, thus 
facilitating the definition of antigenic sites (Westwood and Hay, 2001). This is particularly 
useful for the successful development of improved immunoassays with greater sensitivity 
and reproducibility. Synthetic peptide technology facilitates the production of a series of 
overlapping peptides, offset with respect to each other by one amino acid, which can be 
used to mirmc the linear antibody-binding region. However, synthetic peptide technology is 
lim~ted in that only a small number of overlapping peptides (routinely 96) can be 
conveniently synthesised at once, which is normally too short to cover the whole protein of 
interest (Westwood and Hay, 2001). In order to define the antibody-b~nding domains of the 
L~steria monocytogenes invasion-assoc~ated protein marker, WB, shorter overlapping 
peptide fragments were cloned to determine which InlB polypeptide domain was most 
immunoreactive. This section describes the cloning and expression of the peptide 
fragments in the pQE-60 expression vector (@agen Ltd.). Identification of the antibody 
binding regions was achieved by probing the expressed polypeptide domains with a panel 
of anti-InlB antibodies and antibody fragments. 
3.2.1 Cloning of InlR Fragments into the pQE-60 expression vector 
In order to express high levels of the correct InlB gene products, the InlB gene sequence 
was directionally cloned into the Qiagen pQE-60 expression vector (Section 3.1.1). The 
InlB recombinant protern was sub-dimded into three shorter fragments. This was achieved 
by designing specific primers incorporating suitable res!xiction sites, compahble with 
chosen expression systems for transformahon Into E. coli (Sections 2.2.8-2.2.14). The pQE- 
60 plasmids containing the cloned inserts were then transformed into competent XL-10 
Gold E. cob, since they harbour the lac P mutation and produce enough lac repressor to 
efficiently block transcription, making them ideal for storing and propagating pQE 
plasmids (Qlagen Ltd, 2000). Transformants were screened by growing up single colonies 
of each fragment in small-scale cultures. Factors affecting the expression and recovery 
levels of the recombinant proteins were optimised individually for each fragment. Figure 
3.3 ~llustrates an overview of the processes involved in the cloning of the InlB protein 
fragments. 
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Figure 3.3 Overview of the processes involved in the cloning of the InlB gene sequence for 
epitope mapping. DNA from Listeria mcytoaenes  was prepared and the InlB gene 
sequence (and lnlB gene fragments) amplified by using specific PCR primers. Fresh PCR 
products (PCR A overhangs degrade over time) were directly punped wing a cornmemid 
kit (Promega Wizard Direct PCR Purification). This eliminated the need for sub-cloning 
into the pCR 2.1 vector (TA cloning). Pur@ed plasmid DNA frnn directly ampl$ied PCR 
products were directionally cloned into the pw-60 expression vector by digestion with 
Ncol and M I  restriction enzymes. The pQE-60 vectors, c o d i n g  gene inserts, were 
f i d y  trMsformed into E. XL.10 Gold cells. 
3.2.2 Preparation of genomic DNA 
E. coli XL-10 Gold cells containing the plasmid pQE60, beanng the Internalin B (InlB) 
gene, were donated by Dr. Paul Leonard, Applied Biochemstry Group, DCU(Section 2.2). 
3.2.3 Primer design 
Forward and reverse DNA primers were designed for the genes encoding each section of 
the InlB protein based on DNA sequences previously submitted to GenBank. The primers 
were based on the sequence of the recombinant InlB protein cloned and expressed from L. 
monocytogenes (Accession number AJ012346). The InlB protein is 621 amino acids long. 
In order to perform accurate epitope mapping, primers were designed to divide the protein 
into three distinct regions F3, F4, F5 as shown below in Figure 3.4. 
InlB 
0 62 1 
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F5 0 400 
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Figure 3.4 Schematic of InlB epitope mapping. The full ZnlB recombinant protein was 
portioned into three d~stmct regions F3, ~4 and F5. The expression of smaller protein 
fragments enabled the rdentification of antibody-binding domains. 
The entire InlB protein consisting of amino acids 0-621 includes the hydrophobic region 
and had prev~ously been expressed and purified (Leonard, 2003). The X domain (F5), 
whch does not include the hydrophobic region of the protein, comprises amino acids O- 
400. The 'leucine-rich' repeats which contain the IgG domain (F4) is made up of amino 
acids 0-321. The F3 reDon from 0-248 amino acids represents the 'leucine- rich' repeat 
region with no IgG domain. 
3.2.4. Amplification of InlB gene fragments by PCR 
Listeria monocytogenes (AJ012346-Genhank) genomic D N A  was used as the template for 
the amplification of the InlB gene fragments. Primers were engineered (Section 2.2.8), for 
directional cloning of the fragments into the pQE-60 plasmid. Since protelns expressed 
from pQE-60 contain a C-temnal 6xHis tag, the genes were cloned in frame with the 3' 
sequence encodtng the 6xHis tag. A standard PCR reaction was used to amplify the DNA 
sequences (Section 2.2.9). The optimum annealing temperature for use with each gene was 
determined using a temperature gradient PCR. This involved canying out several standard 
PCR reactions with varying annealing temperatures, ranging from 58 - 65'C. The optimum 
annealing temperature for the ampwcation of each fragment was determined to he 63°C. 
3.5 shows the optimised PCR amphfication of each InlB gene fragment by PCR. 
Figure 3.5 Agarose gel showing the amplification of the InlB gene fragments for mapping 
of anti-ZnlB antibody binding domains. Lanes ( I )  and (17): show a Ikb plus DNA ladder; 
Lanes (2)-(5): show the amplification of the F3 insert with bands visible at approximately 
797bps as predicted from pnmer desrgn; Lane (6): is a negative control for F3 (no 
template DNA); Lanes (7)-(10): show the amplification of the F4 insert with bands visible 
at approxrmately 943bps aspredictedfrom primer design; Lane (11): is a negative control 
for F4 (no template DNA); h e s  (12)-(15): show the amplification of the F5 insert with 
bands visible at approxcmately 1085bps as predictedfrom primer design; Lane (16): is a 
negative control for F5 (no template DNA). 
3.2.5 Direct Purification of PCR products and preparation of pQE60 vector 
The amplified PCR products for each insert (F3, F4 & F5) were pooled and directly 
purified using a commercial kit, the Promega Wizard direct purification kit (Section 
2.2.10). This kit removes the need to sub-clone the vector and inserts into a selection 
system, such as TA cloning system, by allowing direct purification of amplified PCR 
products. The purified PCR products can then be restricted and ligated into the vector of 
choice. The pQE-60 vector stock was grown up under normal conditions (Leonard, and the 
pQE60 plasnud DNA purified using the Promega Wizard Plus miniprep DNA purification 
system. 
3.2.6 BamHl and Ncol restriction analysis on pQE60 plasmid and purified PCR 
products containing cloned gene inserts 
The pQE-60 plasmid DNA was then liiearised using a BamHl 1 Ncol restnctlon digest 
(Section 2.2.11). A BamHl/Ncol restrichon digest was also carried out on the direct PCR 
purified inserts containing the cloned genes of interest, (Figure 3.6). 
InlB fragments F3, F4 & F5 
Figure 3.6 Restriction Digest on PQE-60 vector and InlB cloned inserts F3, F4 & F5. 
Lane ( I ) :  Ikb plus DNA ladder; Lane (2): BamHI/Ncol restricted F3 gene fragment, Lane 
(3): unrestricted F3 gene fragment; Lane (4): BamHI/Ncol restricted F4 gene fragmeng 
Lane (5): unrestricted F4 gene fragment; Lane (6): BamHI/Ncol restrzcted F5 gene 
fragment; Lane (7): unrestricted F5 gene fmgment; Lane (8): BamHUNcol restricted 
pQE-60 vector; Lane (9): unrestrzctedpQE-60 vector; Lane (10): Ikb plus DNA ladder. 
3.2.7 Ligation of vector-insert constructs 
The lineansed plasmid DNA from the vector (pQE-60) and inserts (F3, F4 & F5) was 
subsequently gel purified, following agarose gel electrophoresis, using the Wizard PCR- 
prep punfication kit (Sections 2.2.2-2.2.3). The gel purified vector and insert constructs 
were subsequently ligated (Section 2.2.12). The T4 DNA ligase diectioually cloned the 
DNA encoding the gene fragments of interest into the linearised pQE-60, for 
transformation into competent XL-10 Gold E.coli cells. 
3.2.8 Transformation of competent XL-I0 Gold Rcoli cells with pQE-60 containing 
the cloned inserts 
Competent XL-I0 Gold E coli were prepared using the methods described by Inoue et al., 
1990, (Section 2.2.4). The competent XLIO Gold E coli were then transformed with the 
pQE-60, containing the gene of interest (Section 2.2.13). 
3.3 Expression of the recombinant InlB protein fragments 
Positive clones were screened by picking single colonies from each transformation plate, 
for growth and induction. High-level recombinant protein expression was induced upon 
addition of isopropyl-P-D-thiogalactoside (IPTG). XL 10-Gold cells are eudonuclease- 
deficient (endAl), which greatly tmproves the quality of plasmid miniprep DNA, and 
recombination-deficient (recA), which ensures insert stability. Overmght expression 
cultures were prepared (Section 2.2.14). Following growth and induction the bacterial cell 
pellet was resuspended in PBS (Table 2.4) and sonicated for 30s to lyse the cells. The 
cultures were finally centrifuged at 3,200 x g for 20 min, to remove cell debris and the 
supernatant (cell lysate) analysed by SDS-PAGE. The approximate size of each expressed 
protein was determined prior to small-scale expression analys~s. The amino acid sequence 
of each insert was placed into a software tool from the EMBL database and the molecular 
weight and pI calculated accordingly. These approximate values were confiied by SDS- 
PAGE analysis and the theoretical sizes matched up to the actual values. SDS-PAGE 
analysis on the F3, F4 and F5 initial expression cultures yielded the appropriate bands at 
23,34 and 45kDa, respectively. 
The SDS-PAGE analysis on the initial small-scale expression cultures of the MB 
fragments in X L l O  Gold can be seen in figure 3.7. 
Figure 3.7 SDS-PAGE d y s i s  of the expression of lnlB fragments under native 
conditions. Lanes (1) and (10): Sigma wide range molecular weight markers consisting of 
aprorinin (6.5 ma) ,  a-lactoalbumin (14.2 kDa), hypsin inhibitor (20.1 a), trypsinogen 
(24 kDa), carbonic anhydmre (29 kDa), glycemldehyde-3-phosphate dehydroge~se (36 
k D 4  ovalbumin (45 ma) ,  glutamic dehydrogenase (55 ma) ,  bovine albumin (66 ma) ,  
fructose-6-phosphate kinase (84 ma), phosphorylase B (97 kDa), B-galactosidase (116 
kDa) and myosin (205 a ) ;  Lane (2): F3 induced sample; i h e  (3): F3 un-induced 
sample; Lane (4): F4 induced sample; Lane (5): F4 un-induced sample; Lane (6): F5 
induced sample; Lane (7): F5 non-induced sample; Lane (8): PLD induced sample 
(control); Lune (9): ZdB induced sample. 
This indicates that the three recombinant proteins fragments F3, F4 and F5, were 
successfully expressed in X L l O  Gold frmn the high-level expression vector pQE60. In 
order to obtain the maximum yield of protein, optimkation of several pammeters such as, 
lysis buffer, IPTG concentration, sonication conditions and induction time was necessary. 
For optimisation, a number of small-scale expression experiments were carried out before 
proQeding to largescale expression. 
3.3.1 Determination of InlB fragment (p3, F4 and F5) protein solnbility 
The high-level expression of recombinant proteins in E. coli may result in the formation of 
insoluble inclusion bodies, consisting of aggregates of the expressed protein. Therefore 
optimisation of lysis buffer for soluble protein isolation was perf&. Single colonies of 
XL-10 Gold E. coli, harbouring pQE-60 encoding the F3, F4 & F5 fragments, were picked 
from a freshly streaked plate and used to inoculate small-scale (10ml) cultures (Section 
2.2.14). Following growth and induction the bacterial cells were. pelleted by centrifugation, 
at 3,200 x g for 20 min, and the supernatant discarded. The bacterial pellets were 
resuspended in PBS (0.15M NaCI, 2.5mM KCI, lOmM Na2HP04 18mM KH904, pH 7.4) 
and sonicated (Sectwn 2.2.14). Following centrifugation, at 20,000 x g for 15 min, the 
supernatant (soluble protein) was analysed by SDS-PAGE. Alternatively, the pellet was 
resuspended in lml of denaturing buffer (8M Urea, lOOmM N a H m 4  lOmM Tris, pH 8.0) 
and sonicated (as before). Following centxihgation, at 20,000 x g for 15 min, the 
supernatant (insoluble protein) was analysed using SDS-PAGE. The protein solubility 
determination for each of the fragments can be seen in figure 3.8. 
Figure 3.8 SDS-PAGE analysis on the expression of lnlB fmgmmts under native and 
denaturing conditions. Lanes ( I )  and (12): Sigma wide range molecular weighi markers 
(as before); Lanes (2), (5) and (8): bacterial cell pellet resuspended in PBS for F3, F4 & 
F5 respe&.vely; Lanes (3). (6) and (9): bacterial cell pellet resuspended in denaturing 
b&erfor eachfragment F3, F4 and F5; LMes (4). (7) and (10): Empty lanes; Lane (11): 
PLD control. 
Although, some soluble expression was observed (Lanes 2, 5 and 8, respectively), the 
majonty of the expressed F3, F4 and F5 protein fragments forms insoluble inclusion 
bodies, which were solubilised using 8M urea (Lanes 3, 6 and 9, respectively). This 
suggests the need for denaturing buffer (contaning 8M urea) for the subsequent isolation of 
recombinant InlB fragments, following high-level expression in XL-I0 Gold E. coli. 
A web-based bioinfomatics program was also used to determine the solubility of the 
recombinant proteins (Harrison, 2000). Based on the amino acid sequence of the protein 
this model uses the approximate charge average, to determine protein solubility. This 
program estimated the percentage chance of insolubility for each fragmenf which was 
determined as 68%, 72% and 73% for the F3, F4 and F5 fragments, respectively. This 
confirmed the need for denaturing buffer, containing 8M urea, for the solubilisation and 
isolation of the recombinant InlB protein fragments, following expression in XL-I0 Gold 
E. coli. 
3.3.2 Optimisation of IPTG concentration for induction of protein expression 
Expression of F3, F4 & F5, from pQE-60, is rapidly induced upon addition of isopropyl-P- 
D-thiogalactoside (IPTG). The IPTG binds to the lac repressor protein and inactivates it. 
Once the lac repressor is inactivated, the host cell's RNA polymerase can transcribe the 
sequence downstream from the promoter. However, the concentration of IF'TG required for 
induction must he optimised, so that the highest level of protein expression is achieved 
without the level of protein expression and IPTG concentration becoming toxic to the cell. 
Several small-scale expression cultures were set up and a concentration range of IPTG 
from 0-lmM, was used for induction to determine optimal IPTG concentrations for 
maxunum protein expression (Section 2.2.15). 
Single colonies of XL-10 Gold E colt, harbouring pQE-60 encoding the F3, F4 & F5 
fragments, were picked from a freshly streaked plate and used to Inoculate small-scale 
(10ml) cultures (Sectron 2.2.14). Each culture was then induced with varying 
concentrahons of IF'TG, ranging from 0.01 to ImM and incubated for a further 4 hours. 
The cultures were then centrifuged and the supernatants discarded. The bacterial cell pellets 
was resuspended in denatwing buffer (8M Urea, lOOmM NaHzP04, lOmM Tris, pH 8.0) 
and sonicated (as before) and the supernatants retained for SDS-PAGE analysis. 
Figure 3.9 shows the gel pichues obtained for the expression of P3 in XL lOGold E. coli, 
following induction with the various IPTG concentrations. Variations in IPTG 
concentration did not seem to affect the level of protein expression so the lowest 
concentration of O.lmM was chosen for F3 as optimal. The same IPTG concentration 
gradient was investigated for both F4 and F5, (figures not shown). Basal level expression 
of F3 was visible following induction with zero concentration of IPTG. 
Figure 3.9 Opthisation of IPTG concentmtion for the indudon of InlB F3- expression 
under denahuing coditiom. Lmws (1) and (10): Sigma wide range molecular weight 
markers; Lane (2): induction of F3 expression using lmlM IPTG; Lane (3): indt&on of F3 
expression using 0.5 mM IPTG; Lane (4): inductrctron f F3 expression using 0.1 mMIPTG; 
h e  (5): induction of F3 expression using 0.05 mM IPTG; Lane (6): induction of F3 
expression using 0.01 mM IPTG; h e  (7): induction of F3 expression using 0 mM IPTG; 
Lane (8): PLD control; h e  (9): InlB lysate. 
3.3.3 Optimisation of Sonicalion C o ~ o m  
Following intracellular protein expression the bacterial cells must be lysed to isolate the 
recombinant protein. For the isolation of inclusion bodies the pe11eted bacteria were 
resuspended in denaturing buffer, containing 8M urea, and then sonicated. Sonication is 
used to isolate an expressed pmtein from within the cell cytoplasm. It involves sonically 
pulsing cells with sonic waves, thus disrupting the cell membrane and releasing 
cytoplasmic exlmts. However, the bacterial cells should only be sonicated for the 
minimum time necessary because prolonged sonication may destroy the protein and cleave 
the 6xHis tag (Qiagen, 2000). Therefae, the optimum sonication time for the isolation of 
the F3, F4 and F5 fragments from X L  10-Gold E. coli was investigated. Several small-scale 
(10ml) expression cultures were set up (Section 2.2.14) and a range of sonication times 
from 040s were examined to determine optimal conditions for maximum protein 
expression (Section 2.2.16). 3.10 shows the SDS-PAGE analysis of sonication 
conditions for the expression the M fragment under denaturing conditions. 
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Figure 3.10 Optimisation of sonication conditions for expression of InB F3 under 
denaturing conditiom. h e s  (1) and (10): Sigma wide range molecular markers; h e  
(2): 0 sec sonicatr'on; Lune (3): 10 sec sonicatwn; Lane (4): 20 sec sonicatl'on; Lane (5): 
30 sec sonication; Lane (6): 40 sec sonication; h e  (7): 50 sec sonicarion; Lane (8): 60 
sec sokcation; Lune (9): Empty lone. 
Increased sonication did not seem to have a major effect on protein expression. The 
intensity of the 23kDa band gradually in& as the sonication time increased up until 30 
seconds, after which time the band intensities levelled off. This suggested that a 30 second 
sonication pulse. was Buffcient for the isolation of F3. The same sonication conditions were 
investigated for both the F4 and F5 fragments, (figures not shown) with the same results 
reported, whereby inmased sooication had a minimal effect on protein expression. 
Therefore a sonication time of 30 seconds was chosen as optimal for the expression of the 
three InlB protein fragments. 
3.3.4 Time-course analysis on the e x p d o n  of F3, F4 and F5 
Following optimisation of the parametem for protein expression a timecourse analysis on 
the level of protein expression was canied out in order to determine the optimal induction 
time (Section 2.2.17). This is important in order to get a balance between the amount of 
soluble protein in the cells, the formation of inclusion bodies, and w i n  degradation. By 
checking the recombinant protein present at various times after IPTG induction, the optimal 
induction period can be established. Several small-scale (10ml) expression culhlres were 
set up (Section 2.2.14) and a range of induction times were examined, whereby lml 
samples were taken at intervals of 1, 2,3,4, 5, 6 andl8h post induction. Figures 3.11-3.13 
show the SDS-PAGE analysis of variations in induction time for the expression the each 
fragment 
Figure 3.11 Time course expression amlysis on F3 in XGIO Gold E. coli. Lanes ( I )  and 
(9): Sigma wide-range molecular weight marker; Lane (2): Non- induced control; Lane 
(3): F3 expression 1 hour post IPTG induction; Lane (4): F3 expression 2 hours post ZPTG 
induction; Lane (5): F3 expression 3 hours post IPTG induction; Lane (6): F3 expression 4 
hours post ZPTG induction; Lane (7): F3 expression 5 hours post IPTG indW.on; Lane 
(8): F3 expression following overnight induction using ZPTG. A band representing F3 is 
clearly visible at 23kDa 
figure 3.12 Time course ezpression analysis on F4 in &I0 Gold E. coli. Lanes ( I )  and 
(9): Sigma wide-range molecular weight marker; h e  (2): Non- induced control; Lane 
(3): F4 expression Z hour post IPTG induction; Lane (4): F4 expression 2 hours post ZFTG 
induction; Lane (5): F4 expression 3 hours post IPTG induction; Lane (6): F4 expression 4 
hours post IPTG inductr'on; Lane (7): F4 expression 5 hours post IPTG induction; Lane 
(8): F4 expression following overnight induction using IPTG. A A representing F4 is 
clearly visible at 34Wla 
Figure 3.12 Time course expression analysis on F5 in XL-I0 Gold E. coli. Lanes ( I )  and 
(9): Sigma wide-range mokcular weight marker; Lane (2): Non- induced control; LMe 
(3): F5 expression Z hour post IPTG induction; Lane (4): F5 expression 2 hours post IPTG 
inckcw Lane (5): F5 expression 3 3m post Z P n ;  inmCctim; Lane (6): F5 q r e s s w n  4 
hours post IPTG induction; Lane (7): F5 expression 5 hours post IPTG induction; lane 
(8): F5 expression following overnight induction using IPTG. A A representing F5 is 
clearly visible at 45kDa 
SDS-PAGE analysis on the time course analysis for F3, F4 and F5 suggested the optimal 
induction period for protein expression was 4 hours, after which no major difference in the 
levels of protein expression were observed @gures 3.10,3.11 and 3.12). Although slightly 
higher levels of F4 and F5 expression were obse~ed following a 5-hour induction period, 4 
hours was selected to minimise pmteolytic degradation of the proteins and 6x His-tag 
cleavage. 
3.35 Large-scale expndon culture for pnri6caliion 
LB (1Oml) containing 100 Mml ampicillin, 10 Wml tetracycline and 25 ~ g l m l  
chloramphenicol was inoculated with a single colony of M B  M, F4 and F5 in X L l O  Gold 
E. coli containing the pQ&60 plasmid. The cultures were grown as described in Sectiun 
2.2.18 and protein expression was then induced following addition of O.lmM IPTG. The 
culture was incubated shaking at 37OC for 4 hours and then centrifuged at 3,200 x g for 20 
min. The supernatant was discarded and the pellet resuspended in 25ml of IMAC wash 
buffer (Table 2.15) and sonicated for 30s. The lysed cells were then centrifuged at 3,200 x 
g for 15 min and the supematant analysed for protein expression, using SDS-PAGE (Figure 
3.13). 
Figure 3.13 Expression of InlB protein fragments wrder optimal expression and growth 
conditions. Lane (1): Sigma-wide moleculnr weight marker; Lane (2): F3fragment; Lane 
(3): F4fragmenh Lane (4): F5fragment. 
33.6 Purification of the His-tagged InIB protein fragments by lMAC 
InlB protein fragments engineered to express a 6xHis affinity tag, encoded at the C 
tmmhal were pwif5ed by biding to Ni-NTA resin. The high-affinity interaction between 
histidine residues and Ni* ions enabled specific purification of His-tagged recombinant 
proteins and the high surface concentration of the NTA ligand' was sufficient for the 
binding of approximate1y 5-1Omg of 6xHis tagged protein per millilitre of resin. Lcoli cells 
harbouring an InlB gene insert (F3 fragment) were induced with IPTG for 4 hours and the 
recombinant gene products purilied (Section 2.2.19). The purilication monitoring gel h m  
the pre-optimised expression of the InlS F3 fragment had a faint protein band at the 
predicted MR 23 kDa (data not shown). Low yields of protein were recovered since 
purification pammkn had not been ophised. The pre-optimised IMAC pwif5cation was 
performed at mom temperature and an excess amount of resin was used which explains the 
low yields observed (Barbas et al., 2001). A number of factors were investigated to 
improve purification conditions. These included reaction temperature, amount of resin 
used, amount of imidazole used to elute the protein from the column, wash buffer 
composition and lysate preparation. figure 3.14 shows the optimised pdcation gel for 
InlB F3. 
InlB 
FS~UIW 3.14 SDS-PAGE Analysis on optimised 1mC-pun9cation of InlB r e c o m b h  
protein fragment F3. Lanes (1) and (12): Sigma wide-range molecular weig& marker; 
Lane (2): Crude cytoplasmic lysate from X L l O  Gold following F3 Expression; Lane (3): 
Flow-through from ZMAC column following application o f  crude lysate; Lane (4): Wash 
fraction 1; Lanes (5)-(11): Eluted fractions 1-7, The elution of the InlB protein resulted in 
the presence of a concentratedprotein band at the eqected molecular weight of- 23kDa 
The conditions used for purification are important factors in recovery of functional protein. 
C i t i n g  the amount of resin used to purify His-tagged protein minirmses the purificahon 
of non-specific proteins ~n the sample by introducing competition for binding to the resin. 
The pellet from the centrifuged lysate was resuspended in IMAC wash buffer (50mM 
N&P04,300mM NaC1, 20mM imidazole, pH 8.0) and sonicated three times for 30s. The 
lysed cells were centrifuged (Section 2.2.19) and the lysate filtered before pnnfication. The 
protein was eluted with elution buffer that had a high concentration of imidazole (50mM 
NaHzPO4, 300mM NaC1,250mM imidazole, pH KO), since imidazole competes for binding 
to ~i~~ on the column. The higher the concentration of imidazole tolerated by the protein, 
the cleaner the eluant will be. The optlmised IMAC purification of the InlB recombinant 
protein fragments was performed at 4'C which improved b~nding of specific His-tagged 
protetns to the Ni-NTA resin (Barbas et aL, 2001). The eluted fractions (Lanes 5-11) show 
concentrated protein bands at the predicted MR of 23 kDa. 
3.3.7 Immunoreactinty of recombinant lnlB Protein fragments 
To confirm the presence of a His tag for IMAC purification, E. coli lysates harbouring the 
recombinant protein fragments were probed with a commercial anti-His tag-specific 
monoclonal antibody. The recombinant proteins were electrophoresed alongside a 
prestained molecular weight marker using SDS-PAGE (Section 2.2.5). Figure 3.15 (A) 
shows the Coomassie stained gel with bands representing the F3 (Lane 2), F4 (Lane 3) and 
F5 (Lane 4) InlB fragments and the full InlB protein clearly visible at 23, 34, 45 and 
60kDa, respectively. The protelns were transferred to nitrocellulose for Western blot 
analysis (Section 2.2.7). The nitrocellulose blots were probed with an ant-His tag-specific 
monoclonal antibody, since the pQE-60 vector has a His tag for punficahon. Figure 3.15 
(B) shows the His blot with bands clearly visible at 23, 34, 45 and 60Wa representing the 
F3, F4 and F5 fragment and the full InlB protein, respectively. This blot confirms the 
presence of a 6xHis tag in each of the clones, indicating that the tag is not hidden within the 
protein strncture. 
InlB 
Band 
Figure 3.15 SDS-PAGE gel and Western Blot of InlB peptide fragments (F3, F4 and F5) 
probed with anti-His tag-spec@c monoclonal adbody  i% co@m presence of the His tag. 
(A) Coomsie  stained gel. Lane (1): Sigma-wide molecular weight marker; Lane (2): F3 
fragment; Lane (3): F4fragment; Lane (4): F5fmgment; LMe (5) 1dB protein; (B) His 
blot. Lrme (I): Piercepre-starstarned marker; Lane (2): F3fragment: Lane (3): F4fmgmnt; 
Lane (4): F5 fragment; h e  (5) InlB protein. Bands visible at 23, 34, 45 and 60Wla 
co&mpresence qf the His-tag in each fmgment and in the previous& cloned fill protein 
(Leonard 2003). 
To determine the potential for use of the recombinant InlB protein fragments in 
immunoassay development with fluorescence and impedance-based detection methods, the 
immunoreactivity of the proteins was assessed by Western blotting using a panel of anti- 
InlB antibodies. Figures 3.16-3.18 show the detection of the InlB protein fmgments (l3, F4 
and F5) via Westem blotting with an anti-InlS polyclonal antibody, anti-InlB monoclonal 
antibody and anti-InlB antibody fragment (scFv). Phospholipase D (PLD) is a diagnostic 
marker for Corynebacterirmrpseudotuberculosis infection and although it is not specific for 
L monocytogenes or its associated pmteins, it has shown minor crossreactivity (Dercksen 
et al., 2000). It was therefore assessed as a control in these experiments. 
Band \ 
Figure 3.16 Western Blot of InlB pepridefmgments (F3, F4 and F5) probed with anti- 
InlB polyclonal anti* to determine location of the antibody-binding site. Lane (1): F3 
fragment; Lane (2): F4 fmgment; Lane (3): F5fragment; Lane (4) InlB protein; Lane (5) 
PLD is not recognised by anti-InlB antzanflbodies (negative control); Lane (6): Pierce pre- 
stained marker; Bands visible at 23, 34 and 44 kDa confirm presence of an epitope 
detected by the polyclonal antibody in each of the InlB fmgments, indicating that the 
antibody binding site is located in the F3fiagments (0-248 amino acids). 
d 
- InlB Band 
Figure 3.17 Western Blot of InlB peptide fragments (F3, F4 and F5) probed with anti- 
InlB monoclona~ an&?& to determine location of the antibody-binding site. Lane (1): 
Pierce pre-stained markers; Lane (2): F3 fragment; Lane (3): F4fragment; Lane (4): F5 
fragment; Lane (5) ZnlB protein; Bands visible at 23, 34 and 44 kDa confirm presence of 
an epitope detected by the monoclonal mrtibody in each of the InlB fragments, indicating 
that the antibody binding site is located in the F3fragments (0-248 amino acids). 
E3 PLD Band at 31.5 kDaberving 
(23kDa) \ ~e Ks-, (positive control) 
Figure 3.18 Western Blot ofInlB peptide .fragments (F3, F4 and F5) probed with anti- 
InlB scFv to determine location of the ant&+-binding site. Lane ( I ) :  F3fragment; Lane 
(2): F4fragmen~ Lane (3): F5 fragment; Lane (4) InlB protein; Lane (5) PLD (positive 
control) is also recognised by the HRP labelled anti-His antibody used for detection; Lane 
(6): Pierce pre-stained marker; Bands visible at 23, 34 and 44 kDa confirm presence of an 
epitope detected by the scFv Mtibody fragment in each of the InlB fragments, indicating 
that the antibody binding site is located in the F3fragment (0-248 amino acids). 
The rMB protein fragments (F3, F4 and F5) could be specifically detected with each of the 
anti-InlB antibodies @olycloual, monoclonal and scFv) raised against the native form of 
the full InlB protein. Bands visible at 23, 34 and 45kDa, respectively, confirmed the 
presence of the epitope detected by the anti-InlB monoclonal and scFv antibodies in each 
of the fragments and a major epitope recognised by the anti-InlB polyclonal antibody. This 
indicated that the location of an important epitope for antibody-binding was found in the F3 
fragment (amino acids 0-248). This showed that the F3 peptide hgment could be used for 
the generation of improved immunoassays for the detection of InlB, whereby the part of the 
InlB protein containing the most immunoreactive domain could be used as the antigenic 
determinant in assay development 
33.8 Sequence analysis of recombinant InlB protein fi-agments 
The pQE60 plasmid DNA containing the F3, F4 and F5 inserts was purified from the XL- 
10 Gold E. coli. A Comfort read (in both directions) was then obtained from MWG- 
Biotech on each plasmid and the nucleotide sequence returned. The amino acid sequences 
were then deduced £rom the nucleotide sequences using a web-based translation tool (Table 
2.15). The translated amino acid sequences were aligned with the published amino acid 
sequence of Internalin B (Accession number AJO12346) using the multialin program (Table 
2.15). The aligned sequences were imported into the BLAST database, to check for 
similarities with the known sequence of Internalin B. Figures 3.19-3.21 show the 
alignments of the cloned fragments (F3, F4 and FS) with the published protein sequence, 
displaying 100% identity with the sequence provided by Genedoc (k7012346). 
F3 InlB 
A5012346 
F3 InlB 
AJO12346 
F3 InlB 
A5012346 
Figore 3.19 Amino acid sequence o f  cloned InlB F3 sequence aligned with the sequence 
obtainedfiom Genebank (Accession number AJ012346). The text in red indicates the end 
ofthe signal peptide, while the text in blue is the amino acid sequence ofthe F 3 f m g m t  
F4 InlB 
-32346 
F4 InlB 
A5012346 
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85012346 
figure 3.U) Amino acid sequence of cloned InlB F4 sequence aligned with the sequence 
obtained from Genebank (Accession numberAJ012346). The text in red indicates the end 
of the signal peptide, while the text in blue is the amino acid sequence of the F4fragment. 
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Figure 3.21 Amino acid sequence of cloned InlB F5 sequence aligned with the sequence 
obtained from Genebank (Accession number AJO12346). The text in red indicates the end 
of the signal peptide, while the text in blue is the amim acid sequence of the F5fiagment 
3.4 In vivo biotinylalion of recombinant Internalin B protein fragments 
3.4.1 Cloning of InlB fragments into the pAC4 veetor 
The pAC4 vector for in vivo biotinylation of recombinant pmteins was purchased from 
Avidity Corporation, USA. This vector has both a BamHl and Ncol restriction site, thus 
facilitating easy transfer of InlB protein fragments (F3, F4 and F5) from Qiagen's pQE-60 
vector into the PAC 4 vector. 
3d.l.l Isolation of plssmid DNA h m  pQE-60 clones 
The pAC4 vector stock with InlS insert in AVBlOl cells was cultured and the vector DNA 
purified (Secfion 2.2.1). AVBlOl cells are endA- and as a result they are not compatible 
with the Promega mini-prep kit M o r e ,  the vector was transferred into XLI Blue E. 
coli for optimal purification of vector DNA. The p d ~ e d  pAC4 vector was digested with 
BamHl and Ncol (Section 2.2.11) to remove existing InlB insert and subsequently p d e d  
(Section 2.2.3) for ligation with 111133 fragments (F3, F4 and F5). This is shown in Figure 
3.22. 
Cut pAC4 Vector at 
421% 1 \ uAC4 Vector 
Figme 3.22 Agarose gel showing the restriction of the PAC 4 vector in XI-1 Blue for 
purificm'on of plasmid DNA. Lanes ( 1 )  and (4): Hyperladder DNA ladder; Lane (2): 
Digested PAC 4 vector m XL-1 Blue E with ZnlB gene removed; Lnne (3): Undigested 
pAC4 vector. 
3.4.1.2 BamHl/Ncol restriction analysis on pAC4 vector purified plasmid DNA 
containing cloned gene inserts 
The PAC 4 vector in Xl-1 Blue E.coli and the InlB pQE-60 inserts (F3, F4 and F5) in X1-10 
Gold E. coli were restricted using a BamHl/Ncol double digest (Section 2.3.1). The 
resulting restricted products were run on a 1% (wlv) agarose gel and the appropriate bands 
were cut for purification, (Figure 3.23). 
I 
Digested pAC4 Vector at 4216bp 
with cut InlB insert -1800bp 
Digested InlB fragments 
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Figure 3.23 Agarose gel showing the restriction of the pAC4 vector m d  1nlB pQE-60 
inserts. Lanes (1) and (10): Hyperladder DNA ladder; Lane (2): DigestedpAC 4 vector in 
XL-1 blues with lnlB insert; Lane (3): Undigested pAC4 vector; Lane (4): Digested F3 
insert in pQE-60; Lane (5): Undigested F3 insert in pQE-60; Lane (6): Digested F4 insert 
in pQE-60; Lane (7): Undigested F4 insert in pQE-60; Lane (8) Digested F5 insert in 
pQE-60; Lane (9): Undigested F5 insert m pQE-60. 
3.4.1.3 Ligation, Transformation and Expression of vector-insert constrocts 
A gel purification kit was used to punfy cut pAC4 vector and InlB insert bands, for ligation 
and transformation into AVB 101 E. coli. (Section 2.2.3).The gel purified InlB inserts were 
cloned into linearised pAC4 using T4 DNA ligase (Sectron 2.3.2) and subsequently 
transformed into electrocompetent AVBlOl E. coli, (Section 2.3.3). Posihve clones were 
screened by picking single colonies from each transformation plate, for growth and 
induction (Section 2.3.4). High-level recombinant protein expression was induced upon 
addition of 1mM IPTG and 1OOp.M biotin and the resulting pellets washed with PBS to 
remove any free biotin. The clones were then analysed using SDS-PAGE and Western 
blotting to confirm the presence of the biotin Avflag pnor to purification via affinity 
chromatography, using immobilised monomeric avidin. 
3.4.1.4 Confirmation of biotinylation of InlB fragments in pAC4 vector 
Confmation of in vivo biotinylation of the InlB protein fragments cloned into the pAC4 
vector was detemned by SDS-PAGE analysis and Western blotting. The fragments were 
expressed (Section 2.3.4) and subsequently analysed using SDS-PAGE (Section 2.2.5). To 
confirm the presence of a biotin tag on 'the in vivo biotinylated proteins, E. coli lysates 
harbouring the recombinant protein fragments were probed with a commercial anti-biotin 
anhbody. The recombinant proteins were electrophoresed alongside a prestained molecular 
weight marker using SDS-PAGE. Figure 3.24 (A) shows the Coomassie blue-stained gel of 
the in vivo biotinylated protein fragments F3, F4 and F5 lysates, diluted 1/10 in PBS (Lanes 
2-4). Biotinylated anti-Inll3 polyclonal anhbody (Section 2.5.2.1) was used as a positive 
control (Lane 5), while unbiotinylated fetuin protein was used as a negative control (Lane 
6). The proteins were transferred to nitrocellulose for Western blot analysis (Section 2.2.7). 
The nitrocellulose blot was probed with a commercial anti-blotin antibody, since the pAC4 
vector has a biotin AviTag peptide which should be present on each cloned protein 
fragments. Figure 3.24 (B) shows the blot probed with the anti-biotin antibody with bands 
clearly visible at 23, 35 and 44kDa representing the F3, F4 and F5 fragmenf respectively. 
This blot con f i i s  the presence of a biotin tag in each of the clones. 
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Figure 3.24 SDS-PAGE gel and Western Blot of lnlB peptide fragments (F3, F4 and F5) 
probed with anti-biotin antibody to confirm presence o f  the biotin AviTag, (A) Coomassie 
stained gel; Lanes ( I )  and (7): Sigma wide-range molecular weight marker; h e  (2): inlB 
F3 protein fragment, diluted 1/10: Lane (3): lnlB F4 protein fragment, diluted 1/10: Lane 
(4): 1nlB F5 protein fragment, diluted 1/10; Lane (5): Positive control, anti-Id 
biofinylated polyclonal antibody; I*wle (6): Negative control, non-bwtinylated fetuin. (B) 
Nitrocellulose blot probed with anti-bwrin antibody; Lanes (1) and (7): Amemham 
Rainbow prestained molecular weight marker; Lane (2): InlB F3 protein fragment; Lane 
(3): lnlB F4 protein fragment; h (4): 1nlB F5proteinfragment; Bana's are visible ai 23, 
34, 45 kDa, respectr'vely, for each o f  the protein fmgments indicating the presence of a 
biotin tag on each cloned protein, as q e c t e d  Lane (5): Positive control, anti-ZnlB 
biotinylated polyclonal antibody with heavy and light chains of the d o d y  clearly visible 
at 50 and 25 kDa, respectively, indicating presence of biotin; Lane (6): Negative control, 
feiuin which has no biotin tag and therefore was not detected by the &ti-biotin antibody. 
3.4.1.5 Purif~cation of in vivo biotinylated InlB fragments by a f h i t y  chromatography 
ImmunopureB immobilised monomeric avidin (P~erce), was used for the affinity 
punfication of the zn vivo biotinylated InlB protein fragments (Section 2.3.5). Avidin 
monomers have a much lower biotm-bindmg affinity than native tetrameric avidin enabling 
dissociation of biotinylated molecules using mld elution conditions. Dunng 
immobilisation of monomeric avidin polymeric forms of avidin with strong bmding 
characteristics are immobilised and, therefore, biotin-containing buffer was used to block 
these high affinity biotin-binding sites. The biotin molecules were eluted from the avidii 
monomers with a glycine solution which frees only the reversible binding sites. The in vivo 
biotinylated fragments were then applied to the support for purification and eluted by 
ligand competition using a biotin-containing solutlon (2mM biotin in PBS, pH 7.4). 
ImmunoPureB immobil~sed monomeric avidin is produced using a procedure that results in 
a high-biding capacity support with minimal non-specific binding and excellent recovery 
of biotinylated molecules. The monomeric avidin column is supplied as a 50% slurry 
containing 4% (wlv) beaded agarose. The binding capacity of the column is approximately 
1.2 mg biotinylated protein per ml of settled gel (Instruction manual # 20227, Pierce 
Biotechnology, Inc., 2005). Biotinylated protein was incubated on the column for one hour 
at room temperature. Purified fractions were eluted using 2mM biotin m PBS (0.15M 
NaCl, 2.5mM KC1, l0mM Na2HP04, 18mM KH2P04, pH 7.4) and 2ml fractions were 
collected and monitored spectrophotometrically at 280nm for protein content. The fractions 
that contained protein were pooled and quantified for characterisation using fluorescence- 
based immunoassay and Biacore. Figure 3.25 shows the elution profile for the m vivo 
biotinylated InlB fragment, F3, following affinity purif~cation using monomeric avidin 
immobilised on Sepharose. 
1 2 3 4 5 6 7 8 9 1 0  
Fraction Number 
Figure 3.25 Elution profile of biotinylated InlB fragment F3 following afinity 
purification using a monomeric streptavrdin column (1Oml capacity). biotinylated 
fragments were incubated on the column for one h at room temperature and eluted in 2ml 
fractions using 2mM biotin in PBS (0.15M NaCl, 2.5mM KCI, lOmM NazHP04, 18mM 
KHzP04, pH 7.4). Eluted fractions were monitored for protein content at 280nm and those 
containing protein (Fractions 3-8) were collected and pooled for subsequent 
characterisation. 
3.4.2 Characterisation of in vivo biotinylated recombinant InlB fragments 
The in vivo biotinylated InlB protein fragments, cloned from the pAC4 vector, were 
purified using affinity chromatography and charactensed using both fluorescence-based and 
B~acore-based methods. The following sections describe the characterisation of the in vivo 
biotinylated fragments and their potential use as novel reagents for improved detection of 
InlB. 
3.4.2.1 Enzyme-based detection of in vivo biotinylated fragments 
Each of the purified biotlnylated InlB fragments was titrated against imrnobilised anti-InlB 
polyclonal antibody and traced with extravidin peroxidase (Section 2.3.6.1). This assay was 
performed to ensure that the in vivo biotinylated fragments retained functionality post 
purification and would still bind an associated InlB-derived antibody. Anti-InlB polyclonal 
antlbody at a concentration of 10pgIml in 0.1M carbonate buffer (Table 2.4) was used to 
coat the wells of a microtitre plate. The plates were washed and blocked as per Section 
2.3.6.1. The concentrabon of each fragment (F3, F4 and F5) was determined 
spectrophotomehically post-purification and stock solutions were prepared at a 
concentration of 500pglml. Doubling dilutions (1110 to 115120) of each fragment were 
prepared from these stocks in PBS (0.15M NaC1, 2.5mM KC1, lOmM NazHP04, 18mM 
K&POA pH 7.4) containing 0.2% (wlv) BSA and subsequently added to the plate. The 
amount of bound in vivo biotinylated fragment was determined using extravidin peroxidase 
(Sigma-Aldrich) and TMB substrate. Figure 3.26 shows a titre of the in vivo biotinylated 
InlB protein fragments against immobilised anti-InlB polyclonal antibody. 
In vivo biotinylated WB 
protein fragments 
Figure 3.26 Titre of in biotinylated protein fragments against immobilised antibody. 
Anti-InlB polyclonal antibody was coated on the plate (IOpg/rnl) and a range of dilutions 
( I N 0  to 1/5120) of each of the biotinylated fragments (F3, F4 and F5) was added. The 
amount of bound protern was detected using extravidin-peroxiduse and TMB substrate. 
From Figure 3.36, it is apparent that the F3 fragment gave the most h e a r  response with the 
highest level of biotinylation. This indicated that the efficiency of in vrvo biotinylation of 
the F3 fragment was superior to both the F4 and F5 fragments. The F3 fragment is also the 
portion of the InlB protein that is the most immunoreactive, in that it contains the anabody- 
b~nding domain, as previously determined by SDS-PAGE and Western blotting (Section 
3.3.7) For both these reasons subsequent studies focused only on this part of the InlB 
protein, the F3 fragment. 
3.4.2.2 Fluorescence-based detection of in vivo biotinylated fragments 
The in vivo biotinylated F3 fragment was further investigated using a streptavidin-linked 
fluorescent label. Streptavidin-Cy5 (Amersham) was used to detect the amount of in vivo 
biotinylated protein bound to immobilised antibody (Section 2.3.6.2). Anti-InlB polyclonal 
antibody at a concentration of 10pgIml in 0.1M carbonate buffer (Table 2.4), was used to 
coat the wells of a microtitre plate. The plates were washed and blocked as per Section 
2.3.6.2. Donblimg dilutions (1110 to 115120) of biotinylated and non-biotinylated F3 
fragment were prepared in PBS (0.15M NaCl, 2.5mM KCl, lOmM NazHP04, 18mM 
KH.LPO4, pH 7.4) containing 0.2% (wlv) BSA and subsequently added to the plate. The 
amount of immobilised InlB F3 protein was detected using Streptavidin-Cy5 (Amersham) 
at a dilution of 111000. PBS (as before) was also used in some wells as a control, to 
determine the extent of non-specific binding. Figure 3.27 shows the titre of both the 
biotinylated and non-biotinylated F3 fragments, against immobilised anti-InlB polyclonal 
antibody and traced with streptavidin-Cy5. 
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Figure 3.27 Assessment of specijk rnteractions between biotinylated F3 fragment and 
fluorescent label (streptavidin-CyS). Biotznylated and unbrotinylated protein fragments 
were added to immobilised antibody and the amount of bound protein was detected using 
streptavidin-Cy 5. The fluorescence response units (FRU) were plotted against the InlB 
fragment dilution 
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Non-biotinylated F3 and PBS (0.15M NaCI, 2.5mM KC1, lOmM NazHP04. 18mM 
KHzP04, pH 7.4) were used as negative controls in this experiment, with both showing 
mnimal interaction with the streptavidin-Cy5. This was due to the fact that although the 
non-biotinylated F3 fragment binds immobilised anti-InlB antibody, it did not have a biotin 
tag to allow subsequent detection of bound antigen with streptavid1nXy5. It behaved in the 
same manner as PBS, which as a buffer had no binding capabilities for subsequent 
detechon with Cy5. This Indicated that only negligible amounts of non-specific binding 
was taking place and that the blocking solution, 2% (wlv) BSA in PBS (0.15M NaCI, 
2.5mM KCI, lOmM Na2HP04, 18mM KH2PO+ pH 7.4) was ~ ~ c i e n t .  Only the specific 
interaction between the hiotinylated InlB F3 protein fragment bound to immobilised anti- 
InlB polyclonal antibody and traced with streptavidin-Cy5 was observed. 
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The assay was repeated over a wider range of F3 protein fragment dilutions to assess the 
operating range of the biotinylated F3 protein as reagent for lmmunoassay development. 
3.28 shows a titre of the both the biotinylated and non-biotinylated F3 fragments 
against immobilised anti-InlB polyclonal antibody, traced with Steptavidin-Cy5, whereby 
the fluorescent response was normalised against a zero control (well containing no 
fluorescent molecules). The normalised fluorescence response units PERU) were plotted 
agiunst the InlB F3 fragment dilution (both biotinylated and non-biotinylated) bound to 
immobilised antibody and traced with Cy5. The in vivo biotinylated F3 fragment was 
successfully traced using streptavidin-lmked Cy5, whch highlights its potential use as a 
viable antigen for further fluorescence-based assay development. 
Figure 3.28 Fluorescence-based detection of InlB F3 protein fragments. Anti-ZnlB 
polyclonal antibody was coated on the plate (IOpg/ml) and a range of dilutions (1/10 to 
1/5120) of both the biotinylated and non-biotinylated F3fragment was added. The amount 
of bound protein was detected ustng streptavzdin-Cy5. The fluorescent response was 
normalised against the backgroundjluorescence (NFRU) and plotted against the InlB F3 
fragment dilution (both biotinylated and non-biotinylated). 
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Finally, the use of the in vivo biotinylated F3 fragment as a useful reagent for fluorescence- 
based detection was further investigated using three avidin-hnked fluorescent labels; 
streptavidin-hnked quantum dots, streptavidin-Cy5 and avidin-HTC (Section 2.3.6.4). 
Anti-InlB polyclonal antibody (10pg/ml) was used to coat the wells of a microtitre plate 
and blocked using PBS containing 2% (wlv) BSA. Biotinylated F3 fragment dilutions 
prepared in PBS contaning 0.2% (wlv) BSA were added to the plate and the amount of 
bound protein traced with the fluorescent labels (Figure 3.29). 
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Figure 3.29 Direct detection of bzotinylated F3 fragment using three fluorescent labels; 
Quantum dot-streptavidm conjugate (Qdots), Strepiavidin-Cy5 (Cy5) and Avidin-FITC 
(FITC). Anti-InlB polyclonal antibody was coated on the plate (lOpg/ml) and a range of 
dilutions (I/IO to 1/5120) of the biotinylated InlB F3fragment was added. The amount of 
bound protein was defected using quantum dots, Cy5 and FITC. The fluorescent response 
was normalised against the background fluorescence (NFRU) and plotted against the 
brotinylated ZnlB F3 fragment dzlution. 
Figure 3.29 shows that the biotinylated fragment F3 could be successfully traced with three 
different avidin-linked fluorescent labels. This highlights the potentlal use of the in vrvo 
biotinylated fragment as a reagent for future fluorescence-based immunoassay 
development. 
3.4.23 Biacore analysis of in vivo biothylated fragments 
This section focuses on the use of Biacorebased methods (Section 4.1.3.2) for the 
characterisation of in vivo biofinylated wombinant InlB F3. The biotinylated F3 fragment 
was used as the capture antigen for the preliminary development of a Biacore inhibition 
assay for M o n  of InlB F3, using the anti-InlB polyclonal antibody. A Biacore 
carboxymethylated 5 (CM5) chip was covalently immobilised with the avidin-derivative, 
neutravidin for the specific capture of the biotinylated fragment (F3) on the surface of the 
chip. The chip consists of three layers: glass, a thin gold film and a matrix layer. The 
matrix layer is attached to the gold film through an inert linker layer. In the case of the 
CM5 chip the matrix layer is carboxymethylated dextran, which allows the covalent 
immobilisation of neutravidin on the sensor surface. Biotinylated InlB F3 was then 
immobilised on the neutravidin surface and anti-InlB polyclonal antibody, incubated with 
decreasing concentrations of InlB F3 protein fragmenf injected over the surface. The shift 
in binding response after each injection was recorded and the results presented in Section 
3.4.2.3.4. Figure 3.30 shows a diagrammatic representation of a CM5 chip and the assay 
format used for the detection of InlB, with biotinylated F3 as capture antigen. 
M a e  lays 
Figure 3.30 Diagrammatic representation of the surface of a carboxymethylated 5 ( C W )  
sensor chip. m e  chip consis& of three layex glass, a thin goldfiIm and a matrix layer. 
The matrix layer is attached to the goldJilm through an inert linker layer. In the case of the 
CM5 chip the matrix h e r  is carbarymethyluted dextran, which allows the covalent 
immobilisation ofneutravidin onto the sensor surface. Neutravidin was used to capture the 
in vivo biotinylated ZnlB F3, for subsequent use in the development of an inhibition assay 
-
for the detection ofInlB using the anti-InlB polyclonal anfiboh. 
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3.4.2.3.2 Innnobiiiation of nentravidinhiotinylated F3 onto the CM5-chip surface 
In order to immobilise a ligand onto a CM5 sensor chip, three main phases are involved in 
the process. Firstly the surface is activated, the ligand is subsequently immobilised on the 
activated surface and finally the surface is deactivated or 'capped' to block any remaining 
sites left active by the immobilisation process. Molecules can be covalently coupled to the 
CM5 chip surface via aminc, thiol, aldehyde or carboxyl groups. These chips have a high 
binding capacity, advantageous for capture assays and high surface stability providing 
accuracy and precision. The most commonly used surface chemistry for the immobilisation 
of biomolecules on CM5 sensor chip surfaces is EDC (N-ethyl-W-(dimethylarninopropyl) 
carbodiinnde) and NHS (N-hydroxysuccinirmde) chemistry. The use of carbodimide-EDC 
in conjunction with NHS activates the carboxyl groups of the CM-dextran surface, 
transforming them to active NHS esters that can be used to covalently immobilise the 
protein, in this case neutravidin, via its amino groups. The chip surface is then deactivated 
with 1M ethanolamine hydrochloride, pH 8.5, and all non-covalently bound protein is 
removed by reducing the electrostatic interaction between the CM-dextran surface and the 
protein. 
Immobilisation of neutravidin on the dextran surface was performed as described in Section 
2.6.2. Neuatravidin (5Opg/ml), diluted in lOmM sodium acetate buffer, pH 4.6 (Section 
3.4.2.3.1) was injected over the E D C M S  activated sensor ship surface for 40 minutes at a 
flow rate of 5pVmin. Approximately 25,000 RU of neutravidin was immobilised on the 
surface (Figure 3.32). 
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Figure 3.32 Typical imnobilisation of neutravidin onto a CM-dextran chip surface. (A) 
HBS buffer zs passed over the chip surface and the baseline response is recorded. ((BJ Tke 
CM-dextran surface is activated with an equal volume of lOOmM NHS and 400mM EDC, 
which causes an rncrease in SPR signal due to a bulk refractive zndex change. (C) HBS 
buffer is passed over the surface again, post-activation and the baseline response 
measured (D) Neutravidin (50pg/ml) diluted in IOmM sodzum acetate buffer, pH 4.6, is 
passed over the surface for 40 mznutes, a large increase in SPR signal is observed as the 
bulk refractive index changes. (E) HBS buffer is passed over the surface and the amount of 
bound neutravidin recorded (F) The surface is deactivated or 'capped' using ZM 
ethanolamine hydrochloride, pH 8.5, which removes non-covalently bound neutravidin and 
blocks any remaining NHS esters. (G) The surface is regenerated with two 30 second 
pulses of 5mM NaOH, to ensure all immobilised neutravidin is bound covalently, before a 
measurement of total imnwbilised neutravidin is recorded Approximately 25,000 response 
units (RU) of neutravidin were bound to the sensor chip surface post immobilisation 
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The biotinylated InlB F3 protein fragment, diluted in HBS bnffer to a concentration of 
60~gIml was manually injected over the surface for six minutes, at flow rate of 5pVrnin. 
Approximately 450 RU of biotinylated F3 was immobilised on the surface. Although the 
affinity between neutravidin and biohn is strong (Green, 1965), dissociahon of the 
biotinylated fragment occurred as soon as HBS buffer solution was passed over the surface. 
This was possibly due to the efficiency of the m vivo biotinylation process. Theoretically, 
in vivo biotinylation of recombinant proteins using the pAC4 vector system should be up to 
90% efficient (Tatsumi et aL, 1996), however, this 1s dlfhcult to control. Further 
optimisation of growth and expression conditions would be required to ensure maximum 
potential biotinylation of the cloned protein. Therefore an alternative strategy for 
stabilisation of the surface was investigated. 
The immobilised biotinylated F3 protein fragment was subjected to a 30s pulse of 400mM 
EDC1100mM NHS at a flow rate. of SpYmin, to stabilise the biotinylated protein on the 
surface (Karlsson et al., 2000; Markgren et al., 2001). This treatment activates the carboxyl 
groups in the protein, whereby subsequent reaction with primary amines (also in the 
protein) results in intra- and intermolecular cross-links. Intermolecularly cross-hnking 
monomers that were not covalently fixed to the matrix, therefore, enhances the stability of 
the surface, whereby the chemically modified surface showed an almost constant baseline 
level and improved binding capacity. Inihal experiments post-crosslinking showed that the 
biotinylated fragment became tightly bound to neutravidin surface and was not dissociated 
even upon washing with buffer for several hours (not shown). The surface was then 
regenerated with a 30s pulse of 5mM NaOH to ensure all immobilised biotinylated F3, 
cross-linked with EDC/NHS stayed on the surface, before a measurement of total 
immobilised biotinylated F3 was recorded. Approximately 900 response units (RU) of 
cross-linked biotinylated F3 were bound to the sensor chip. Figure 3.33 shows the manual 
injection and stabisation of the biotinylated fragment with EDC/NHS. 
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Figure 3.33 Immobilisation of biotinylated F3 protein onto neutravrdin surface and 
subsequent cross-linking using EDCDIHS. (A) HBS buffer is passed over the chip suflace 
and the baseline response rs recorded (B) A manual tnjectron of && brotinylated ZnlB 
F3 protein is passed over the surface for 7 minutes. (C) The biotinylated F3 protein is 
stabilised on the surface with 30 second pulse of 400mM EDC/100mM NHS, whrch causes 
an increase in SPR signal due to a bulk refractive index change.(D) HBS buffer IS passed 
over the surface agam, post cross-lrnking wrth EDC/NHS and the baseline response 
measured (E)  The surface u regenerated with a 30 second pulses of 5mM NaOH to ensure 
all immobilised brottnylated F3 protetn rs tightly bound, before a measurement of the 
amount of biotinylated F3 is recorded (F) Approximately 900 response units (RU) of 
biotinylated F3 are bound to the sensor chip surface post immobilrsation and stabtlisation 
with EDCATHS. 
3.4.2.3.3 Assessment of non-specific K i n g  and regeneration studies 
The degree of non-specific binchug of the polyclonal aria-InlB ant~body to the 
neutravidinlbiotinylated fragment immobilised on the CM5 chip was assessed. This was 
achieved by passing the polyclonal anti-InlB antibody (diluted 1/20) over the neutravidin 
surface when both in the presence (flow cell 2) and absence (flow cell 1) of biotinylated F3. 
Figure 3.34 shows the overlay plots obtained following injection of anti-InlB polyclonal 
anttbody on the neutravidin surfaces with and without biotinylated M. Injection of the anti- 
hlB polyclonal antibody over both surface resulted in approximately 300 response units of 
binding to the neutravidii surface with immobilised biotinylated F3, while negligible 
binding (< 10 RU) was observed for the neutravidin surface with no biotinylated F3. 
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Figure 3.34 Overlay plot showing simultaneous injection of the anti-ZnlB polyclonal 
antibody over neutravidin-immbilised surfaces both with and without biotinylated F3 
protezn. (A) HBS buffer is passed over the chzp surface and the baselme response is 
recorded (B) A manual injection of antz-ZnlB polyclonal antibody is passed over both 
surfaces for 2 minutes. (C) Approximately 300RU of anti-ZnlB polyclonal antzbody was 
captured on the biotinylated F3 protein surface. (D) Negligible binding was observed for 
the neutravidin surface containing no biotinylated F3. 
Optimisation of the anti-InlB polyclonal antibody dilution and effective regeneration 
conditions were also investigated. The anti-lnlB polyclonal antibody was diluted to 1/20 in 
HBS buffer and injected over the immobilised neutravidin/biotinylated F3 surface at a 
flow-rate of 10pVmin. Initial studtes showed little dissociation of the polyclonal antibody 
from the immobilised surface. A regeneration solution consisting of 27.5mM NaOH 
enabled complete removal of the bound polyclonal antibody using a 30 second pulse at a 
flow-rate of 10pl/min. The efficiency of the regeneration process was then evaluated by 
performing multiple (i.e. 10) binding-regeneration cycles on the chip surface. At this point, 
stocks of anti-InlB polyclonal antibody were in short supply and so only ten regenerations 
were performed to demonstrate proof of principle, that the surface could be regenerated 
effectively. Over the 10 binding-regeneration cycles the antibody binding capacity varied 
slightly but it did not significantly affect the assay performance. The binding of the anti- 
InlB polyclonal antibody to the neutravidin/biotiuylated F3 surface was highly 
reproducible, with approximately 300RU of the antibody biding to the surface each time. 
This indicates that the regeneration solution of 27.5mM NaOH for the anti-InlB polyclonal 
antibody did not affect antibody binding throughout the regeneration study and was 
sufficient for complete removal of bound antibody. 
Figure 3.35 shows regeneration studies using the polyclonal antibody, diluted 1/20 in HBS 
r u w g  buffer and passed over the surface using a 2 minute pulse at lOp/min. The bound 
antibody was completely removed using a 30 second pulse of 27.5mM NaOH. 
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Figure 3.35 Regeneration studies using the polyclonal antibody, diluted to 1/20 in HBS 
running bufSer and passed over the su$ace using a 2 minute pulse at IOp!lmin. The bound 
antibody was completely removed using a 30 second pulse of 27.5mM NaOH. In order to 
conserve polyclonal antibody stocks, only 10 regeneration cycles were performed. 
However 10 cycles were suffzczent to hcghlight that the surface was regenerable with 
approximately 300 RU of antibody gocng on and being removed during each cycle. 
3.4.2.3.4 Development of a Biacore inhibition assay for the detection of InlB 
Following optimisation of the various assay parameters, a preliminary inhibition assay, 
incorporating the polyclonal antibody, was developed for the detection of InlB F3 (Section 
2.6.5). This assay employed neutravidin for the specific and directed immobilisation of in 
vivo biotinylated InlB F3 protein on the CM5 sensor chip. Free (non-biotinylated) InlB F3 
standards, rangrng in concentration from O- 1250ng/ml were prepared in HBS. Each free 
lnlS F3 concentration was incubated with an equal volume of the anti-InlB polyclonal 
antibody diluted 1/10 (to ensure a final dilution of 1/20) and allowed to equilibrate for 30 
nun at 37°C. The equilibrated samples were then passed over the sensor surface, in random 
order, and followed by regeneration of the biotinylated F3 sensor surface using 27.5mM 
NaOH. 
Figure 3.36 shows a typical overlay sensorgram showing the antibody binding responses of 
the polyclonal antibody in the presence of a range of free InlB F3 standards. 
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Figure 3.36 Typical overlay sensorgram showing the antibody binding responses of the 
anti-ZnlB polyclonal aatibody in the presence of a range o f f e e  InlB F3 standards. Free 
InlB F3 dilutzons, ranging 1n concentration from 19 - 1250 ng/ml, were pre-incubated with 
an equal volume of the anti-InlB polyclonal antibody and passed over the sensor surjace. 
The sensor su$ace was regenerated using 27.5mM NaOH. (A) The normalzsed baselines of 
each sensorgram when HBS is injected over the chip surface. (B) The binding of increased 
free antibody wzth decreaszng InlB F3 protein concentrations. (C) Baseline shzft when 
buffer is passed over the surface afier each injection. 
Figure 3.37 shows the use of the in vivo biotinylated InlB F3 protein as a capture antigen, 
for the sensitive detection of InlB in a Biacore-based inhibition assay. 
Figure 3.37 Calibration curve for the detection of free ZnlB F3, using a Biacore-based 
lnhibztion assay. Anti-InlB polyclonal antzbocty was incubated with varlous lnlB F3 
concentrations and injected over a neutravidin/biotinylated F3 surface. A 4-parameter 
equation was $fined to the data set using Biaevaluation 3.1 sofrware. The percentage B/Bo 
was determined and plotted against log concentration o f f e e  InlB F3. B/Bo is calculated as 
the mean response at each antigen concentration (A) minus the mean response at excess 
antigen (A  excess) divided by the mean response determined in the presence of zero antigen 
(Ao) minus the mean response at excess antigen concentration (A excess). The BBo value is 
expressed as a percentage to determine the percentage inhibition at each antigen 
concentration. Each point on the curve is the mean of three replicate measurements and 
CVs of between 0.48-3.05% were found. 
This calibration curve demonstrates a proof of principle concept showing the use of the 
biotinylated InlB protein fragment as a reagent for further assay development. 
Unfortnnately, this cahbration profile 1s only based on the mean value of three replicates 
since the stocks of the anti-InlB polyclonal antibody were depleted. Further reproducibility 
studies would be required for assay validation, possibly with an alternative anh-InlB 
antibody. However, overall this section demonstrates the potential use of the in vivo 
biottnylated protein as useful tool for the sensitive detection of InlB. 
3.5 Optimisation of expression of anti-InlB scFv from nalve human library 
An anti-InlB human scFv clone, previously isolated from a naive phage &splay library by 
Dr. Paul Leonard, was made available (Leonard, 2003). The antibody fragment was 
expressed in a suppressor host strain TGl E.coli. This host stran produces a suppressor 
tRNA which allows read-through of the amber stop codon located between the scFv and 
gene 3 sequences of the pCANTAB vector. Suppression of the amber stop codon is only 
about 20% efficient; therefore, a small amount of soluble antibody is produced in addition 
to phage-displayed anhbodies in this strain. To switch to optimal expression of soluble 
recombinant antibodies it was necessary to transform the scFv into a non-suppressor strain, 
namely TOP 10F E.coli In this strain of E.coli, the amber stop codon is recognised and 
only soluble antibodies are produced, thus allowing optimal expression of antibody for 
subsequent purification (Barbas et al., 2001). 
3.5.1 Expression of anti-InlB scFv in a non-suppressor strain E. coli, TOP 10F' 
The BMV hbrary is a large nou-immunised scFv phage display hbrary developed by 
Vaughan et al. (1996). ScFv fragments were cloned into the phagemid vector pCANTAB6 
by I)r. Paul Leonard, which enabled the production of phage-displayed scFv in the 
presence of helper phage and soluble scFv in the presence of IPTG. A positive clone (G3) 
from successful rounds of panning against Internalin B was obtamed in TG1 E. colr. 
Although the scFv was expressed in these cells, the efficiency was sub-optlmal and so 
electroporation of the plasmid DNA into a non-suppressor strain was performed. A stock of 
anti-InlB scFv clone G3 in TGl E.coli were streaked out onto LB agar and a single colony 
from the plate was picked and used to inoculate an overnight culture. The plasmid DNA 
was purified using a wizard mini-prep kit (Section 2.2.1) for subsequent electroporation 
into competent TOP 10F' E.coli. Positive transformants were screened for the scFv insert 
by performing a double restriction digest with SfilNotl. Figure 3.38 shows an agarose gel 
of the restricted clone with the scFv band vlsible at -800bp. 
800bp band 
Figure 3.38 Agarose gel showing the Sfilflvotl restriction digest of transformed anti-lnlB 
scFv clone G3 in TOP IOF' E. coli. Lane (1): DNA Hyperladder; Lanes (2) and (4): 
Digested anti-ZnlB G3 clone with -800bp band confirming the presence of the scFv insert; 
Lanes (3) and (5): Undzgested anti-ZnlB G3 clone. 
Once m the non-suppressor strain, TOP 10F' E. coli, the expression conditions of the anti- 
InlB scFv were subsequently examined to assess what methods produced the maximum 
expression yield of antibody fragment. Many factors can affect protein expression (Section 
3.1.3) and so optimisation of growth and expression parameters were investigated. The 
various parameters assessed included culture media, IPTG concentration, lysis buffer and 
lysis method. Four different culture media were evaluated Super broth (SB), Terrific broth 
(TB), Luria Bertani (LB) and 2xTY (Table 2.3). Each of these media preparations were 
used to culture eight small scale (5ml) cultures, which were grown as per Sectcon 2.2.22, 
but with the following parameters varied; IPTG concentration: 1mM or 2mM; Lysis buffer: 
Tris-EDTA sucrose buffer (TES) comprising 200mM Tris-HCI, 0.5M Sucrose, 0.5mM 
EDTA, pH 8.0 or phosphate buffered saline VBS) comprising 150mM NaCl, 2.5mM, KC1, 
lOmM Na2HPO4,lSmM KH2P04, pH 7.4; Lysis method: FreezeIThaw (FIT) or Sonicatiou. 
Figure 3.39 shows a schematic detailing the parameters investigated for optimal expression 
of the anti-InlB scFv. 
Figure 3.39 Parameters investigated for optimal expression of anti-ZnlB scFv. A number of 
expression conditions were varied in several small scale cultures, using four types of 
culture media; Super Broth (SB), Terrific Broth (TB), Luria Bertani broth (LB) and 2xTY 
broth; Two IPTG concentration were evaluated: ImM and 2mM, two lysis buffers were 
assessed: Tris-EDTA Sucrose (TES) and phosphate buffered saline (PBS) and two lysis 
methods were investtgated: freezdthaw (FA") and sonication. Each of the four culture 
medium were used to prepare eight small-scale cultures in which the above enpression 
conditions were vaned as per the matrix shown. 
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Single colonies of the anti-InlB scFv clone G3 in TOP 10F' E. coli were used to inoculate 
5ml overnight cultures usmg the various culture media (SB, TB, LB and 2xTY) under 
investigation. Different IPTG concentration, lysis buffer and lysis method were 
investigated for each medium and the results of the expression analysis were assessed by 
performing a direct ELISA on the lysates from each culture (Section 2.2.23). The results 
are shown in Figure 3.40. 
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Figure 3.40 Optimisation of expression conditions of anti-ZnlB scFv. Four culture medium; 
Super broth (SB), Terrific Broth (TB), Luria Bertani broth (LB) and 2xTY were investigated 
for optimal antibody expression, while varying the following expression conditions; lPTG 
concentration lysis buffer and lysis method, as detailed in figure 3.39. The optimal 
conditions for expression of the anti-InlB scFv were determined to be culture using Super 
Broth, induction with lPTG at a concentration of lmM, use of PBS as lysis buffer and 
sonication as lysis method. This was determined as the value which gave the highest 
absorbance at 450nm 
These optimal expression conditions of culture using Super Broth, induction with IPTG at a 
concentration of ImM, use of PBS as lysis buffer and sonication as lysis method were used 
in a large scale expression culture (500ml) for IMAC purification of the anti-InlB scFv. 
3.5.2 JMAC purifkation of anti-InlB scFv 
The presence of a His-tag on the anti-InlB scFv, allowed it to be purified using IMAC 
(Section 2.2.19). SB broth containing the appropriate antibiotics was inoculated with a 
single colony of TOP 10F' E. coli containing the anti-InlB scFv plasmid. The cultures were 
gown using the optimised growth and induction conditions described in Section 2.2.22. 
The culture was centrifuged at 3,200 x g for 20 min, the supernatant discarded and the 
pellet resuspended in 25ml of lysis buffer PBS) and sonicated for 30s. The lysed cells 
were then centrifuged at 3,200 x g for 15 min and the supernatant retained for purification 
by IMAC. Initial purification was sub-optimal and so opthisation of the purification 
process was undertaken. Figure 3.41 shows the optimised purification gel for the anti-InlB 
scFv. The main difference between the improved purification method and the original 
techniqne is as follows; the pellet from the centrifuged lysate was resuspended in IMAC 
wash buffer (50mM NaH2P04, 300mM NaCI, 30mM Irnidazole, pH KO), with a higher 
irnidazole concentration (30mM) and sonicated three times for 30s. This produced a cleaner 
purified sample, since the higher the concentration of imidazole tolerated by the protein the 
cleaner the eluant (Barbas et al., 2001). The eluted fraction (Lane 2) shows a concentrated 
protein band at the predicted molecular weight of 30 kDa with minimal contaminating 
proteins, left in the sample (Figure 3.41). 
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Figure 3.41 SDS-PAGE analysis on an optimised lMAC purification of anti-lnlB scFv. 
Lane (1): Sigma wide-range molecular weight marker; Lane (2): Purified anti-lnlB scFv 
fraction. The elution of the scFv with 250mM imidazole resulted in the presence of a 
concentrated protein band at the expected molecular weight of - 30kDa. 
3.6 Discussion 
Tlns aim of tlns chapter was to generate recombinant InlB protein fragments for subsequent 
use tn the development of novel immunoassay formats, using fluorescence and impedance- 
based detection. The cloning and subsequent high-level expression of InlB-associated 
proteins, F3, F4 and F5 into two vector systems (Qiagen's pQE-60 for His-tag purification 
and Avidity's pAC4 for m vivo biotinylation) was undertaken. 
Firstly, InLB protein fragments F3, F4 and F5 with relative molecular weights (MIX) of 23, 
34 and 45 kDa respectively, were derived from Internalin B, a cell surface protein of L. 
monocytogenes, which had been previously cloned and expressed (Leonard, 2003). The 
InlB recombinant protein was portioned into three shorter overlapping peptide fragments 
(F3, F4 and F5) to determine the relative location of the epitope for antibody binding, 
within the full InlB protein (Figure 3.4) usmg specifically en~neered forward and reverse 
primers. The InlB-specific primers were based on the nucleotide sequence (Accession 
number AJ01234) of InlB previously submitted to GenBank by Chakraborty and associates 
(1995). An Ncol restriction site was engineered into the forward primers and a BamHl site 
into the reverse to enable the directional cloning into pQE-60. Since proteins expressed 
from pQE-60 contain a C-terminal 6xHis tag, the genes were cloned in frame with the 3'- 
sequence encoding the 6xH1s tag. The authentic ATG start codons within the protein 
sequences were used to imaate protein expression using the optimised Shine-Dalgarno 
region of the pQE-60. 
A standard PCR reaction was then used to amplify the genes encoding the InlB protein 
fragments F3, F4 and F5. The PCR amplified genes were then directly purified using a 
commercial lut (Sectcon 2.2.10) which eliminated the need to sub-clone the vector and 
inserts into a selection system such as the TA cloning kit. Following direct purification of 
the amplified PCR products, the genes encoding the F3, F4 and F5 fragments (-800, -950 
and -1090 bps, respectively) were confiied following a BamHl/Ncol restriction digest 
(Figure 3.6). The BamHl/Ncol restricted genes encoding each fragment were then gel- 
purified and directionally cloned into the high-level expression vector pQE-60 using T4 
DNA ligase (Section 3.2.7). The pQE-60 plasmids containing the cloned inserts were 
transformed into CaC12-competent XL-10 Gold E. coli, a fast growing E. coli that allows a 
sufficiently high transformation rate (Section 3.2.8). Following the successful cloning of 
the M, F4 and F5 genes into the high-level expression vector pQE-60 the suttability of XL- 
10 Gold E. coli as a host strain was investigated. Initial small-scale expression cultures 
were carried out on the F3, F4 and F5 X L l 0  Gold E. coli clones (Section 3.3) and 
following protein expression the cell lysates were analysed using SDS-PAGE (Figure 3.7). 
Strong bands at 23, 34 and 45 kDa respectively for the M, F4 and F5 clones (as predicted 
from the EMBL database protein predict tool), confirmed the suitability of XL-10 Gold E. 
coli as a host strain for the expression of the InlB protein fragments from the high-level 
expresslon vector pQE-60. 
High-level protein expression within E. coli host strains can often result in the formation of 
msoluble aggregated folding intermediates. There are many approaches available for the 
expression of soluble proteins such as the co-expression of chaperones (Hannig and 
Makndes, 1998), which assist in protein folding and the use of gene fusions to improve 
expresslon levels (Smith and Johnson, 1988; Murhy et al., 1996). However, these methods 
can often be time-consuming. A more simple solution is the solubilisation of inclusion 
bodies nsmg a strong denaturant such as 8M urea. This method is not without its drawbacks 
and can often result m non-functional, inactive protein. The functionality of the protein 
may be restored by removing the denaturant (via a buffer exchange methods such as 
halysis or ultracentrifugation), thus isolating the active protein from the inclusion bodies 
Solubfiiy determinahon studies on the recombinant InlB proteins (Figure 3.8) indicated 
that the htgh-level expression of F3, F4 and F5 resulted in the formation of insoluble 
exclusion bodies, which could be solub~lised using 8M urea (Lanes 3, 6 and 9, 
respechvely). A web-based bioinformatics program, used to determine the solubility of the 
recombinant proteins (Harrison, 2000), predicted that the F3, F4 and F5 proteins had a 
68%, 72.9% and 73% chance of insolubility, confirming the need for denatnrmg buffer, 
containing 8M urea, to ensure hgh-level recovery of the InlB protein fragments following 
expression in XL-10 Gold E. coli. As described in Section 3.1.1, the expression of 
recombinant proteins from pQE60 is under the control of an optimised promoter-operator 
element consisting of the phage T5 promoter, which is recognised by E. coli RNA 
polymerase, and two lac operator sequences, which increase lac repressor binding. The 
lacl" gene contained on the F episome of X L l O  Gold E. coli ensures the production of 
high levels of the lac repressor protein and tightly regulates recombinant protein 
expression. High-level protein expression from pQE-60 is rapidly induced upon addition of 
~sopropyl-P-D-thiogalactoside (IPTG), which binds to the lac repressor protein and 
Inactivates it. However, optunisatlon of IPTG concentrauon for induction of the protein 
fragments was assessed to ensure minimal toxicity to the host cell (LiuC et al., 1999). 
Varying P T G  concentrations ranging from 0.01-lmM were investigated. Figures 3.9 show 
the SDS-PAGE analysis on F3 expression, variations in R'TG concentration did not seem 
to affect the level of protein expression and so the lowest concentration of 0.1 mM was 
chosen as optimal (Lane 6).  Basal level expression of F3 was visible following 'induction" 
with zero concentration of IPTG (Lane 7). 
Recovery of intracellular proteins from each fragment (F3, F4 and F5) involved 
resuspending the pelleted bactena in 8M urea denaturing buffer and pulsing the 
resuspension with sonic waves using a sonicator. Sonication perforates the cell membrane 
and allows the cell contents to be released. However, over-sonication can be detrimental, 
leading to co-purification of E. coli host proteins (Ansubel et al., 1994) and so the lowest 
useful sonication time was chosen. This is the sonication time which gave the maximum 
expressed protein (strongest hand on SDS-PAGE gel) in the shortest time. The SDS-PAGE 
analysis on the optimisation of somcation m e  for the F3 protein suggested that a 30 
second sonication pulse was sufficient for the isolation of protein, from n l O  Gold E. coli 
(Figure 3.10). The same sonication conditions were investigated for both the F4 and F5 
fragments, (figures not shown) with the same results reported, whereby sonication over 30 
seconds had a minimal effect on proteln expression. 
Time course expression cultures were also carned out to determine the optimal induction 
period, post IPTG addition, for InlB fragment expression. Intracellular protein content is a 
balance between the amount of soluble protein in the cells, the formation of inclusion 
bodies and protein degradation. Analysis on the levels of protein expression at hourly 
intervals post IPTG induction was used to determine the optimal induction time. SDS- 
PAGE analysis (Figures 3.11-3.13) on the time-course expression cultures for the InlB 
protein fragments suggested that a 4-hour induction period enabled sufficient levels of 
protein production. Slightly higher levels of InlB F3, F4 and F5 expression were observed 
following a 5-hour induction period. However, the 4-how' induction ieriod appeared 
sabsfactory and minimised the risk of potential proteolytic degradation and 6xHis tag 
cleavage (Makrides, 1996). 
The genes encoding the F3, F4 and F5 recombinant proteins were sequenced for 
comparison with the known nucleotide and amino acid sequences of InlB previously 
submitted to GenBank. Nucleotide and ammo acld sequence alignments were then used to 
compare the cloned InlB fragments F3, F4 and F5 described in this chapter with the 
sequences previously submitted to GenBank and the NCBI database. Amino acid sequence 
analysis on the each fragments showed 100% homology between the cloned F3, F4 and F5 
fragments with the full recombinant 60 kDa protein previously identified by Chakraborty et 
al., (1995), (Accession number AJ01234). 
The imrnunoreactivities of the recombinant proteins were then determined using Western 
blomng. The recombinant proteins were electrophoresed using SDS-PAGE pig.  3.15 A) 
with the bands representing the expressed F3, F4 and F5 visible at 23, 34 and 45 kDa, 
respectively. The proteins were then transferred to nitrocellulose for Western blotting. 
Initially the nitrocellulose was probed with an anti-His antibody to ensure the recombinant 
proteins were expressed in frame. The presence of the bands at 23, 34 and 45 kDa confirm 
the proteins were fully expressed in frame with a 6xHis tag (Fig. 3.15 B). 
The ability of the recombinant proteins to bind associated anti-InlB antibodies was 
subsequently examined. Nitrocellulose containing the transferred proteins was probed with 
three anti-InlB-derived antibodies (polyclonal, monoclonal and scFv). This allowed 
identLtication of the relative location of epitopes on the surface of the protein, thus 
deternuning antigenic sites (Rao et al., 1996). It can be clearly seen that the antibody- 
binding region is located in the fust 0-248 amino acids of the protein (F3), as the panel of 
antibodies used to investigate irnmunoreactivity bind the three fragments and the full 
protein. This showed that the location of the antibody-biding domain is in the first portion 
of the recombinant protein, the F3 fragment. This information is useful for further assay 
development, whereby the first section of the protein containing the 'leucine-rich' repeats 
with no IgG domain (Schubert et al., 2001; Kobe and Kajava, 2001; Freiberg et al., 2004) 
is the most immunoreactive portion of the protein, containing all epitopes for antibody 
binding. This eliminates the need to grow and purify the rest of the recombinant protein as 
all the antigenic sites are contained witbin this fust section (F3), thus making antigen 
preparation far simpler. 
Since F3 was identified as the most immunoreactive portion of the InlB protein, it was 
subsequently used for further assay development. The optimised parameters for protein 
expression were applied for the large-scale production of F3 and the protein was punfied 
using immobiised metal affinity chromatography (IMAC). Figure 3.14 shows the 
optimised purification of F3, uslng imidazole elution, whereby high levels of purity were 
obtained. The concentration of the purified protein was subsequently estimated using a 
BCA assay (Section 2.2.21). A standard curve was constructed using BSA and 
concentration values for the purified protein obtained from it. The final concentration of 
purified F3 was calculated to be 1.5mgIml. 
The recombinant protein fragments (F3, F4 and F5) were also subcloned into another 
vector system (pAC4) for in vivo biotinylation (Schatz, 1993). In vivo biotinylation of 
proteins has been shown to be extremely useful in analysing protein-protein interactions 
(Tana et al., 2004, Krepkiy et al., 2006). The pAC4 vector has both a BamHl and Ncol 
restriction site, thus facilitating easy transfer of InlB protein fragments (F3, F4 and F5) 
fiom Qiagens pQE-60 vector into the PAC 4 vector. The InlB inserts (Section 3.4.1.2) with 
the genes encoding the F3, F4 and F5 fragments (-800, -950 and -1090 bps, respectively) 
were directionally cloned into the pAC4 expression vector for in vivo biotinylation, using 
T4 DNA Ligase (Section 3.2.7) and subsequently transformed into electrocompetent 
AVBlOl E. coli, (Section 2.3.3). Positive clones were screened by picking single colonies 
from transformation plate, for growth and induction (Section 2.3.4). High-level 
recombinant protein expression was induced upon addition of 1mM IlTG and lOOpM 
biotin and the resulting pellets washed with PBS to remove any free biotin. 
Characterisation of the in vzvo biotinylated InlB protein fragments cloned from the pAC4 
vector system was undertaken uslng traditional immunochemical techniques, SDS-PAGE 
and Westem blotting, prior to purification via affinity chromatography, using immobilised 
monomeric avidin. The recombinant proteins were electrophoresed using SDS-PAGE (Fig. 
3.24 A) and the proteins transferred to nitrocellulose for Western blotting. The 
nitrocellnlose was probed with an anti-biotin antibody to c o n f i i  the presence of the biotin 
AviTag. The presence of the bands at 23, 34 and 45 kDa confirm the proteins were fully 
expressed in frame with the biotin AviTag (Fig. 3.24 B). The m vivo biotinylated InlB 
protein fragments cloned from the pAC4 vector were punlied using affinity 
chromatography and characterised using both fluorescence-based and Biacore-based 
methods This h~ghlighted the potential use of these cloned M B  proteins as novel reagents 
for enhanced assay development. 
The in vivo biotinylated fragments were investigated using direct binding assay with an 
anti-InlS polyclonal antibody. Both extravidin-peroxidase and streptavidin-Cy5 were used 
to detect the amount of in vivo biotinylated protein bound to immobilised anti-InlB 
antibody (Figures 3.36-3.38). The F3 fragment gave the most sensitive response, which 
indicated that the in vivo biotinylation efficiency of the M fragment was superior to both 
the F4 and F5 fragments. Demonstrabon that the biotinylated fragment F3 could be 
successfully traced with three different avidin-linked fluorescent labels was also shown. 
This highlights the potential use of the in vrvo biotinylated fragment as a reagent for future 
fluorescence-based immunoassay development. Biacore-based methods (Section 4.1.3.2) 
were also used for the characterisation of in vivo biotinylated InlB F3. The biotinylated F3 
fragment was used as the capture antigen for the preliminary development of a Biacore 
inhibition assay for detection of InlB F3, using the anti-InlS polyclonal antibody. A range 
of detection of between 19-1250 nglrnl was derived and CVs of between 0.48-3.05% were 
found. However, as stocks of the anb-MB polyclonal antibody were depleted, the 
preliminary assay was only based on three replicates and as such, could only demonstrate a 
proof of principle concept. However, it did demonstrate the potential use of the biotinylated 
I n B  protein fragment as a reagent for further assay development for the sensitive detection 
of InlB. 
Overall, the cloning, expression and purification of the F3, F4 and F5 gene sequences in E. 
coli us~ng the two strategies described in this chapter, showed a safe and reliable method 
for the production of InlB-derived recombinant protein fragments. Following optimisation 
of the various parameters required for high-level protein expression the recombinant 
proteins were purified using IMAC and monomeric avidin affinity chromatography. The 
ability of the proteins to recognise InlB-associated antibodies was confirmed using SDS- 
PAGE, Western blotting, fluorescence-based immunoassay and Biacore methods. The 
recombinant proteins described in this chapter are important for the development of novel 
immnnoassays for the detection of InlB usmg both fluorescence and impedance-based 
technology (Chapters 4 and 5). 
Chapter 4: Evaluation of anoven Wuoresce~t 
Babels almd assay formats for aantigenn detecti~m 
4.1 Introduction 
Sensors based on optical phenomena are widely used for the sensitwe detection of 
biological molecules &uppa er al., 2001). This is mainly due to the advantages of 
applying vis~ble radiation which include a non-destructive operation mode, rapid signal 
generation and high levels of accuracy for clinical applications (Aizawa, 1994). Changes 
in optical phenomena such as adsorption, fluorescence, luminescence, scatter or 
refractive index (RI) can occur when light is reflected at sensing surfaces and these 
changes form the physical basis for optical sensor technology. The light comng from a 
source can be either transmitted through or reflected back from the sample via optical 
waveguides, which direct the light to a suitable detector (Eggns, 1996). Photodiodes or 
photomultipliers are generally used as the detectors in such systems and optical filters are 
available for applications where specific wavelengths are to be monitored (Wolfbeis, 
1993). The main operational principles for optical biosensors include absorption and 
reflection spectroscopy, including surface plasmon resonance and luminescence-based 
detect~on, including chemiluminescence, fluorescence and phosphorescence (Buerk, 
1993). 
4.1.1 Absorption & Reflection Spectroscopy 
Absorption spectroscopy refers to the interact~on of electromagnetic radiation with 
matter. It is used to characterise the intensity of transmitted light through a uniform 
medium as a function of the incident light, when the optical properties are affected by 
chemical concentration (Buerk, 1993). A spectrum of light will be absorbed at a 
particular wavelength, which is distinct for each chenucal species. This is due to the fact 
that they absorb energy at different wavelengths since differing chemical bonds 
expenence differing vibrational and rotational movements; therefore variations in light 
absorption occur for each molecule. Absorption spectroscopy can be affected by light 
scattering, disturbances from external light sources and non-uniform optical properties in 
a chemical species, all of which make acquisition of a specific absorption peak difficult 
However, this method is a useful optical tool for the analysis of biological molecules 
such as protein or DNA, both of which have known absorption peaks at 260nm and 
280nm, respectively. Reflection spectroscopy on the other hand measures light reflected 
back from the surface where changes in the intensity of the reflected light represent both 
the physical and chemical events occurring in the medium. Light transmitted through an 
optical fibre penetrates into the surface material to depth that is dependent on the 
hfference in refractive index of the material. 
4.1.2 Luminescence 
Luminescence can be defmed as the emission of light fmm atoms or molecules as a result 
of a transition from an electronically excited state to a lower energy state (Lackowicz, 
1999). Luminescence-based detection encompasses three basic phenomena; fluorescence, 
phosphorescence and chemiluminescence. The principles of fluorescence and 
phosphorescence-based detection have already been discussed in d e t d  (Section 1.5.1). 
Chemiluminescence occurs by the oxidation of a substance to produce visible light in the 
absence of any exciting illumination and without the emission of heat. No external source 
of light is required to initiate the reaction and the whole sample is involved. Luminol is 
one of the best known chemiluminescent species and is used extensively in immunoassay 
techniques (Dotsikas and Loukas, 2004) where it reacts with oxygen, hydrogen peroxide 
or peroxldase. When luminol reacts with these molecules, a chemical reaction occurs 
producing an excited state and the decay of this excited state to a lower energy level is 
responsible for the emission of light. In theory, one photon of light should be produced 
for each molecule of reactant, but in actual practice, non-enzymatic reactions seldom 
exceed 1% quantum efficiency (Eggins, 1996). The key difference between 
chemiluminescence and fluorescence or phosphorescence is that no radiation is absorbed. 
The energy required to emit light comes from the energetics of the chemical reaction. 
Chemiluminescent-based detection has been used extensively in biosensor technology for 
the detection of various analytes (Ji et al., 2006; Liu et al., 2007; Luo et al., 2007). 
4.13 Optical-based detection 
4.1.3.1 Optieal wave guides 
Optical fibres are waveguides for light, in that light waves are propagated along the fibre 
by total internal reflection (TIR). Total internal reflection depends on the angle of 
incidence and the refractive indices of the media. Waveguides can be either extrinsic or 
inhinsic. Extrinsic waveguides transmit light from a light source to a light collector. In 
the intrinsic mode, the phase polarisation and intensity of the light are modulated within 
the waveguide by a measurand lying w i t h  the penetration depth for the evanescent field 
adjacent to the guide (Eggins, 1996). Optical waveguides can be glass, quartz, polymer 
film or fibers made of high refractive index OU) material embedded between lower index 
dielectric materials. Excitation light travelling through an optical waveguide is confined 
by total internal reflection at the interface, defmed by the waveguide surface. TIR occurs 
only under a particular set of conditions and 1s dependent on many factors, including the 
wavelength, incidence angle, and the relahve refractive indices of the waveguide and the 
surrounding medium (Kumar el al., 1994). The surrounding medium has to be of a lower 
refractive index than the waveguide in order to achieve TIR. Optical waveguides operate 
when an evanescent field develops at the sensor's surface, generated by the excitation of 
the light itself in the dielectric layer. Laser light is transmitted into the device and when it 
encounters a biomolecule immobilised on the surface, multiple reflections occur. Some of 
the hght, however, penetrates the biolayer and as this light is reflected back into the 
waveguide, a shii  in phase occurs that interferes with the transmitted light. Thus, any 
changes occurring at the biomolecule interface (such as during immunocomplex 
formation) can be detected by monitoring the changes in interference (SzkkAcs et al., 
2003; Wu et al., 2006). 
4.1.3.2 Surface Plasmon Resonance 
SPR is a sensing technique that can be used to monitor 'real-time biospec~fic reactions'. 
Refractive index (RI) changes occurring m close proximity to a thin metal surface at the 
interface between a glass sensor surface (high refractive index) and a buffer (low 
refractive index) are detected via an evanescent field generated at the site of total internal 
reflection (Homola et al., 1999). The evanescent field penetrates the metal film, with 
exponentially decreasing amplitude from the metal-sensor interface and surface plasmons 
oscillate and propagate along the surface of the metal film (Mullett et al., 2000). Surface 
plasmons absorb some of the light energy from this evanescent field, thus changing the 
TIR light intensity. The resonance angle at which this intens~ty minimum occurs is a 
function of the refractive index of the solution close to the metal layer on the opposing 
face of the sensor surface. Surface plasmon resonance (SPR) occurs in the visible region 
m free electron-like metals such as silver and gold, when the thickness of the metal film 
is a fraction of the wavelength. Changes in the optical properties of this region will, 
therefore, ~nfluence the SPR angle, whch is the basis of the SPR technology for 
biosensing purposes (Liedberg el al., 1995). The general principle of SPR measurement 
is depicted in Figure 4.1. SPR b~osensors allow direct monitoring of the biospecific 
interactions taking place at sensor surfaces. They do this by measuring changes in the 
intensity and the resonance angle of reflected light, caused by the alterations in RI at the 
surface interface. 
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Figure 4.1 Schematic showing principle o f  operation of a surfme plasmon resonance- 
based biosensor. M o n o c h ~ ~ c  p-polarised light is focused onto a metal thin j%n 
sulface immobilised with a biological sample (antibody), via a glass prism under 
conditions o f  total internal reJ1ectrctron (TIR). (A) As W e r  is passed over the surface, the 
dip in rgected light intensity is recorded (shown in pink) at rejlected light angle I. (B) 
On introduction of antigen, a subsequent binding event occurs which changes the optr'cal 
properties of the system. Changes in the rej?active index at the inte?face between the 
suface and a solution flowing over the surface (bGer containing corresponding 
aniigen), alter the angle at whish reduced-intensity polarized light is rejlectedfrom the 
supporting glass p h  (shown in blue) at reflected light angle II. The changes in angle 
are cawed by association or dissociation of molecules from the sensor sufme and are, 
therefore, proportional to the mass of bound material (Anonymous, 2007). 
4.1.3.3 Applicaiions of optical-based detection 
There are many applications of optical sensors in clinical chemistry and diagnosis 
(Cullum and Vo-Dinh, 2000; Alivisatos, 2004; Goldman et al., 2004; Medintz et al., 
2005). Optical immunosensors utllise both lahelled and label-free technologies. The 
optical detection of the immunological reactions using labelled immunospecies has been 
described by many authors (O'hordan et al., 2002; Sutherland, 2002; Lochner et al., 
2003; Tully et al., 2006). Labels can be fluorescent but enzymatic, biological and 
chemiluminescence species are also utilised (Nimeri et al., 1994; Matz et al., 1999). 
 owe^ et al. (1999) describe the use of an array biosensor employing lahelled antibodies 
coupled to a glass chip, for the simultaneous detection of bacterial, viral and protein 
analytes. The array biosensor utihses evanescent wave excitation to interrogate patterns 
of fluorescently-labelled antihod~es, immobilised on planar waveguides. This system 
detects and measures analytes in buffer and in a number of physiological fluids and is 
relatively unaffected by non-specifically hound components from complex samples. 
Optical detection via a thermoelectrically cooled CCD camera captures the fluorescent 
signal from bound analytes upon excitation with a laser diode. 
While labelled antibodies and antigens give rise to highly specific and sensitive results, 
improvement in ophcal transduction and associated technologies can enhance collected 
signals. Stranik et al. (2005) describe the use of a chip-based sensor employing metallic 
nanoparticles in conjunction with fluorescently-labelled antibodies for the detection of 
hov~ne serum albumin (BSA). A plasmonic enhancement effect is reported whereby the 
presence of metallic particles in the vicinity of a fluorophore dramatically alters the 
fluorescence em~ssion and absorption properties of the fluorescent dye. The effect, which 
is associated with the surface plasmon resonance of the metallic surface, depends on 
parameters such as metal type, particle size, fluorophore type, and fluorophore-particle 
separation and is a useful tool for the optical detection of biologically important analytes, 
~n this case BSA. 
Label-free optical methods are also widely used in biosensors and a number of sensitive 
systems exlst (Wei et al., 2003; Muller-Reuaud et al., 2004; Mauriz et al., 2007). Label- 
free evanescence wave-related sensors represent a valuable alternative to traditional 
solid-phase immunoassay technology (Huang et al., 2006) and surface plasmon 
resonance (SPR) can also be employed for the immunosensing of biomolecules (Leonard, 
2003 and Leonard et al., 2005). However, label-free systems are often prone to non- 
specific binding effects and poor analytical sensitivity to analytes with low molecular 
weight (Berger et aL, 1998) is also common. The problem of non-specific binding is also 
a major issue, however; this can be reduced by applying a reference sensing region to the 
label-free optical sensor; the BiacoreTM system (Biacore AB, Uppsala, Sweden) allows 
users to use a flow cell as reference cell. Subtraction of the sample response from the 
reference cell response allows deduction of a true signal; therefore, the effects of non- 
specific binding are corrected for. 
Biosensors are used for the analysis of complex fluids and, in recent years, the fabrication 
of biosensors able to distinguish multiple analytes in a single sample has become an 
increasingly well recognised research goal (Ekins and Chu, 1993). Several research 
groups have described advances in multianalyte sensor arrays using optical methods 
(Bakaltcheva et al., 1998). The types of optical devices fabncated for interrogation of 
such arrays varies depending on the type of molecule attached to the sensor surface and 
the mode of immobilisation. Instruments for the analysis of small biological elements 
(nucleotides, armno acids, RNA) can be based on total internal reflection fluorescence 
and confocal microscopy, where high resoluhon and pattern recognition are key elements 
(Sapsford et al., 2002; Zhang et al., 2006;). The approach taken for the detection of larger 
molecules such as antibodies or longer nucleic acid strands (Wadkins et al., 1998; Blawas 
and Reichert, 1998; Charles et al., 2004) 1s significantly different. These molecules are 
involved in highly specific binding interactions, whereby a detection event at a single 
spot is sufficient for identification. The central element for antibody-based optical sensor 
systems is planar ophcal waveguides. Waveguides are used to direct excitation light to 
biomolecule-linked fluorophores bound to the waveguide surface (Rowea et al., 1999) 
and form the basls of the chip-based immunosensors described in this research. 
4.1.4 Chapter Outline 
This chapter focuses on the development of enhanced detection strategies using 
luminescence-based methods for the quantification of a number of important targets. The 
incorporation of novel antigens (Chapter 3) and fluorescent labels (with improved optical 
properhes) into fluorescence-based systems with enhanced detection capabilities is 
shown. The combination of such technologies highlights the potential use of novel labels 
in the development of better detection systems with greatly increased sensitivities. The 
detection of warfarin, listerial proteins, human IgG and whole Listeria cells is described. 
The use of novel fluorescent labels with superior optlcal properties in solid-phase plate- 
based immunoassays, polymer chip-based systems and for the immunostainiug of 
bacterial cells, on modified glass surfaces is shown. Antibodies, coupled to fluorescent- 
tracer molecules (phosphorescent porphyrin labels and quantum dots) via streptavidin- 
biotin attachment, were assessed in plate-based formats for the detection of warfarin and 
Internalin B. The synthesis and characterisation of ruthenium dye-doped high-brightness 
nanoparticles was also explored and use of such parbcles for the detection of human IgG 
examined. The assays described in this chapter highlight the potenhal use of novel labels 
in the development of improved fluorescence-based strategies for the detection of 
important analytes. Ophmisation of assay parameters and comparison of assay 
sensit~vities and limits of detection with current techniques are discussed. Polymer chip- 
based strategies for the detection of lnlB and the parvovims capsld protein, VP2 were 
also Investigated using a CCD set-up. The immobiiisation and subsequent detection of 
biomolecules on modified polymer chips was explored and the potential use of such 
biochips with enhanced labels d~scussed. 
The incorporation of immunoreagents with better specificity for antibody-antigen 
recognition coupled with novel fluorescent labels into detechon systems with enhanced 
signal capturing properties (biochips with cone structures) facilitates the improved 
detection of target analytes. In this chapter, the potential use of such formats is discussed 
and associated obstacles examined. 
4.2 Fluorescence immunoassay (FIA) development 
There are a number of important parameters that must be investigated for successful 
fluorescence-based immunoassay development. These are the choice of analyte, choice of 
label, conjugation strategy, assay format and detection system. The chosen targets 
Listeria monocytogenes cell surface protein Intemalio B, warfmn and Parvovirus B19 
are all of commercial and clinical significance. Antibodies directed against these targets 
had been produced and fully characterised by ELISA and Biacore-based assays, prior to 
this research (Fitzpabick and O'Kennedy, 2004; Leonard et al., 2005; Hearty et al, 2006; 
Tully et al., 2006). In this chapter the use of quantum dots and porphyrin-derivatives in 
the development of novel assays for the detection of the target analytes previously listed 
is described. 
The main advantages of novel fluorescent probes such as quantum dots are their narrow 
predictable emission, extreme photostability, multiple tunable colours, brightness, broad 
excitation, large Stokes shift and high quantum yields (West and Halas, 2000). 
Functionalisation of the polymer shell of such molecules is relatively simple and allows 
direct coupling of the label to biomolecules. In the case of quantum dots, the polymer 
shell is directly coupled to streptavidin through a carbodiiide-mediated covalent 
reaction. The commercially available streptavidin-conjugated quantum dots used in this 
research emit brightly at 605nm and can be excited with a broad range of sources. 
The selected porphyrin dyes used here, emlt strong phosphorescence at room 
temperatures, which is characterised by long lifetimes in the sub-millisecond range and 
long-wave spectral characteristics (Martsev et al., 1995). These features make the dyes 
useful as probes for a number of bioanalytical applications since they can provide htgh 
sensitivity and selectivity, together with easy detection using a simple instrumental set- 
up. Novel derivatives of plahnum and palladium coproporphynn were used to make 
phosphorescent conjugates of antibodies, avidin, biotin and neutravidin (O'Riordan et al., 
2001). These labels and conjugates have previously been evaluated in solid phase 
imrnunoassays using commercial phosphorescent detectors. Successful use of these 
probes was reported for a number of plate-based assays formats (Papkovsky, 1991). A 
slmple conjugation procedure was used for labelling biomolecules such as neutravidin or 
ant~bodies with this dye. A carbodurnide preactivates the porphyrin dye (platinum or 
palladium coproporphyrin) in organic solvent in the presence of N-hydroxysuccinimide. 
Proteins are subsequently conjugated to the porphyrin derivative via their amino groups 
(O'Riordan et al., 2001). 
Initially direct binding assays were pedormed to investigate label sensitivities and 
fluorescence signal to noise ratios, whereby coating concentration, blocking solution, 
antibody dilution and label d~lution were optimised. Competitive immunoassays for the 
detection of InlB using both an anti-InlB polyclonal antibody and an anti-InlB scFv were 
developed. Competitive immunoassays for the detection of warfarin using an anti- 
warfann monoclonal antibody were also investigated using quantum dots and porphyrin 
dye as the fluorescent tracer molecules. 
Dye-doped nanoparticles were prepared and optlrnisation of the conjugation strategy with 
antibodies was exarmned. Silica nanoparticles are easy to modify, either through NHS 
activation, silanisation or carboxyl modification (Lian et al., 2004). Ruthenium dye- 
doped nanoparticles were surface-modified for both avidin and antibody attachment. 
Human IgG was used as the target molecule for the nauoparticle development, described 
in this chapter. Initially, InlB was chosen as the target molecule, however, the anti-InlB 
polyclonal antibody was in short supply and so a commercial source (Sigma) of antibody 
and antigen was selected. This was deemed necessary as large quantities of reagent were 
required for the optimisation of antibody-nanoparticle conjugation and assay 
development. 
The following sections (Sections 4.3-4.6) describe the optimisation and associated 
problems in the development of fluorescence-based immunoassays for the detection of 
InlB, warfarin and human IgG, using novel fluorescent labels. 
4.2.1 Biotinylation of Antibodies 
Biotin is a vitamin, whch binds with high affinity to the tetrameric protein avidm (also 
streptavidin and neutravldm), with a dissociation constant (Kd) in the order of 10-15 mol/l 
(Green 1965; Wilchek and Bayer, 1988). Biotin is a relatively small molecule of 244 
daltons and it can be conjugated to proteins without significantly altering the biological 
activity of the protein, via armno, carboxyl or sulfhydryl groups. A protein can be reacted 
with several molecules of biotin that, in turn, can each bind a molecule of avidin. This 
greatly increases the sensitivity of many assay procedures. The highly specific interaction 
between streptavidin and biotin allows biotin-containing molecules, in this case 
biotlnylated antibodies, to be discretely bound with streptavidm-linked fluorescent 
conjugates i.e. quantum dots or porphyrin dye. Polyclonal, monoclonal and scFv 
antibodies were biotinylated (Section 2.5.2.1) and subsequently used in association with 
avidi-linked fluorescent probes. 
A long chain analog of biotin, with an extended spacer arm (22.4 A) to reduce steric 
hindrances was used to biotinylate the antibodies for this application. Long-chain blotin 
forms a stable amide bond with primary arnines at pH 7-9. The optimal antibody 
concentration for successful biotinylation was determined to be approximately lmglml 
and a 10-20 molar excess of biotin was used to promote efficient biotinylation. The 
HABAIavidin method is used to determine the degree of biotinylation of antibodies and 
recombinant proteins biotinylated 'in-house'. The method is based on the K i n g  of the 
dye HABA to avidin and the ability of biotin to displace the dye. The displacement of 
dye is accompanied by a change in absorbance with a known extinction co-efficient; 
therefore, the biotin labelling levels can be determined spectrophotometrically (Sectton 
2.5.2.1). 
4.3 Development of fluorescence-based immunoassays for the detection of InlB 
Fluorescence-based immunoassays (FIA) for the detection of InlB a cell surface protein 
of Lzsteria monocytogenes were developed, using quantum dots and porphyrin dye as 
fluorescent labels. The F3 ftagment of the recombinant InlB protein was used as the 
antigen for the development of these assays since it was deemed to contain the most 
immuuoreactive portion of the protein (Section 3.3.7). InlB-F3 was grown under 
optimum conditions (Section 2.2.18), subsequently purified using immobilised metal 
affinity chromatography (MAC) and the concentrahon of purified protein determined 
(Sectzons 2.2.19 and 2.2.20) 
Rabblt anti-serum contaimng polyclonal ant~bodtes directed against InlB was obtained 
from Dr. Paul Leonard and made available for this application. The polyclonal antibodies 
were initially purified from the rabbit serum using saturated ammonium sulphate 
precipitation followed by protein G affinity chromatography, (Sections 2.4.11 and 
2.4.1.2). The purified anh-InlB polyclonal antibody was subsequently biotinylated 
(Sectlon 2.5.2.1). for use in the development of fluorescence-based immunoassays for the 
detect~on of free InlB. Extensive characterisation of this antibody was undertaken 
previously (Leonard, 2003; Leonard et al., 2005; Hearty et al., 2006). However it was 
necessary to repeat the checkerboard ELISA for the biotinylated anh-InlB polyclonal 
antibody, using an avidin-conjugated probe (extravldin-peroxidase). 
4.3.1 Checkerboard assay to determine optimal antigen coating concentration and 
biotinylated antibody dilution for assay development 
In order to determine the optimal working dilution of the biotinylated antibody and the 
optimal recombinant InlB-F3 coating concentrations, a checkerboard ELISA was 
performed (Section 2.4.1.3). Varying concentrations of InlB-F3 ranging from 0 - 
40pgIml were coated on a microtitre plate and dilutions of biotinylated antibody from 
1/50 to 1112800 were added to each InlB-F3 concentration. The amount of bound 
antibody was detected using extravidin peroxidase and the resulting response was 
measured using a Tecan s&' plate reader (Figure 4.2). 
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Figure 4.2 Checkerboard ELlSA for the determination of optimal InlB-F3 coating 
concentration and biotinylated antibody dilution for use in a competitive fluorescence- 
based immunoassay (FIA). Varying InlB-F3 coating concentrations ranging from 0 - 
40pglrnl and biotinylated antibody dilutions from 1/50 - 112800 were assayed and the 
amount of bound biotinylared antibody was determined using, extravidin peroxidase. 
The optimal coating concentration of InlB-F3 was 20pgIml and the optimal biotinylated 
anti-InlB antibody dilution that gave the geatest change in absorbance per change in 
antibody dilution was determined to be 100. 
4.3.2 Optimisation of blocking reagents and diluents 
In order to reduce non-specific binding (NSB) a number of blocking solutions were 
exarmned. When no protein was coated on the surface, a signal was observed following 
the addition of varylng dilutions of biotinylated antibody. Therefore, it was necessary to 
optimise the blocking reagent to establish the best solution that kept NSB to a minimum. 
Casein, glycerol, gelatin, BSA, OVA, Tween 20 and Triton X have been reported as 
sultable solutions for reducing NSB in immunoassays. 
In order to determine the optimal blocking solution for this assay format, varying 
concentrations of BSA, Tween 20 and glycerol were investigated. Plates were coated 
with recombinant InlB protein fragment F3 (InlB-F3) at the optlmal concentration 
(20pg/ml) and blocked with the followmg range of solutions: PBS contrumng 0.1-2% 
(wlv) BSA, 0.01-0.5% (wlv) Tween 20 and 10% (vlv) glycerol. Biotinylated antibody*, 
diluted 300-fold was added to the plate and the fluorescence measured following the 
addihon of streptavidin-Cy5 at a dilutlon of 111000. The fluorescent response was 
normalised by subtracting the response in the absence of fluorescent tracer molecule 
(streptavidin-Cy5) from all values. The fluorescence response units (FRU) for each 
blochng solution were plotted both ~n the presence and absence of coating antlgen (InlB- 
F3) to evaluate which blocking solution reduced non-specific binding (NSB) of the 
blotinylated anti-InlB antibody to the plate. The results of blocking solution optinusation 
are shown in Figure 4.3. 
" Optrmisatron of blocking solution forfluorescence-based immunoassays was initrally 
pelformed using a biotinylated anti-lnlB polyclonal antibody. The optimal blocking 
solut~on was detennrned to be PBS contaming 1% (w/v) BSA in this case. The selected 
blocking solution was subsequently assessed for compatibility with both a biotinylated 
anti-walfarin monoclonal antibody and warfarin-BSA conjugate and an antr-lnlB scFv 
and InlB-F3, which were also used for fluorescence-based immunoassay development, 
whereby it was also found to be suitable for use with these alternative antibody-anhgen 
pairs (data not shown). 
w e  4.3 Selection of blocking reagent. Plates were coated with 20pg ZnlB-F3 and with 
PBS containing no protein. A 1/300 dilution of biotinylated antibody was prepared in 
PBS and traced with streptavidin-Cy to determine the optimal blocking solution to 
reduce non-specifi binding. lhe jluorescence response units (FRU) for each blocking 
solution were plotted both in the presence and absence of coating antigen (ZnlB-F3) 
The variation between blocking solutions suggested that non-specific binding was 
occurring between the biotinylated antibody and the plate surface. Interactions involving 
solutions containing Tween 20 showed a high degree of NSB. The use of Tween 20 was 
not suitable since studies have shown that non-ionic detergents can prevent attachment of 
proteins to polystyrene or nitmcellulose membranes (Gardas and Lewartowska, 1988). 
When the blocking solutions contained BSA, however, only minimal interactions were 
observed, when no antigen (IolB-F3) was coated on the plate surface. In order to 
maximize the signal for fluorescenc~based immunoassays, the solution which gave the 
largest difference in observed specific and non-specific response was chosen. PBS 
containing 1% (w/v) BSA was found to be the most suitable blocking reagent for this 
format since the solution significantly reduced the NSB of the biotinylated antibody to 
the plate. 
A tltre of biotinylated antibody against the optimal coating concentration of recombinant 
InlB-F3 (20~gIml) was performed using PBS containing 1% (wlv) BSA as a blocking 
agent. From Figure 4.4 it can be seen that the use of BSA as a blocking solution greatly 
reduced non-specific binding lnterachons and resulted in only specific binding between 
immobilised InlB-F3 and the biotinylated anti-InlB polyclonal antibody. For subsequent 
assay development, plates were blocked with PBS containing 1% (wlv) BSA. 
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Figure 4.4 Titre of biotinylated antibody labelled with sheptavidin-Cy5. PBS containing 
1% (w/v) BSA was used as the blocking solution to ensure that non-specific binding 
interactions between the biotinylated antr-ZnlB polyclonal antibody and the plate surface 
were reduced. The fluorescent response was nonnalised by subtracttng the response m 
the absence of fluorescent tracer molecule (streptavidin-Cy5) from all values and the 
nonnalised fluorescence response untts (NFRU) plotted against biotinylated antibody 
dilution both in the presence and absence of coating antigen (InlB-F3). 
4.3.3 Competitive fluorescence-based immunoassay (HA) for the detection of InlB- 
F3 in PBS, using quantum dots as fluorescent label 
A model competitive FIA was developed using the optimised dilutions detennined from 
the checkerboard assay, where the biotinylated anti-InlB polyclonal antibody competes 
for binding to free MB-F3 in solution and immobilised InLB-F3 on the plate. A microtitre 
plate was coated with 20pg/ml of InlB-F3 and blocked with PBS containing 1% (wlv) 
BSA. Standards of InlB-F3 were prepared in PBS ranging from 1.5 to 50,00Ong/ml and 
mixed with an equal volume of biotinylated anti-InlB polyclonal antibody to give a final 
dilution of 11300 (Section 2.8.2). Quantum dots were used at a concentration of 2nM, 
(Sectron 2.8.1). 
Results were normalised by dividing the mean fluorescence obtained at each InlB-F3 
concentration (F) by the fluorescence values detemuned in the presence of zero antigen 
I&). These values (F&) were plotted against the logxithm of MB-F3 concentration 
using Biaevaluahon 4.0.1 software and a four-parameter equation was fitted to the data. 
The four parameter function provides an accurate representation of the sigmoidal 
relationship between the measured response and the logarithm of concentration observed 
for immunoassays (Findlay et al., 2000). 
Figure 4.5 shows the FIA inter-day cahbration curve using the polyclonal antibody, 
where the lower limit of detection for the compehtive assay was detennined to be 
12ng/rnl. This h u t  of detection is defined as the lowest concentration that could be 
statistically determined as different from the FO value and is calculated by determining as 
the mean value of the blank (Fo) plus 3 times the standard deviation. 
Figure 4.5a Inter-day calibration curve for competitive FLA for the detection offree InlB- 
F3 in PBS using the anti-lnlB polyclonal antibody and streptavidzn-linked quantum dots 
as the fluorescent label. Results were normalzsed by divzding the mean fluorescence 
obtained at each InlB-F3 concentration (F) by the fluorescence values determined in the 
presence of zero antigen (Fo). A lower limit of detection of 12ng/ml was determined by 
calculating the mean of the blank value (Fo) plus 3 times the standard deviation. 
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Figure 4.5b Residuals of Biaevaluation plot using 4-parameter equation fit for data 
shown in Fig 4.5a, a competinve fluorescence-based immunoassay for the detection of 
InlB-F3, using streptavidin-lmked quantum dots as thefluorescent label. 
In order to measure the accuracy of the fluorescence-based immunoassay using quantum 
dots as the label, intra-day and inter-day assay variability stu&es were performed, 
whereby three sets of standards were assayed over three days. The coefficients of 
variahon (CV's) were detemuned to assess the reproducibility and precision of the 
analytical method, expressing the standard deviation as a percent function of the mean. 
Inter-day assay CV's ranged from 0.37% to 8.43% (Table 4.1), which are well within the 
20% limits suggested by Findlay et al. (2000). 
Table 4.1. Inter-day FIA coeficient of variation (CVs) for the detection of free InlB-F3 
using the ZnlB-specific polyclonal antibody and streptavidin-linked quantum dots. Tirree 
sets of each standard were assayed over three days d the CVs calculated. Back- 
calculated concentratiom were determined using Biaevaluation 4.0.1 sofrware and 
expressed as a percentage of the theoretical concentrations (% recovery). 
Concentration F/F, * SD CV Back calculated Recovery 
(nglml) (%) concentration (%I 
(nglml) 
6250 0.445 0.02 4.56 6889, 110 
3125' 0.49+ 0.00 0.40 2898 92 
1563 0.54+ 0.00 0.37 1424 91 
781 0.58+ 0.01 2.57 74 1 94 
391 0 62+ 0.02 2.88 392 100 
195 0.65f 0.04 6.60 256 131 
98 0.71f 0.01 2.10 96 98 
49 0.77+ 0.03 4.41 41 83 
24 0.81f 0.05 5.70 23 96 
12 0.84+ 0.07 8.43 13 111 
The assay was found to be accurate w~th the percentage recovery of back-calculated 
valuks determined to be between 83-111% of the,meksuied cohcen&ations.'"This. was in 
,line with , , the percentage accuracies suggested byl F~ndlay - etaZ., (2000) whereby the 
, > ,  .. - i';< 
values should be within a 25% acceptance limit. This was true for'all co*cen@itions 
except for the concentration of 195nglml. This point'on the curve was askew in bbth the 
. . 
. . 
.inter and intra-day variability studies and had a percentage re&very'of I%%, ach is 
, , 
outs~de,of the suggested range. 
. , 
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An anti-InlB recombinant antibody fragment (scFv) isolated from a naive human library 
(Vaughan et al., 1996) by Dr. Paul Leonard, was also used to develop a compet~tive assay 
for the detection of free InlB-F3. The scFv was biotinylated as detailed in section 2.5.2.1. 
A model competitive assay was developed where the biotinylated anti-InlB scFv 
competes for binding to free InlB-F3 in solut~on and immobilised InlB-F3 on the plate. 
Standards of InlB-F3 were prepared in PBS ranging from 1.5 to 50,00Ong/ml and mxed 
with an equal volume of biotinylated anti-InlB scFv to give a final dilution of 11300. 
Quantum dots were used at a concentration of 2nM, (Section 2.8.1). Intra-assay 
variability studies were performed to demonstrate the reproducibility of the compehtive 
FIA. Results were normalised by dividing the mean fluorescence obtaned at each InlB- 
F3 concentration (F) by the fluorescence values determined in the presence of zero 
antigen (Fo). These values (F/Fo) were plotted against the logarithm of InlB-F3 
concentration using Biaevaluation 4.0.1 software and a four-parameter equation was 
fitted to the data. Figure 4.6 shows the FLA inter-day calibration curve using the scFv 
antibody fragment, where the lower limit of detection for the scFv competitive assay was 
determined to be 12ng/ml. 
InlB cunc. (nglml) 
Figure 4.6 lntra-day calibration curve for competitive FLA for the detection of free 1nlB- 
F3 in PBS using the antz-lnlB scFv. Results were noml i sed  by dividing the mean 
fluorescence obtained at each InlB-F3 concentration ( F )  by the fluorescence values 
determined in the presence of zero antigen (Fo). A lower limit of detection of 12ngIml was 
determined by calculatzng the mean of the blank value (Fo) plus 3 times the standard 
deviation. 
Efficiency of biotinylation was a problem in this format. Enbre antibody molecules were 
biotinylated via conjugation to a chemically active biotin denvative (Section 2.5.2.1), 
however scFv molecules are less stable than their whole IgG counterparts and more 
sensitive to chemical modifications. Additionally, their monovalent nature can be a 
disadvantage when the triggering of biological responses is desired. The anti-InlB scFv 
was also far less concentrated than polyclonal or monoclonal stocks and thus 
biotinylation was more difficult. This had an effect on the reproducibility of this assay 
format, whereby only intra-assay variability studies were performed. Santala and 
Lamminm&i, (2004) describe an alternative method which can be used for site-specific 
biotinylation of recombinant antibodies. This method uses the enzyme biotin ligase to 
catalyse the attachment of a biotin to a lysine residue in specific protein substrates, which 
in turn can be genetically linked to the antibody to generate a fusion protein. Enzymahc 
biotinylation of the scFv molecules would therefore produce a more stable and efficiently 
biotinylated complex (Sibler et al., 1999; Clontier et al., 2000), which could be explored 
in future work. 
4.3.4 Competitive fluorescence-based immunoassay (FIA) for the detection of InlB 
in PBS, using porphyrin-labelled neutravidin as the fluorescent label 
Fluorescence-based immunoassays for the detection of InlB-F3 were also developed 
using an anti-InlB polyclonal antibody, with porphyrio-labelled neutravidin as the 
fluorescent label. Standards of InlB-F3 were prepared in PBS ranging from 1.5 to 
50,00Ong/ml and mixed with an equal volume of biotinylated anti-InlB polyclonal 
antibody to give a final dilution of 11300 (Section 2.8.3). Porphyrio-labelled neutravidin 
was used at a concentration of 2nM (Section 2.8.1). 
Results were normalised by dividing the mean fluorescence obtained at each InlB-F3 
concentrahon (F) by the fluorescence values determined in the presence of zero antigen 
Po). These values @En) were plotted against the logarithm of InlB-F3 concentration 
using Biaevaluation 4.0.1 software and a four-parameter equation was fitted to the data. 
Figure 4.7 shows FIA inter-day calibration curve using the polyclonal antibody for the 
detection of free InlB-F3 m PBS, where the linut of detection for the competitive assay 
was determined to be 87ngiml. The limit of detection was determined as the mean of the 
blank PO)  plus 3 times the standard deviahon. 
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Figure 4.7a inter-day calibration curve for competitive FIA for the detection of free ZnlB- 
F3 in PBS using the anti-ZnlB polyclonal antzbody and porphyrzn-labelled neutravidin as 
the fluorescent label. Results were nonnalised by dividing the mean fluorescence 
obtained at each ZnlB-F3 concentration (Fj by the fluorescence values determined in the 
presence of zero antigen (Foj. A lower limit of detection of 87ng/ml was determined by 
calculating the mean of the blank value (Foj plus 3 times the standard deviation. 
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Figure 4.7b Residuals of Biaevaluatron plot using 4-parameter equation fit for data 
shown in Fig 4.7a, a competit~ve fluorescence-based immunoassay for the detection of 
ZnlB-F3, using porphyrin-labelled neutravzdin as label. 
Intra-assay and inter-assay vanability studies were performed to demonstrate the 
reproducibility of the competitive F'IA. Inter-day assay CV's ranged from 0.71% to 
3.43%, (Table 4.2). 
Table 4.2. Inter-day FIA coeficzent of variation (CVs) for the detection off& I ~ B - F ~ ,  
usini'the in l~-s~ec i j i c  polyclonal antibody and poiphyrin-labellea'&utrahdiii. Three 
sets of each standard were assayed over three days and the CVs calculated. Back- 
calculated concentrations were determined using Biaevaluation 4.0.1 sofhvare and 
expressed as a percentage of the theoretical concentrations (% recovery). 
Concentration FIFO t SD CV Back calculated Recovery 
(nglml) i%) concentration i%) 
ingld) 
62500 0.38t 0.01 3.43 5604 89 
3125 0.42t 0.01 1.91 3584 114 
1563 0.5& 0.01 1.77 1612 103 
781 0.61i-0.01 2.1 1 716 91 
391 0.70t 0:00 0.71 393 100 
195 0.8& 0.01 0 74 191 98 
98 0.89t 0.01 1.92 107 110 
48 0.98t 0.01 101 46 93 
The assay was found to be accurate w~th the percentage recovery of back-calculated 
values determined to he between 89-1 14% of the measured concentrations. This was in 
line with the percentage accuracies suggested by Findlay et al. (2000). 
4.3.5 Biochip application for the detection of InlB 
A novel, disposable, antibody-based bic-chip sensor was developed by the research group 
led by Prof. MacCraith of the National Centre for Sensor Research (NCSR), DCU (Blue 
et aL, 2005, Stranik et al., 2005). This system utilises patented optical enhancement 
platforms which demonstrate up to an 80-fold increase. in the collection of 
luminescence/fluoresceuce, thereby improving sensitivity. The optical enhancement 
platforms used in the biochip system are illustrated in Figure 4.8. 
Figure 4.8 Optical enhancement platforms. (a) Cone-shaped structure of polymer 
pl@m ill~s~rating the lighr emission rays emitted from a surface-con&edfluorophore. 
(6) Anisotropic emission study showing the majority of light is waveguided at high 
angles, thur enhancing captured fluorescence (c) Typical enhancement pe~ormance of 
cones vs. flat surfaces showing 25-80 fold signal enhancement. (d) Image of the polymer 
chip platform incorporating patented cone structures for enhancedfluorescence capture. 
The polystyrene chips are produced by mi-injection moulding and the use of enhanced 
cone structures for fluorescent detection greatly increases signal amplification. Biochips 
with enhanced cone structures are used as the substrate for the immobilisatim of 
fluorescently-labelled antibodies and antigens. The signal generated during 
immunocomplex formation produces a fluorescence that can be captured using a 
photomultiplier tube and CCD camera. 'Ihe excitation and detection setup employs a 
laser diode as the light source, as shown in F i  4.9. This dows biotinylated antibodies 
bound to antigen on the chip surface to be tlaced with streptavidin-linked fluorescent 
dyes. These dyes fluoresce upon excitation with a laser light and the resultant signal is 
recorded with a cooled charged coupled device (CCD) camera. 
Slmphidin-Cy.5 label 
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Fignre 4.9 Antigen is imnwbilised on a polymer chip with optical enhancement 
structures (cone). Biotinylated antibody binds to immobilised antigen on chip surface and 
bound &dies are traced using a sh'epim,idin-Iinked fl~~rophore (streptavidin-05). 
A h e r  light is used to excite any boundJluorescently-labelled antibody and background 
fluorescence is reduced by an optical filter. The resultingfluorescent signal is captured 
using a charge coupled device (CCD) camera and the signal is monitored on a laptop 
with imaging sofhvare. 
A proof of pnnciple experiment was set up initially, to evaluate b~omolecule 
immob~lisation, detection capabilities and the degree of captured fluorescence using the 
CCD set-up. A simple assay using a biotinylated antibody spotted onto the cone surfaces 
and detected with the addition of streptavidin-Cy5 was performed. B~otinylated anti-InlB 
polyclonal antibody was immobillsed on the surface of the polystyrene cone structures by 
passive adsorption and any remruning b~nding sites on the biochip blocked using PBS 
containing 1% (wlv) BSA (Section 2.8.4). Following washing bound biotinylated 
antibody was detected with the addition of Strep-CyS and the fluorescent signal generated 
was captured with a cooled CCD camera. The resulting images are shown in Figure 4.10. 
(A) Control Chip 
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Figure 4.10 Prelimmary chip-based assay (A) Captured image of blank control chip (B) 
Captured image of test chip. Biotinylated antz-lnlB polyclonal antibody was immobilised 
on the sulface of the rrght hand side of the chip (test cones) whrle the lefr hand side was 
lej? blank (control cones). Following the addition of Strep-Cy5 to the entire chip surface, 
the fluorescence was captured with a CCD camera. 
The fluorescent signal from a blank chip was recorded to estimate the degree of 
background fluorescence (A), where the mean fluorescent intensity (n=6) was found to be 
26,983 + 2,204. The fluorescent signal was then recorded for the test chip (B); antibody 
immobilised (test) cones (n=3) were calculated to have a mean fluorescent intensity of 
317,630 f 5,395, whereas the coutrol cones (n=3) had a mean value of 31,889 f 2,457. 
CVs were calculated to determine the reproducibility of spot intensities and were found 
to be 1.70% and 7.71%. for the antibody lmmobilised (test cones) and control cones, 
respectively. Normalised values (minus background fluorescence fiom chip A) were 
therefore calculated to be 290,647 and 4,906 for the antibody immob'iised and control 
surfaces respectively @).The results from Figure 4.10 showed that bound biotinylated 
antibody could be detected using the CCD detechon set-up, when traced with 
streptavidin-Cy5. 
The next step in the development of a biochip-based assay was to assess the system's 
capab~lities for the detection of biotinylated antibody, bound to immobilised antigen on 
the cone structures. Recombinant InlB-F3 was immobilised on the surface of the 
polystyrene cone structures by passive adsorption and any remaimng binding sites on the 
hiochip blocked using PBS containing 1% (wlv) BSA (Section 2.8.5). Following 
washing, biotinylated anti-InlB polyclonal antibody was added to the chip and incubated 
for 1 hour. Bound biotinylated antibody was detected with the addition of Strep-Cy5 and 
the fluorescent signal generated was captured with a cooled CCD camera. The resulting 
images are shown in Figure 4.11. 
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Figure 4.11 (A) Captured image of blank control chip (B) Captured image of test chrp. 
InlB-F3 was immobilrsed on each of the six cones by passive adsorption. The chip was 
then washed and blocked, as per section 2.8.6. Biotinylated anti-InlB polyclonal antibody 
was spotted onto the surface of the right hand side of the chip (test cones) while the left 
hand side was lefi blank (control cones). Following the addition of Strep-Cy5 to the 
entire chrp surface, the fluorescence was captured with a CCD camera. 
The fluorescent signal from a blank chip was recorded to estimate the degree of 
background fluorescence (A), where the mean fluorescent intensity (n=6) was found to be 
41,447 -1 2,550. The fluorescent signal was then recorded for the test chip (B); test cones 
(n=3) with biotinylated anti-InlB polyclonal antibody bound to InlB-F3 and traced with 
streptavldin-Cy5, were calculated to have a mean fluorescent intensity of 356,764 f 
26,163, whereas the control cones (u=3) with no biotinylated antibody present, had a 
mean value of 42,717 f 6,546. CVs were calculated to determine the reproducibiilty of 
spot intensities and were found to be 7.33% and 15.32%, for the antibody immobll~sed 
and control cones, respectively. Nomalised values (minus background fluorescence from 
clup A) were calculated to be 315,317 and 1,270 for the test and control surfaces, 
respectively (B). 
4.4 Development of fluorescence-based immunoassays for the detection of warfarin 
Anti-warfarin monoclonal antibody was previously produced by Dr. Brian Fitzpatrick 
(Applied Biochemistry Group, DCU). Although extensive characterisation of the 
antibody had been undertaken previously (Fitzpatrick and O'Kennedy, 2004), a different 
clone of the monoclonal antibody was selected from cryogenically frozen hybridoma 
stocks. Therefore, it was deemed necessary to repeat the checkerboard ELISA for the 
anti-warfarin monoclonal antibody. Supernatants from warfarin-specific antibody- 
secreting hybndomas were collected for concentration and purification (Section 2.4.2.1). 
The purified anti-warfarin monoclonal antibody was subsequently biotinylated (Section 
2.5.2.), for use in the development of fluorescence-based immunoassays for the detection 
of free warfarin. 
4.4.1 Checkerboard assay to determine optimal antigen coating concentration and 
biotinylated antibody dilution for assay development 
A standard checkerboard ELISA was set up as described in Section 2.4.2.2 to determine 
the optimal conjugate coating concentration and monoclonal antibody dilution for use in 
a competitive assay. For this purpose, anti-warfarin monoclonal antibody was 
biotinylated, (Section 2.5.2.1), for use in a competitive assay and traced using an avidin- 
conjugated probe (extravidin-peroxidase, Sigma). Wells of a microtitre plate were coated 
with varying conceutrations of warfarin-BSA and blocked with PBS containing 1% (wlv) 
BSA. Varying concentrations of the biotinylated anti-warfarin-specific monoclonal 
antibody were then added to the plate and the amount of bound antibody detected with 
the addition of extravidin-peroxidase (Figure 4.12). 
Warfario-BSA mating conc. 
--c 1Wpglml 
--O-- 50pglml 
t 25wgld 
x 12 5pgld 
x 6 25pglml 
L 3 125pglml 
t 1565wglml 
- Owglml 
1 I antibody dilution 
Figure4.12 Checkerboard FIA for the determination of optimal warfarin-BSA 
conjugate coating concentration and biotinylated anti-waifann monoclonal antibody 
dilution for use in a competitive FIA. Varying warfarin coating concentrations ranging 
from 0 - 100pg/ml and bzotinylated antlbody dilutions from 1/100 - 1/10000 were 
assayed. The amount of bound biotinylated antibody was determined using, extravidin 
peroxidase conjugate at a dilution of 1/1000. 
A 5OpgIml warfarin-BSA coating concentration and biotinylated antibody dilution of 
11300 were chosen for use in a cornpetlave FIA for the detection of free warfarin. 
4.4.2 Competitive fluorescence-based immunoassay (F'IA) for the detection of 
warfarin in PBS, using quantum dots as the fluorescent label 
An anh-warfarin monoclonal antibody was used to develop a competitive assay for the 
detection of free warfarin in PBS, using quantum dots as the fluorescent label (Section 
2.82). A model competitive assay was developed where the biotinylated anti-warfarin 
monoclonal antibody competes for binding to free warfarin in solution and immobilised 
warfarin-BSA on the plate. Standards of warfarin were prepared in PBS ranging from 1.5 
to 50,00Ong/ml and mixed with an equal volume of bioiinylated anti-warfarin antibody to 
give a fmal dilution of 11300 (Section 2.8.2). Quantum dots were used at a concentration 
of 2nM (Section 2.8.1) 
Results were normalised by dividing the mean fluorescence obtained at each warfarin 
concentration by the fluorescence values determined in the presence of zero drug Po). 
These values (Fm) were plotted against the logarithm of warfarin concentration using 
Biaevaluation 4.0.1 software and a four-parameter equation was fitted to the data. Figure 
4.13 shows the FIA inter-day calibration curve using the monoclonal antibody, where the 
lower limit of detection for the competitive assay was determined to be 20lng/ml. This 
was determined as the mean of the blank (fi) plus 3 times the standard deviation of the 
blank. 
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Figure 4.13a inter-day calibration curve for competitrve FIA for the detection of free 
warfarin in PBS using the anti-warfarrn monoclonal antibody and quantum dots as 
fluorescent label. Results were normalrsed by dividing the mean fluorescence obtained at 
each warfarin concentration (F) by the fluorescence values determined in the presence of 
zero drug (Fo). A ltmit of detectton of 20lng/ml was determrned as the mean of the blank 
value (Fo, plus three times the standard deviation of the blank. 
Figure 4.13b Residuals of Biaevaluation plot using 4-parameter equatronfit for the data 
shown in Figure 4.13a, a competitrvefluorescence-based immunoassay for the detection 
offree warfarin, using quantum dots as label. 
Inter-assay variability studies were performed to demonstrate the reproducibility of the 
competitive FIA for the detection of warfarin, using quantum dots as the fluorescent 
label. Inter-day assay CV's ranged from 1.36% to 9.90%, (Table 4.3). 
Table 4.3 Inter-day FIA coeflcient of variation (CVs) for the detectton of free warfarzn 
using the warfarin-specrfic monoclonal antibody and quantum dots. Three sets of each 
standard were assayed over three days and the CVs calculated. Back-calculated 
concentrntlons were determtned using B~aevaluation 4.0.1 software and expressed as a 
percentage of the theoretical concentrations (% recovery). 
Concentration F/F, i: SD CV Back calculated Recovery 
(nglml) (%I concentration (%I 
(ngfml) 
The assay was found to be accurate w~th the percentage recovery of back-calculated 
values determined to be between 85.103% of the measured concentrations. This was in 
line with the percentage accuracies suggested by Findlay et al. (2000). 
4.4.3 Competitive fluorescence-based immunoassay (FIA) for the detection of 
warfarin in PBS, using porphyrin-labelled neutravidin as the fluorescent label 
The anti-warfarin monoclonal antibody was used to develop a competitive assay for the 
detection of h e  warfarin in PBS, using porphyrm-labelled neutravidin as the fluorescent 
label (Sect~on 2.8.3). A model competitive assay was developed where the biotinylated 
anti-warfarin monoclonal antibody competes for bindmg to free warfarin in solution and 
~mmobilised Warfarin-BSA on the plate. Standards of warfarin were prepared in PBS 
ranging h m  1.5 to 50,00Ong/ml and mixed with an equal volume of biotinylated anti- 
warfarin antibody to give a final dilution of 11300. Porphyrio-labelled neutravidin was 
used at a concentration of 2nM (Sectcon 2.8.1) as determined by conjugate titre. 
Results were nonnalised by dividing the mean fluorescence obtained at each warfarin 
concentration by the fluorescence values determined in the presence of zero drug PO). 
These values (Ffi) were plotted against the logarithm of warfarin concentration using 
Biaevaluation 4.0.1 software and a four-parameter equation was fitted to the data. Figure 
4.14 shows the FIA inter-day calibration curve using the monoclonal antibody, where the 
lower limit of detection for the competihve assay was determined to be 228ng/ml using 
the three sigma method as before, whereby the limit of detection is calculated as the mean 
value of blank sample PO) plus 3 standard deviations. 
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f i g ~ r e  4.14a Inter-day callbration curve for compehhve FIA for the detechon offree wa$ann 
zn PBS using the anfz-warfann monoclonal antzbody and porphyrin-labelled neutravzdin 
fluorescent label. Results were normalised by dividing the mean fluorescence obtained at 
each warfarin concentration (F) by thefluorescence values determined in the presence oj 
zero drug (Fo). A lzmit of detechon of 228 ng/ml was determined as the mean of the blank 
value (fi, plus three ttmes the standard deviatzon of the blank. 
Figure 4.14b Residuals of Biaevaluation plot using 4-parameter equation fit for data 
shown in Figure 4.14a, a competttiveflrrorescence-based immunoassay for the detection 
offree warfarin, ustng porphyrtn-labelled neutravtdin as the fluorescent label. 
Inter-assay variability stn&es were performed to demonstrate the reproducibility of the 
competitive FIA. Inter-day assay CV's ranged from and 0.40 to 14.54%, (Table 4.4). The 
assay was found to significantly less accurate than the quantum dot-based assay for the 
detection of warfarin (Section 4.4.2). 
Table 4.4 Inter-day FIA coefficient of variation (CVs) for the detecaon of free warfarin 
using the warfarm-specific monoclonal antibody and porphyrin-labelled neutrav~din. 
Three sets of each standard were assayed over three days and the CVs calculated. Back- 
calculated concentrations were detemzzned using Biaevaluatzon 4.0.1 software and 
expressed as a percentage of the theoretrcal concentratiom (% recovery). 
Concentration F/F, + SD CV Back Recovery 
( n w )  (%) calculated (%I 
concentration 
(nglmlf 
50000 0.15-1.0.01 9.20 48539 97 
25000 0.17-1. 0.00 0.57 27413 109 
12500 0 22+ 0.03 14.54 9818 78 
6250 0.26+ 0.03 12.15 6246 99 
3125 0.28+ 0.03 8.86 3879 124 
1563 0.34k 0.04 11.30 1958 125 
781 0 45-1.0.03 5.50 577 73 
391 0.49-1. 0 00 0 40 402 103 
195 0.58-1. 0.08 12.93 193 98 
Back-calculated values were found to be within 78-125% of the measured concentrations, 
whch is at the far end of the limits suggested by Findlay et al. (2000) which states that 
the values should lie within c 25% accuracy. 
4.5 Immunostaining of Listerin monocytogenes cells 
Quantum dots were successfully used as a suitable label for fluorescence-based 
imrnunoassay for the detection of InU3 (Section 4.2), and so their applicability as reagents 
for immunostaining were also investigated. Quantum dots conjugates were used to stain 
bacterial cells imrnobilised on treated glass slides. Immnnostaining of Listeria 
monocytogenes whole cells using quantum dots was compared to other more traditional 
probes such as Cy5 and FITC. L mnocytogenes cells employ surface bound proteins 
known as Internalins to promote invasion into host cell, with Internalin A ( I d )  and 
Internalin B (InlB) being the best characterised. The use of the Internalin B fragments 
and associated antibodies for epitope mapping and subsequent development of 
fluorescence-based immnnoassays was described earlier (Section 4.2). However, 
Internalin A protein is more readily accessible on the cell surface and therefore it is more 
slutable for immunostaining applications. A monoclonal antibody directed against InlA 
(Hearty et a[., 2006) was used for the specific and non-specific immunostaimng of whole 
cells (Section 2.10.3). The antibody was biotinylatcd as before (Section 2.5.2.1). Listeria 
monocytogenes and Bacillus cereus whole cells were investigated, with the Bacillus cells 
used as a negative control. The fluorescent signal was captured using a Nikon fluorescent 
mcroscope and 12-bit cooled QICAM fast monochromatic camera (Section 2.10.4) with 
suitable optical fdters for the sensitive detection of the fluorescent labels. 
The multicolour sensitivity and stability of quantum dots makes them ideal for the 
analysis of complex samples for hstology, pathology and cytology in immnnostaining 
applications. Quantum dots are similar in size to organic dyes so can be substituted for 
cnrrent fluorescent techniques. The imnunolabelling of Listerla monocytogenes for 
fluorescent detection with quantum dots was carried out in collaboration with industrial 
partners (Slidepath Ltd., DCU) who have access to sophisticated image analysis 
equipment and software. Glutaraldehyde (Seveus et aL, 1994) was used to fix Listeria 
monocytogenes whole cells on Poly-L-Lysine treated glass slides (Section 2.10.1). The 
cells were then incubated with previously biotinylated anti-InlA monoclonal antibody and 
traced using a range of streptavidin-conjugated fluorescent probes. The resulting labelled 
cells were imaged using a fluorescent microscope with monochrome camera and Image 
Prom Software (Fignres 4.15-4.17). 
Figure 4.15 clearly show the use of streptavidin-linked quanhun dots and a biotinylated 
anti-lnlA monoclonal antibody for the imagmg of whole L. monocytogenes cells. 
Figure 4.15 Use of anti-lnlA antibody-linked red lzght-emztting quantum dots (605nm), 
for the visualisation of L. monocvtoaenes cells on poly-llysine-treated glass slides. The 
rmages show different dilutions of L. monocvtoRenes cells, fixed with glutaraldehyde, 
immunostained and visualised underfluorescence at a total magnification of 400x. (A) 
1/10 dzlution of L. monocvtoaenes cells and (B) 1/25 dilution of L. monocvtoaenes cells. 
Figure 4.15 (A) & (B) clearly emphasise the suitability of quantum dots for the 
immunostaining of bacterial cells. The specificity of the biotinylated an&-InLA antibody 
in targeting the cell surface proteln InlA is evident in the clear staining of the cell wall of 
the L. monocytogenes cells, as shown particularly in figure 4.16 (B) where a more dilute 
concentration of cells was fixed to the glass slide usiug glutaraldehyde. The strong 
affinity between the biotinylated antibody which targets the cell wall protein, InlA, and 
the streptavidin linked quantum dots gives a clear image of the imrnunostained cell. 
lo order to evaluate quantum dots as a superior fluorescent label for immunostaining, the 
use of avidin-FITC and streptav~din-Cy5 (traditional organic probes) was also 
investigated. The use of these fluorescent tracers as immunostabng probes gave lower 
quality results whereby the images were more blurred and less bright. Figure 4.16 (A) & 
($4) show the immunostaining of L. monocytogenes cells with FITC and Cy5 probes. 
(A) Avidin-FITC Stain (B) Streptavidin-Cy5 Stain 
Figure 4.16 (A) Antzbody-linked avzdin-FITC immunostaining of L. monocvtoaenes cells 
on poly-L-lysine treated glass slide. @) Antrborfy linked streptavidin-Cy5 immunostain of 
L. monocvtoaenes cells on poly-L-lysine treated glass slides. The image shows L. 
monocvtoeenes cells &ed wzth glutaraldehyde, immunostained and visualised under 
fluorescence at a total magnification of 400x. 
Baczllus cereus is an endemic, soil-dwelhg, Gram-positive, rod shaped, beta haemolytic 
bacterium that causes foodborne illness. Generally spedung, Bacillus foodborne illnesses 
occur due to survival of the bacterial spores when food is improperly cooked, which is 
further compounded with the storage of food at unsuitable temperatures. Bacterial growth 
results in production of enterotoxin, and ingestion causes diarrhoea. It is similar in 
sbucture and mode of action to L. monocytogenes and for these reasons was chosen as the 
control cells in these experiments. Cells were stained in exactly the same was as L. 
monocytogenes cells (Section 2.10.3) using a biotinylated anti-InlA monoclonal ant~body 
and avidin-conjugated fluorescent probes. Since InlA is not a cell surface protein of B. 
cereus, InL4 can be used as a negatlve control for these investigations (Figure 4.17). 
(A) Streptavidin-Qdot Stain (B) Brightfield view of fixed cells 
Figure 4.17 (A) Antibody-linked streptavidin-Qdot rmmunostain of B. cereus cells on 
poly-1-lysine treated glass slide. The tmage shows B. cereus fired with glutaraldehyde, 
rmmunostained with biotinylated anti-lnlA antibody and streptavid~n-linked quantum 
dots. The cells were visualised under jluorescence at a total magnzfication of 400x 
(negative control). @) Bright field view of B. cereus cells on glass slides fired with 
glutaraldehyde and visualised at a total magn~fication of 400x 
From Figure 4.17 (A) & (B) it is evident that the anti-InlA antibody did not specifically 
target any cell surface protein in B. cereus and so the cells were not stained when 
streptavidin-linked quantum dots were added to the slide. The B. cereus cells could 
therefore be used as a negative control to show that the anti-InL4 antibody was only 
specific for L. monocytogenes cell surface protein InlA and therefore could be used for 
the specific inmunostaining of L. monocytogenes cells using quantum dots. 
4.6 Development and characterisation of ruthenium dye-doped nanoparticles 
Luminescence-based methodologies are widely employed throughout the biological and 
chemical sensor areas. However, autofluorescence arising from the system detection 
platform or the matrix can often causes interference, thus preventing the achievement of 
lower detection limits. Ruthenium complexes are designed specifically to have long 
fluorescence life-times close to 500 nanoseconds. These labels are laser-excitable metal 
ligand complexes and can be used to label amines on biomolecules under mild 
conditions. Labeling of proteins with ruthenium is via a ruthemum-activated ester for 
acylation of amino acid side chains. The main advantages of ruthenium-based dyes as 
protein-labels include high photostab~lity, good water solubility, a lack of dye-dye 
interactions and large Stokes shifts. In addition, the fluorescence signal of long-lived 
fluorophores such as ruthemum can be gated to eliminate the emission from short-life- 
time fluorophores and autofluorescence from cells and biomolecules to further improve 
sens~tiv~ty (Castellano et al., 1998). The opbcal properties of ruthenium dyes have an 
excitation maximum at 453nm and an emssion maximum at 6l8nm. The structure of the 
ruthemum NHS ester for antibody labelling is shown ~n Figure 4.18 
Figure 4.18 Structure of Ruthenium-NHS ester used for antibody labelling (Fluka, 
product number 96632, Bis(2,2'-bipyr~d~ne)-4,4'-dicarboxybipyridine-ruthenium-di-(N- 
succinimidyl-ester)bis(hexafluorophosphate). 
The work described in this thesis focused on three main target analytes, namely the L. 
monocytogenes cell surface protein InlB, the ad-coagulant warfarin and the Parvovirus 
B19 capsid protein, VP2. Initially it was proposed to use InlB protein fragment F3 and its 
associated polyclonal antibody for the characterisation and investigation of ruthenium 
dye-doped nanoparhcles in fluorescence-based immunoassays. However, since the work 
involved in nanoparticle synthesis and characterisation employed completely new 
technologies and methods a large amount of antibody was reqlured for the optimisation 
of numerous conjugations and assay parameters. Therefore, it was proposed to employ a 
cheap commercially aviulable antibody-antigen pair for all nanoparticle-based assay 
development, since the ant-InlB polyclonal antibody was in short supply and so the 
selected analyte for nanoparticle studies was human IgG @I@). 
Ruthenium-NHS (Fignre 4.18) was conjugated to anti-hIgG polyclonal antibody (Section 
2.5.3) for use in fluorescence-based immnnoassays for the detection of hIgG. The 
development and optimisation of a solid-phase fluorescence-based immnnoassay using a 
labelled antibody-ruthenium conjugate was then compared to antibody-conjugated 
ruthenium dye-doped nanoparticles in a sandwich assay format. &ian et al., 2004). The 
use of nanoparticles to improve the performance and sensitivity of immunoassays is an 
emerging technology. Seydack (2005) described the use of nanoparticles in 
munoassays resulting in improved detection limits, rnultiplexlng of assays, reduction in 
photobleaching, signal amplificahon and improved sensihvity. In the work described in 
this thesis, ruthenium dye-doped nanoparticles were fabricated in association with Dr. 
Robert Nooney, Biomedical Diagnostics Institute (BDI) in Dublin City University for use 
as fluorescent tags in novel immunoassay formats. Here, the preparation and 
characterisation of ruthenium dye-doped nanoparticles is discussed and their application 
in solid-phase applications demonstrated. 
4.6.1 Ruthenium-antibody conjugation 
Ru-NHS is a functionalised succinimidyl ester of ruthenium that reacts w~ th  p m a q  
amines to form stable dye-protein conjugates. The NHS ester labelling reaction proceeds 
rapidly at slightly alkaline pH values resulting in a stable amide-hked derivative. 
Sodium bicarbonate bnffer (Table 2.4) was determined to be the optimal buffer for 
ruthenium labelling of antibodies. This was established by performing a number of 
conjugation reactions with various buffers and comparing conjugate activity by titration. 
Ruthenium-NHS was conjugated to the anti-NgG polyclonal antibody (Section 2.5.3). 
Unreacted dye was removed from the antibody-dye conjugate by gel filtration or dialysls 
and the conjugate concentration and dyelprotein ratio were calculated 
spectrophotometrically. 
4.6.1.1 Direct detection of hIgG using ruthenium labelled anti-human IgG 
Human IgG was physically adsorbed onto the polystyrene plate surface. Immunoassays 
were established in the traditional manner with blocking and washing steps included. The 
performance of the ruthemum-antibody conjugate was assessed via traditional 
fluorescence-based immunoassay, for subsequent comparison with nanoparticles. Anti- 
human IgG was labelled with Ru-NHS (Section 2.5.3). The conjugate concentration was 
determined spectrophotometrically as 1.7mglml and dyelprotein ratio calculated to be 2.7 
(using equations 2.1 and 2.2, Section 2.5.3) To demonstrate proof of principle that the 
ruthenium antibody remained active post-conjugation, a plate was coated with human 
IgG (5pg/ml) and subsequently blocked with PBS containing 1% (wlv) BSA to prevent 
non-specific binding. The ruthemum-labelled anti-human antibody was diluted in PBS 
(112-11512) and added to the plate. After one hour the amount of bound fluorescently- 
conjugated antibody was determined by reading at optimal excitation (453nm) and 
emssion (618nm) wavelengths. The fluorescent signal generated was nonnahsed a m s t  
a zero control, where no fluorescent material was added to the well (Figure 4.19). 
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Figure 4.19 Fluorescent response of ruthenrum conjugated anti-human IgG in solid- 
phase direct binding assay. The fluorescent response was normalised against the 
background fluorescence and the normal~sed response plotted (NFRUJ. 
Figure 4.19 shows the use of ruthenium-labeled anti-hIgG in a direct binding format with 
lmmobilised hIgG, demonstrahng that the labelled antibody retaned antigen-binding 
functionality post-conjugation. This conjugate would be directly compared to ~ t h e n i ~ m  
dye-doped nanoparticle-anhbody conjugates, in a sandwich assay format for the detection 
of hlgG, to determine the advantages of nanoparticles as detection moieties for increased 
assay senmtivity. 
4.6.2 Nanoparticle synthesis and characterisation 
Nanopmcles are microscopic particles with at least one dimension of less than 100 um. 
Nanoparticle research is currently an area of intense interest, due to a wide variety of 
potential applications in biomedical, optical, and electronic fields. Many materials have 
been investigated for the fabrication of nanoparticle probes and these include 
semiconductor nanocrystals (Matoussi et al., 2000), metals such gold or silver, 
(Schneider et al., 2000), polystyrene latex (Sun et al., 2004) and dye doped silica (Santra 
et al., 2000). Sihca shell dye-doped nanoparticles have a number of advantages over 
conventional fluorescent labels in that they are inherently brighter than their constituent 
dye, the silica surface displays an easily modifiable chemistry for attachment of 
biomolecules and the fabrication of such particles is both reproducible and robust. Silica 
nanoparticles have &en successfully utihsed in both bioseparation and bioanalysis 
applications. The fabrication and use of these ultrasensitive labels in fluorescence-based 
immunoassays 1s described here. 
Ruthenium dye-doped high-brightness nanoparticles were synthesised in association with 
Dr. Robert Nooney, Biomedical Diagnostics Institute (BDI) as described m Section 2.7. 
Modification of the synthesised nanoparticles for antibody conjugation was investigated 
for use in fluorescence-based lmrnunoassays for the detechon human IgG. A reverse 
microemulsion technique adapted from the methods described by Santra et al. (2001), 
Quoboshene et al. (2001) and  an^ et al. (2004) was used for nanoparticle synthesis 
(Section 2.7.1). The main advantages of dye-doped nanoparticles for immunoassays are 
stab~lity, brightness and ease of functionalisahon for bioconjugahon. Fabrication by 
microemulsion, whereby the dye is encapsulated within a silica matrix prov~des good 
photostability, since oxygen is excluded by the sihca encapsulation. The microemulsion 
method is both isotropic and thermodynamically stable (Wangb et al., 2004). 
Nanodroplets of water form in the bulk-oil phase, which acts as a confined medium for 
discrete particle formation. The microemulsion yields monodispersed and highly uniform 
nanoparticles, but takes 2 4 4 8  hours to complete. 
After the initial microemulsion stage, the nanoparticle snrface is subsequently 
functionalised for mteraction with target molecules for biological applicabons. However, 
prior to functionalisation the nanoparticles were characterised using fluorescence analysis 
for calculation of enhancement effects, transmission electron microscopy (TEM) for 
concentration and size determination and dynamic light scattering analysis to measure the 
zeta potential of the particles. 
4.6.2.1 Calculation of enhancement effects of dye-doped nanopartieles 
A study of the relative brightness of ruthenium dye-doped nanoparticles and a 
comparison with the brightness of a single dye molecule was performed to calculate the 
fluorescent enhancement effects of dye-doped nanopmcles, A known mass of dried 
ruthemum dye-doped silica NPs (60 nm in diameter) were dispersed in ultra pure water*. 
The particles remained aggregated due to cross lmking. Therefore, NaOH was added to 
dissolve the silica and free the dye. A fluorescence study was then performed on the freed 
dye and compared against a series of ddutions of pure Ru(bpy)3Clz in solution phase. The 
emission profile (between 500-800nm) of 60nm silica nanoparticles was compared to 
pure dye, Ru(bpy)3Clz. The pure dye concentration was 0.5x10-~ mom and the 
nanoparticle concentration was calculated as 10~'~moVl, using equations 4.1- 4.3. 
Equation 4.1 Volume of sphere cm3= 4nr3 
3 
where r = radius of the nanoparticles 
Equation 4.2 Mass (a) = P x V 
where P = density of uanoparticle (s~lica is 2.6gI cm3) and V = volume of nanoparticles 
Equation 4.3 Number of mom =mass x NA 
where NA = Avogadro's Constant (6.0221415 x loz3 mol-1) 
Based on these values the relative bnghtness of the nanoparticles was calculated to be 
39,000 times brighter that the constituent mthenium dye. Figure 4.20 shows the emission 
spectra of the nanoparticles and ruthenium dye between 500-800nm. 
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Figure 4.20 Comparison of emiss~on spectra of ruthenium dye-doped sillca nanopartlcles 
and constituent dye Ru(bpy)jClz for calculation of enhancement effect. The nanopanicles 
were determined to be approximately 39,000 times brighter than the ruthenium dye, used 
to dope the particles. 
The enhancement effect of the nanoparticles can be calculated by determining the relative 
fluorescent intensity of a known concentration of both the ruthenium dye-doped 
nanoparhcles and their constituent dye. A scan of the emission spectra between 500 and 
800nm was performed and the resultant fluorescent response plotted for both the 
nanoparticles (concentration 10~'Omol/l) and the ruthenium dye (concentration 0.5 x 
molil). By calculating the relabve intensity of a single mole of nanoparticle and 
comparing t h ~ s  w~th the relative intensity of a single mole of dye, an enhancement ratio 
can be determined. Based on these data, the nanoparticles are approximately 39,000 times 
brighter than rnthemum dye. 
+ Please not that due to the proprietary nature of these methods (BDZ, DCU) details on 
actual volumes and experimental conditions cannot be given. The methods used were 
adaptedfrom Sanfra &. (2001), Qhobosheane (2001) and  an^ (2004). 
Transmission electron microscopy (TEM) analysis was also performed to determine the 
actual size and concentration of the particles (Figure 4.21). 
Figure 4.21 Transmission electron microscopy (TEM) micrograph of the hzgh brightness 
ruthenium dye-doped nanoparticles. Assuming a particle size of 60nm f 2nm and a mass 
of 2 mg/ml, the number of particles/ml was determined as 7.36 x ld2 and the 
concentration of nanopatiicles was 1 . 2 2 ~  mom (Scale =100nm). 
Santra et al. (2001) described aggregation issues with dye-doped silica nanopartxles 
formed by microemulsion. In correlation with these findings, aggregation problems were 
observed, which altered the actual size of the particles. Dynamic light scattering analysis 
was performed (by BDI collaborators) to measure the zeta potential of the aggregating 
particles and the actual zeta potential determined as 19.7 mV. This potential is below 20 
mV whch is commonly thought of as the threshold for stable nanoparticles  an^ et al., 
2004). The low surface potential could have contributed to the aggregafiou of the 
nanoparticles and so addition of a protectmg group, was required. 
TO reduce aggregabon of the dye-doped nanoparticles, 3-(trihydroxysilyl) propyl-methyl 
phosphonate, monosodium salt was added particles (Section 2.7.1). NaOH was then 
added to dissolve the silica and free the dye. A fluorescence study was performed on the 
freed dye and compared against a series of dilutions of pure Rn(bpy)Flz in solution 
phase. The results of the fluorescence study were as follows. Nanoparticles and 
ruthenium dye were diluted to a concentration of lx10~mol/l in ultra pure water and the 
fluorescence measured. The relative intensity of the dye was determined to be 3578 at 
this concentranon while the nanoparticles gave a value of 6.58 x 10'. The ratio of 
brightness and therefore enhancement was approximately 18,381. These nanoparticles 
were less bright than those m Rgure 4.20 for two reasons. Firstly, addition of protecting 
groups essentially reduces the abil~ty of the nanoparticles to collide with other particles 
and secondly, the release of ruthenium dye from the silica ma- reduces its fluorescence 
as quenching by oxygen in the atmosphere can occur (Bagwe et al., 2006). Figure 4.22 
shows a TEM micrograph of the nanoparticles with THPMP and A F E S  added. 
Figure 4.22 Transmission electron mrcroscopy (TEM) micrograph of the high brighmess 
ruthenium dye-doped nanoparticles with protecting groups THPMP and APTES added. 
The average particle size was calculated as 77.9nm G.09 nm (Scale = 100nm). 
Dynamic light scattering analysis showed that the diameter of the nanoparticles with the 
protecting groups THPMP and APTES added was 93.2 nm and the surface zeta potential 
was calculated to be 36.4 mV. The TEM analysls values are smaller than those obtained 
from dynamic light scattering analys~s, since it includes the hydrodynamic radius which 
is the shell of solvabng water molecules that move around with the nanopaaicles. After 
the addition of glutaraldehyde and antibody (anti-human IgG) the particle size rose to 
102nm. 
4.6.2.2 Antibody conjugation to ruthenium dye-doped nanoparticles 
The surface modification of ruthenium dye-doped nanopaJtdes for biomolecnle 
attachment was a two-fold process. Silica is easy to modify using a number of methods 
such as NHS achvation, silanisation, carboxyl modification (Lian et al., 2004). In this 
case, anunopropylhimethoxysilane (APTES) modification (Section 2.7.1) was used to 
add amino groups to the silica shell. This was followed by glutaraldehyde crosslinking 
for antibody attachment. This method has been extensively used by many authors for 
biomolecule conjugation to amine modified surface (Nakanishi et al., 1996; Hermanson, 
1996). 
Modification of the protocols described by Santra et al. (2001), Smith et al. (2006) and 
h an^ et al. (2004) was undertaken to optimise biomolecule attachment. High-brightness 
ruthenium dye-doped nanoparticles were conjugated to polyclonal anti-hIgG antibody as 
described in Section 2.7.2. The antibody-modified particles were centrifuged at 20,000 x 
g and then resuspended m 0.1M phosphate buffer (Iml) containing 0.2% (wlv) BSA and 
0.02% (vlv) NaN3 and stored at 4 "C for used in fluorescence-based immunoassays for 
the detection of human IgG. 
4.6.3 Nanoparticles as fluorescent labels for use in immunoassays 
4.6.3.1 Titre of nanoparticle-antibody conjugate 
A number of anti-human IgG antibody-nanoparticle conjugates were prepared using 
differing ratios of glutaraldehyde and BSA for biomolecule crosslinking to ammo- 
functionalised particles. Each conjugate was titrated against immobilised human IgG 
(5pg) and the fluorescent response measured (Section 2.7.3.2) using a Tecan safire2 
monochomator-based microplate reader, with excitation at 453nm and emission at 
618nm, (Figure 4.23). 
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Figure 4.23 Fluorescent response of anti-human ZgG-nanoparticle conjugates in a solid- 
phase drrect binding assay, titrated against irnrnobrlised human IgG, for selection of 
optimal antibody-nanoparticle conjugate. The antibody-nanoparticle (Ab-NP) conjugates 
were prepared uszng varying ratios of glutaraldehyde-BSA for antibody crosslinking. The 
fluorescent response from each conjugate was plotted against conjugate dilution (1/10- 
1/1024). 
Dieren t  ratios of glutaraldehyde-BSA were used for antibody conjugation; the sample 
which gave the highest fluorescent signal was selected for further assay development. 
This synthesis of this antibody-nanoparticle conjugate did not utilise any BSA and had 
glutaraldehyde at a fmal concentration of 0.1% (v/v), as per Section 2.7.2. 
4.6.3.2 Sandwich assay for the detection of hIgG using ruthenium dye-doped 
nanoparticles and ruthenium dye as fluorescent label 
The ant-human IgG antibody-nanopartlcle conjugate was compared to ruthenium labeled 
anti-human IgG usiug a fluorescence-based sandwich assay. A black FluoronuncTM 96- 
well microtitre plate was coated with anti-human IgG (5pg) and the assay performed as 
described in Section 2.7.3.2. Free human IgG dilutions, ranging from 0.005 - 500,000 
nglml were prepared in PBS containing 0.1% (w/v) BSA and added to the plate in 
triplicate. Bound antigen was subsequently detected using anti-hIgG-conjugated 
nanopaaicles and ruthenium labeled anti-human IgG (both previously diluted to 11100). 
The plate was incubated at 37°C for 1 hour and washed as before. Following the wash 
step, the fluorescent response was determined usmg a Tecan safxe2 monochomator- 
based microplate reader, witb excitation at 453nm and emission at 618nrn. The 
fluorescent response was normalized against a zero control (blank well containing no 
fluorescent molecules) and the normalised fluorescence plotted against the logarithm of 
human IgG concentration in nglml. 
Figure 4.24 shows the calibration curve for a fluorescence-based sandwich assay for the 
detection of hIgG. Three sets of each standard were assayed over two days and the CVs 
calculated. CVs of between 0.41-7.60% and 0.36-4.73% were determined for the 
ruthenium nanoparhcle assay and ruthenium dye assay, respecttvely. 
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Figure 4.24 Fluorescence-based detection of human IgG in PBS, using a sandwich assay 
format. Both an anti-human IgG antibody-nanoparticle conjugate (RuNP) and ruthencum 
labeled anti-human IgG (RuNHS) were used for the detection of hlgG. The fluorescent 
response of each conjugate was nomlised against a zero control (blank well contanzing 
no jZuorescent molecules) and the normaltsed fluorescence (NFRU) plotted against the 
logarithm of human IgG concentratton (ng/ml), for direct comparison of assay 
sensitivitres. (A) Graph depicting the noml i sed  fluorescent response vs. WgG 
concentration using both the antibody-nanoparticle conjugate and ruthenium-labelled 
anhbody for detection. (B) Graph depicting the normalised fluorescent response vs. WgG 
concentration using the ruthenium-labelled antcbody for detection (enlarged for clarity). 
The assays were repeated twice and data fitted to a 4 parameter equation uslug 
BiaevaluattonTM software. A calibration curve was constructed for determination of the 
lower limit of detection (mean value of the blank plus 3 times the standard deviation) of 
hIgG in a sandwich assay format for both the nanoparticle and ~the111um dye-antibody 
conjugates. Using ruthenium dye-doped nanoparticles as fluorescent label, a lower limit 
of detection of 1.3 pglml was calculated. Figure 4.25 shows the calibration curve for the 
fluorescence-based detection of hIgG using  the^^ dye-doped nanopart~cles as  
fluorescent label. 
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Figure 4.25 Calibration curve for the fluorescence-based detection of hIgG using 
ruthenrum dye-doped nanopartlcles as fluorescent label. The lower limit of detectcon was 
determined to be 0.0013ng/ml (1.3pg/ml) calculated from the mean value of the blank 
plus 3 times the standard devration. The fluorescent response was normalised against a 
zero control (blank well containing no fluorescent molecules) and the normalised 
fluorescence (NFRU) plotted against the logarithm of human IgG concentration (ng/ml). 
The same analysis was performed for the assay incorporating ruthenium dye as the 
fluorescent label, for direct comparison of assay sensitivities. The assay was repeated 
twice and data fitted to a 4 parameter equation using Biaevaluationm software. A 
calibration curve was constructed for detemnation of the lower limit of detection (mean 
value of the blank plus 3 times the standard deviation) for the detection of hIgG using 
ruthenium dye as fluorescent label and a lower limit of detection of 84 pglml was 
determined. Figure 4.26 shows the calibration curve for the fluorescence-based detection 
of hIgG using ruthemum dye as fluorescent label. 
Figure 4.26 Calibration curve for the fluorescence-based detection of hZgG using 
ruthenium-dye as fluorescent label. The lower limit of detectton was determined to be 
0.084ng/ml (84pg/ml) calculated @om the mean value of the blank plus 3 times the 
standard deviatton. The fluorescent response was normalised against a zero control 
(blank well containing no fluorescent molecules) and the noml i sed  fluorescence 
(NFRU) plotted agatnst the logarithm of human IgG concentratton (ng/ml). 
Fluorescence-based detection of hIgG using ruthenium dye-doped nanoparticles as the 
fluorescent label was approximately 60 times more sensitive than detection with pure 
ruthenium dye. This demonstrates the potential use of dye-doped nanoparticles in 
unmunoassay development, whereby the limitations (photobleaching, quenching) 
associated with the use of organic dyes could he overcome. Doping of highly functional 
nanoparticles that are easily modified for biomolecule attachment, with fluorescent dye 
molecules allows development of immunoassays with enhanced sensitivities. 
4.7 Development of immunoassays for the detection of Parvovirus B19 
In conjunction with industrial partners at Biotrin International Ltd. (Dublin, Ireland), a 
series of assays were developed, comparing various methods for the detection of 
Panrovirus B19. Commercial antibodies and a recombinant capsid protein (VP2), specific 
for Parvovirus B19 were donated by the research partners at Biotrin for assay 
development. A standard ELISA-based antigen capture assay, previously developed at 
Biotrin Ltd. was used as the model system. A recombinant VP2 strnctural protein was 
added to antibody-coated wells of a microtitre plate and subsequently detected with an 
anti-Parvovirus B19 enzyme conjugated antibody. This assay detects antigen in vuaemic 
plasma at 10' genome eqnivalentslml and is sensitive to approximately 10pgIml of 
recombinant antigen (Doyle et al., 2000). Fluorescence and luminescence-based 
detection methods were investigated for the same antigen capture assay for the detection 
of Pmovirus B19. Comparative studies were performed between the three methods and 
sensitivity, reproducibility and specificity assessed. 
The main aim of validating these detection methods in solid phase plate-based assays was 
to transfer the assay for the detection of Parvovims B19 onto enhanced cone platforms. In 
order to assess the suitability of Pmovirus detection on cone platforms, initially plate- 
based comparative studies were performed, investigating fluorescence and 
chemiluminescence-based detection and comparing these methods to the existing ELISA- 
based strategy. Reagents, antibodies and antigens* were supplied by Biotrin for use in a 
96-well plate format and subsequently transferred to chip-based platforms. The chips 
utilised for this project, were the novel luminescence enhancement platforms designed 
and fabricated by NCSR researchers, previously described for the detection of InlB 
(sechon 4.3). 
*Please note that due the proprietary naiure of the commercial reagents provided by the 
industrial partners (Biotrin International Ltd., Dublin) all buffer and reagent 
formulations have been omitted These reagents are referred to only by generic terms 
(low pH diluent, blocking solution, and enzyme conjugate diluent) on the request of the 
industrial partners, Biotrin International Lid. 
In order to evaluate the suitability of the cone structures for the development of chip- 
based assays for the detection of Parvovirus B19, a number of immobilisation strategies 
were first investigated. These iwnobilisation approaches were performed on both cone 
and planar surfaces and included passive adsorption, silanisation on in&m tin oxtde 
@TO), plasma-enhancement via sputtering and glutaraldehyde activated cross-linking. 
Each method was investigated with immobilised horseradish peroxidase @RE'). Finally, 
the anti-VP2 antibody was immobilised on the cone structures using the best method for 
attachment and the optical enhancement generated from the immobilised 
immunoreagents was assessed. 
4.7.1 Enzyme-linked immunosorbent assay for the detection of Parvovirns El9 
An ELISA-based assay for the detection of Parvovirus B19 was investigated to see if 
limits of detection achieved by Biotrin researchers could be reproduced. A microtitre 
plate was coated with 4 pg/d of coatmg antibody (anti-VP2 capture antibody from 
Parvovirus B19) and incubated (Section 2.9.1). Recombinant VP2 capsid protein 
dilutions were prepared in low pH sample &luent in concentrations rangng from lpg - 
10 pglml. Bound antigen was subsequently detected using horse-radish peroxidase- 
labelled anti-VP2 antibody with TMB as substrate (Figure 4.27). 
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Figure 4.27 Schematzc showing soltd-phase assay format for the ELISA-based detectton 
of Parvovirus B19 capsid protein VP2. An anti-VP2 antibody is used in a sandwich assay 
format to capture varying amounts of recombinant VP2 capstd protein. Bound protein is 
detected using a HRP-conjugated anti-VP2 antibody, which is subsequently traced using 
TMB substrate. 
Figure 4.28 shows the calibration curve for an ELISA-based sandwich assay for the 
detection of Parvovirus B9 capsid protein VP2. Three sets of each standard were assayed 
over three days and the CVs calculated. CVs of between 0.44-18.66% were found. 
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Figure 4.28 Calibration curve for ELISA-based detection of Parvov~nrs B19 VP2 capsid 
protein in PBS using a sandwcch assay format. Restduals of Biaevaluatcon plot ustng 4- 
parameter equation fit for data are also shown. The lower ltmit of detection was 
determined to be 3 pg/ml, (mean value of the blank plus 3 times the standard devcation). 
A lower limit of detection of 3 pglml for Parvovirus B19 capsid protein VP2 was 
calculated as the mean value of the blank (sample containing no VP2 capsid protein) plus 
3 times the standard deviation of the blank. This was lower than the detection limit 
achieved by the Biotin assay (IOpg/ml) and suggested successful replication of the 
ELISA-based sandwich assay for the detection of VP2. The next step was to investigate 
the sensitivity and reproducibility of the VP2 assay using fluorescence and 
chemiluminescence-based detection methods. An avidim-FITC label was chosen for the 
fluorescence-based assay, while a luminol substrate was used for chemiluminescence- 
based detection of VP2. Optimisation of the assay using both fluorescence and 
chemiluminescence-based detection would allow transfer of the assay to chip format, 
which was the overall aim of the collaboration. 
4.7.2 Fluorescence-based immunoassay for the detection of Parvovirus B19 
A fluorescence-based immunoassay (HA) for the detection of Parvovirus B19 was 
investigated. A microtitre plate was coated with 4 p g l d  of coating anhbody (anti-VP2 
capture antibody from Parvovirus B19) and incubated (Section 2.9.2). Recombinant VP2 
capsid protein dilutions were prepared in low pH sample diluent (proprietary) in 
concentrations ranging from 1 pg - 10 pglml. Bound antigen was subsequently detected 
using biotin-labelled anti-VP;? antibody and avidin-FITC (Figure 4.29). 
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Figure 4.29 Schematic showing solid-phase assay format for the ELZSA-based detection 
of Parvovincs B19 capsid protein VP2. An anti-VP2 antibody is used in a sandwich assay 
format to capture varying amounts of recombinant VP2 capsid protein. Bound protein is 
detected using a biotin-conjugated anti-VPZ antibody, whzch is subsequently traced using 
an avidin-FITC label. 
Figure 4.30 shows the calibration curve for a fluorescence-based sandwich assay for the 
detection of Pmovirus B9 capsid protein VP2. Three sets of each standard were assayed 
over thiee days and the CVs calculated, CVs of between 0.39-6.02% were determined. 
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Figure 4.30 Calibration curve for the fluorescence-based detection of Parvovrrus B19 
VP2 capsid protein in PBS using a sandwich assay fonnat. Residuals of B~aevaluation 
plot using 4-parameter equationfit for data are also shown. The lower limit of detection 
was determined to be 17 pg/ml, calculated from the mean value of the blank plus 3 trmes 
the standard deviation and the fluorescent response was normalised against the 
backgro~ndjluorescence (NFRU). 
The fluorescence-based assay produced a lirmt of detection less sensitive than the 
equivalent ELISA assay. The lunit of detection for the fluorescence-based assay was 
determined to be 17 pg/ml, when calculated from the mean value of the blank (sample 
containing no VP2 capsid protein) plus 3 standard deviations. This was thought to be 
related to the immunoreagents used m the fluorescence-based assay which employed a 
biotinylated ant&-VP2 antibody, as opposed to the HRP-conjugated anti-VP2 antibody 
used in the ELISA-based method. Fluorescence-based detection is generally more 
sensitive than enzyme-based methods, however, s~nce there were proprietary issues 
concermng the reagents and buffers; optimisation of biotinylation and assay conditions 
were not permitted. 
4.7.3 Chemiluminescence-based immunoassay for the detection of Parvovirus B19 
A chemiluminescence-based immunoassay (CIA) for the detection of Parvovirus B19 
was investigated. A microtitre plate was coated with 4 pglml of coating antibody (anti- 
VP2 capture antibody from Parvovirus B19) and incubated as described in Section 2.9.3. 
Recombinant VP2 capsid protein hlutions were prepared in low pH sample diluent ~n 
concentrations ranging from lpg - 10 pglml. Bound antigen was subsequently detected 
using horserachsh peroxldase-labelled anh-VP2 antibody and luminol/iodophenol 
substrate (Fignre 4.31). 
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Figure 4.31 Schematrc showing solid-phase assay format for the ELISA-based detection 
of Parvovirus B19 capsidprotein VP2. An anti-VP2 antibody is used in a sandwrch assay 
format to capture varying amounts of recombinant VP2 capsid protein. Bound protein is 
detected using a HRP-conjugated anti-VP2 antibody, which is subsequently traced using 
a luminoUiodophenol substrate. 
Figure 4.32 shows the calibration curve for a chemiluminescence-based sandwich assay 
for the detection of Parvovirus B9 caps~d protein W2. Three sets of each standard were 
assayed over three days and the CVs calculated, CVs of between 1.11-9.16% were 
reported. 
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Figure 4.32 Calibratzon curve for the chemilumznescence-based detection of Parvovzrus 
B19 capsid protein VP2 in PBS wing a sandwich assay format. Residuals of 
Blaevaluation plot using $-parameter equatron fit for data are also shown. . The lower 
limit of detection was determined to be 38 pg/ml calculated from the mean value of the 
blank plus 3 times the standard devration and the chemiluminescent response was 
normalised against the background lumrnescence (NLRU). 
The chemiluminescence assay also established an LOD of 38 pglml, which was less 
sensitive than both the ELISA and the fluorescence-based assays. Although, the 
chemiluminescence-based assay used the same HRP-conjugated anti-VP2 antibody as the 
ELISA, it was far less sensitive. It has been suggested that chemiluminescence possesses 
much better signal-to-noise ratios than absorbance-based assays (Kricka, 2003). 
However, it did not perform significantly better in this assay format. In conclusion, the 
successful transfer from ELISA based detection on solid phase to fluorescent and 
chemlumnescent versions of the assay were established, the former being 4 times less 
sensitive than the established ELISA with an LOD of 17 pglml and the latter being 
almost 10-fold less sensitive with an LOD of 38 pglml reported. 
4.7.4 Biomolecule irnmobiisation on cone structures The plate-based immunoassay for 
the detection of Pmovirus B19 capsid protein VP2 was successfully reproduced uslng 
enzymebased detection. The assay was also successfully replicated in plate-based format 
uslng both fluorescence and chemiluminescence-based detection, albeit at slightly less 
sensitlve LODs. The next phase involved transfer of the plate-based assays to a chip- 
based format using a polymer platform with cone structures for enhanced fluorescence 
and chemiluminescence-based detection. The mcmtitre plates used in the plate-based 
assays were MaxiSorbm plates (Nunc, Denmark), which have a high affinity to 
biomolecules due to their mixed hydrophilic/hydrophohic domains. The MaxiSorbm 
polystyrene surfaces therefore, promote biomolecule attachment through passive 
adsorption onto well surfaces (honymous, 1998). The polymer chips do not exhbit the 
same characteristics and so a number of surface modificat~on strategies for biomolecule 
immobilisation were evaluated (Section 2.9.4). Both polycarbonate (PC) and polystyrene 
(PS) cone platforms were inveshgated for biomolecule immobilisation. The polymer 
chips were adapted in a number of ways to assess what kind of modification processes 
provided optimal biomolecule attachment. 
Polymer chips were treated with an oxygen plasma and subsequently modified with 
aminopropyl-tri-ethoxysilane and glutaraldehyde prior to biomolecule immobilisation. 
The use of indium tin oxide (IT0)-coated polymer materials with and without 
aminopropyl-tri-ethoxysilane treatment was also examined. Each strategy was evaluated 
f is t  using horseradish peroxidase (HRP), before being used to assess the immobilisation 
of the anti-VP2 coating antibody. The most consistent surface modifcation technique 
(that gave the highest levels of HRP immobilisation), was subsequently used in the 
fluorescence and chemiluminescence-based assays for the detection of Parvovirus B19 
capsid protein VP2, on the chip platforms. Figure 4.33 shows a schematic of the surface 
modification techniques evaluated for biomolecule immobilisation on cone platforms. 
Figure 433 Schematic of s e m e  modification techniques evaluated for biomolecule 
immobilisatwn on cone platform. PC - polycarbonate; PS - polystyrene; Plasma - 
Oxygen plusma treatmen!; IT0 - Indium tin oxide sputtering; Glm - GlWaraldehyde 
rnod@cation; Silane - Aminosilanisatwn. Both polycarbonate (PC) and polystyrene (PS) 
cone p l a t f m  were subjected to s@e d p c a t w n  treatments. An oxygen plasma 
was sputtered onto the polymer chips, followed by silanisatwn to facilitate 
glutamldehyde cross-linking. Another batch of chips were coated with indium tin oxide 
and subsequently treated with aminopropyl-tri-ethonysilane. Negative controls were 
prepared for each suMme modification step (whereby no treatment occurred) and the 
strategies were evaluated by assessing the amount of immobilised HRP post- 
mod1~ati0n 
Plasma treatment is a useful tool for biomolecule attachment to polymer surfaces for 
immunosensor applicat~ons (Wu et a1 , 2000; Li et al., 2004). The treatment of polymer 
surfaces with oxygen plasma is reported to enhance immobilisation of biomolecules (Jo 
et a/., 2000; Michalzik et al., 2005) and, therefore, was assessed in this study. 
Glutaraldehyde is frequently used ~n biochemistry applications as an amine-reactive 
homo-bifunctional cross-linker, promohng biomolecule immobCisat~on in a number of 
sensor platforms (Ln et al., 1997; Liua eta/., 1999; Deng et al., 2004). Silanisation of the 
surface with aminopropyl-bi-ethoxysilane (APTES) allowed glutaraldehyde crosslmking 
and covalent immobilsation of antibodies to the chip surface. The use of glutaraldehyde 
both in the presence and absence of oxygen plasma treatment and silane was assessed. 
The sputtering of polymer surfaces with ind~urn tin oxide @TO) for enhanced 
immob~lisation of biomolecules was reported by Fang et al. (2003), and this method was 
also investigated. Direct silanisation is a commonly used method for the immobilisation 
of biornolecules at chip surfaces (Nisnevitch et a/., 2000; Betty et al., 2004). Thus, this 
method was also examined. Plant horseradish peroxidase (Sigma) is a cheap, robust 
molecule that is easily detected using TMB substrate and so was chosen as the test 
molecule for immobilisation for these preliminary studies. 
4.7.4.1 Immobilisation of HRP on modified polymer chips for enhanced fluorescence 
and chemilnminescence-based detection 
Both polycarbonate and polystyrene chips were investigated. Plant horse-radish 
peroxidase (HRF') was immobilised on the surface of modified cone structures (Section 
2.9.4.1) and any remaining binding sites on the biochip blocked using PBS (0.15M NaC1, 
2.5mM KC1, lOmM Na2HP04, 18mM KH2PO4, pH 7.4) contaming 1% (wlv) BSA. 
Following washing, bound HRP was detected following the addition of TMB substrate 
(Section 2.9.4.1). The CCD detection set-up (Section 4.4.4) used to assess the amount of 
bound biomolecule on chip surfaces, is only suitable for measuring fluorescence and 
chemiluminescence and does not have absorbance-detection capabilities. Therefore, 
reacted TMB substrate from each cone was transferred to wells of a microplate 
containing 135pl of umeacted substrate (1110 dilution) and the absorbances for each 
sample was read at 620nm using a &fire2 plate n?ader. Figure 4.34 shows the results for 
polycarbonate chips, modified as deta~led in Figure 4.33. 
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Figure 4.34 lmmobilisation studies on polycarbonate. P - oxygen plasma treaimenh S - 
silanisation with aminopropyl-tn'-ethoxysilane; G - glutaraldehyde treatment; IT0 - 
indium tin oxide sputtering; NOT - no treatment. The strategy that gave the most 
consrstent immobilisation results for the polycarbonate chips was no plasm treatment 
but with both silanisation and glutaraldehyde modification. Controls included completely 
untreated chzps. The background absorbance was subtracted from all values. 
From Figure 4.34 it was detemned that the oxygen plasma treatment was not enhancing 
HRP immobilisation either with or without subsequent glutaraldehyde crosslinking The 
indium tin omde sputtered cones that were silanised showed good levels of HRP 
immobilised at higher concentrations, however, this levelled off at the lower end of the 
concentration range. From this data, the most promising strategies were silanisation with 
glutaraldehyde tleatment and silanised chips with no pre-treatment. These methods gave 
the most consistent immobilisation throughout the entire concentrahon range of HRF'. 
The polystyrene chips were evaluated in exactly the same way as the polycarbonate 
chips, except that the oxygen plasma pretreatment and IT0 sputtering strategies were. not 
investigated, since they showed no obvious benefits on the polycarbonate cones. Figure 
4.35 shows the results for polystyrene chips modified as detailed in Figure 4.33. 
Figure 435 Immobilisation studies on polystyrene. G - glutaraldehyde trea!men$ S - 
silanisation with aminopro~l-tti-ethoxysilane, Untrented - no treatment. The strategy 
that gave the most consistent immobilisation results for polystyrene chips was determined 
to be glutaraldehyde crosslinking o f  HRP via the amino groups of aminoprogyl-tri- 
ethoxysilane on the chip. Controls included completely untreated chips. The background 
absorbance was subtmctedfrom all values. 
The next phase involved assessing which polymer material was most suitable for use with 
glutaraldehyde for the bobilisation of HRP. A range of HRP concentrations (O- 
lOOOpg/ml) were spotted onto the cone platforms of both polycarbonate and polystyrene 
chips, in the presence and absence of silandglntmaldehyde to determine which chip 
material was optimal (Figure 4.36). 
Figure 4.36 Irnmobilisation studies to determine optimal polymer type for biomolecule 
immobilisation. , PS -polystyrene; PC - polycarbonate; G - glutamldehyde treatment; S - 
silanisation with minopr~l-tn'-ethoxysilmre (APTES). Polystyrene chips with 
silane/glutamldehyde modification showed the most consistent immobilisatr'on of HRP. 
The background absorbance was subtmctedfrm all values. 
Polystyrene chips that were modified with silane and glutaraldehyde consktmtly showed 
the mwt uniform immobilisation levels of HRF'. Therefore, polystyrene was deemed to 
be the optimal chip material since it produced the most repmducible results of HRP 
immobilsation. This was further impmved by m w i n g  the chip surfaces with 
aminopmpyl-tri-ethoxysilane to assist in the immobilisation of HRP by glutaraldehyde 
cmsslinking. 
A consistent strategy for HRP immobilisation was defined on polystyrene chips that had 
been m&ed with silanelglutaraldehyde. The next phase involved the immobilisation of 
HRP-coujugated anti-VPZ antibody on the chip surface, using this immobilisation 
technique. A range of HRP-conjugated anti-VF2 antibody concentrations (0-1OM)pglml) 
were prepared and spotted onto the optimally-modified cones of polystyrene chips 
(Section 2.9.4.2). The amount of bound antibody was detected in the same way as 
immobilised HRP, using TMB substrate (Figure 4.37). 
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Figplre 4.37 Zmmobilisation of aniibodies. PS - polysqvrene; G - gglutaraldehyde 
trea-nt; S - silanisation with aminopropyl-tri-etmsilune (APTES). Polystyrene 
platjbrms were treated with aminopro~l-tri-ethoxysilane and subsequently investigated 
both with and without glutnrakiehyde to determine the optimal coating concentration of 
HRP-conjugated d - V P 2  mrtibody for assay development on cone plagonns. 
Figure 4.37 shows that the presence of glutaraldehyde had a positive effect on 
immobiition. Glutaraldehyde can be used to mss link biomolecules to polymer 
surfaces via activated functional groups (IN et al., 1997; Rgueiro et al., 2006). In this 
case amino grwp were available fium the aminosilanisation of the sudace prior to the 
addition of glumaldehyde. There seemed to be little variation in signal with decreasing 
concentrations of anti-VP2 coating antibody and so a low concentration was chosen, to 
conserve antibody supplies. An anti-VP2 antibody concentration of 3.91pgIml was 
selected for use in the futher chip-based studies. 
Figure 4.38 shows the different percentage glutaraldehyde solutions for use in chip-based 
assays for the detection of Parvovi~~s B19 capsid protein VP2. An ELISA-based assay 
was performed (Section 2.9.4.3) using varying percentage concentrations of 
glutaaldehyde for immobilisation of the coating antibody, 2.5%, 1% and 0.25% (vlv). 
Anti-VP2 coating antibody (3.91pg) was spotted on modified cones and incubated for 2 
hours at RT. The chip platforms were washed and blocked in the same way as the plate- 
based assay. Recombinant VP2 capsid protein dilutions were prepared in low pH sample 
diluent (Biotrin International, Dublin), at concentrations ranglng from lng - 10,000nglml 
(Section 2.9.4.3). Each of the W2 concentration was added in triplicate (3 cones) and 
incubated at RT for 2 hours. The chlp platforms were washed, as before, and perox~dase- 
labelled anti-VP2 antibody added to detect the amount of capsid protein bound to each 
cone. TMB substrate (20pVcone) was used to trace the HRP-conjugated anti-VP2 
antibody bound to the differing concentrations of VP2 capsid protein. After 10 minutes 
incubation, 15p1 of the reacted TMB substrate from each cone was pipetted into a 
microplate and 135~1  of reaction soluhon was added and mixed for 3mins (1110 dilution, 
total volume of reaction in each well 1s 150pI). The absorbances for all samples were 
read at 620nm and normalised against the background absorbance. 
Figure 4.38 Determination of optimal percentage glutaraldehyde concentmtion for W2 
sandwich assay on poIyviyrene cone platforms. The TheS.4-based assay was reproduced 
on the cone plmforms using varying concentrations of glutaraldelyde for coating 
antibody immobilisatim The optimal concentmtion ofglutaraldehyde was determined to 
be 23% (v/v). Both TMB substrate and bGer were also tested as negative controls, to 
determine background absorbance, which was subtracted from all test values. 
Various surface modification methods were investigated to evaluate the most suitable 
strategy for biomolecule attachment onto the cone platforms, allowing the transfer of the 
plate-based assays to a chip fonnat Directed immobilisation of antibodies onto the cone 
p l a t b m  using glutataldehyde crosslinlcing via aminosilane macation allowed 
transfer of the ELISA-based assay to chip format, where a detection limit of lnglml was 
achieved This strategy also was investigated for both chemiluminescence and 
fluorescence-based detection of VP2, to see if the plate-based assays could be replicated 
in cbip format in the same manner as the ELISA-based assay. 
4.7.4.2 Chemiluminescence-based detection on cone platforms 
In order to assess compatibiltty of the CCD detection set-up for transfer of the 
chemiluminescence-based W2 assay to a chip platform, the chemiluminescence-based 
detection of HRP was firstly investigated. HRP was immobil~sed as before and detected 
using a chemiluminescent substrate, using the CCD set-up (Section 4.4.4). The 
immobilisahon of HRP (0-lmglml) via s~lanelglutaraldehyde crosslinking on polystyrene 
(PS) cone platforms was visualized by the in situ addition of luminoViodopheno1 
substrate using a luer lock syringe (Section 2.9.4.4). The detection of the generated 
chenuluminescent signal from immobtlised-HRP was captured with a CCD camera. 
However, very long exposure times were required (-40 s). A number of problems such as 
depositionflight-capture issues were encountered. Figure 4.39 shows the 
chemiluminescent detection of immoblltsed HRP. 
visible at 7uglml 
Figure 4.39 Chemiluminescent detection of immobilrsed HRP on glutaraldehyde- treated 
polystyrene cones. LumrnoUiodophenol substrate was added to cone platforms and the 
generated luminescent srgnal from immobilised HRP at each spot was captured wrth a 
CCD camera. This was performed to assess the lowest amount of HRP detectable using 
this substrate and detectron set-up. A faint spot was visible at 7.81 pg/ml. However, some 
concentrattons above this point are not visible, indicating that the method was sub- 
optimal. 
From Figure 4.39, a number of ~rnrnobilised HRF' spots are visible; however the sequence 
of spot intensities from the highest concentrations (lmg) to the lowest concentration 
(Opg) does not follow the expected pattern. Spot intensities (representing decreasing 
concentrations of immobilised HRP) decrease from lmg/ml down to 125pg/ml, as 
expected, but after t h~s  point, at 62.5pg/ml, 31.25pg/ml and 15.65pg/ml, no 
chemiluminescent signal is apparent. However, on the cone representing 7.81 pglml, there 
is a faint spot visible, even though concentrations above this pomt were undetectable 
This indicated that this strategy was unsuitable for full transfer to a chip format at this 
point, due to significant problems in set-up and detection, whereby the accurate 
quantification of individual spot intensities was not possible. These problems were 
associated with concentration issues of lununol at the optical interface, which exhibited 
l i i t e d  sensitivity for chemiluminescent HRF' detection in t b ~ s  format. If this strategy 
were to be explored further, a surface-immobilised chemiluminescent label would be 
investigated. 
4.7.4.3 Blnorescence-based detection of VP2 eapsid protein on cone platforms 
The transfer of the fluorescence-based detection of VP2 capsid protein from a plate-based 
method to cone platforms was evaluated. The immobilisation of biotin conjugated anti- 
VP2 antibody via glutaraldehyde crossl~nking onto polystyrene cone platforms (Section 
2.9.4.5) was performed. This allowed bound anti-VP2 antibody to be visualised with the 
addition of streptavidin-linked Cy5. Figure 4.40 shows a schematic of this format. 
Biotin-conjugated anti-W2 antibody 1 
- I Silanelglutaraldehyde modified cone - 
Figure 4.40 Fluorescence-based detection of biotin-conjugated anti-VP2 antrbody 
immobilrsed on polystyrene cone plafoms. Bound antrbody was traced with 
streptavidin-Cy5 and the fluorescent signal generated was captured using both a CCD 
and CMOS camera. 
A range of biotin-conjugated anti-VP2 antibody concentrations (0-1000pg/ml) were 
spotted onto cone surfaces of the chip. Four antibody concentrations (1000pg/ml, 
125pg/ml, 7.81pglml and a control, Opglrnl) were also spotted onto planar areas on the 
chip surface. This allowed visualisation of the enhancement effects of the cone 
structures, which are reported to enhance collected fluorescence up to 80 fold (Blue et al., 
2005). The fluorescent signal generated from the immobilised biotin-conjugated anti-VF'2 
antibody spots was traced with streptavidin-Cy5 and detected using a charged coupled 
device (CCD) camera, with an exposure time of 5 secs. The successful demonstration of 
fluorescence-based anti-VPZ antibody detection 1s shown in Figure 4.41. 
Figure 4.41 CCD image of immobilised biotin-conjugated antr-VP2 antrbody, traced with 
streptavidin-Cy5. The concentrations of the antibody spots depicted tn white text are on 
cone surface, whereas antibody concentrattons on planar surfaces are show in red. A 
clear enhancement from antibody immobilised on the cone surfaces is evident and shows 
that the fluorescence-based detection of VP2 rs possible using this setup. 
Figure 4.41 shows the captured fluorescence and associated enhancement of bound 
biotin-conjugated anti-VP2 antibody, traced with streptavihn-Cy5. Spot intensities 
(representing decreasing concentrations of immobilised biotin-conjugated anti-VP2 
antibody) decrease as expected, from 1mg/ml down to 7.81CLg/ml, since there were fewer 
antibodies available for the reaction with streptavidin-Cy5. The fluorescent signal 
strengths from antibody immobilised on the cone parts of the chip were considerably 
higher than the comparative signals on the planar areas of the polymer surface at the 
same concenbation. l h s  is particularly ev~dent at 7.81pg/ml, where the signal from the 
cone (white text) is sigmficantly brighter than the signal from the planar surface at the 
same concentration (red text). This is a key outcome and clearly demonstrates pmof of 
principle for enhanced fluorescence-based detection using the chip format. 
Further improvements in detection setup, chip fabrication and fluorescent tracer 
molecules would be necessary for optnnisahon of this method if it is to aclneve 
widespread use in immunoassay-based applications. 
4.8 Discussion 
The work described in this chapter involved the development of improved fluorescence- 
based detection methods for the immunosens~ng of various analytes. The chosen targets 
were warfarin, a small hapten, the bacterial protein InlB, L. monocytogenes bacter~al cells 
and human IgG. Details of assay limits of detection are shown in table 4.5. 
Table 4.5: Huorescence-based assay limits of detection 
The use of biochip-based systems using traditional fluorescent labels such as FWC and 
Cy5 have been reported by several authors (Rowe-Taitt e f  al., 2000; Rubina et al., 2005; 
Sapsford et aL, 2006). Microarray-based systems were successfully demonstrated for the 
detecaon of biotoxins, tumow markers, DNA and clinically important analytes (Ekins et 
al., 1999; Feldstein et al., 1999; Rowea et al., 1999; Espina et al., 2004). However, 
sensitivity is often h i t e d  by the spectral characteristics of the fluorescent probe and the 
quantum yield of the emitting molecules. The performance of a fluorescence-based 
immunoassay depends on both the specificity and affinity of the immunomolecules 
involved and also on the labevdetection system chosen. Moreover, within the 
labelldetection system association, there are two major considerations; one based on the 
specific activity of the labelled molccule and secondly, the sensitivity of the detection 
system for that molecule (Marquette et al., 2006). In fluorescence-based detection 
platforms, the background noise of the measurement set-ups (photo-multiplier tube, CCD 
camera) is usually very low As a consequence, in equivalent conditions of 
immunological reactivity and signal detection, the sensitivity of the assay is directed by 
the label activity or the labelling quality. Therefore, the use of improved fluorescent 
probes is a key consideration for the accurate and sensitive detection of analytes. 
The application of enhanced fluorescent probes m immunosensing technology is an area 
of expanding recent interest (Seydack, 2005; Hun and Zhang, 2007). Fluorescent silica 
nanoparticles display excellent optical properties and are particularly useful as sensitive 
and photostable fluorescent probes for improved immunosensing and bioanalytical 
appl~cations (Zhao et al., 2004). With this in mind, this chapter focused on the use of 
novel fluorescent labels and biochip platforms for the improved detechon of target 
analytes. 
Fluorescence-based immunoassays for the detection of InlB were established using both 
streptavidin-linked quantum dots and porphyrin-labeled neutravidin as fluorescent labels 
(Sectron 4.2). The polyclonal antibody-based competitive assay us~ng quantum dots as 
label has a limit of detection (LOD) of 12ng/ml (Table 4.5). This was determined by 
calculating the mean value of the blank (Fo) plus three times the standard deviation. The 
LOD for the scFv competitive assay was determined to be 12ng/ml (Table 4.5) and the 
polyclonal antibody-based cornpetitwe assay using porphyrin-labeled neutravidin as label 
has a limit of detection (LOD) of 87ngIml (Table 4.5). These assays successfully 
demonstrated the use of quantum dots and porphyrin for the fluorescence-based detection 
of InB. However, signifcant problems were encountered with the commercially acquired 
quantum dots. Large batch-to-batch vanations were found and the fluorescent signal 
strengths of stock solutions were inconsistent. Many assays incorporating quantum dots, 
particularly those based on immunofluorescence, have been reported to be less sensitive 
than other assays (Jamieson et al., 2007). The large size of quantum dots, relative to 
current fluorophores reduces their ability to access and label immunomolecules, and 
uncertainty over the tox~city of these molecules is a key issue. In addition, the 
fundamental characterishcs of their surface chemistry and physiochemical properties in 
assay situations are poorly understood. For this reason the quantum dots were not further 
investigated as potenhal labels for the transfer of fluorescence-based detection of InlB to 
a blochip-based system. 
However, the fluorescence-based detection of InlB in a biochip format was attempted 
with the near lnfra red label (NIR) Cy5; using specialised polymer platforms with cone 
structures for enhanced fluorescence capture (Section 4.3). The snccessful detection of 
anti-InlB polyclonal antibody, bound to immobilised antigen (InlB-F3) and traced with 
Cy5 was demonstrated using a CCD detection set-up (Section 4.3.5). This highligbted the 
potential use of the cone platforms for fnrther chip-based detection of analytes using 
alternative fluorescent labels. The use of dye-doped nanoparhcles in such a system would 
greatly improve assay sensitivities. 
Although little has been published on the use of quantum dots in solid-phase 
unmunoassays, many authors have reported on their suitability for imaging applications 
(Mattheakis et al., 2004; Sukhanova et al., 2004). Quantum dots were therefore 
Investigated for the imaging of L. monocytogenes bacterial cells using antibodies directed 
against InLA, a ready accessible cell surface protein on L. monocytogenes. The 
multicolour sensitivity of quantum dots makes them ideal for the analysis of complex 
samples using immunostaining techmques, (Wang et al., 2004; Jaiswal et al., 2003 and 
2004). The main advantage of quantum dots for the ~mmunostaining of bacterial cells is 
the ab~lity to multiplex without the need for multiple excitation sources, thus facilitating 
double or even triple immnnostaining of the cells. Whole L monocytogenes cells were 
imaged using biotinylated anti-InlA monoclonal antibody tagged with streptavidin-linked 
quantum dols. This method was then compared to both FITC and Cy 5 staining (Section 
4.5). The superior optical properties of quantum dots as imaging molecules was apparent 
when compared with these organic probes and the studies presented here show that 
quantum dots do have potential for use in imaging applications. However, only when the 
s~gnificant concerns regarding quantum dot stability and toxicity are fully addressed, will 
it be possible to fully assess their potential for use in fluorescence-based immunoassays. 
The most commonly used detection methods for L. monocytogenes to date, include 
culture, biochemical testing, ELISA and nucleic acid amplification (Dunbar et al., 2003). 
The majority of assays for detection are cell-based giving the value of L. monocytogenes 
whole cells in the sample. Dunbar et al. describe the use of microsphere-associated 
fluorescence-based detection of L monocytogenes cells using a Luminexm LabMAP 
microsphere system. L i t s  of detection achieved are 10~110~ genome equivalents for L. 
monocytogenes. The most common high-throughput screening system for detection of 
L.monocytogenes in food samples is the mini-VIDAS L. monocytogenes (LMO), (Mena 
et al., 2004), where antibodies specific for the bacteria are used in an enzyme-linked 
fluorescence-based irnmunoassay. These methods were useful for determining the 
number of L. monocytogenes cells in a sample and, therefore, are unsuitable for direct 
comparison to the assay sensitivities reported in this chapter for the detection of InlB. 
However, by employing internalin protelns and associated antibodies in immunoassay 
development, alternative strategies for detection are created. This is an important 
breakthrough as the use of L monocytogenes-associated proteins eliminates the need to 
culture and handle dangerous pathogenic whole cells, when characterising novel 
immunoassay formats. Overall, it was demonstrated that anti-InlB antibodies and 
recombmant lnlB fragments, could be used to generate specific assays for the detection of 
L. monocytogenes cell surface proteins. The use of avidin-linked fluorescent labels such 
as quantum dots and plathum-porphyrin dye was demonstrated for the detection of InlB 
in plate-based assays, while Cy5 was successfully used for the detection of both InlA and 
InlB in both chip-based and immunostaimng formats. 
Nanopa~ticles are highly complex, spectroscopically tailored tags that improve assay 
sensitivity, reproducibility and multiplexing capabilities, therefore, their potential use as 
labels for fluorescence-based detection was examined. Silica nanoparticles were doped 
with ruthenium dye for use in fluorescence-based assays for the detection of human IgG 
(Section 4.6). Antibody nanoparticles were prepared using methods adapted from Santra 
et al. (2001),   an^ et al. (2004) and Qhobosheane et al. (2001) by amino-modification 
using APTES and glutaraldehyde crosslinking. The antibody-coated nanoparticles were 
utilised in a sandwich assay formats for the detection of human IgG and directly 
compared with an assay using ruthenium-labeled anti-human IgG. The dye-doped 
nanoparticles demonstrate a huge potential for improved fluorescence-based 
immunoassays with doped particles between 20,000-40,000 times brighter than their 
constituent dye. Comparison of the antibody-conjugated particles to dye-conjugated 
anhbodies in a sandwich assay format for the detection of human IgG, gave normalised 
fluorescent signals up to 60 times brighter than the rnthenium dye-conjugated antibodies. 
Limits of detection of 1.3 pglrnl and 84 pg/ml (Table 4.3, were determined for the 
nanopamcles and ruthenium dye, respectively. The target detection limits were calculated 
using the 3 sigma method (mean of blank plus 3 x SD). 
These results were better than the findings of Lian et al. (2004) who reported on the use 
of nanoparticles in immunoassays for the detection of human IgG using similar doped 
nanoparticles, fabricated in a comparable manner. They achieved a LOD of 1.9ng/ml for 
the detection of human IgG using FlTC-doped nanoparticles. This suggests that the 
mthenium dye-doped nanoparticles presented in this chapter are far superior to the 
particles described by Lian and co-workers. They have wide-ranging potential in the 
Future of fluorescence-based detection, w~th  improved detection hmits, reduced 
photobleaching and increased sensitivity. 
Lian et al. (2004) however, did demonstrate the use of doped particles in both solid-phase 
and blochip applications. The applicatlous of nanoparticles in immunoassay formats 
included direct and indirect biding assays for the detection hIgG, using avldin 
nanopartlcles in direct comparison with Texas red and quantum dots. Lian et al. also 
investigated the use of nanoparticles in a protein microarray application with high 
detection sensitivity reported. The man advantages of these probes over conventional 
small organic dyes and luminescent quantum dots is their ease of preparation, small lot to 
lot variability (as was significantly observed with commercial quantum dots) high 
functionality for biomolecule attachment, good photostability and absence of toxic 
constituent materials (as with quantum dots). Therefore, the potential applications of dye- 
doped nanoparticles are endless and the integration of this technology with chip-based 
detection methods should dramatically increase assay sensitivity even further. 
The use of novel fluorescent probes for the detection of a hapten, namely warfarin, the 
ninth most prescribed drug in the world, was also investigated. Fluorescence-based 
immunoassays for the detection of warfarin were demonstrated using quantum dots and 
porphyrin as fluorescent labels (Section 4.4). The fluorescence-based immunoassays for 
the detection of warfarin were not as sensitive as conventional ELISA techniques. The 
limit of detection of free warfarin in ELISA was found to be 1.5ngIml (Fitzpatrick and 
O'Kennedy, 2004). However, in the fluorescence-based immunoassays; the linnts of 
detection were 20lng/ml and 221ng/ml (Table 4.9, respectively, for quantum dots and 
porphyrin. Problems were encountered with quantum dot stability (as before) and this 
could have led to decreased assay sensitivities. Issues w~th  the protein-drug conjugate 
(warfarin-BSA) were also experienced which also could have also had an effect on assay 
performance. Frozen stocks of warfarin-BSA were thawed unintentionally (when a 
h.eezer defrosted), wluch affected the functionahty of the conjugate. Preparation of fresh 
warfarin-BSA was unsuccessful due to limitations in conjugate characterisation. 
However, these assays did demonstrate the potential of novel labels for the fluorescence- 
based detection of haptens and assay sensitivities could be improved through more 
efficient biotinylation of the monoclonal antibody or fresh preparation of the drug- 
conjugate. The use of more stable fluorescent labels such as dye-doped nanoparticles in 
association with the biochip cone platforms, described in Sections 4.3.5 and 4.7, could 
provide more sensitive fluorescence-based detechon of warfarin, in line with the assay 
sensttivities previously established using ELISA and Biacore @tzpahick and 
O'Kennedy, 2004). 
Chip-based methods for the detection of Parvovirus B19 capsid protein VP2 were 
examined in association with an &strial p m e r  (Biotriu International Ltd. Dublin). 
The immobilisation of biomolecules on chip surfaces was investigated for the 
development of chipbased assays for the detection of parvovirus B19 (Section 4.7). 
Successful optimisation of biomolecule immobilisahon on polymer chips was achieved 
using HRP and various surface modification techniques (Section 4.7.7). Transfer of an 
enzyme-based assay for the detection of Parvovirus B19 capsid protein VP2, from plate 
to chip was demonstrated. Fluorescence and chemiluminescence-based detection of the 
VP2 capsid protein on chip platforms was not successful. Problems with detection set-up 
were encountered, however, proof of principle showing fluorescent detection of 
immobilised anti-VP2 antibody was shown. The fluorescent signal strengths from 
antibody immobilised on the cone parts of the chip and traced with fluorescent dye, were 
significantly higher than the same reagents immobilised on the planar surface of the chip. 
This demonstrates the potential of these cone-based platforms for use in biochip 
apphcations, whereby comparison of fluorescent signal from cones to planar surfaces 
showed a clear enhancement of collected fluorescence (Blue et al., 2005). Further 
improvements to cone platforms and detection set up will enable this technology to 
become a useful tool for biochip applications. Significant developments have been 
ongoing within the NCSR to further improve the optical enhancement structures. These 
have included changes in the material used for fabrication, in the design of the cone to a 
parabaloidal structure, increasing the light collection efficiency stdl further, and 
improved precision in fabrication leading to better defined optical performance. Work is 
also underway to Improve the optical detechon set-up, which would enable the use of 
novel fluorophores such as nanoparticles in the chip-based systems. 
Future trends in fluorescent-based detection of biological molecules lie with a number of 
emergmg technologies that comh~ne nanotechnology with biomolecules for biochemical 
analysis. In this chapter, novel approaches for the enhanced fluorescence-based detection 
of molecules were examine4 utilising ~mproved reagents, novel probes and superior 
fluorescence capture systems. The benefits obtained through the use of novel labels on 
classical microtitre plates were presented and discussed and preliminary studies showing 
the application and potential transfer of these labels to protein biochips were also shown. 
Labels with better spectral properties including greater photostability, solubility in 
aqueous solution and high brightness (such as those described in this chapter) will play an 
important role in the future of munodetection. The development of polymer biochips 
with cone structures for enhanced fluorescence capture will also have a significant 
influence in the area of fluorescence-based analysis. However, the approaches presented 
here are still in an early phase of development, and considerable improvements m 
sensitivity and limit of detection can be expected with further study and development. It 
is expected that improved labels and chip-based technologies will revolntionise 
biochemical analysis and the future of clinical diagnostics. 
Chapter 5: 
The deveBopmeant of a 61abele~~' 
immunosennsor ffor the detection of 
L.monocytogenes cell surface protein 
fragment, h l B  F3 
5.1 Introduction 
Immunosensing devices transduce antigen-antibody interactions into drectly 
measurable signals and allow smple, rapid and sensitive quantification of analytes in 
biologxally complex samples (Byfield and Abuknesha, 1994). These devices 
incorporate either antigen or antibody at the sensor surface and subsequent probing 
with the opposite form, results in a highly specific immuuocomplex. There are two 
main types of immunosensors; direct and indirect. Indiuect immunosensors employ 
labels (fluorescent tags, enzymes, radio-isotopes, etc.), whereas direct methods are 
'label-free'. The main difference between these sensor types is that direct 
immunosensors detect physical changes during immunocomplex formation, whereas, 
indirect immunosensors use signal generating labels that allow sensitive detection of 
the complex. In simple terms, labelled immunosensors are based on the direct 
detectlon of a specific label, whereas unlabelled types rely on a change in physical 
properties. The use of labels can often result in longer analysis times, with extra steps 
required, thus increasing the complexity of the procedure. Enzymes and fluorescent 
tags are by far the most commonly used components in indirect biosensors, whereas 
most affiity sensors are based on ant~bodies. The theory and background of the 
development of basic biosensors and immunosensors was discussed m Chapter 1. 
Here a more detailed account of affinity-based immunosensors is presented, in 
relatton to an impedance-based sensor, developed for the detection of Intemahn B. 
5.1.1 Affdty  Sensors 
Affinity sensors detect the binding events occurring at sensor surfaces. They are 
excellent tools for the biosensing of blologcally important reactions and subsequent 
detecuon of analytes in complex matrices (Tijssen, 1985). Affinity sensors are 
generally ligand-based solid-state devices, in which munochemical reactions are 
coupled to a transducer (Buerk, 1993). The fundamental basis of these sensors is the 
specificity of the molecular recognition of antigens by antibodies to form a stable 
complex, whereby the binding of such a complex is monitored electrochemically or 
optically (Mullett et al., 2000; Skottrup et al., 2007; Pohanka et al., 2007). The 
biologcal component in affinity immunosensors (either antibody or antigen) can be 
immobilised at the sensor surface via a number of methods, as shown m Table 5.1. 
Table 5.1 Methods of immobilisation of biological components at biosensing surfaces 
dnectly adsorbed onto a 
Biological component is 
antibody within polymer 
trapped within a matrix. 
Microencapsulat~on monolayers to entrap 
Covalent Attachment immobilise antibodies on 
surface via a senes of 
polymer chip surfaces. 
ovalent chemical bonds. 
chemically bonded to the 
of antibodies on polymer 
sensor sluface via use of 
The other vltal element in bioaffmty immunosensor fabrication is the type of detector 
involved. The direct detection of bioaffinity reactions can be performed with 
piezoelectric, optical, and electrochemical transduction methods (Dong et al., 2000; 
Sadik e t  al., 2002; Slavlk et al., 2002). Electrochemcal transducers are most popular 
for affinity-based immunosensors and include potentiometric, amperometric and 
conductimetnc devices 
The selectivity of an immunosensor is based on the unique relationship between 
antibodies and their corresponding antigens. Antibodies bind specifically with their 
respective antigen providing ultra-high sensitivity and selectivity for immunosensors. 
The bondmg between antigens and antibod~es is dependent on a number of forces 
such as hydrogen bonds, hydrophobic bonds, electrostatic forces, and Van der Waals 
interactions While these are all bonds of a weak, non-covalent nature, the 
associations between antigen and antibody can be quite strong. Antigens can exhibit 
mulhvalency, either through the existence of multiple copies of the same epitope or 
through the presence of mulhple epitopes, which are recognized by multiple 
antibodies. Interactions involving multivalency produce more stabilized complexes; 
however, multivalency can also result in steric hindrances, which can reduce the 
possibility for binding (Benjanum, 2000). All antigen-antibody binding follows the 
basic thermodynamic principles of a reversible bimolecular interaction. The affinity 
constant KA is determined as follows: 
Equation 5.1 KA = [Ab-Ag] 1 [Ab]*[Ag] 
Where [Ab] and [Ag] are the molar concentrations of unoccupied bindmg sites on the 
antibody and antigen respectively, and [Ab-Ag] is the molar concentration of the 
antibody-antigen complex. The tlme taken to reach equilibrium is dependent on the 
rate of diffusion and the affinity of the antibody for the antigen, and can vary widely 
(Aalberse et al., 2001). The affinity constant for antibody-antigen binding can span a 
wide range, extending between lo5 mol-' to 10" mol-' and can be affected by a 
number of factors such as the temperature, pH and solvent. 
5.1.2 Probing biomolecular interactions by impedance spectroscopy. 
Bloelectronics is a rapidly progressmg field that employs principles and techniques 
from chemistry, biochemistry, physics and materials science (Willner, 2002). The 
main features of a bloelectro~c device include a conductive or semiconductive 
support for biomolecnle immobilisation ,and an electronic transducer for processing of 
the biological functions occurring at the inte~face. Biomolecules that can be integrated 
with electronic transducers include proteins such as enzymes (Willner and Katz, 2000; 
Momn et al., 2003), receptors (Goepel and Heiduschka, 1995) antibodies or antigens 
(Rogers, 2000), oligonucleotides or DNA fragments (Yang et al., 1997; Davis and 
Wgson, 2005), or low molecular weight molecules exhibiting affinity interactions 
with other biomaterials such as biotio (Anzai ef  al., 1998). There are a number of 
different electronic methods that can be employed to transduce the biological 
functions occumng at the electronic suppoas (Sethi, 1994). These include electrical 
transduction such as current (Xu et al., 2006), potenual changes (Ghindiis and 
Kurochkin, 1994), piezoelectric transduction (Ben Dov et al., 1997), field effect 
transistor transduction (Zayats et aL, 2000), photoelectrochemical transduction 
(Fardo-Yissar et al., 2003) and others such as surface plasmon resonance (Liedberg et 
al., 1995; Jordan and Corn, 1997; Raitman et al., 2002). 
Electrochemical immunosensors are used extensively for the direct detection of 
antibody-antigen interactions. Then main advantages are that they are non-ivasive 
and require little sample pre-treatment (Grant et al., 2003). Electrochemical 
immunosensors involve the formation of a recognition complex between the sensing 
biomaterial and the analyte under investigation in a monolayer or thin-film 
configuration on an electronic transducer (Khantonov et al., 2000; Ouerghi et al., 
2002, Davis and Higson, 2005). The formation of a complex on a conductive or semi- 
conducbve surface may alter the capacitance and the resistance at the surface- 
electrolyte interface (Katz and Willner, 2003) and-this can be exploited to determine 
the concentration of the required analyte. 
Impedance spectroscopy is a powerful tool for the analysis of the interfacial property 
changes of modified electrodes, upon the occurrence of biorecognition events at 
modified surfaces (Gum et al., 2004). The imrnobilisation of biomolecules at 
electrode or semiconductor surfaces alters both the capacitance and interfacial 
electron transfer resistance of the surface (Berggren and Johansson, 1997). Impedance 
spectroscopy permits analysis of the changes occumng, that onginate from the 
underlying biorecognition events. Thus, impedance spectroscopy (Nahir and 
Bowden, 1996; Pejcic and DeMarco, 2006), including non-Faradaic impedance 
measurements resulting in capacitance sensing (Bart et al., 2005), is becoming an 
attractive electrochemical tool to charactense biomaterial f h s  assocrated with 
electromc elements. 
5.1.3 Immunosensors Based on Impedance Spectroscopy 
Impedance spectroscopy 1s a useful electrochemical tool for the characterisation of 
biologcal tbm-films involved in the transduction of biomolecular interactions at 
electrode surfaces (Ameur et al., 1997; Sargent and Sadii  1999). Electrical 
Impedance Spectroscopy (EIS) methods can be employed to investigate 'labeless' 
detection of analytes via impedimehic transduction. Several methodologies for the 
electrochemical transduction of antibody-antigen binding on modified electrode 
surfaces have been reported (Sadik et al., 2002; Grant et al., 2005). 
Conductive polymers are excellent platforms for the immobilisation of b~omolecules 
at electrodes. Sargent and Sadik, (1999) have investigated the binding mechanisms of 
antibody-antigen interactions on conducting polypyrrole films using impedance 
spectroscopy While the charge transfer mechanisms are yet to be fully understood, it 
has been accepted now for sometime that antibody-antigen affinity associations'may 
be momtored electrochemically via AC and other current transient approaches (Grant 
et al., 2003 and 2005). Concentration-dependent impedance measurements are based 
on the theory of charge-generation and transportation at the polymer interface. This is 
due to the fact that proteins in solution act as polyelectrolytes and hence, as an 
ant~body is a protein, its electrical charge will be affected on binding an antigen 
(Prasad and Lal, 1999). The impedance of the system increases as antigen 
concentrations are increased, especially at lower frequencies (Katz et al., 1998). The 
imped~metnc response of an antibody-loaded film may be represented as either a 
Bode or Nyquist plot. A Bode plot shows the module of impedance of the system 
versus frequency and is indicative of the overall result. A Nyquist plot however, 
illustrates the real impedance of the system vs. the imaginary components 
(Kharitonov et al., 2000). Although several processes can contribute to both the real 
and imaginary components, in most cases it can be assumed that 2' corresponds to 
charge transfer processes while Z" refers to the capacitive component (Katz et al., 
2001). The typical shape of a faradaic impedance spectrum can be presented in the 
form of a Nyquist plot (Figure 5.1). 
Figure 5.1 Schematic Faradaic impedance spectra presented in the form of a Nyquist 
plot. (a) A mod~fied electrode where the impedance is controlled by difusron of the 
redox probe (low frequencies) and by the interfacial electron transfer (high 
frequencies). (b) A mod@ed electrode where the impedance rs marnly controlled by 
difislon of the redox probe. (c) A modified electrode where the impedance is 
controlled by the interfacial electron transfer within the entire range of the applied 
frequencies. The arrow shows the direction of the frequency increase. 
A classical Nyqlust plot consists of a semicircle region representing the capacitive 
component and a straight line with a slope of 45" that indicates the contribution made 
by the resistive component to the total impedance of the circuit, as shown in Figure 
5.1, curve a. The semcircular portion is normally observed at higher frequencles and 
corresponds to electron transfer-limited processes; the linear part, however, is 
charactenstic of the lower frequency ranges and corresponds to electrochemical 
processes that are diffusionally limted (Brett and Oliveira Brett, 1993). When 
electron transfer processes are fast, the impedance spectrum changes to Include only 
the linear part, curve b, whereas a slow electron-transfer step is represented by a large 
semicircle region with no straight line, curve c. The electron transfer lanetics and 
diffusional characteristics can be extracted from the spectra. The semicircle diameter 
equals to the electron transfer resistance Re,. The intercept of the semicucle with the 
Z'axls at high frequencies (w 3 oa) is equal to the solution resistance; R,. 
Extrapolation of the circle to lower frequencies yields an intercept corresponding to R, 
+ R,. Eqluvalent clrcuits are often included to help illustrate this; however, an 
equivalent circuit is not included here, since due to the complexity of the 
polymerlantibodylantigen interachon, many equivalent circuits could be equally valid. 
Once antigen is introduced to the system and binding occurs at the polymer interface, 
the shape of the Nyquist plot become more difficult to interpret. Both the real (Z') and 
imagnary ( Z )  components tend to increase as antigen concentrahon increases, with 
the increases in the real component dominating the total increase in impedance, i.e. 
the faradaic component of the impedance increases more dramatically and is 
frequency independent (Ameur et al., 1997). This principle forms the basis of the 
'labeless'-immunosensor described here. 
One of the most important parameters governing the technique is the applied 
frequency. At low frequencles (f<lmHz), the impedance value is basically determined 
by the DC-conductivity of the electrolyte solution. At high frequencies (f >1001cHz), 
inductance of the electrochemcal cell and connechng wires could contribute to the 
unpedance spectra. Thus, the analytically meaningful impedance spectra are usually 
recorded at frequencies where they are mainly controlled by the interfacial properties 
of the modified electrodes (lOmHzq<lOOkHz). 
InlB contains four distinct domans, s M a r  to the other members of the internalin 
family. This division of the recombrnant protein into smaller truncated sectlons F3, F4 
and F5, (Tully et al., 2006) facilitated expression of only the most innnunoreactive 
portion of the recombinant proteln for immunosensing applications. The fragment F3 
comprises of the N-terminal signal sequence, cap domain and 'Leucine-rich' repeat 
(LRR)-domain and was chosen as the target antlgeu for the development of an affimty 
sensor for the detection of InlB. The recombinant InlB F3 fragment was used in 
conjunction w~th an anti-InlB polyclonal antibody, for the development of a labeless, 
impedimetric immuuosensor. Labeless affinity sensors are a new generation of 
biosensors and address a number of problems associated with the rapid dlagnosls of 
food-borne pathogens by allowing cost-effective, specific and sensitive detection. 
5.1.4 Electroactive Polymers 
In order to produce conductive surfaces suitable for biomolecule attachment at the 
electrode, electroachve polymers are employed. These include, but are not limited to, 
polyacetylene, polypyrrole, polythiophene and polyaniline (Eggins, 1996; Lillie et al., 
2001; Li et al., 2005). These conducting polymers are easily prepared by the 
electrochemical oxldation of the substrate at the electrode surface (Ramanavicius et 
al., 2006). Factors which influence the suitability of a particular polymer for sensor 
applicahons are the type of solvent used and the counter anion in the solution, both of 
which can have a major effect on the polymer's conducting properties. The 
electrically conductmg polymer p o l y d n e  was used to develop the sensor surfaces 
for the labeless detection of Internalin B described here. Polyaniline exists in three 
well-defhed oxidation states: leucoemeraldine, emeraldine and permgra~hne, as 
shown in Figure 5.2. 
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Figure 5.2 Generahsed Scheme of the oxidatcve and non-oxzdatrve doping of 
polyaniline: n, number of aniline units, m = 411, (adapted from Eggins, 1996). 
The accepted mechanism for the electropolymerisahon of aniline (Eggins, 1996) is 
illustrated in Figure 5.2. The formation of the radical cation of aniline oxidation on 
the electrode surface is considered to be the rate determining step. This is followed by 
the coupling of radicals and the elimination of protons. The dimer formed undergoes 
oxidation on the electrode surface, along with aniline. The radical cation of the dlmer 
couples with the aniline radical cation, resulting in propagation of the chain. The 
polymer formed is doped by the acid present m the solution. Leucoemeraldine and 
p e n u r n l i n e  represent the fully reduced and fully oxidised forms, respectively. In 
emeraldine the ratio of amine to innne rntrogen atoms is -0.5. Electrically conducting 
emeraldine is produced either by standard chemical or electrochemical oxidation. 
During electrochemical polymerisahon at pH 1.0, aniline is formed as its electrically 
conductive emeraldine form. Conduchng polymers are those that permit some 
electrical conduchvity in at least one redox state (Grennan et al., 2006). The polymer 
may be oxidised or reduced, so the conductivity of the polymer depends on its redox 
state. Polyaniline has three redox states, as shown in Figure 5.2 whch permt the 
polymer to exhibit either reasonable conductivity or insulating behavionr via its 
polarisation. Polyaniline is easily electropolymerised from an aqueous solution of 
aniline monomer. Biomolecules may be lmmobilised within the polymhne (PAM) 
matrix and for the purposes of this research anti-InlB antibodies have been 
innnobiiised within PANI via an avidm-biotin coupling method (Cui et a l ,  2003; 
Dong et al., 2004). Although only minute quantities of the biological component 
(antibody) are required, higher punty offers greater reliabihty (Turner et al., 1989) 
and so a highly concentrated and pure sample of antibody is necessary. 
5.1.5 Chapter Outline 
The main objective of this chapter was to explore the development a labeless affinity 
biosensor for the rapid detection of Internalin B, a cell surface protein of the bacterial 
pathogen, Listeria rnonocytogenes. The methods utilised include electrochemical 
polymerisation and biohn-avidin coupling for site-specific unmobilisation of 
antibodies onto specialised bio-modified surfaces. An anti-InlB polyclonal antibody 
was used for the development of 'labeless' itmnnnosensor for the detection of 
Internalin B. The anti-InlB polyclonal antibody was specifically immobilised at the 
electrode surface via a senes of surface mo&fication steps. The sensors were then 
probed with varying concentrations of InlB antigen (F3 fragment) and impedimetric 
responses recorded. An anti-IgG antibody was also immobihsed at electrode surfaces, 
as a control and subsequently exposed to the same concentrations of InlB antigen. 
Impedimetric data for the control sensors were also recorded. The antibohes act as 
the capture biocomponents for the antigen under investigation. They are used for 
impedimetric investigahons into the binding event and associated processes, using the 
concepts described by Grant et a!. (2003), to obtain affinity binding and signal 
transduchon processing for the electrode platform assemblies. Complex plane 
impedance analyses were used to relate the differing redox states of the polymer to 
possible charge transfer mechanisms occurring at the interface and to explain how 
these may be used to modulate the impedance of the polymer. The planar electrodes 
and impedimetnc detection methods were subjected to reproducibility and control 
analysis studies for assay validation. 
5.2 Labeless af6inity sensing of Internalin B 
5.2.1 Eleetmchemieal deposition of Polyaniline (PAM) at sensor d a c e  
The electrochemical f o d o n  of polymer layers of controlled thickness at electrode 
surfaces via potentiometric deposition, gives rise to a reproducible method for 
biosensor fabrication. In this case, polyaniline (PANI) was used, as it can be easily 
electropolymerised from an aqueous solution of aniline monomer. Potenticdynamic 
cyclic voltammetry was employed and PAM was laid down as a planar thin-fih over 
the working electrode of a carbon sensor as described in Section 2.11.3 (and by 
Barton et aL, 2004). A typical cyclic voltammogram for the electrodeposition of 
plyaniline (PANI) is shown in figure 5.3. The working electrode potential was 
scanned from -200mV to +800mV (vs. Ag/AgCl) at a sweep rate of 50 mV/s. The 
buffer species, cycle number and polymerisation time were investigated to determine 
the most efficient and reproducible method for polymerisation of the PANI films. 
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Figure 5.3 W l i c  voliimnmgram showing the potentiodynmnic eelectmdepositian of 
polyaniline (PANI) m a thin-Jilm on planar carbon screen-printed electrodes. The 
working electrode potential was scanned from -200mV to 800mV (vs. Ag/AgCl) and 
peak increases in anodic and cathodic curren% tmnsients were recorded 
Peak increases in both anodic and cathod~c current transients were insignificant after 
15 cycles, indicating that optlmnm conduchve deposition had occurred and the 
polymerisation was complete within ten minutes (Barton et ul., 2004). The controlled 
potential electrolysis of an aqueous soluhon containing monomers produces a suitable 
surface for antibody immobilisation. The main advantage of electrochemical 
polymensation is that films can be prepared easlly in a rapid one-step procedure. 
Furthermore, this method enables exact control of the thickness of the polymer layer 
based on the measurement of the electrical charge passed during the electrochemical 
polymerisation. 
The exact mechanism of polymerisation 1s not fully understood and many authors 
have reported possible mechanisms (Gospodinova and Terlernezyan, 1998; Losito et 
al., 2001,). Anodic polymerisation is, however, known to proceed via a two-electron 
oxldation (Losito et al., 2001). The electropolymerisation of PANI is a self-regulating 
process smce PANl is an insulahng polymer and so the workmg electrodes become 
fully insulated after 15 potential sweeps. This limits the deposition of fuaher polymer, 
thus regulating the final thickness of the film. 
Electrochemical polymerisation 1s generally carried out in an acidic aqueous solution 
of amline. A low pH is required to solub~lise the monomer and generate emeraldme 
salt, the conducting form of polyanilme (Eggins, 1996). Constant potential or 
potentiodynamic techn~ques are employed since the over-oxidation potential for PANI 
is close to that required for monomer oxidation. A short-term increase of the applied 
potential to 800mV (vs. AgIAgCl) during deposition was reported to @ve more 
adherent films (Barbero et al., 1993) and therefore is utilised in this case. The growth 
of PAN1 is self-catalysing, whereby the greater the amount of polymer deposited at 
the surface, the higher the rate of polymer formation. The mechanism for this, as 
described by Zotti et ul. (1998), lnvolves the adsorpt~on of the anilininm ion onto the 
most oxidised form of PANI, followed by electron transfer to form the radical cation 
and subsequent reoxidahon of the polymer in its most oximsed state. During the 
electrochemical polymerisation at pH 1.0, aniline is formed as the electrically 
conductible emeraldine form. 
5.2.2 Preparation of biomolecules for affinity immobilisation 
Antibody biotinylatlon was performed pnor to all other sensor fabncation steps and 
the biotinylated antibodies were stored frozen in working aliquots of lmglml at -20°C. 
To remove sodium azide preservative, the antibody was subjected to gel-filtration 
using a Sephadex (G25) gel-filtration column prior to protem labelhug, since sodium 
avde can have an adverse effect on the biotinylation of antibodies. 
The avidin-biotin system provides a powerful tool for research and analysis due to the 
specific and high affinity (Ka = 10 l5 M -I)  interaction between avidin and biotin. 
Biotinylated antibodies, enzymes and other biological molecules are increasingly used 
as highly specific probes in immunolog~cd methods (Heggeness and Ash, 1977; 
Gretch et al., 1987; Wilchek and Bayer, 1988,). There are a number of commercial 
products and techniques aviulable for the simple biotinylation of biological molecules. 
One of the most reliable commercially available kits is the ImmunoProbeTM 
Biotinylatiou kit from Sigma. This kit can be used to prepare blotin-labelled 
polyclonal and monoclonal antibodies for use in a wide variety of applications such as 
ELISA, immunoblotting, immunohistochemistry and other immunosensing 
techniques. This kit may also be used for conjugation of biotin to other proteins, 
peptides, hormones or cytokines. 
Biotinylation is often performed with N-hydroxysuccinimide WHS) esters of biotin or 
biotinamdohexanoic acid (BAC), (Wilchek and Bayer, 1988). The extended spacer 
arm from the hexanoic acid greatly improves the Interaction behveen avidin and the 
biotinylated macromolecules by overcoming steric hindrance present at the biotin 
binding sites of avidin (Green, 1965). For this application using the Sigma 
ImmunoProbeTM Kit, biohnylation was performed with BAC-SnlfoNHS, (Section 
2.5.2.2). Sulphonation of the hydroxysuccinimide increases the polarity of the 
reagent, allowing it to dssolve easily in aqueous buffer. The ester provides a carbonyl 
carbon adjacent to the ester linkage, as a target for primary amine side-chains of 
accessible lysine residues, which joins the biotinamidocaproate to the protein via an 
amide bond (Immunoprobe biotinylation kit bulletin, Sigma). This derivative is 
soluble m water and biotinylation proceeds at near neutral pH values The reagent is 
part~cularly useful when mild reaction conditions are required, for the biotinylatlon of 
sensitive biomolecules such as antibodies, enzymes and cell surface protems (Gretch 
et al., 1987). Following the labelling reaction, the biotinylated protein was separated 
from unreacted or hydrolysed reagent by a fast-gel filtration step, using a PD-10 
desalting column (Amersham Pharmacia). The column, prepacked with Sephadex G- 
25, was used for the separation of unreacted BAC-SulfoNHS and buffer exchange. 
The column with a bed volume of 9.lml and a bed height is 5 cm was pre-swollen in 
water containing 0.1% (wlv) KathonB CG as preservative. Figure 5.4 shows the 
elution profile of the biotinylated anti-InlB antibody, using lOml of PBS (0.15M 
NaCl, 2.5mM KCl, lOmM NazHP04, 18mM KHzPO* pH 7.4), collected in lml 
frachons. The protein content of each fraction was momtored by measuring 
absorbance at 280 nm and the fractions containing protein were pooled (Fractions 3- 
7). 
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Figure 5.4 Elution profile of biotinylated anti-lnlB polyclonal antibody following 
separation of unreacted biotin by fast-gel filtration using a PD-I0 desalting column 
(bed volume of 9.Iml and bed height of 5 cm). Elutron was pelformed using PBS 
(0.15M NaCl, 2.5mM KCI, lOmM NazHPOd, 18mM KHzPOd, pH 7.4) and 10 x lml 
fractrons were collected. The protezn content of each fraction was determrned by 
measuring the absorbance at 280nm and the fractions containing the majority of the 
biotinylated antibody (Fractions 3-7) were pooled for calculation of brotrn content 
using the avidin-HABA assay. 
The extent of biotinylated protein and ratio of biotin to protein were determined by the 
avidin-HABA assay (Green, 1965). The absorption of avidin-HABA complex at 
500nm decreases proportionally with increased concentration of biotin as the HABA 
dye is displaced from avldin due to the lngher affimty of avidin for biotin. Using a 
ratio of BAC-Sulpho-NHSI IgG of 10.1, the level of biotin incorporation was 
detemned to be approximately 4 moles of biotin per mole of anti-InlB antibody, 
which is in line with predicted values (Innnunoprobe biotinylation kit bulletin, Sigma) 
5.2.3 Affinity immobilsatiun of antibodies within polymer films 
The major advantage of affinity immobilisation techniques is that there is no 
biomolecule present when the polymer matrix is formed PANI can thus be 
electrogenerated at the carbon sensor surface using optimum deposition conditions 
and any low pH effects on antibody are rendered irrelevant, as the antibody is 
immobilised after polymer deposition. A 0.2M aniline solution was prepared in a 
pH1.0 chloride buffer (0.5M KC1) to provlde sufficient countet-ions for 
polymerisation. Cyclic voltammetry was then performed at a scan rate of 5OmVls 
from -200mV to +800mV and back to the starting potential (vs. Ag/AgCl). A linear 
sweep from -200mV to +800mV was performed at the end of cyclic voltammetry to 
leave the polyamline in its conductive emeraldme salt form. The biotin NHS ester salt 
was prepared in deionised water at a concentration of lmg/ml. The PAM-coated 
sensors were submerged m the biotinylabng solution (30~1) for 24hours. The biotin 
coupled to the primary amines at the end of the polyaniline chain and to secondary 
amnes throughout the polymer. 
Neutravidin biotin-binding agent was prepared in de-ionised water at a concentration 
of IOug/ml. The neutravidln (30fl) was added to the working electrodes of the 
biotmylated sensors, by pipetting, and left to incubate for 1 hour (Section 2.11.4) The 
sensors were then thoroughly flushed with de-ionised water to remove any non- 
specifically weakly absorbed matter. The biotinylated antibody at a concentration of 
Img/ml was defrosted and the sensor working electrodes were covered in the antibody 
solution (100fl) for another 1 hour period. De-lonised water was then used again to 
thoroughly flush the sensors and remove any non-specifically bound antibody at the 
end of the exposure 
Avidin-biotin attachment bridges were formed on the polymer films, by taking 
advantage of the strong specific biological interactions between avidin and biotin 
(Ouerghi et al., 2002; Dong et al., 2004). Biotinylated antibodies were specifically 
coupled to the biotinylated polymer films via neutravidin. This method allowed 
controlled immobilisation of biomolecules at the sensor surface. A schematic 
representation of the irnmobilisation approach is illustrated in Figure 5.5. 
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figure 5.5 Schematic representation of biomolecule immobilisation onto polyaniline 
(PANI) sensor surfaces via biotin-avidin coupling. Biotinylated antibodies, both 
sample (anti-InlB antibody) and control (anti-lgG antibody) were speczj?cally coupled 
to the biotinylatedpolymer (polyani1ine)films using the avidin derivative neutravidin, 
which formed avidin-biotin bridges. This method allowed controlled immobilisation 
of biomolecules at the sensor su$ace. 
This approach for antibody immobilisation provides orientation-specific attachment of 
a monolayer of antibodies at the surface of the polyaniline film Optimum deposition 
criteria can be utilised for polyaniline electrogeneration (low pH), since the antibody 
is immobilised post-PAN1 deposition, and therefore, antibody attachment can occur at 
neutraI pH. In order to reduce any non-specific binding effects, BSA blocking 
solution was prepared at a concentration of 10% in de-ionised water and the 
electrode surfaces were submerged in this solution, for 1 hour at mom temperature. 
BSA does not contain endogenous biotin and therefore is compatible for use in 
biotidavidin systems as a blocking agent. 
5.2.4 Electrochemical impedance interrogation of PANI thin-6lm carbon 
electrode platforms 
Following electropolymerisation of the sensor surfaces with PANI, the electrodes 
were modified as descnhed in SectLon 2.11.4 and sample and control antibodies were 
site-specifically coupled to the sensors as per Section 2.11.5. Impedimettic data were 
collected for the InlB-doped sensor between 10,000Hz -1Hz in PBS (0.15M NaC1, 
2.5mM KCl, l0mM NazHP04, 18mM KHzPO* pH 7.4) i.e. buffer containing no 
antigen, as a baseline trace. Four sensors were used for each experiment (two sample 
and two control) and each sensor was interrogated in triplicate for reproducibility 
analysis (six replicates in total). After 30 mnntes exposure to buffer alone (baseline 
trace), the sensor was flushed thoroughly with 50ml of PBS (as above) and the 
impedance spectrum was recorded. This sensor was then exposed to increasing 
antigen (1-100ngIml) and the process was repeated for the full range of 
concentrations. Six-matched sensor pairings (sample and control) were evaluated at 
each concentration and the corrected responses plotted. Spectra were analysed over 
the full frequency range and for clarity represented in terms of percentage impedance 
changes from the baseline impedance trace 
The probing of the modified sensors with antigen (TnlB F3 fragment), demonstrated 
the principle of a labeless detection method for the L. monocytogenes cell surface 
protein hlB. Impedimetric data were collected for the anti-InlB-doped sensors after 
exposure to increasing antigen concentrations (lnglml-100ng/ml), as described in 
Section 2.11.6. Impedances were recorded for each InlB concentration over a range of 
frequencies from 10,000-1 Hz. For construction of a calibration curve, a frequency of 
1Hz was chosen for interrogations since this is the frequency which allowed the 
greatest changes in impedietric response to be observed. Initial examination of the 
total overall impedance (Z) of each of the films at various concentrations of InlB, 
allowed construction of a calibration curve. Three replicate measurements were 
recorded on two separate electrodes for each antigen concentration and CVs of less 
than 5% were determined (Figure.5.6). 
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Figure 5.6 Calibratzon curve of InlB concentration at IHz. The calzbration curve was 
generated as a result of exposure of an anti-InlB loaded PANT-film to increasing 
concentratzons of ZnlB (I-100ng/ml). The curve dzsplays total impedance (Z) agaznst 
InlB concentration (ng/ml). Error bars are calculatedfrom the standard deviations of 
the mean value of three replicates on two separate electrodes and CVs of less than 
5% were found 
Imtial examination of the total impedance of the anti-InlB loaded PANI thin-film 
electrodes at various concentrations of InlB (1-lOOng/ml) gave CVs of less than 5% 
and the cahbration profile showed near-linear behavionr between 1-100ng/ml. It can 
be clearly observed fiom Figure 5.6 that the anti-InlB-loaded PANI thin-film 
electrodes provide specitic recognition sites for InlB detection. Increasing changes in 
total impedance (Z) were attributed to the changes occurring at the electrodelpolymer 
interface, as a result of ~mmunocomplex formation, whereby antibody-antigen binding 
affected the electrochemical activity of the modified electrode surface. 
5.2.5 Specific recognition of MB with anti-InlB-doped sensors (sample) 
In order to differentiate between the individual components of the total unpedance of 
the system, both the capacitive and faradaic components of the composite 
impedimetric response were investigated. Electrochemical unpedance spectra 
obtained for anti-InlB-doped PANI thin-film electrodes, exposed to increasing InlB 
concentrations were presented in the form of a Nyquist plot (Figure 5.7). The Nyquist 
plot depicted the real (Z') and imaginary (Z") components of the AC impedance of the 
sensors, following exposure to InlB antigen (1 - 100nglml). 
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Figure 5.7 Nyquist plot showzng the faradaic component (Z') agaznst the capacitive 
component (2'7 for anti-lnlB-doped PANI-film on carbon electrodes, following 
exposure to vanous concentrations of InlB (1 -100ng/ml). 
From Figure 5.7 it is apparent that the real (Z') component and the imaginary (2") 
component of impedance both increased with decreasing frequency from the baseline 
trace The impedance spechum is indicative of a surface-modified electrode system 
where the electron transfer is slow. However, Figure 5.7 also shows that the increase 
in the real component (Z') dominated the total increase in impedance. It can therefore 
be deduced that a charge-transfer mechanism between the antibodylantigen had 
occurred, since a response corresponding to a change in the real component (Z') 
accounted for the largest increase in impedance observed (Stoynov, 1989; Pejcic and 
De Marco, 2006). The real component yields data that are frequency independent 
whereas the imaginary component is frequency dependent (Grant et al., 2005). The 
imagmary component (Z") decreased slowly at greater antigen concentrations 
(towards 100ng). This was expected as a change in the capacitive component is 
indicative of frequency independent changes in the conductivity of the polymer film, 
due to double layer charging effects. It was found that the Faradaic (real) component 
of the mpedmetnc response acted as the dominant component of the ac impedimetric 
response of anti-Id3 loaded PANI films on exposure to increasing concentrations of 
InlB, 
For clarity, the vector quantity impedance can also be represented in the form of a 
Bode plot (vs. log freqnency). Data were plotted for the low frequency region (10Hz 
to 1Hz) where the differences in the spectra obtained are greatest. The normalised 
impedimettic response (Z/Za) was then obtained by dividing the mean impedimetric 
response at each InlB concentration (Z) by the mean impedimetric response at zero 
InlB concentration (Zo), 1.e. the baseline signal with no antigen (Ouerghi et al., 2002). 
This gave a normalised response that can be plotted against frequency in the form of a 
Bode plot as shown in F~gure 5.8. 
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Figure 5.8 Bode plot showing the faradaic and non-faradaic changes in total 
impedance for anti-InlB-doped PANI-jilm on carbon electrodes following exposure 
to various concentrations of InlB, normalisedfrom baseline trace (m). 
The impedance of the system increased with exposure to increasing InlB antigen 
concentration from the baseline trace up to 100ng/ml. The interaction of the protein 
and the formation of stable antibodylantigen complexes could possibly account for the 
changes in the resistive and capacitive properties of the conducting polymer thin-film 
electrode. These effects were observed at frequencies lower than 10Hz. Figure 5.9 
represents the data plotted as a percentage change in impedance from the baseline 
values, in the lower frequency range (f 5 lo&), for the full range of antigen 
concentrations (1-lOOng/ml). 
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Figure 5.9 Percentage impedance change from the baseline trace for increasing 1n1B 
antigen concentrations (I-100ng/ml), in the frequency range 1- IOHz, for ZnlB 
sensors. The percentage impedance change increases for increasing InlB antigen 
concenhations between 1-1OHz. 
Figure 5.9 shows that the greatest percentage differace was obsenred at the applied 
frequency of lHz, where the range of impedance change over concentmtions from 1- 
100nglml is 21-37%. The percentage impedance change at 1Hz was used to form the 
basis of a calibration profile for differentiation of the various concentrations of InlB, 
applied to the anti-InlB-doped PANI films on carbon host electrodes. 
5.2.6 Calibration curves showing faradaic and non-faradaic response of anti- 
InlB-doped electrodes against increasing concentrations of InlB 
The percentage impedance change from the baseline at 1Hz was used to form the basis 
of a calibration profile for differentiation of vanous concentrations of InB, applied to 
anti-InlB antibody-doped PAM films on carbon planar electrodes. Figure 5.10 is the 
calibration profile obtained at 1Hz where the greatest percentage impedance Increases 
at each concentration were noted. 
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Figure 5.10 Calibration curve of InlB concentration at 1Hz. The curve was generated 
as a result of exposure of anti-lnlB-loaded PANIji lm to [ncreasing concentrations of 
ZnlB at I Hz. The curve displays the percentage change in impedance for each InlB 
concentratcon (ng/ml), normalised against the baselcne response (zero antigen). Error 
bars are calculated from the standard devzations of the mean value of three replicates 
on two separate electrodes (six replccates in total). 
The faradaic response was represented as percentage impedance change for InlB- 
doped PANI thm-film carbon electrodes, following exposure to increasing InlB 
concentrations. The mean impedance value at each concentration (2) was normalised 
agarnst the mean impedance value at zero antigen concentration i.e. Z/& (Ouergh~ et 
al., 2002). This calibration profile suggests that the technique offers a viable approach 
for the labeless impedimetnc detection and subsequent qnantrfication of InlB antigen 
F3. 
An alternative method of representing the response of the anti-InlB doped polyaniline 
coated electrodes to increasing concentrations of InlB is by observing the non- 
faradaic or capacitive response of the system. In order to successfully use the anti- 
InlB-doped PANI-coated electrodes as a capacitance-based immunosensor, the type of 
biomaterial immobilisation strategy was important. The polymer layer should be 
insulating to prevent interferences from redox couples in the electrolyle solution and 
high faradaic background currents, otherwise increases in resistive current will apply, 
thus decreasing the capacitance response (Pan, 2007). The biomolecnle 
immob~l~sation layer also needed to be as thin as possible in order to detect the tlny 
capacitance changes caused by anhbody-antigen interactions. The capacitive response 
(C) can by calculated from the imaginary ( Z )  value at the predicted characteristic 
frequency (Hays et al., 2006), using the following equation; 
Equation 5.2 
where the charactenstic frequency (0 was determined as the frequency (Hz) where the 
phase angle is closest to 90'. indicahng that the system exhibits near ideal capacitor 
behavionr (Bemey et al., 1998). For InlB-doped sensors, the characteristic frequency 
was calculated to he approximately 28 Hz, as shown in Figure 5.11 and Table 5.2. 
Figure 5.11 Plot showing frequency vs. phase angle for each concentration of InlB 
(I-lOOng/ml). The characteristic frequency, where the phase angle is closest to 90' 
was determined to be approximately 28 Hz  
The phase angle values at each antigen concentration were investigated and the 
frequencies where values were closest to 90" were examined to determine the 
characteristic kquency (Table 5.2). 
Table 5 2  Determination of characteristic fmquency for InlB-doped sensors 
In this case, a frequency of 28.48 Hz was chosen as the characteristic frequency since 
the phase angle values at this frequency were closest to 90". The non-faradaic 
response of the immunosensor was determined from this characteristic frequency 
value using Equatlon 5.2 and a calibrahon c w e  was constructed. Figure 5.12 shows 
the calibration curve for the non-faradaic capacitive response against InlB 
concentration for anti-IdB-doped PANI electrodes at the charactenstic frequency of 
28.48 Hz. 
Figure 5.12 Calibration curve of the non-faradaic capacitive response against InlB 
concentration (ng/ml) for anti-In1B-doped PANI-coated carbon electrodes at the 
characteristzc frequency of 28Hz. The characteristic frequency is the frequency where 
the phase angle is closest to 9 0 2 r r o r  bars are calculated from the standard 
deviations of the mean value of three replrcates on two separate electrodes (six 
repl~cates in total). 
5.2.7 Non-Specific recognition of InlB with anti-IgG-doped sensors (control) 
Using the same experimental procedures for InlB antigen exposure, the anti-IgG- 
doped thin-films were exposed to increasing concentrations of h l B  antigen. Control 
experiments using anti-IgG-doped electrodes were used to validate the specificity of 
the observed impedance responses for the anti-InlB-doped electrodes. Alfonta et al. 
(2001) employed this method of using a non-speclfic antibody for control sensors. 
Contlol sensors were fabricated in exactly the same way as the anti-hlB-doped 
sensors and were exposed to increasing concentrations of InlB under the same 
experimental conditions. The impedimetsic responses were then compared and 
specific impedance changes reported. Figure 5.13 shows the spectra obmned from the 
control sensors, represented in the fonn of a Nyquist plot. This graph depicts the 
faradaic and capacitive components of the AC impedance, of the control anti-IgG- 
doped PANI-films following exposure to the same concentration range of InlB antigen 
(1 -100nglml). 
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Figure 5.13 Nyquist plot showing the faradaic component (Z') agamst the capacitive 
component (Z") for anti-IgG-doped (control) PANZ-films on carbon electrodes, 
following exposure to various concenhations of InlB (1-lOOng/ml). 
The faradaic component of the Nyquist Plot (21 increased for increasing 
concentrations of InlB exposed to the control sensors. However, the signal responses 
were much lower than that of the specific respollse of Internalin B in the sample 
Nyquist plots, (Figure 5.7). Saturation of the films (as the antigen concentration 
incmased), led to a decrease in the overall impedance (Z) observed on the control 
sensors. It is possible that excess analyte could have given rise to an alternative 
condoction pathway, which in turn reduced the total impedance within the cell (Sadik 
et d, 2002). Figure 5.14 shows the normalised impedance changes ( Z I G )  from the 
baseline trace for the lower frequencies (1-lo&), for the control sensors in the fonn 
of a Bode plot. This figure for InlB recognition on anti-IgG-doped films can be 
d h A y  compared to Figure 5.8 (anti-InlB-doped films). 
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Figure 5.14 Bode plot showing the faradaic and non,faradaic changes in total 
impedance for ad-IgGdoped PAM-film on carbon electrodes following exposure to 
various concenfratiom OflnlB, mrmalisedfrom the baseline trace (2%)). 
The Bode plot for InlB recognition on the anti-IgG-doped sensors (control) followed a 
similar pattern to that obtained for increasing InlB concentrations on the anti-InlB 
doped sensors, ( F i i  5.8). The changes observed with respect to the baseline trace 
for the control sensors, were comparable, albeit at much smaller values, indicating that 
the impedimetric response of the control sensors was not specific. Any increases in 
impedance were due to non-specific interactions occuning at the electrode/solution 
interface and were not a result of immunocomplex formation. Figure 5.15 depicts the 
percentage impedance changes from the baseline trace for the control sensors. The 
values of the specific responses obtained from the anti-InlB-doped sensors, where a 
percentage change of 17% was reported, were greater than the control results (8%) 
and as such differentiation between the two were possible. 
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Figure 5.15 Percentage impedance change from the baseline trace for increasing InlB 
antigen concentration in the frequency range I-IOHz, for IgG (control) sensors. The 
percentage zmpedance change increases for zncreasing InlB antigen concentrations, 
behveen I-IOHz. However, the overall increase in impedance is low (<8%). 
For the control sensors, the total change in percentage impedance at 1Hz was 4 % .  
This increase in impedance was attributed to polymer effects at the electrode surface 
(Souteyrand et al., 1994). Non-specific mterachons were mininused by blochng and 
the speciiic sample response determined by subtraction of the control response. 
Amenr et al. (1997) reported a method for determining the specific signal of an 
impedimetric sensor, as the difference in response to the injection of antigen between 
a sample and a reference sensor (sample and control). 
5.2.8 Comparison of sample and control data 
Figure 5.16 shows the calibration profile obtained at 1 Hz, for InlB recognition on the 
control sensors. This figure can be directly compared to Figure 5.10 for InlB 
recognition on the sample sensors (anti-InlB-doped) where the specific antibody- 
antigen response is shown. 
Figure 5.16 Calibration curve of InlB concentration at IHz. The curve was generated 
as a result of exposure of anti-lgG-loaded PANI-films (control sensors) to increasing 
concentrations of InlB at 1 H z  The curve displays the percentage change in 
zmpedance for each h l B  concentrafion (ng/ml), normalrsed against the baselrne 
response (zero antigen). Error bars are cdculated~om the standard deviations of the 
mean value of three replicates on two separate electrodes (SIX replicates m total). 
However; they are dz$j'?cullt to distinguish from the symbols used to plot the &a 
points, since the error is so small, indicating that the overall percentage change was 
minimal. 
Figure 5.16 suggests that the anti-IgG doped PAN1 thin-films showed a small degree 
of interaction with InlB anagen and to a c e m n  extent this was to be expected due to 
the anti-IgG antibody being polyclonal in nature. It is also possible that irreversible 
non-specific adsorption of InlB to the conduct~ve film may have occurred, due to 
polymer effects at the electrode surface. The percentage change in impedance for the 
sample sensors using the anti-InlB antibody and InlB antigen was greater, show~ng a 
definite interaction and therefore this technique could be employed for the specific 
detection of InB. Control experiments were also carried out to investigate the 
observed resistive and capacitive changes of the PAN1 thin-film electrodes with no 
antibody present, to assess and subsequently mininuse non-specific interactions at the 
sensor surface. Impedance effects were observed at the electrode/solution interface 
for thin-films contaming no immobihsed antibody. T h ~ s  provided additional 
information on polymer hehaviour at the electrode surface, and, as such assisted in the 
understanding of the non-specific impedance effects on control sensors. The thin-film 
electrodes were exposed to InlB over the full concentration range previously 
employed (1-100ngIml) and the impedance data were recorded as hefore (Sectton 
2.11.6). Figure 5.17 shows the Nyquist plot depicting the real and imaginary 
components of impedance (2' & 2"). 
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Figure 5.17 Nyquist plot showing the faruduic component (Z') against the capacitive 
component (2'3 for PANIjilms on carbon electrodes, containing no antrbody, 
followtng exposure to various concentrattons of InlB (I-100ng/ml). 
It was immediately obvious that even though no antibody has been immobilised 
within the PANI thn-film, an almost identical response was observed to that when 
anti-IgG-doped sensors were exposed to InlB. These results suggest that the 
impedance changes encountered were not solely due to the specific interaction of 
antibody with antigen and subsequent complex formation. It is proposed that 
irreversible non-specific adsorption of anagen to the PANI thm-film surface had 
occurred and this partially accounted for the changes (increases) in both the resistive 
(2') and capacitive (Z") components of the system impedance. It was also observed 
that this non-specific adsorption increased with exposure to increasing antigen 
concentration. This was likely due to the nature of recombinant InlB protein, in that it 
inherently has a high a f f i t y  for adsorption to surfaces. 
Another possibihty is that there may have been underlying conformational and 
structural changes within the PAN1 thin-films themselves over time, when exposed to 
the buffered antigen soluhons, that may he respons~ble for the impedance changes 
observed (Myler et al., 2004 and 2005). These may include the proton doping of films, 
wet-up and polymer swelling (Eggins, 1996) all of which can have an effect on the 
impedimetric response of the thin-film, causing non-specific increases in impedance 
over time, even in the presence of no antibody. However, the observed responses for 
the sample sensors with respect to the control responses were significantly smaller, 
which allowed deduction of a true signal based on the specific impedimetric response 
of the sample sensors (as a result of antibody-antigen binding). Any effects as a result 
of non-specific interactions were reduced in two ways: by blocking with BSA and by 
correcting the specific ~mpedance response by subtracting the control plots (IgG) from 
the sample @dB) plots. 
Figure 5.18 shows that although anti-IgG-doped PANI thin-films show a degree of 
interaction with InlB antigen, it is sufficiently lower than those of the anti-InlB-doped 
sensors, thus allowing deducaon of the sample signal and construction of a calibration 
curve for the detection of InlB. 
Figure 5.18 Caltbration curve showing the percentage impedance change from the 
baseline trace for increasing InlB antigen concentrations, at afrequency of IHz (5mV 
a.c) for both sample (InlB response) and control (IgG response) sensors. Error bars 
are calculated from the standard deviations of the mean value of three replicates on 
two separate electrodes (six repltcates in total). 
By subtracting the control response OgG) from the sample response (InlB), the 
background signal could be eliminated and a true representation of the events 
occurring at the sensor surface could be deduced. This corrected response (sample 
data minus control data) is shown in Figure 5.19. 
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Figure 5.19 Corrected calibration curve showing the percentage impedance change 
from the baseline trace for increasing InlB antigen concentrations, at a frequency of 
1Hz (5mV a.c). Error bars are calculated from the standard deviations of the m a n  
value of three replicates on two separate electrodes (six replicates in total). 
Figure 5.18 shows both the specific and control responses of the antibody-doped 
sensors for the concentration range 1-100ng/ml. However, there is a significant 
difference between the two curves at lngld,  which indicates that that there was some 
useful range to be explored below that concentration. Indeed, talang into account the 
data presented in the corrected calibration curve shown in Figure 5.19, it seems that 
the slope of the curve is highest at lower concentrations. It is reasonable to expect the 
full plot to be S shaped and, therefore, there is some space at lower concentrations to 
be explored. The Nyquist plot in Figure 5.7 confirms this, showing that the sensor was 
saturating towards the upper concentrations and that a significant gap behveen the 
baseline response and the response at the lowest concentration of lnglml was present. 
This suggested that the sensor strategy could be useful for exploring picogram levels 
of Internalin B and so a range of lower concentrations were examined. 
5.2.9 Investigation of specific InlB response at lower concentrations 
Experiments were performed in exactly the same way as before except that lower 
concentrations of antigen were inveshgated (1-100pg/ml). Anti-InlB antibody at a 
final concentration of 1 mg/ml was incorporated into the thm-films of electrodeposited 
PAN1 at planar carbon electrodes, via affinity immobilisation as before (Sect~ons 
2.11.3 and 2.11.4). Following the immobllisation of antipody, EIS was then 
performed to interrogate the sensor electrodes. Antibody-loaded PAN1 thin-film 
electrodes were then exposed for 30 nunute hme penods to Increasing concentrations 
of antigen. After 30 minutes exposure to a single concentration, the working electrode 
was flushed with phosphate buffer and the impedance trace was then recorded in 
phosphate buffer alone between 1Hz to 10000Hz. This process was then repeated for 
the full range of antlgen concentrations (1-100pgIml). A representative Nyquist plot 
depicting the variation of the resistive (Z') and capacihve (Z) components of the 
vector quantity impedance is shown in Figure 5.20, for the anti-InlB-doped t h in - fh  
carbon sensors following exposure to increasing concentrahons of InlB antigen (1- 
100pg/ml). The baseline trace was recorded after a 30-minute stabilisation period in 
the buffer alone to reduce polymer swelling and wet-up. 
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Figure 5.20 Nyquistplot showrng the faradaic component (Z') against the capacitive 
component (Z") for anh-InlB-doped (sample) PANI-films on carbon electrodes, 
following exposure to various concentrations of lnlB (1-1 OOpg/ml). 
figure 5.20 shows that there were increases over time for both resistive (Z') and 
capacitive ( Z )  components of impedance. Both of these components increased wlth 
increasing antigen concentration exposure. The greatest impedance changes were 
observed at the lower frequencies with the hlghest impedance changes from the 
baseline response, measured at 1Hz. The spectra obtained are generally indicative of a 
modified electrode where the impedance is controlled by the interfacial electron 
transfer within the entire range of the applied frequencies (Katz and Willner, 2003). 
Figure 5.20 does, however, display spectral responses that tend slightly more towards 
those of a modified electrode where the impedance is mainly controlled by diffusion 
of the redox species. It can be seen from Figure 5.20 that the resistive component of 
impedance (2') bas a neghgible increment for increasing InlB concentration at 1Hz. 
However, the capacitive component (2") is seen to increase, agan at lHz, following 
exposure to lncreaslng antigen concentrations (1-100pg/ml). It can therefore be 
deduced that the specific interactions of antlbody and antigen resulted in a charge 
transfer mechanism and this charge transfer mechanism was responsible for the 
observed changes in the Z' and more evidently the Z" component of the measured 
mpedance. Buffer solution effects were minimised by including a 
30-minute stabilisation period, whereby the electrodes were left ~n buffer for 30 
minutes prior to the recording of any impedance measurements. This allowed the 
electrodes to stab~lise within the buffer solution and hence, any observed increases in 
Z' and more evidently Z" after this stabllisation period, could only be attributed to the 
specific interaction of antibody and antigen at the polymer surface. 
Figure 5.21 shows a calibration curve representing the total impedance of the system 
plotted against InlB concentration (1-lOOpg/ml). 
Figure 5.21 Calibration profile showing percentage impedance response against InlB 
concentrations (1-100 pg/ml) for anti-InlB-doped PAM-coated electrodes at IHz. 
Error bars are calculated from the standard deviations of the mean value of three 
replicates on two separate electrodes (six replicates in total). 
Figure 5.21 shows that there is a quasi-hear response for the percentage Impedance 
change when measured against InlB concentration in the picogram range. This 
technique therefore, offers a viable approach for the detection and subsequent 
quantifcation of InlB over a range of concentrations (I-100pgIml). Data were fitted to 
a Cparameter eqnahon using BiaevaluationTM software and a limit of detection of 
1.3pgIml was found using the 3 sigma method. However this limit of detection only 
took into account the uncorrected response of the system, whereby the background 
signal from the anti-IgG-doped (control) sensors had not been subtracted. This meant 
that the influence of non-specfic interachons on the total Impedance of the system 
was not represented, and background impedance could still be contributing to the 
overall signal. In order to eliminate the background impedance (and as such the non- 
specific response of the system) the impedmetnc response from the control (IgG) 
sensors was subtracted from the sample (InlS) sensors and the corrected response of 
the system detemuned. A calibration profile show~ng the percentage change in 
impedance against antigen concentration for both the sample (InlB response) and 
control (IgG response) sensors was first constructed (Figure 5.22). 
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Figure 5.22 Calibration cune showzng the percentage impedance change from the 
baseline trace for increasing 1nlB antigen concentrations, at a frequency of 1Hz (5mV 
AC) for both sample and control doped sensors in the ptcogram range. Error bars are 
calculatedfrom the standard deviations of the mean value of three replicates on two 
separate electrodes (six replicates zn total). 
The signal from the control sensors (6 replicates) was then subtracted from the sample 
response (6 replicates) and a corrected limit of detection of the system was calculated. 
Figure 5.23a shows the corrected response (sample minus control) of the 
impedimetric sensor for IalB detection. The lower h i t  of detection of the system 
was calculated using the 3 sigma method and the data fitted to a 4paramater equation 
using BiaevaluationTM software This is shown in figure 5.23b. 
Figure 5.23a Corrected calibration curve showing the percentage impedance change 
from the baseline trace for increasing InlB antigen concentranons (1-100pg/ml), at a 
frequency of lHz. Error bars are calculated from the standard deviations of the mean 
value of three replicates on two separate electrodes (six replzcates in total) for both 
the sample and control sensors. The corrected percentage change in impedance was 
calculated by plotting the difference between the sample and control sensors 
(calculated by subtraction) against InlB concentration (pg/ml). 
Figure 5.23b Calibration curve showing the corrected response of the system for InlB 
detection. The data were$tted to 4-parameter equation using Biaevaluation software, 
for calculation of lower limit of detection using the 3 sigma method. The curve 
displays total impedance (Z)  against lnlB concentration. The lower limit of detectcon 
(LOD) is equal to 4.lpg/ml 
The results were favourable suggesting that the anti-InlB antibodyAnlB F3 antigen 
pair tested in the lower concentration range (picogram) yielded a viable technique for 
labeless impedimetric immunosensing of InlB, where the lower lunit of detection for 
the corrected response was determined to be 4.lpglml. 
5.3 Discussion 
The development of a generic platform for the 'labeless' transduction of bindmg 
events was examined in this chapter. The InlB protein fragment F 3  was used in 
association with an anti-InlB polyclonal antibody for 'laheless' sensing of InlB 
binding using an electrochemical immunosensor. Polyaniline was successfully laid 
down as a conductive thin-film layer on planar carbon electrode surfaces, which 
facilitated antibody immobilisation within the thin-film. Sensor modification with 
neutravidin and hiohn allowed site-specific coupl~ng of the antibody to the 
polyaniline matrix. Formation of antibody-antigen complexes on conductive supports 
yielded a chemically modified film on the surface which altered the impedance 
features of the interface (Flitchard et al., 2004). The preparation of stable sensor 
surfaces is an important consideration for reproducibihty, and in order to measure low 
protein concentrations, a thin sensing layer with a high capacitance is required. The 
formation of the antibodylantigen complex on such a surface perturbs the double- 
charged layer existing at the electrodelelectrolyte interface, resulting in an increase of 
its thickness and the insulation of the electrode. This causes both capacitance changes 
and electron transfer resistance changes at the interface (Katz et al., 1998 and 2001). 
Impedimetxic interrogation of the thin-film carbon sensors yielded positive results 
with more rigorous, reproducible data collected at the lower end of the frequency 
range (I-10Hz). The specific interachons and resultant complexes formed gave rise to 
an overall increase in terms of impedance change from the baseline response, at the 
electrode/solution interface. Impedances were recorded by multiple interrogations of 
both sample and control sensors (6 replicates), with InlB-F3 antigen. Plots of the real 
(Z') and imaginary (Z') components of the impedance, at a specific frequency (lHz), 
provided information for construction of calibration curves. Initial investigations of 
this sensor system explored the labeless detection of InlB in the nanogram range. 
However, there was significant evidence that lower detection levels could he achieved 
so fwther exploration of the sensor stlategy was performed. Lower concentrations of 
antigen were examined under the same conditions and a detection range of 1- 
100pg/ml was found. The results were favourable suggesting that detection of the 
anti-hlB/InlB pair in the plcogram range was a suitable method for the laheless 
impedimetric immunosensing of InlB, where the lower limit of detection for the 
corrected response was determined to be 4.lpg/ml. 
Mrnity sensors employing electrochemical methods, offer good possibilities for the 
sensitive detection of unlabelled biomolecules such as proterns and peptides. Sargent 
and Sadik (1999) described a method for the detection of human serum albumin 
(HSA) using conducting polypyrrole electrodes and impedance spectroscopy 
techniques. They studied the capacitive behaviour of antibody-doped thin-film 
electrodes in the presence of antigen, as was demonstrated in this chapter. The theory 
of charge generation in the polymeric domains are predominantly responsible for the 
analytical signals observed in such investigations and form the basis of the labeless 
immunosensor presented in this chapter. 
Lillie et al. (2001) developed a labeless bioaffinity sensor for the detection of 
lntenising hormone uslng polypyrrole-doped interdigitated electrodes and cyclic 
voltammetry. They demonstrated that immobilised protein in a conducting film could 
be indirectly recognised using electrochemical methods, allowing the sensitive 
transducbon of bindmg events following exposure to tbe desired analyte. This 
suggested that the thin-fh structure of antibody-doped electrodes is altered upon 
occurrence of a broaffiniy reaction and the monitoring of the resulting 
electrochemical events, permits the sensitive detection of analytes on such surfaces. 
Alfonta et al. (2001), reported on the use of faradaic impedance spectroscopy and 
chronopotentiometry as transduction methods for biorecognition events at modified 
electrode surfaces for the detection of enzymes, DNA and anbhodies. Ths  system 
focused on the hiocatalysed precipitation of insoluble product produced on electrode 
supports and subsequent transduction of the precipitation process using faradaic 
impedance spectroscopy and chronopotentiometry. Information on the electron- 
transfer resistances of the electrodes covered by the rnsoluble product can be denved 
thus providing vital information on the total electrode resistances at the conducting 
supports. Katz et al. (2001) describe a similar strategy for the development of an 
affinity sensor based on the bio-catalysed precipitation of an insoluble product on 
modified electrodes. The precipitation of the product onto the electrode allows 
amplification of the underlying biorecognition event occnmng on the electrode 
smface. Therefore, the amount of prec~pitate generated is controlled by the original 
concentration of antibody-antigen and the time interval for precipitation, allowing 
sensitivity to he controlled by these parameters. 
Direct immunosensors based on impedance measurements have also been developed, 
using antibod~es or antlgens immobilised at electroactive polymer-coated electrodes. 
Kharitonov et al. (2001) presented a similar study based on the electrochemical 
probing of bioaffinity interactions using both impedance spectroscopy and 
chronopotentiometry. Grant et al. (2003) describe a label-free, reagentless 
immunosensor for the detection of BSA, with a linear response from 0-75ppm 
reponed while Myler et al. (2004 and 2005) showed the development of 
microelectrode arrays for the immunosensing of e~ano l .  Electrochemical 
immunosensors offer good possibilities for sensitive detection of unlabeled proteins, 
with potential for reusability possible. The most significant problem encountered with 
these sensors, however, is the contribution of non-specifically adsorbed proteins to the 
overall signal. In many cases, this contribution is disregarded; however, methods to 
correct for the specificity of the signal have been described, (Ameur et al., 1997), 
whereby the control sensor response to antigen probing can be subtracted from the 
sample signal to give corrected response. This technique was adapted for the affinity 
sensing of InlB, described in this chapter. 
Sensors based on the immobilisation or entrapment of immunomolecules (antibod~es 
or antigens) onto modified electrode surfaces, for subsequent detection using 
electrochemical methods are becoming increasingly popular for rapid and sensitive 
detection of biologically important analytes. In conclusion, tremendous improvement 
in the sensitivity of immunosensing can be achieved using 'labeless' affinity sensors, 
such as the one presented here for the direct and specific detection of InlB. This 
technique could be further developed for the rapid detection of bacterial protein 
markers in real samples using a multiplexed set-up. Antibohes directed aganst a 
number of protein markers speclfic for the detection of different bacterial pathogens 
could be ~mmobilised on electrode surfaces, thus enabling the rapid and sensitlve 
detection of such pathogens using 'labeless' impedimetric techniques. The potential 
of the 'labeless' affimty sensor, described here as v~able method for the detection of 
biomolecules, highlights the importance of impedance-based detection in the evolving 
field of immunosensors. 

6.1 Overall conclusions and future work 
The aim of thls thesis was to develop novel biosensing strategies for the detection of 
biologically important analytes using both optical and electrochemical methods. A 
number of transduction approaches were investigated for unproved immunodetection 
of a small hapten, bacterial proteins, whole cells and IgG. The specific targets chosen 
for imrnunoassay development were Intemalin B, an invas~on-associated protein of 
Listeria monocytogenes; parvovirus B19, the first human parvovirus; warfarin, the 
ninth most prescribed drug ~n the world and human IgG. 
Biosensing methods rely on a number of key elements for successful operation and 
these include; biomolecule lmmobilisation strategy, analyte biorecognition, platform 
design, presence or absence of labels, detection strategy and system used. Each of 
these components plays an important role in the ability of the sensor to sensttively 
detect the analyte under investigation. Therefore, the work described in this thesis 
focused on a number of topics associated with these elements in order to generate 
novel assays for improved detection of target molecules. The generation of novel 
reagents using molecular cloning techniques, for improved detection of the bacterial 
protein Internalin B from L monocytogenes was assessed. Novel fluorescent labels 
with better optical properties were also exammed and the advantages of such probes 
in the development of novel immunoassay formats were discussed. Fluorescence and 
impedance-based detection systems were studied and a number of platforms were 
assessed including microtitre plates, polymer chips with enhanced fluorescence 
capture capabilities and screen-printed electrodes incorporating electroactive thin- 
films. Sensor platforms, tncorporat~ng specially designed materials for enhanced 
immobilisation and thus btorecognition can be used for the improved detection of 
analytes (Pavlickova et al., 2004; Wingen et al., 2005). In the research described in 
this thesis, chemical, electrochemical and physical modifications were mvestigated. 
Surface moditication of polymer substrates for biochip applications, 
electropolymerisat~on of electrodes for tmmunoassay development and the thin-film 
deposition of biocompatible surfaces for implants were studied. The development of 
new and improved biosenslng strategies, incorporating novel transduction methods, 
both labelled (fluorescence-based) and nn-labelled (impedance-based) were evaluated. 
Chapter 3 focused on exploring a key element in immunosensor design, 
biorecogmtion. The development of new and improved antigens and antibodies using 
antibody engineering and recombinant protein techniques, promotes biorecognition at 
sensor surfaces, by generating highly specific targets and tailored antibodies with 
increased affinities and specificities. The cloning and subsequent high-level 
expression of the recombinant InlB fragments F3, F4 and F5 created alternative InlB 
antigemc determinants for innnunoassay development. The InlB recombinant protein, 
that was previously cloned and expressed (Leonard, 2003), was sub-divided into three 
shorter overlapping peptide fragments which were cloned into the Qiagen pQE-60 
expresslon vector for His-tag purification and expressed in E. coli. The protein 
fragments were optitnised for maximum expression and purified using IMAC. The 
purifed proteins were characterised SDS-PAGE and Western blotting. The His- 
tagged protein fragments @QE-60) were assessed for immunoreactivity with a panel 
of anti-InlB antibodies to see which portion of the recombinant InlB protein contained 
the epitope for antibody binding. Through a series of Western blotting experiments 
the antibody-binding region was located in the first 248 amino acids of the protein (F3 
fragment), near the 'leucine-rich' repeats (Section 3.3.7). Freiherg et al. (2004) 
reported that this region is highly stable against thermal denaturation and plays a 
critical role in the in vivo stability of Internalin B. The F3 fragment was thus used for 
all further assay development and characterisation since it was defined as the most 
immunoreactive portion of the enbre InlB protein. This made antigen preparation far 
simpler, eliminating the need to grow and purify the rest of the protein. 
The InlB fragments were also successfully cloned into the pAC4 expression vector for 
in vlvo biotinylation. The in vivo biotmylated fragments were expressed in E.colz and 
purified using monomeric avidin afhnity chromatography. The purified fragnents 
were characterised using fluorescence-based immunoassays with streptavidm-linked 
fluorescent probes and Biacore (Sectzon 3.4.2). The in vivo biotinylated M fragment 
was successfully immobilised onto a CMS-dextran chip that had been modified with 
neutravidin for the specific capture of the protein fragment. The immobilised surface 
was subsequently used in a Biacore-based inhibition assay for the detection of InlB. 
The b~otinylated F3 fragment was also shown to he a useful reagent for fluorescence- 
based detection using fluorescent labels such as Cy5, FlTC and quantum dots. This 
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highlighted the potential role of the in vrvo biotinylated InlB fragments in the further 
development and optimisatlon of both fluorescence-based and Biacore-based assays 
for the detection of Internalin B protein and L monocytogenes cells. 
Chapter 4 focused on fluorescence-based detect~on and altemahve platform designs. 
Fluorescencebased detection is a highly sensitive and safe method for the sensing of 
target molecules. The evaluation fluorescence-based methods for detection of analytes 
were therefore examined on two different platforms; microtitre plates and polymer 
ch~ps with cone assemblies. Fluorophores can be covalently attached to 
macromolecules and the emission of these fluorescent probes can be from UV to NIR. 
Probes are available with short (nanosecond) to long (micro to millisecond) life-times. 
Current trends in fluorescent labelling for biological applications lie with a number of 
emerging technologies e.g. quantum dots and nanocrystals. The evolution of these 
tags coupled with advances in functionalisation methods for hiomolecule attachment 
gives rise to a new generation of sophisticated labels suitable for high throughput 
screening in diagnostics. The use of novel probes such as quantum dots and porphyrin 
labels for the detection of InlB and warfarin in plate-based competitive assays was 
successfully demonstrated (Sections 4.3 and 4.4). Future work could include further 
optimisation of conditions to improve assay sensitivity and limits of detection for 
warfarin and Internalin B and subsequent assessment of fluorescence-based assay 
sensitivities using real sample analysis (Findlay et al., 2000). In the case of warfarin, 
spiked urine samples could he assayed to investigate if the fluorescently-labelled 
antibodies could detect warfarin in a complex matrix of clinical significance (Capitan- 
Vallvey et al., 1999). While, for InlB detection, real sample analysis in chocolate milk 
could be examined, since it is the most common source of L. monocytogenes in food 
(Doganay, 2003). 
Quantum dots were also used in an immunostaining application for the imaging of 
whole L. monocytogenes cells (Section 4 3 ,  where photostability and brightness are 
key factors. Future work could include the multiplexing of quantum dots with other 
labels for immunostaining apphcations, thus allowing the multiple staining of cells 
with a single excitation source. 
Nanoparticles are another group of inorganic probes that are highly complex, 
spectroscopically tailored tags that can be used to improve assay sensitivity, 
reproducibility and multiplexing capabilities. The synthesis and characterisation of 
ruthenium-doped nanoparticles was shown (Sectton 4.6). The use of such particles for 
the detection of biological molecules (in this case human IgG), in fluorescence-based 
immunoassay formats was successfully demonstrated. Nanopartlcles can be easily 
functionalised for biomolecule attachment and are consistently brighter and more 
robust than tradiaonal fluorescent probes. The ruthenium-nanoparticles described in 
this thesis were up to 20,000 brighter than their constituent dye and provided a 60 fold 
increase in sensitivity for the detection of human IgG, when compared with 
ruthenium-labeled antibody. The potential of dye-doped nanoparticles as important 
reagents for the future of fluorescence-based detection is apparent, especially if 
coupled with the chip-based methods described in the following paragraphs. 
The use of polymer chips with cone assemblies as suitable platforms for the chip- 
based detection of InlB and the parvovirus capsid protein VP2 was examined 
(Sections 4.4.5 and 4.7). The establishment of preliminary assays on the optical 
enhancement structures was successful, and, although significant optimisation is stiU 
required, the methodology looks promsing to bring about signal enhancement and 
ultimately, increased sensitivity. Significant developments have been ongoing within 
the NCSR to further improve the optical enhancement structures. These have included 
a change in the material used for fabrication and a change in the design of the cone to 
a paraboloid structure, increasing the hght collection efficiency still further, and 
improved precision leading to better defined optical performance. Further 
improvements in the detection system to allow the incorporation of suitable filters and 
excitation sources, would permit the use of novel fluorescent labels such as 
nanoparticles and quantum dots in chip-based assays. T h s  will have a significant 
influence in the area of fluorescence-based analysis in the near future. 
Chapter 5 examined the use of a 'laheless' impedance-based sensor for the detection 
of hlB. Polyaniline was successfully laid down as a conductive thin-film layer on 
planar carbon electrode surfaces. This facilitated the immobiiisation of antibody 
within the conducting thin-film at the electrode surface. Sensor modification with 
avidin and hintin allows site-specific coupling of the antibody to the polyanihe 
matrix. Impedimetric interrogation of the thm-film carbon sensors yielded positive 
results, whereby data at the lower end of the frequency range (1-10 Hz) showed the 
greatest consistency. The specific interactions and resultant stable complex formed 
gave nse to an overall increase in terms of impedance change from the baseline 
response at the electrode assemhlylsolution interface. This indicated that impedance- 
based detection was a suitable method for the labeless immunosensing of InlB, where 
the lower hmit of detection for the corrected response was deternuned to he 4. lpglml. 
Future work on this sensor system could include further investigation of the specific 
protein interactions occurring at the antibody-doped thin-film sensor surface, in order 
to enhance antibody orientation and therefore improve immune complex formation. 
This would provide the possibility to control and improve the composition of the 
biomolecnle-polymer layer and part~cularly the biomolecule loading. The loss of 
biomolecule in the aqueous electrolyte during polymer formation can be determined 
by measuring the biological activity or the protein content of the electrolyte medium. 
Therefore the real quantity of biomolecule entrapped could be determined by looking 
at the difference between the initially deposited amount and the amount loss to the 
electrolyte. Optirmsation of anhbody-loadmg in such a way would enhance the 
operat~onal capabilities of the sensor. Further work could also include testing the 
'labeless' ~mpediietric sensor ~n real samples for the detection of L.monocytogenes 
cell surface proteins i.e. spiked milk and food samples. By examining the sensors 
using representative samples, a rough estimate of the systems applicability with real- 
world samples for the detection of Internalin B, could be examined. 
In conclusion, the key merit of the work presented in this thesis lies in the 
demonstrated potential applications of novel antibody-based biosensors for the 
detection of haptens, proteins and whole cells. The results clearly emphasise the 
possible use of novel antigens (Chapter 3), novel labels and associated detection 
platforms (Chapter 4), and novel transduction strategies (Chapter 5) in the 
development of improved senslng techmques for the detection of clinically significant 
targets. The methods shown for enhanced fluorescence-based detection could be 
further improved by combining the descnbed fluorescence-based assays using novel 
fluorescent labels (quantum dots and nanoparticles) with the polymer chip platforms 
(with cone structures for optical enhancement), in order to develop highly sensitive 
and reproducible methods for the detection of I&, warfarin, VP2, hIgG and many 
other analytes. The results also show the successful integration of an improved 
antigen for InlB sensing @), within a 'labeless' impedance-based sensor platform to 
facilitate the sensitive detection of InlB. The results hghlight the suitability of InlB 
F3 as a marker for the specific immunodetection of InlB and the potential use of 
impedance-based transduction for the detectton of many targets using a non-invasive 
'labeless' technique. 
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Appendix: 
BECVD of BiocompatibBe coatings OHTI 31QL 
stainless steel for an-Ue.rrba1 stenat applications. 
A1 Introduction 
This section describes the strategies involved in assessing the biocompatibility of 
sllica-like thin films, deposited on stainless steel by Plasma Enhanced Chemical 
Vapor Deposition (PECVD). The main application of such coatings is the fabrication 
of arterial stents and, therefore, biocompatibility of the material is a key issue. 
Medical devices are subject to stringent controls and safeguards, under EU law and 
are subject to rigorous testing prior to use. The component materials of medical 
devices may leach compounds, or have undesirable surface characteristics, which 
render them unsuitable for clinical use. Biocompatibility is defined as 'the ability of a 
material, device or system to perform without a clinically sigInficant host response in 
the specific application' (Gurland, 1994). Preliminary biocompatibility studies in the 
early R&D stage of a biomaterial, generally employs the use of cell culture models for 
initial characterisation. 
A2 Thin film composition & behaviour 
SiOxCyHz film are produced by plasma polymerization of hexamethyldisiloxane 
and oxygen. This study dekuls the vadation of the SiOxCyHz film properties 
deposited on 316L stainless steel in a RF reactor. The films were characterized for 
their hardness, hydrocarbon content and wettability. The film properties are found to 
be dependent on the Oxygen/HMDSO flow ratio and RF power. The film-tissue 
interaction depends on the hydrophobicity or hydrophilicity of the film; therefore, the 
wettabdity of the film was measured by contact angle analysis. Preliminary 
biocompatibility studles were carried out using Rat Aortic Smooth Muscle (RASM) 
cells. The data collected for assessment of cell proliferation, viability and toxicity are 
presented. 
The biomedical behaviour of implanted material can be altered by modifying its 
surface properties, without affecting the bulk mechanical propemes (Li et al., 1998). 
Plasma polymerized hexamethyldisiloxane (HMDSO) films deposited by PECVD is 
found to improve the cell activity at the implant-tissue interface (Hayakawa et al. 
2004). The success of a biomatenal depends on the name and composition of the fust 
adsorbed protein layer and its activabon rather than on the surface chemistry of the 
implant (Nimeri et al., 2002). The protein adsorption and implant-tissue interaction is 
dependent on the hydrophobicity and hydrophilicity of the surface (Janocha et al., 
2001). Several studies have reported the possibil~ty of tuning the film properties by 
varying the 02/HMDSO ratio and RF power, (Vantin-IJI et al., 2000) but less 
attention has been paid to the contact angle variation with plasma parameters 
(Behnisch et al., 1998) We have investigated the variation of water contact angle with 
0 m S O  ratio, pressure and R F  power. Preliminary characterisation to assess the 
biocompatibility of the films has been carried out and initial results of cell 
prohferation, viability and toxicity is presented for diffe~nt  02/HMDSO ratio. 
A3 Biocompatibility testing 
To study the bioresponse of the films, rat aortic smooth muscle (TWSM) cells were 
cultured in standard 75cm2 cell culture flasks in a cell culture medium composed of 
Dnlbecco's modified Eagle's medium (DMEM) supplemented with 10% (vlv) fetal 
calf serum (FCS), 2% (vlv) L-glutamine and appropriate antibiotics (Detailed in 
Section 2.12.1). The cells were grown at 37°C in a humidified atmosphere with 5% 
COz The thm film coated samples were seeded in 24 well culture plates at a density 
of 10,000cells/ml (Villa et al., 2002). Each batch of samples was plated in triplicate 
for both the MlT  assay and cell prolderation and viability determination, with 
appropriate controls. Assays were conducted on Days 2,4 and 6. 
A4 Cell proliferation & viability 
Cells were grown (Section 2.12.1). On day 2, 4 and 6 of the experiment, samples 
were removed for morphological analysis post incubation in culture and the cultured 
cells assessed for cell proliferation and viability, by Trypan blue vital dye staining. 
The trypsinised cells were counted as per Section 2.12.3 and viability calculated. This 
process was repeated on days 4 and 6 of the experiment and the data complied 
graphically (Figure Al). The cells from wells containing untreated substrates and no 
substrate were also tested as controls. 
10:l untreated cells 
substrate 
Figure A1 Initial d t s  of the cell proliferation & viability tests, which are 
determined by Trypan blue staining and counting with a Neubauer haemocytometer. 
The lowest ratio of Oxygen to HDMSO (21) showed the greatest prolifemtrmtron, almost 
comparable to the growth of cells seeded in absence of any substrate. The cell 
viability tests are based on the ability of dead cells to take up Tvpan blue dye, where 
as live healthy cells remain white. Percentage viability was calculated to be > 90% in 
all cases exceptfor the negative control, latex, where the % viability was < 10%. 
It is clear from Figure A1 that the film surface does not adversely affect the growth of 
the cells, and that the RAM cells do not die off in culture. in the presence of these 
materials. In fact the growth of the cells with coated substrates is comparable to those 
seeded without substrates. Films with varying wettabiity were deposited by varying 
the OJJ3MDSO ratio. The hydrocarbon content decreases with increasing Oz/HMDSO 
ratio and RF power. This leads to an increase in the film hardness as the f h  becomes 
'silica-like' at high adHMDS0 d o  and high FW power. The high 02/HMDSO ratio 
films show a temporal effect exhibiting high hydruphilicity immediately after 
deposition but the hydrophilicity decreases with time. The low OJHMDSO ratio (21) 
films show a higher proliferation rate than the high OJHMDSO ratio (10: 1) film. 
A5 Cytotoxieity testing 
A commercial MTT assay kit (Roche Diagnostics) was used to assess cytotoxicity of 
the cells in culhlre, post-incubation with the coated substrates, as described in section 
2.12.5. MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyItetrazolium bromide) is a 
yellow tetrazolinm salt that cleaved by metabolically active cells to form purple 
formazan salt crystals. An increase the in number of living cells results in an increase 
in the total metabolic activity in the sample. This increase directly correlates to the 
amount of purple formazan crystals formed, as monitored by the absorbance (Rodil et 
al., 2003). The M7T test was performed for each substrate in 8 separate wells and 
each experiment was repeated for the full set of samples on three occasions 
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Figure A2 Initial results of the cytotoxicity tests, which are determined by MIT 
assay. The lowest ratio of oxygen to HDMSO (2:I) showed the greatestproliferation, 
almost comparable to the growth of cells seeded in absence of any substrate. The cell 
viability tests were based on the ability of dead cells to take up Tiypan blue dye, 
where as live healthy cells remained white. Percentage viability was calculated to be 
>90% in all cases except for the negative control, latex, which is know to be highly 
toxic to cells. 
It is clear from Figure A2 that the film surface does not adversely effect the growth of 
the cells, and that the RASM cells do not die off in culture in the presence of these 
foreign materials. In fact the growth of the cells with coated substrates is comparable 
to those seeded without substrates. 
A6 SEM analysis of substrates post incubation in culture with RASM cells. 
Substrates were removed from culture and cells fixed with glutaraldehyde and 
osmium tetroxide (Section 2.12.7) prior to examination using Scanning Electron 
Microscopy (SEW. Figure A3 (A-D) shows SEM pictures for each raao of 
OuiHDMSO tested 
A B 
2:l ratio of O e M S O  5:l ratio of O@MSO 
- 
10:1 ratio of O m M S O  Untreated 316L stainless steel 
figure A3 SEM images of stainless steel substrates post incubation in culture with 
varying ratios of HDMSO/Oz . Cell adhesion and proliferation is greatest on the films 
wrth lowest ratio of oxygen to HDMSO (2: l ) .  Hzgher magnrjication and examinatron 
of a greater sample set would give more detarl as to the actual effect of the thinfilm 
on the stainless steel substrates. 
A7 Discussion 
The films do not seem to adversely affect the growth of the cells. The RASM cells do 
not die off in culture in the presence of the coated stainless steel. The growth of the 
cells with coated substrates is comparable to those seeded w~ th  no substrates. A 
small sample set was used to conduct these preliminary investigations. For a more 
complete assessment of the biocompatibility of these thin films, a greater sample set 
and larger number of replicates for each experiment would be necessary. 
Future work on this project could include the assessment of the biocompatibility of 
PECVD thin-film coated polymers such as PMMA, PDMS and Polycarbonate. 
Protein absorption analysis of thin film coated polymers for biochip application could 
also be investigated. Directed cell attachment on various substrates using 
biocompatible thin films and the incorporation of various fluorescent labels into such 
cells via immunostaining, would allow the monitoring of the cell growth on the films 
using fluorescent microscopy. 
